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Summary 
i
Summary 
This thesis presents 4′-substituted-2,2′:6′,2″-terpyridine ligands and their complexes 
within the perspective for supramolecular chemistry.  
Chapter 1 gives a brief introduction to supramolecular chemistry, 
metallosupramolecular chemistry, 2,2′:6′,2″-terpyridine complexes and dynamic 
combinatorial libraries. 
Chapter 2 discusses the synthesis and characterisation of ligands L1-L9 containing 
one 2,2′:6′,2″-terpyridine metal-binding domain. These ligands contain different 
substituents at the 4′-position of the 2,2′:6′,2″-terpyridine which differ from one 
another in the length of the chains, in the linkages of the chains or in the terminal 
domains.  
Chapter 3 describes the synthesis and characterisation of the mononuclear iron(II) 
and ruthenium(II) complexes formed with L1-L9. 
Chapter 4 describes the synthesis and characterisation of the mononuclear cobalt(II) 
complexes formed with L1-L9. A newly established method for the NMR 
spectroscopic assignment of Co(II) complexes, and some preliminary studies of 
combinatorial libraries by mixing two Co(II) complexes, are also discussed. 
Chapter 5 discusses the synthesis and characterisation of ligands L10-L17, which 
contain two 2,2′:6′,2″-terpyridine metal-binding domains. These two 2,2′:6′,2″-
terpyridine metal-binding domains are linked by different naphthalene 
bis(ethyleneoxy) spacers at their 4′-positions. 
Chapter 6 discusses the synthesis and characterisation of dinuclear ruthenium(II) 
complexes formed by ligands L11-L14, L16-L17. 
Chapter 7 describes the synthesis and characterisation of [n+n] ruthenium(II) and 
iron(II) metallomacrocycles which formed by cyclisation reactions involving ligands 
L11-L17.
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1. General 
Ant Anthryl 
A sol CH3CN: saturated aqueous KNO3: H2O in 14:2:1 ratio 
Bipy 2,2′-Bipyridine 
Bbipy-(GalNHAc) N-Acetyl galactropyranose functionalised with 2,2′-bipyridine 
6-Br-terpy 6-Bromo-2,2′:6′,2″-terpyridine 
CD Circular dichromism 
Cl-terpy 4′-Chloro-2,2′:6′,2″-terpyridine  
DMF N,N-Dimethylformamide
DMSO Dimethylsulfoxide 
DNA Deoxyribonucleic acid 
EtO-terpy 4′-Ethoxy-2,2′:6′,2″-terpyridine 
Fc-terpy 4′-Ferrocenyl-2,2′:6′,2″-terpyridine  
HO-terpy 4′-Hydroxy-2,2′:6′,2″-terpyridine 
HPLC High performance liquid chromatography 
Nap Naphthyl 
NEM N-Ethylmorpholine 
OAc Acetate 
OMs Methylsulfonyl 
Phen 1,10-Phenanthroline 
Poterpy 4′-(2-Propyn-1-oxy)-2,2′:6′,2″-terpyridine 
Qterpy 2,2′:6′,2″:6″,2″′-Quaterpyridine 
Rf Retention factor 
TDDFT Time-dependent density functional theory 
TEM  Transmission electron microscopy 
Terpy 2,2′:6′,2″-Terpyridine 
THF Tetrahydrofuran 
TLC Thin layer chromatography 
Ts p-Toluenesulfonyl 
X Different substituents attached to the ligands (e.g. bipy, phen, 
terpy) 
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2. Experimental methods 
Nuclear Magnetic Resonance (NMR) Spectroscopy  
1H NMR Proton nuclear magnetic resonance  
13C NMR Carbon nuclear magnetic resonance  
COSY Correlated spectroscopy 
NOESY Nuclear Overhauser effect spectroscopy 
HMQC Heteronuclear multiple quantum correlation 
HMBC Heteronuclear multiple bond correlation 
EXSY Chemical exchange difference spectroscopy  
ROESY Rotating frame nuclear Overhauser effect spectroscopy 
T1 Relaxation time in seconds 
δ Chemical shift in ppm 
J Coupling constant in Hz 
s Singlet 
d Doublet 
t Triplet 
dd Doublet of doublets 
ddd Doublet of doublets of doublets 
dt Doublet of triplets 
td Triplet of doublets 
m Multiplet 
br Broad 
Mass Spectrometry (MS) 
EI Electron impact 
ES Electrospray ionisation 
FAB Fast-atom bombardment 
M Parent ion 
m/z Mass to charge ratio 
Ultra-violet Visible (UV/VIS) Spectroscopy  
LC Ligand centred 
MLCT Metal-to-ligand charge transfer 
λmax Wavelength at which maximum absorption occurs in nm
ε max Extinction coefficient in M-1cm-1
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Infrared (IR) Spectroscopy  
w Weak 
m Medium 
s Strong 
br Broad 
Cyclic voltammetry 
tBu4N Tetrabutylammonium 
Fc Ferrocene 
Fc+ Ferrocinium ion 
Elemental analysis 
Calc. Calculated 
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General experimental 
NMR spectroscopy 
1H NMR spectra were recorded on Bruker AM 250 MHz, AV 400 MHz, Bruker DRX-500 
MHz and Bruker Avance 600 MHz spectrometers. 13C NMR spectra were recorded at 125 
MHz on Bruker DRX-500 MHz spectrometer and 100 MHz on AV 400 MHz spectrometer.  
Mass spectrometry 
Fast-atom bombardment (FAB) and electron impact (EI) mass spectra were recorded on 
Kratos MS-50, Kratos MS-890, VG 70-250 or Kratos MS 902 spectrometers. For FAB 
spectra, 3-nitrobenzyl alcohol was used as supporting matrix. Electrospray ionisation (ES) 
mass spectra were recorded on Micromass LCT or LCQ spectrometers. 
Ultra-violet visible spectroscopy 
Ultra-violet visible (UV/VIS) spectra were recorded on a Shimadzu UV-3101PC 
UV/VIS/NIR spectrophotometer and a Varian 5000 UV-VIS-NIR spectrophotometer. 
Infrared Spectroscopy 
Infrared spectra were recorded on a Shimadza FTIR-8300 fourier transform infrared 
spectrophotometer and a Shimadza FTIR-8400S fourier transform infrared 
spectrophotometer. 
Cyclic voltammetry 
Electrochemical measurements were performed with an Eco Chemie Autolab PGSTAT 20 
system using glassy carbon working and platinum auxiliary electrodes with silver as reference 
using purified acetonitrile as solvent and 0.1M [tBu4N][PF6] as supporting electrolyte; 
ferrocene was added at the end of each experiment as an internal reference. 
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General labelling scheme of ligands L1-L9 describes in Chapter 2. 
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Ru(II) and Co(II) complexes in Chapter 3 and Chapter 4. 
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and Ru(II) complexes in Chapter 7.  
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Chapter 1 
Introduction
In this chapter, a brief introduction to four areas related to this thesis is presented. The 
four areas are supramolecular chemisty, metallosupramolecular chemistry, 2,2?:6?,2?-
terpyridine complexes and dynamic combinatorial libraries. 
1.1 Supramolecular chemistry 
Supramolecular chemistry has become an active research area over the past 25 years.
1-
6
 Lehn and Vögtle have defined supramolecular chemisty:  
Lehn- "Supramolecular chemistry is the chemistry of the intermolecular bond, 
covering the structures and functions of the entities formed by the association of two 
or more chemical species."
1
Vögtle- "In contrast to molecular chemistry, which is predominantly based upon the 
covalent bonding of atoms, supramolecular chemistry is based upon intermolecular 
interactions, i.e. on the association of two or more building blocks, which are held 
together by intermolecular bonds."
2
.
Supramolecules normally contain more than one component held together by 
intermolecular non-covalent interactions, for example, hydrogen bonding, 
electrostatic interactions, hydrophobic or hydrophilic associations, ?-stacking, metal 
coordination interactions and host-guest interactions.
7
There are two important mechanisms for the construction of a supramolecule. 
? Molecular recognition1,6
This involves selection and binding of substrates by a given receptor molecule 
similar to the "lock and key" concept devised by Emil Fischer.
8
 The binding site 
can distinguish the shape, size, bonding, and electronic properties of the 
substrate.
9
Chapter 1 
2
? Self-assembly2,5
This is a spontaneous assembly process of molecules into structured, stable, non-
covalently joined aggregates by simply mixing two or more small species.  
In nature, deoxyribonucleic acid (DNA)
10
 forms a double helix from two 
complementary oligonucleotides and this is an example of a self-assembly process 
(Figure 1). Similar synthetic system can also be made. Lehn’s group have reported 
oligobipyridine-based double helices [Cu3(1)2]
3+
, which are held by metal-directed 
self-assembly interactions (Figure 2).
11,12
Figure 1. Diagram showing (a) three-dimensional space filling diagram of the B-form 
of DNA and (b) the structures of the DNA base pairs.
13
Figure 2. Diagram showing double helices which are held by metal-directed self-
assembly interactions between three copper(I) metal ions and two tris(2,2?-
bipyridine) ligands (1). 
Finally, supramolecular chemistry not only offers us opportunities to gain a better 
understanding of biological systems such as binding of a substrate to a receptor 
[Cu3(1)2]
3+
1
(a) (b) 
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protein, enzymatic reactions, translation or transcription of genetic code and of 
complicated structures found in biological systems, but also has potential applications 
such as chemically, electrochemically and photochemically induced artificial 
molecular machines and devices
5-6,14-17
, molecular wires
5,18
 and sensors
19
.
1.2 Metallosupramolecular chemistry 
Metallosupramolecular chemistry has become a main research area in supramolecular 
chemistry. Constable has defined metallosupramolecular chemistry as follows: 
"Metallosupramolecular chemistry is concerned with the use of metal ions to control 
the assembly of appropriate molecular components containing metal-binding 
domains."
20
The principle of the formation of metallosupramolecules depends mainly on (1) the 
number and orientation of the coordination sites of ligands [molecular components 
containing metal-binding domains] and (2) the coordination number and geometry of 
the metal ions. A variety of metallosupramolecular architectures
21,22
, including rods
23-
27
, helices
28-41
, knots
42
, catenates
42-45
, rotaxanes
46-48
, boxes
49-62
, grids
63-71
, racks
72
,
ladders
73
, cylinders
74
, cages
75-82
, and dendrimers
83-86
, has been formed spontaneous by 
self-assembly labile metal ions with multidentate ligands. In the following discussion, 
examples of a few metal-directed self-assembly systems are presented. 
The supramolecular architectures obtained from copper ions and bidentate ligands 
(e.g. 2,2?-bipyridine and 1,10-phenanthroline), and/or tridentate ligands (e.g. 
2,2?:6?,2?-terpyridine ligand) are good examples which demonstrate the importance of 
metal ion geometry and of number of the coordination sites of ligand. The Cu(I) ion 
has a d
10
 electron configuration. It prefers a coordination number of 4 and a 
tetrahedral geometry. It can achieve this with two bidentate 2,2?-bipyridine or 1,10-
phenanthroline ligands. The Cu(II) ion has a d
9
 electron configuration. It prefers a 
coordination number of 5 (or 6) and favours a square pyramidal geometry with one 
tridentate 2,2?:6?,2?-terpyridine and one bidentate 2,2?-bipyridine or 1,10-
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phenanthroline ligands (or favours an octahedral geometry with two tridentate 
2,2?:6?,2?-terpyridine or three bidentate 2,2?-bipyridine or 1,10-phenanthroline 
ligands). 
Lehn recently reported ligands (2-3) that contain two different coordinated subunits.
87
Two self-assembled architectures resulted from using the same ligand but with 
different specific coordination algorithms. Ligand 2 contains four 2,2?-bipyridine units 
and one pyridazine unit. Two possible supramolecular architectures (A and B) could 
be formed by reacting ligand 2 with tetrahedral metal ions (Figure 3a). When ligand 2
reacted with Cu(I) ions, an almost quantitative yield of supramolecular architecture B 
was obtained (Figure 3b).
(a)      (b) 
Figure 3. (a) Two possible self-assembled architectures (A and B) when ligand 2
reacted with tetrahedral metal ions and (b) the structure of the circular 
complex [Cu12(2)4]
12+
 when ligand 2 reacted with Cu(I) ions.
87
There are reports on the reaction of 4,6-bis(2?,2?-bipyrid-6?-yl)-2-methylpyrimidine 
(3a) with octahedral ions, such as Co(II), Ni(II), Cu(II), Zn(II). These result in a 
square [2x2] grid-type complex (Figure 4).
66,68
 On the other hand, ligand 3b, which 
contains two 2,2?-bipyridine units bridged by oxomethylene, reacted with tetrahedral 
coordination ions, such as Cu(I) and Ag(I), and gave a double-helical complex 
(Figure 4).
11,12,88
Ligand 2 
[Cu12(2)4]
12+
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Figure 4. Diagram representing ligand 3, which contains 3a and 3b units, and the 
structure of the complexes formed from 3a and 3b.
66,68,22,12,88,87
Ligand 3 contains two subunits, two 2,2?-bipyridine units bridged by an oxomethylene 
unit (3b) and one 4,6-bis(2?,2?-bipyrid-6?-yl)-2-methylpyrimidine unit (3a) (Figure 
4).
87
 This ligand possesses both bidentate and teidentate binding sites which can bind 
to hexacoordinate, tetracoordinate and/or pentacoordinate ions. Therefore, ligand 3
will be expected to generate two possible supramolecular architectures (C and D) 
(Figure 5). When one equivalent of an octahedral ion [Fe(II), Co(II), Ni(II), Cu(II) 
ions] and two equivalents of a tetrahedral ion [Cu(I) ion] react with one equivalent of 
ligand 3, architecture C , which combined a [2x2] grid-like structure in the centre and 
four double-helical structure at the corner, resulted. On the other hand, reacting two 
equivalents of a pentacoordinate ion [Cu(II) ion] and one equivalent of a tetrahedral 
ion [Cu(I) ion] with one equivalent of ligand 3 leaded to architecture D.
87
In these two examples, the self-assembled architectures A, C and B, D could be 
obtained by self-assembly of different ligands with different metal ion coordination 
algorithms. 
N N O N N O N
N
N N
N
N NNONNO
R N
N
N N
N
N R
+
NNONNR
octahedral coordination ions
(Co2+, Ni2+, Cu2+, Zn2+)
tetrahedral coordination ions
( Cu+, Ag+)
O O
Ligand 3
Ligand 3a
Ligand 3b
Square [2x2] grid-type structure
Double-helical structure
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Figure 5. The diagrammatic representation of supramolecular architectures C and D 
when ligand 3 reacted with different metal ion with different coordination 
geometries.
87
Figure 6. The diagrammatic representation of the molecular motion processes of the 
rotaxanes ([Cu·4]
+/2+
) by oxidising and reducing the metal centre.
15
Ligand 3
[M4Cu8(3)4]
16+ 
(M = Fe, Co, Ni, Cu) [Cu12(3)4]
20+ 
[Cu·4]2+
[Cu·4]+
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Sauvage has reported a rotaxane [Cu·4]
+/2+
 incorporating two different ligand domains 
(a 1,10-phenanthroline and a 2,2?:6?,2?-terpyridine) in the thread and a bidentate 1,10-
phenanthroline unit in the ring.
47,48
 The system can be switched from a four-
coordinate Cu(I) to a five-coordinate Cu(II) and vice versa by oxidising or reducing 
the metal (Figure 6). There are other similar systems, a [2]catenate [Cu·5]
+
incorporating a terpyridine unit in one of its two macrocyclic components with a 1,10-
phenanthroline unit in both and a [2]catenate [Cu·6]
+
 incorporating two identical 
macrocyclic components with a 2,2?:6?,2?-terypridine unit and a 1,10-phenanthroline 
unit, have been reported by Sauvage (Figure 7).
89-91
Figure 7. Diagram showing [2]catenate [Cu·5]
+
 and [2]catenate [Cu·6]
+
.
15
From the above examples, we understand the importance of designing ligands with 
correct number and orientation of the coordination sites (molecular components 
containing metal-binding domains) and of choosing metal ions with the correct 
coordination number and geometry. More examples of different 2D and 3D metal-
directed self-assembly molecular boxes are discussed below. 
Figure 8. Diagram showing rotaxanes (7
4+
) and catenands (8
4+
) that were synthesised 
by the group of Stoddart.
92,93 
[Cu·5]+ [Cu·6]+
O O O OOO
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N N
N+
+
+
+
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S
S
S
OOO OO
OOO
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O
O
O
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OOOO OO
N
N
+
+
N
N
+
+
O
OO O
O
O
OO O
O
N
N
O O
OO
OOO 2
8
4+
7
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The supramolecular rotaxanes (7
4+
) and catenands (8
4+
), which contain 1,1?-
bipyridinium as the building unit, were synthesised by Stoddart’s group (Figure
8).
92,93
 These rotaxanes and catenands were held by ?-donor and ?-acceptor 
interactions. Similar to these box like self-assembly molecules (7
4+
) and (8
4+
), Fujita 
and Steel reported numbers of metal-directed self-assembly molecular boxes, where 
the corner of the ring of the catenands are replaced by square planar Pt(II) and Pd(II) 
metal units (Figure 9).
49-52,94
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Figure 9. A variety of metal-directed self-assembly Pt(II) and Pd(II) molecular 
boxes.
49-52,94
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Figure 10. [2+2] Macrocycles formed by two metal ions and two ligands with 2,2?-
bipyridine units which are linked by different spacer groups (9-17).
53-58
The groups of Beer
53
 and Harding
54-58
 synthesised ligands (9-17) that contain two 
2,2?-bipyridine units which are linked by different spacer groups (Figure 10). By 
mixing the ligand with metal ions, both [2+2] helical and [2+2] box (non-helical) 
were readily formed. When ligand 13 reacted with Zn(II) ions, a [2+2] non-helical 
species [Zn(13)]2[CF3SO3]4 was formed.
55
 This was assigned by NMR spectroscopy 
and has been confirmed by X-ray crystallography. Each of the Zn(II) ions is bound to 
four nitrogen atoms from two 2,2?-bipyridine units and two oxygen atoms from the 
ether links in a distorted octahedral geometry. When ligand 15 reacted with Ni(II) 
ions, a [2+2] non-helical species [Ni(15)2][PF6]4 was formed.
56
 X-ray crystallography 
confirmed the structure of this species is similar to [Zn(13)]2[CF3SO3]4. When ligand 
16 reacted with Zn(II) ions, a [2+2] helical species [Zn(16)]2[CF3SO3]4 was formed 
and this has been confirmed by X-ray crystallography.
57
 Each of the Zn(II) ions is 
NN
++
O
O
O
O
O
O
NN
O
O
O
O
O
O
O
O
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bound to four nitrogen atoms from two 2,2?-bipyridine units and one oxygen atom 
from water molecule in a distorted trigonal bipyramidal geometry. The crystal 
structure of the helical [Zn(16)]2[CF3SO3]4·2H2O contained either p- or o-
dimethoxybenzene bound in the cavity in between the two spacer groups. 
1.3 2,2?:6?,2?-Terpyridine complexes 
2,2?:6?,2?-Terpyridine (terpy) is a molecule with three pyridine rings connected 
together through the ? positions of the nitrogen. Its synthesis was first reported by 
Morgan in 1932.
95,96
 2,2?:6?,2?-Terpyridine readily reacts with Mn+ octahedral metal 
ions to give [M(terpy)2]
n+
 complexes.
97
 Making octahedral complexes formed by 
2,2?:6?,2?-terpyridine with different substituted groups at the 4?-position avoids the 
formation of isomers that formed by bidentate 2,2?-bipyridine (bipy) and octahedral 
metal ions (Figure 11).
98-100
 However, the photophysical properties of [Ru(terpy)2]
2+
are not as promising as those of [Ru(bipy)3]
2+
 at room temperature.
98,99
 Therefore, 
there are many attempts to introduce a wide variety of functional groups at the 4?-
position of 2,2?:6?,2?-terpyridine to modify the photophysical properties of the 
complexes. 
Figure 11. Structures representing some complexes of 2,2?-bipyridine and 2,2?:6?,2?-
terpyridine with an octahedral metal centre (X = substituted groups). 
?-[M(bipy)3]n+? ?-[M(bipy)3]n+? mer-[M(X-bipy)3]n+? fac-[M(X-bipy)3]n+?
[M(terpy)2]
n+? [M(X-terpy)2]n+?
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Figure 12. Diagram showing 2,2?:6?,2?-terpyridines with a variety of different 
functional groups (18-38) at the 4?-position.101-113
Constable and Housecroft have reported a variety of 2,2?:6?,2?-terpyridine ligands 
containing different functional groups at the 4?-position. These include ferrocene 
18
101
, anthracene 19
102
, thienyl groups 20-21
103,104
, sugar functionalised group 22
105
,
cobalt carbonyl cluster functionalised group 23
106,107
, 4-fluorophenyl 24
108
,
pentafluorphynyl 25
105
, and C60 functionalised groups 26-28
109,110
. The inclusion of 
these substituents alters the redox and photophysical properties of the complexes 
(Figure 12). There is a report that the different electron-withdrawing and -donating 
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groups (29-34) alter the photophysical properties of the ruthenium complexes.
111,112
Chiral substituents (35-38) have also been introduced at the 4?-position of 2,2?:6?,2?-
terpyridine (Figure 12) in the group of Constable and Housecroft to investigate the 
possibility of forming an diasteromeric or enantiomeric excesses of products when 
mixing the R and S enantiomers with metal ion.
113
 X = 
N N
39
P
40
N HN
NH N
41
N HN
NH Nn
42 (n = 0)       43 (n = 1)
O
O
O
ON
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44
O
O
O
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45
N X
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N
N
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N
46
N
NH
HN
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47
(OCH3)14
O
(OCH3)6
48
Figure 13. Diagram showing 2,2?:6?,2?-terpyridines with a variety of different 
functional groups (39-48) at the 4?-position.114-125
By introducing other binding functional groups, for example 2,2?-bipyridine 39114,
diphenylphosphino 40
115,116
, porphyrins 41-43
117-120
, macrocycles 44-47
121,122
, and ?-
cyclodextin 48
123-125
 functional groups, it has been possible to bind a variety of metals 
or guest molecules (Figure 13). Constable and Housecroft’s group synthesised ligand 
39 with 2,2?-bipyridine directly attached at the 4?-position of 2,2?:6?,2?-terpyridine. 
Chapter 1 
13
The two different binding domains of ligand 39 can bind to two different metal 
ions.
114
 The 2,2?-bipyridine domain can bind to a Ru(II) metal centre while the 
2,2?:6?,2?-terpyridine can bind to Co(II), Fe(II) or Os(II) metal centre.114 Another 
ligand 40 contains the diphenylphosphino group at the 4?-position of 2,2?:6?,2?-
terpyridine. The phosphorus atom of this diphenylphosphino group acts as a soft metal 
donor and can bind to soft metal centres, for example Pd(II) and Pt(II).
115,116
Sauvage
117-120
 has reported a few porphyrin-linked 2,2?:6?,2?-terpyridines 41-43 and 
investigated the photophysical properties of the complexes. The introduction of aza-
crown macrocycles 44-47 at the 4?-position of 2,2?:6?,2?-terpyridine not only allows 
the binding of an appropriate guest but can sequentially trigger a change in the 
luminescence of the ruthenium complexes.
121,122
 Ward et al.
121
 have reported the 
synthesis of 4?-substituted and 4?-phenyl-substituted 2,2?:6?,2?-terpyridine with an aza-
18-crown-6 group (44-45). Martínez-Máñez et al.
122
 have described the preparation of 
4?-substituted and 4?-phenyl-substituted 2,2?:6?,2?-terpyridine with 1,4,8,11-
tetraazacyclotetradecane (46-47). Pikramenou et al.
123-125
 have synthesised a 4?-
phenyl-substituted 2,2?:6?,2?-terpyridine with ?-cyclodextrin 48. The ?-cyclodextrin 
cavity can bind to a biphenyl group attached at the 4?-position of a 2,2?:6?,2?-
terpyridine Os(II) complex. This results in electron transfer from the Ru(II) complex, 
which contains the ?-cyclodextrin unit, through the ?-cyclodextrin unit to the Os(II) 
complex, which contain the biphenyl group. 
Ligands with two 2,2?:6?,2?-terpyridine metal-binding domains linked by a spacer can 
form rod-like complexes or cyclise to form macrocycles depending the rigidity of the 
spacer. Normally, the spacer has two main roles: (1) to control the supramolecular 
structure, especially the intercomponent distances and angles, and (2) to control the 
electronic communication between components through bond energy or electron 
transfer. Ligands 49-56 (Figure 14), which contain rigid spacer groups, were 
synthesised to investigate the photophysical properties of their dinuclear 
complexes.
24,126-131
Ziessel et al.
61
 have been reported the reaction of ligands 57, 58 with Fe(II). A deep-
blue insoluble compound, very likely a linear polymer, was formed when ligand 57
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reacted with Fe(II). When ligand 58 reacts with Fe(II), a soluble deep-violet solution 
was obtained. Using electrospray ionisation (ES) mass spectrometric and NMR 
spectroscopic analysis, it was found that there were two cationic polynuclear iron 
complexes (a [3+3] and [4+4] metallomacrocycles) present in the solution. 
Spacer
49, 50 56
51 N
N
57
52 
N N
58
N
N
N
N
N
N
Spacer
n n = 0, 1, 2 53-55
Figure 14. Diagram showing ligands (49-58) which contain two 2,2?:6?,2?-terpyridine 
metal domains with a spacer group linked at the 4?-position.24,126-131,61
A few metal-directed assembly systems (59-63) which involve ligands containing 
2,2?:6?,2?-terpyridine metal-binding domains have been reported by Constable and 
Housecroft’s group (Figure 15). A dinuclear octacationic box-like structure 59 is 
assembled by the reaction of a dicationic bis(2,2?:6?,2?-terpyridine) ligand with 
iron(II).
59
 A [1+1] cyclometallopeptide 60 was obtained after purification by HPLC of 
the reaction product of a bis(2,2?:6?,2?-terpyridine) peptide-functionalised ligand and 
iron(II).
132
 Similarly, a reaction of a heterotritopic ligand which contains one bis(5,5?-
phenyl)-2,2?-bipyridine and two terpyridine metal-binding domains linked by a 
flexible (OCH2)3O spacer, with iron(II) resulted in a [1+1] metallomacrocycle 61.
133
A single crystal structure of 61 was also obtained. A ligand with a short spacer 
(OCH2)3O linked between the two terpyridine domains reacts with iron(II) to give a 
[3+3] 62 and a [4+4] 63 metallomacrocycle. These were analysed by NMR 
spectroscopy and ES-MS.
60
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Figure 15. Diagram showing metal-directed assembly systems (59-63).
59,132,133,60
Moore has reported the single crystal structures of [1+1] metallomacrocycles 64-65
formed from the reaction of 1,3-bis(2,2?:6?,2?-terpyridiyl-5-ylmethylsulfanyl)propane 
[which contains two 2,2?:6?,2?-terpyridine metal-binding domains that linked by a 
CH2S(CH2)3SCH2 spacer at the 5-position] or 1,4-bis(2,2?:6?,2?-terpyridiyl-5-
ylmethylsulfanyl)butane [which contains two 2,2?:6?,2?-terpyridine metal-binding 
domains that linked by a CH2S(CH2)4SCH2 spacer at the 5-position] with Ni(II) 
respectively (Figure 16).
134
 Sauvage has reported a single crystal structure of a 
double-stranded dinuclear iron(II) helix 66 which resulted from the reaction of Fe(II) 
with a bis(2,2?:6?,2?-terpyridine) ligand containing 2,2?:6?,2?-terpyridine metal-
binding domains linked by a CH2CH2 group at the 5-positions (Figure 16).
135
59 
60
61
62
63
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Newkome has described the self-assembly of hexagonal macrocyclic complexes 67-
68, where the ligands contain two 2,2?:6?,2?-terpyridine metal-binding domains. The 
hexanuclear iron(II) metallomacrocycle 68 was also studied with TEM (transmission 
electron microscopy) (Figure 16).
62
Figure 16. Diagram showing metal directed assembly systems (64-69).
134,135,62,136
A doubly looped (bow tie) structure 69 formed when 3 equivalents of iron(II) reacted 
with two equivalents of a ligand which contains three 2,2?:6?,2?-terpyridine metal-
binding domains linked by flexible O(CH2)10O groups at the 4?-position and 5-
position of the terpyridine domains (Figure 16).
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Figure 17. Diagram showing ligands 70-73 which contain multiple 2,2?:6?,2?-
terpyridine metal-binding domains.
83
Figure 18. Reaction scheme for the synthesis of the octadecaruthenium complex 76.
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Ligands 70-73 contain multiple 2,2?:6?,2?-terpyridine metal-binding domains and have 
been used as the dendritic core for building metallodendrimers (Figure 17).
83
 The 
triruthenium complex 74 reacted with hexakis(bromomethyl)benzene 75 to give the 
desired octadecanuclear complex 76 (Figure 18). This contains the dendritic core 
71.
84
 By using pentaerythritol functionalised with 2,2?:6?,2?-terpyridine to give cores 
72, reaction with the Ru(III) complex 77, a first generation tetranuclear complex 78
was formed (Figure 19). The pentaerythritol functional groups in 78 allow the growth 
of second generations and resulted in complex 79 (Figure 19).
137
Figure 19. Reaction scheme for the synthesis of metallodendrimers 78 and 79.
137
The ligands described above, which contain one or more terpyridine metal-binding 
domains, illustrate the possibility of building a wide range of supramolecular 
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architectures. These oligopyridines have proved to be popular choices in self-
assembly coordination chemistry. 
1.4 Dynamic combinatorial libraries 
Combinatorial chemistry has been used to produce a member of different molecules 
with different combination of several species in the area of pharmaceutical chemistry. 
The dynamic combinatorial library is based on the concept of combinatorial 
chemistry.
138-143
 Lehn has stated the meaning of a dynamic combinatorial library as 
follows: 
"Dynamic combinatorial libraries are designed as mixtures of components that can 
reversibly interconvert in a dynamic equilibrium that is driven by molecular 
recognition of a specific molecular target toward that assembly or a subset of 
components that form the library constituent best bound to the target."
143
A dynamic combinatorial library is based on the two main principles of 
supramolecular chemistry: molecular recognition in interactions of the entities, and 
self-assembly in generation of the library components. In the library, all members 
exist in equilibrium. By introducing a template, the desired product may be stabilised. 
This results from a thermodynamic redistribution within the equilibrium mixture since 
the collection of molecules can reversibly form the initial building blocks. According 
to the Le Chatalier’s principle, this will not only amplify the concentration of the 
"best fit" product but also reduce the concentration of the poorer binding product 
(Figure 20).
139
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Figure 20. Schematic representation of the interconversion of a series of library 
members (M) by equilibrium processes and the subsequent product 
distribution change exerted by a template (T). The size of the letters (M 
and T) represented the concentration of library components.
139
Figure 21. Diagrammatic representation of casting and molding in dynamic 
combinatorial libraries.
139
Huc and Lehn have introduced two templating fashions, casting and molding, in 
dynamic combinatorial libraries (Figure 21).
142
? Casting process: 
? Receptor-induced self-assembly of the complementary substrate from a 
collection of components serving as building blocks. 
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? Selection of the optimal substrate from a virtual substrate library. 
e.g. In the presence of B4 lectin, the desired product ?-mer[Fe(bipy-(GalNHAc)3]
was amplified from a library of four stereomers of ?-mer, ?-mer, ?-fac and 
?-fac iron(II) complexes [(bipy-(GalNHAc) = N-acetyl galactropyranose 
functionalised with 2,2?-bipyridine].139,144
? Molding process: 
? Substrate-induced self-assembly of the complementary receptor from a 
collection of structural components. 
? Selection of the optimal receptor from a virtual receptor library. 
e.g. The hexanuclear circular helicate, {[Fe5(80)5][Cl]}
9+
, was formed 
predominately in the presence of chloride ions (Figure 22).
145
Figure 22. Dynamic combinatorial libraries of circular helicates generated from a 
tritopic 2,2?-bipyridine ligand (80) and octahedral iron(II) ions.139
The above example shows the specific features of the dynamic combinatorial 
libraries. They are reversible, recognition-directed and self-assembled in the presence 
of the template or target. The dynamic combinatorial libraries offer the following 
advantages.
138
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? There is no need to synthesise each substance individually since a range of 
substances is assembled from the libraries. 
? Product distribution is controlled by the thermodynamic factors and template 
effects. 
? There is no need to explicitly identify the library members because only the most 
strongly bound guest or host will result. 
Therefore, many efforts have been made by scientists to seek the correct template that 
amplifies the desired product. 
1.5 Aims 
Ligands L
1
-L
9
 and L
10
-L
17
 (see the compound labelling scheme in page x & xi), which 
contain one and two 2,2?:6?,2?-terpyridine metal-binding domains respectively, are 
synthesised and discussed in Chapter 2 and Chapter 5. Mononuclear Fe(II), Ru(II) and 
Co(II) complexes formed by ligands L
1
-L
9
 are fully presented in Chapter 3 and 
Chapter 4. A newly established method for the NMR spectroscopic assignment of 
Co(II) complexes, and some preliminary studies of combinatorial libraries by mixing 
two Co(II) complexes, are described in Chapter 4. The ligands L
11
-L
14
, L
16
-L
17
containing two 2,2?:6?,2?-terpyridine metal-binding domains that linked by a 
naphthalene bis(ethyleneoxy) spacer, can formed linear diruthenium(II) complexes 
with [Ru(L)Cl3] (L = terpy or L
4
) and the complexes are discussed in Chapter 6. 
Ligands L
11
-L
17
 can also cyclise to form [n+n] Fe(II) and Ru(II) metallomacrocycles 
and these metallomacrocycles are synthesised and presented in Chapter 7. 
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Chapter 2 
Synthesis of 4?-Substituted-2,2?:6?,2?-Terpyridine Ligands
2,2?:6?,2?-Terpyridine is a molecule with three pyridine rings connected together 
through the ? positions of the nitrogen. The synthesis was first reported by Morgan in 
1932.1,2 It was obtained from the oxidative coupling of pyridine using FeCl3 at 
elevated temperature and pressure in a steel autoclave. 
Besides the coupling methodology mentioned above, certain general strategies were 
used to synthesise the 2,2?:6?,2?-terpyridine and its derivatives. The Hantzsch 
synthesis is one of the oldest methods used to synthesise pyridine rings.3 This reaction 
involves reaction of a ?-ketoester or other activated methylene compound with an 
aldehyde in the presence of ammonia (Scheme 1).
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Scheme 1. The Hantzsch pyridine synthesis. 
The Kröhnke synthesis is another method for the synthesis of pyridine rings.4 This 
reaction involves a ring closure of a 1,5-diketone intermediate by ammonium acetate. 
The 1,5-diketone intermediate was obtained by Michael addition5 of an unsaturated 
ketone with a pyridinium salt (Scheme 2). In comparison with the Hantzsch reaction, 
there is no formal oxidative dehydrogenation reaction, with the required oxidation of 
the dihydropyridine intermediate being achieved by the loss of pyridinium. 
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Scheme 2. The Kröhnke pyridine synthesis. 
Potts and co-workers reported another method which involved methyl ketone enolates 
as a reaction intermediate. These are generated with potassium tert-butoxide and 
further react with ?-oxoketene dithioacetals to form 4?-methylthio-2,2?:6?,2?-
terpyridine. The ?-oxoketene dithioacetals are prepared from 2-acetylpyridine by 
reaction with CS2 and CH3I. Ring closure with ammonium acetate of the enedione 
intermediate results in 4?-methylthio-2,2?:6?,2?-terpyridine (Scheme 3).6-9
O
CH3
N 1. t-BuOK, THF
2. CS2
3. CH3I
O
SMe
SMe
N
N
-OK+
NH4OAc
AcOH, heat
N
SMe
N N
Scheme 3. The Potts’ terpyridine synthesis.  
By introducing other functional groups onto the 4?-position of the 2,2?:6?,2?-
terpyridines described above, other 4?-substituted-2,2?:6?,2?-terpyridines can be 
synthesised.10-14
In this chapter, the syntheses of several 4?-substituted-2,2?:6?,2?-terpyridine ligands 
(L1-L9) are discussed. Most of these 4?-substituted-2,2?:6?,2?-terpyridine ligands 
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contain polyethyleneoxy chains and differ from one another in the length of the 
chains, in the terminal domains or in the linkages. 
N
O
N N
O
OX
n
L
N
Y
N N
L
2.1 Synthesis 
Different substituents can be introduced at the 4?-position of preformed 2,2?:6?,2?-
terpyridine ligands by nucleophilic substitution as shown in Scheme 4. Starting with 
4?-hydroxy-2,2?:6?,2?-terpyridine (HO-terpy), an oxygen nucleophile is generated by 
deprotonating the hydroxyl group, which subsequently reacts with electrophiles to 
form the desired substituents.15-17 Alternatively, one can start with 4?-chloro-
2,2?:6?,2?-terpyridine (Cl-terpy) as an electrophile to react with nucleophilic reagents 
such as X-SH, X-OH, X-NH2.
14,18-30 
The syntheses of different 4?-substituted-2,2?:6?,2?-terpyridine ligands are described 
below. The ligands L4-L9 were designed with a tridentate binding site for 
complexation with metal ions and with terminal domains (i.e. 2-naphthyl or 9-anthryl 
L n X 
L
1 0 H 
L
2 1 H 
L
3 2 H 
L
5 0 CH2-2-naphthyl 
L
6 1 CH2-2-naphthyl 
L
7 2 CH2-2-naphthyl 
L Y
L
4 O-CH2-2-naphthyl 
L
8 O-CH2-9-anthryl 
L
9 S-2-naphthyl 
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domains). These have potential for ?-? stacking interactions either between like 
molecules or with appropriate substrates.31-35 The 2,2?:6?,2?-terpyridine and naphthyl 
or anthryl domains were connected by different linking groups, which were also 
important for controlling potential intermolecular interactions. 
HO-terpy
OH
N
N N
Cl-terpy
Cl
N
N N
+
+
X-Cl/ Br
X-SH/ OH/ NH2
SX/ OX/ NHX
N
N N
Electrophilic 
reagents
Nucleophilic 
reagents
Scheme 4. Nucleophilic substitution reactions to prepare 4?-substituted-2,2?:6?,2?-
terpyridines. 
The syntheses of 4?-(2-hydroxyethoxy)-2,2?:6?,2?-terpyridine (L1), 4?-[2-(2-
hydroxyethoxy)ethoxy]-2,2?:6?,2?-terpyridine (L2) and 4?-{2-[2-(2-
hydroxyethoxy)ethoxy]ethoxy}-2,2?:6?,2?-terpyridine (L3) are depicted in Scheme 
5.15,16 
Scheme 5. Syntheses of L1, L2 and L3.
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L
1, L2 and L3 were prepared from 4?-hydroxy-2,2?:6?,2?-terpyridine (HO-terpy), which 
is a tautomer of 2,6-bis(2?-pyridyl)-4-pyridone36,37, ClCH2(CH2OCH2)nCH2OH in 
which n = 0, 1, 2 and K2CO3 in DMF at 70°C for 2 days. These reactions gave the 
desired products in 45-56% yield after work up. 
Treatment of HO-terpy, K2CO3 and 2-bromomethylnaphthalene in DMF at 70°C for 3 
days followed by recrystallisation from methanol gave the 4?-(naphthalen-2-
ylmethoxy)-2,2?:6?,2?-terpyridine (L4) as white fine needles in 48% yield (Scheme 
6).38-40
Scheme 6. Synthesis of L4.
4?-[2-(Naphthalen-2-ylmethoxy)ethoxy]-2,2?:6?,2?-terpyridine (L5), 4?-{2-[2-
(naphthalene-2-ylmethoxy)ethoxy]ethoxy}-2,2?:6?,2?-terpyridine (L6) and 4?-(2-{2-[2-
(naphthalen-2-ylmethoxy)ethoxy]ethoxy}ethoxy)-2,2?:6?,2?-terpyridine (L7) were 
prepared from L1, L2 and L3 respectively in 68%, 53% and 15% yields. Treatment of 
L
1, L2 and L3, NaH and 2-bromomethylnaphthalene in THF at 80°C for 2-3 days, 
followed by work up using alumina column chromatography with CH2Cl2/ 1% 
CH3OH as eluent resulted in L
5 as a white powder, and L6 and L7 as pale yellow oily 
liquids (Scheme 7).41
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Scheme 7. Syntheses of L5-L7.
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4?-(Anthracen-9-ylmethoxy)-2,2?:6?,2?-terpyridine (L8) was prepared by a similar 
method for synthesising L4 (Scheme 8). Treatment of HO-terpy, K2CO3 and 9-
bromomethylanthracene in DMF at 70°C for 1 week in the dark followed by column 
chromatography (alumina, CH2Cl2/ hexane 3:1 and then CH2Cl2/ hexane 2:1) gave L
8
as a yellow powder in 15% yield.42-44 The product is stored in the dark as it tends to 
decompose in sunlight. 
2.
HO-terpy
OH
N
N N
1. K2CO3, DMF, 70
oC
N
N
N
O
Br
L
8
Scheme 8. Synthesis of L8.
Heating 4?-chloro-2,2?:6?,2?-terpyridine (Cl-terpy) and naphthalene-2-thiol at 200°C 
for 2 days, followed by column chromatography (alumina, CH2Cl2/ hexane 2:1), gave 
the white product 4?-(naphthalen-2-ylsulfanyl)-2,2?:6?,2?-terpyridine (L9) in 67% yield 
(Scheme 9).45
SH
Cl-terpy
Cl
N
N N 200oC
N
S
N N
L
9
Scheme 9. Synthesis of L9.
2.2
1
H NMR spectroscopic characterisation 
All the ligands were characterised by 1H NMR spectroscopy in CDCl3 solution. The 
spectroscopic signatures of the ligands compare well with those of other terpy 
systems, and the terpyridine proton signals are similar in all ligands with the 
exception of HT3? (the atom labelling scheme is given in Table 2 and Table 3) which 
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is subject to the influence of the 4?-substituents attached to the terpyridine domain 
(Table 1).17,46-48
The 1H NMR spectra of CDCl3 solutions of the ligands L
1, L2 and L3 have the usual 
features of other terpyridine based ligands.17,46-48 The terpyridine proton signals are 
essentially the same as those in 4?-(2-propyn-1-oxy)-2,2?:6?,2?-terpyridine (poterpy).17
There are five signals in the aromatic region and the ethyleneoxy spacer signals are 
found between ? 3.6-4.5 (Table 2).
L
3 has the longest spacer group of the three ligands L1, L2, L3. There are five signals 
in the aromatic region excluding the signal for CHCl3 (Figure 1). The assignment of 
the spacer protons was made by COSY and NOESY techniques and confirmed by 
HMQC and HMBC spectroscopy. The triplet in the 1H NMR spectrum at ? 4.42, 
which exhibits an NOE signal to HT3? at ? 8.05, is assigned to HS1 (Figure 2a). The 
signal for HS1 gives a COSY cross peak to the signal for HS2 at ? 3.94 (Figure 3). The 
signal for HS2 exhibits an NOE signal to the signal at ? 3.77 and this signal is assigned 
to HS3 (Figure 2b). The signal for HS3 gives a COSY cross peak to the signal for HS4
at ? 3.69 (Figure 3). The signal for H S4 exhibits an NOE signal to the signal at ? 3.62, 
which is assigned to HS5 (Figure 2b). Finally, the signal for HS5 gives a COSY cross 
peak to the signal at ? 3.73, and this signal is assigned to HS6 (Figure 3).
Figure 1.
1H NMR (500 MHz) spectrum of L3 in CDCl3 solution at room temperature. 
(the signal marked * is the signal for CHCl3)
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(a) (b) 
Figure 2. NOESY spectrum (500 MHz) of L3 in CDCl3 solution at room temperature. 
(the signal marked * is the signal for CHCl3)
Figure 3. COSY spectrum (500 MHz) of L3 in CDCl3 solution at room temperature. 
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Proton resonance (?)
L
HT5 HT4 HT3? HT3 HT6
terpy
47,48 7.42 (ddd) 7.95 (td) 8.54 (d) 8.66 (d) 8.69 (dd) 
poterpy
*,17 7.30 (ddd) 7.81 (td) 8.06 (s) 8.58 (d) 8.66 (dd) 
L
1 7.34 (ddd) 
J 1.3, 4.8, 7.3 Hz 
7.85 (td) 
J 1.7, 7.7 Hz 
8.05 (s) 
8.62 (d) 
J 7.6 Hz 
8.69 (d) 
J 5.3 Hz 
L
2 7.35 (ddd) 
J 1.0, 5.1, 7.6 Hz 
7.87 (td) 
J 1.7, 7.7 Hz 
8.13 (s) 
8.62 (d) 
J 7.6 Hz 
8.69 (d) 
J 4.0 Hz 
L
3 7.33 (ddd) 
J 1.1, 4.8, 7.5 Hz 
7.85 (td) 
J 1.8, 7.7 Hz 
8.05 (s) 
8.61 (d) 
J 8.0 Hz 
8.68 (ddd) 
J 0.8, 1.7, 4.8 Hz 
L
4 7.34 (ddd) 
J 1.2, 4.8, 7.5 Hz 
7.86 (m) 8.17 (s) 
8.63 (dt) 
J 1.0, 8.0 Hz 
8.70 (ddd) 
J 0.9, 1.8, 4.8 Hz 
L
5 7.32 (ddd) 
J 1.0, 4.8, 7.5 Hz  
7.82 (m) 8.09 (s) 
8.62 (dt) 
J 1.0, 8.0 Hz 
8.69 (ddd) 
J 0.9, 1.8, 4.8 Hz 
L
6 7.32 (ddd) 
J 1.2, 4.8, 7.5 Hz 
7.82 (m) 8.08 (s) 
8.62 (dt) 
J 1.0, 8.0 Hz 
8.69 (ddd) 
J 0.9, 1.8, 4.8 Hz 
L
7 7.34 (ddd) 
J 0.9, 4.9, 7.3 Hz 
7.86 (td) 
J 1.6, 7.7 Hz 
8.07 (s) 
8.62 (d) 
J 8.0 Hz 
8.69 (dd) 
J 0.7, 4.7 Hz 
L
8 7.35 (ddd) 
J 1.2, 4.7, 7.5 Hz 
7.88 (td) 
J 1.8, 7.8 Hz 
8.29 (s) 
8.66 (dt) 
J 1.1, 8.0 Hz 
8.69 (ddd) 
J 0.9, 1.8, 4.7 Hz 
L
9 7.34 (ddd) 
J 1.1, 4.9, 7.4 Hz 
7.88 (m) 8.27 (s) 
8.59 (d) 
J 8.0 Hz 
8.65 (dd) 
J 0.7, 4.8 Hz 
Table 1. Terpyridine proton signals of L1-L9 in CDCl3 solution at room temperature. (The 
1H NMR spectra for L1 and L2 were measured at 400 
MHz and all the others were measured at 500 MHz; *poterpy = 4?-(2-propyn-1-oxy)-2,2?:6?,2?-terpyridine). 
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N
O
N N
O
OH
n
L
1
-L
3
T5
T4
T3
T6
T3'
S1 S(2n+2)
Table 2.
1H NMR spectroscopic data of CDCl3 solutions of L
1 and L2 (400 MHz) and L3 (500 MHz) at room temperature (see Table 1 for the 
terpyridine signals). 
Proton resonance (?)
L
HS1 HS2 HS3 HS4 HS5 HS6
L
1 4.37 (t) 
J 4.5 Hz 
4.04 (m)     
L
2 4.45 (m) 3.93 (m) 3.77 (m) 3.68 (m)   
L
3 4.42 (t) 
J 4.7 Hz 
3.94 (t) 
J 4.7 Hz 
3.77 (m) 3.69 (m) 3.62 (m) 3.73 (m) 
L1 n = 0 
L2 n = 1 
L3 n = 2 
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Proton resonance (?)
L
HS1 HS2 HS3 HS4 HS5 HS6 HS7
L
4 5.50 (s)       
L
5 4.45 (t, J 4.7 Hz) 3.94 (t, J 4.7 Hz) 4.82 (s)     
L
6 4.42 (t, J 4.7 Hz) 3.95 (t, J 4.7 Hz) 3.81 (m) 3.71 (m) 4.74 (s)   
L
7 4.41 (t, J 4.7 Hz) 3.94 (t, J 4.7 Hz) 3.78 (m) 3.71 (m) 3.68 (m) 4.72 (s) 
Proton resonance (?)
L
HN6, N7 HN3 HN5, N8 HN4 HN1
L
4 7.50 (m) 
7.59 
(dd, J 1.7, 8.4 Hz) 
7.86 (m)
7.89 
(d, J 8.6 Hz) 
7.97 (s) 
L
5 7.46 (m) 
7.51 
(dd, J 1.7, 8.4 Hz) 
7.82 (m)
L
6 7.44 (m) 
7.49 
(dd, J 1.6, 8.4 Hz) 
7.82 (m) 7.79 (s) 
L
7 7.44 (m) 
7.46 
(dd, J 1.7, 8.4 Hz) 
7.80 (m) 7.77 (s) 
Table 3.
1H NMR spectroscopic data (500 MHz) of CDCl3 solutions of L
4, L5, L6, L7 at room temperature (see Table 1 for the terpyridine 
signals).
L
4
N1
N3
N4 N5
N6
N7
N8
N
O
NN
T3
T4
T5
T6
T3'
S1
L
5
-L
7
T5
T4
T3
T6
T3'
S1 S(2n+3)
N4 N5
N6
N7
N8N1
N
O
N N
O
On
N3 L
5       n = 0
L
6       n = 1
L
7       n = 2
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There are thirteen signals excluding the signal for CHCl3 in the 
1H NMR spectrum of a 
CDCl3 solution of the ligand L
4 (Figure 4). Five terpyridine signals were found as 
expected by comparison with L3; the rest of the signals belonging to the naphthyl rings 
and the methylene group were further identified by NOESY and COSY techniques. The 
singlet at ? 5.50, which exhibits an NOE signal to the signal for HT3? at ? 8.17, is 
assigned to HS1 (Figure 5a). The signal for HS1 also exhibits NOE signals to HN1 and 
HN3 at ? 7.97 and ? 7.59 respectively (Figure 5a). The signal for HN1 exhibits an NOE 
signal to the signal at ? 7.86 and this signal is assigned to HN8 (Figure 5b). HN8 gives 
COSY cross peak to the signal for HN7 at ? 7.50 (Figure 6). From the COSY spectrum 
(Figure 6), the signal for HN3 gives a cross peak at ? 7.89, is assigned to HN4. Finally, 
the last two signals at ? 7.86 and ? 7.50 are assigned to HN5 and HN6 respectively 
according to the fact from the NOESY spectrum that HN4 at ? 7.89 does not exhibit an 
NOE signal to the signal at ? 7.50, which is now assigned to HN6 (Figure 5b). The 
assignment is also confirmed by HMQC and HMBC. 
5.45.65.86.06.26.46.66.87.07.27.47.67.88.08.28.48.68.8
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Figure 4.
1H NMR (500 MHz) spectrum of L4 in CDCl3 solution at room temperature. 
(the signal marked * is the signal for CHCl3)
*
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(a)      (b) 
Figure 5. NOESY spectrum (500 MHz) of L4 in CDCl3 solution at room temperature. 
(the signal marked * is the signal for CHCl3)
Figure 6. COSY spectrum (500 MHz) of L4 in CDCl3 solution at room temperature. (the 
signal marked * is the signal for CHCl3)
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The 1H NMR spectra of L5, L6 and L7 are also assigned by using COSY and NOESY. 
The HN6, N7 signal of all the 2-naphthyl attached ligands appeared as a multiplet rather 
than a simple triplet and the multiplicity of the signal could be simulated using the 
Mestrec programme. All the naphthalene protons are shifted to slightly higher field as 
the ethyleneoxy spacer gets longer (Table 3).
The 1H NMR spectrum of L8 in CDCl3 solution exhibits ten signals from the terpyridine 
and the anthryl domains. The five terpyridine signals are assigned as before. The singlet 
signal at ? 6.26 is assigned to HS1. The signal for HS1 gives an NOE signal to a singlet at 
? 8.29 and a doublet at ? 8.31, which is assigned to HT3? and HA1, A8 respectively (Figure 
7). From the COSY spectrum, the signal for HA1, A8 gives a cross peak to a signal at ?
7.55 and this is assigned to HA2, A7 (Figure 8). The singlet at ? 8.57, which has half the 
relative integral of the signal for HS1, is assigned to HA10. The signal for HA10 gives an 
NOE signal to a signal at ? 8.07, and this signal is assigned to HA4, A5 (Figure 7). From 
the COSY spectrum, the signal for HA4, A5 gives a cross peak to a signal at ? 7.51 which 
is assigned to HA3, A6 (Figure 8).
Figure 7. NOESY spectrum (500 MHz) of L8 in CDCl3 solution at room temperature. 
(the signal marked * is the signal for CHCl3)
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Figure 8. COSY spectrum (500 MHz) of L8 in CDCl3 solution at room temperature. 
(the signal marked * is the signal for CHCl3)
Figure 9.
1H NMR spectra (500 MHz) of (a) L4 and (b) L9 in CDCl3 solution at room 
temperature. (the signal marked * is the signal for CHCl3)
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The 1H NMR spectrum of a CDCl3 solution of ligand L
9 is very similar to the 
spectrum of L4 (Figure 9) and was fully assigned using COSY and NOESY methods. 
It is worth noting that HT3? of L4 is shifted to higher field than those of L8 and L9
because the inductive and anisotropic ?-cloud effects associated with the adjacent 
substituents are weaker. 
2.3
13
C NMR spectroscopic characterisation 
Table 4(a) shows the terpyridine carbon signals of L3-L9 in CDCl3 solution. The 
assignments were done by using HMQC and HMBC techniques. There are no 
significant changes in these signals as the length of the spacer between the terpyridine 
and the substituents is lengthened. However, there are 12 ppm, -2 ppm, -15 ppm 
changes of CT3?, CT2?, CT4? (the atom labelling scheme is given in Table 4(a))
respectively when the OCH2 linkage between the terpyridine domain and the 
substituent in L4 is changed to the S linkage in L9. All the signals of the naphthyl and 
anthryl rings lie between the CT5 and CT4 signals. The naphthyl carbons also show no 
significant shifts as the length of the spacer is varied. However, there is -8 to +8 ppm 
shift in the signals for CN1-N4 when the OCH2 linkage is changed to the S linkage 
(Figure 10 and Table 4(b)).
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Carbon resonance (?)
L
CT3? CT3 CT5 CT4 CT6 CT2 CT2? CT4?
L
3 107.6 121.5 123.9 137.0 148.9 155.8 156.9 167.1 
L
4 107.7 121.4 123.9 136.8 149.1 156.1 157.3 167.0 
L
5 107.5 121.4 123.8 136.8 149.0 156.1 157.1 167.1 
L
6 107.6 121.4 123.9 136.9 149.0 155.9 157.0 167.1 
L
7 107.8 121.6 124.0 137.2 148.7 155.6 156.6 167.2 
L
8 107.8 121.6 124.0 137.0 149.2 156.3 157.6 167.5 
L
9 119.1 121.8 124.1 137.6 148.6 155.1 154.8 152.2 
Table 4(a). Terpyridine 13C NMR signals of L3-L9 in CDCl3 solution at room temperature. (The 
13C NMR spectra for all the L were measured at 
125 MHz) 
N
N
N
O
O
O
OH
L3
T3'
T2'
T4'
L5-L7    (n = 0, 1 2)
T3'
S(2n+3)
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O
N N
O
On
N3
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S2 S3
S4
T2
S5
S6
T5
T4
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N
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N N
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N3
T3
T4
T5
T6
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A11
A12A13
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N6
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Carbon resonance (?)
L
CN3 CN6, N7 CN1 CN5 CN8 CN4 CN10 CN9 CN2
L
4 125.2 126.2, 126.3 126.4 127.8 128.0 128.5 133.1 133.3 133.6 
L
5 126.1 125.7, 125.9 126.5 127.7, 127.9, 128.3 133.0 133.3 135.5 
L
6 125.80, 125.84, 126.0 126.5 127.7, 127.9, 128.2 133.0 133.2 135.8 
L
7 125.78, 125.83, 126.03 126.5 127.8, 127.9, 128.1 133.0 133.3 135.8 
L
9 130.8 126.8, 127.2 134.4 127.9, 128.0 129.7 133.3 134.0 127.5 
CA1, A8 CA3, A6 CA9 CA2, A7 CA4, A5 CA10 CA12, A13 CA11, A14
L
8 124.1 125.3 126.1 126.9 129.3 129.5 131.3 131.6  
Table 4(b). 13C NMR spectroscopic data for L3-L9 in CDCl3 solution at room temperature. (The 
13C spectra for L were measured at 125 MHz). 
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Figure 10. 
13C NMR spectra (125 MHz) of (a) L4 and (b) L9 in CDCl3 solution at 
room temperature. 
2.4 Mass spectrometric characterisation 
Electrospray ionisation (ES) and electron impact (EI) mass spectrometry were also 
used to characterise the ligands. Since ES-MS is a relatively soft ionisation method, 
no fragmentation occurs. The value recorded for each signal is the mass to charge 
ratio (m/z). Normally, [M+Na]+ and [M+H]+ peaks are found as the major peaks. 
However, EI-MS is a harsher method and fragmentation is observed. Therefore, not 
only is the parent peak [M+H]+ usually found, but also other fragmentation peaks are 
detected (see Section 2.7). 
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2.5 Crystal structures of L
2
 and [HL
9
]
+
Cl
-
·H2O
(a) Crystal structure of L
2
A single crystal of L2 which was obtained by recrystallisation from ethanol was 
suitable for X-ray crystallographic analysis (Figure 11). Crystallographic data are 
given in Appendix I and selected bond lengths and angles are given in Table 5. The 
crystal structure of L2, like other free 2,2?:6?,2?-terpyridine ligands13,17,49, exists in a 
trans-trans conformation which minimises the repulsive N-N lone pair interactions 
that are present in the cis-cis conformation. The interannular C-C bonds, C8-C7, 
1.485(4) Å and C13-C14, 1.491(3) Å, and the other N-C, C-C bond lengths are within 
the reported range of 4?-[3-(1,2-dicarbadecaboranyl)propoxy]-2,2?:6?,2?-terpyridine.17
The three pyridine rings are not exactly coplanar and the torsion angles C12-C8-C7-
N2 and C15-C14-C13-N2 are 7.88˚ and 6.20˚ respectively. These small deviations 
from planarity are typical for the free ligands.13
Figure 11. An ORTEP representation (50% probability ellipsoids) of L2. Hydrogen 
atoms are omitted for clarity. 
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C7-C8 1.485(4) C6-C7 1.396(4) O3-C5 1.360(3) 
C13-C14 1.491(3) N2-C13 1.341(3) O3-C4 1.424(4) 
N1-C8 1.346(3) C13-C19 1.400(4) C3-C4 1.514(4) 
C8-C12 1.390(4) N3-C14 1.337(4) O2-C3 1.406(4) 
N1-C9 1.343(4) C14-C15 1.391(4) O2-C2 1.470(5) 
N2-C7 1.342(3) N3-C18 1.352(4) C1-C2 1.452(6) 
    O1-C1 1.417(4) 
      
C8-N1-C9 117.5(3) N2-C13-C19 123.6(2) O3-C5-C19 124.4(3) 
N1-C8-C12 122.0(3) N2-C13-C14 116.3(2) O3-C5-C6 115.4(2) 
N1-C8-C7 116.8(2) C14-C13-C19 120.1(2) C4-O3-C5 118.8(2) 
C7-C8-C12 121.1(2) N3-C14-C13 117.7(2) O3-C4-C3 103.9(3) 
C6-C7-C8 120.3(2) C13-C14-C15 120.2(2) O2-C3-C4 109.0(3) 
N2-C7-C8 116.6(2) N3-C14-C15 122.0(2) C2-O2-C3 107.5(3) 
N2-C7-C6 123.0(2) C14-N3-C18 117.9(3) O2-C2-C1 110.1(3) 
C7-N2-C13 118.0(2) C6-C5-C19 120.1(3) O1-C1-C2 110.9(3) 
      
C12-C8-C7-N2 7.88 C19-C5-O3-C4 1.33 
C15-C14-C13-N2 6.20    
Table 5. Selected bond lengths (Å) and angles (˚) of L2.
For the ethyleneoxy chain, the angle C5-O3-C4 is 118.8(2)˚, which is comparable with 
the corresponding angle in 4?-ethoxy-5,5?-dimethyl-2,2?:6?,2?-terpyridine50 and 4?-[3-
(1,2-dicarbadecaboranyl)propoxy]-2,2?:6?,2?-terpyridine17. The bond length O3-C5 is 
1.360(3) Å which, within experimental error, is the same as that in 4?-ethoxy-5,5?-
dimethyl-2,2?:6?,2?-terpyridine (1.357(3) Å)50 and 4?-[3-(1,2-
dicarbadecaboranyl)propoxy]-2,2?:6?,2?-terpyridine (1.361(1) Å)17. Also, the bond 
length O3-C4 is 1.424(4) Å, which is within the range reported in 4?-ethoxy-5,5?-
dimethyl-2,2?:6?,2?-terpyridine (1.425(3) Å)50 and 4?-[3-(1,2-
dicarbadecaboranyl)propoxy]-2,2?:6?,2?-terpyridine (1.428(1) Å)17. The bond length 
O3-C5 is shorter than O3-C4 which suggests a degree of ?-conjugation of the oxygen 
O3 atom with the aromatic ring. The C and O atoms of the chain (except O1) are 
nearly coplanar with the central pyridine ring with a small torsion angle (C19-C5-O3-
C4) 1.33˚. Interestingly, there is a hydrogen bonding interaction between O1-H1 of 
one molecule to N3 atom of another molecule (Figure 12). Since the hydrogen 
positions in the crystal structure were calculated instead of measured, the hydrogen-
bonded interactions were investigated by measuring the distance between the atom 
connected to the hydrogen, which is the oxygen atom O1, and the nitrogen atom N3. 
The O1···N3 distance is 2.871 Å, which is within a range for a hydrogen bond.51
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Figure 12. Packing diagram of L2 in the crystal lattice (the dotted lines are the 
hydrogen bonding interactions).
(b) Crystal structure of [HL
9
]
+
Cl
-
·H2O
A single crystal of [HL9]+Cl-·H2O which was suitable for X-ray crystallographic 
analysis was obtained by the slow diffusion of diethyl ether into a chloroform solution 
of L9. The crystallographic data are given in Appendix I and the selected bond lengths 
and angles are given in Table 6. In contrast to the trans-trans conformation in L2, the 
three pyridine rings in [HL9]+Cl-·H2O exists in a cis-trans conformation because one of 
its pyridine rings is protonated (Figure 13). This has been previously described in the 
solid-state structure of 2,2?:6?,2?-terpyridinium trifluoromethanesulfonate.52 One water 
molecule of crystallisation is present in the crystal structure. The oxygen atom of the 
water molecule acts as a hydrogen bond acceptor to the hydrogen atom H3 and H221. 
The distances between O1 and N1, O1 and C22 are 2.735 Å and 3.416 Å respectively, 
which are comparable with the hydrogen bonds with water molecules as acceptors 
reported by Steiner et al.51 These H-bonding interactions stabilise the cis-trans
conformation in the crystal structure. Interestingly, if the pyridine rings are 
diprotonated, the three pyridine rings exist in a trans-trans conformation. This is 
reported in 2,2?:6?,2?-terpyridinium bis(tetraphenylborate) monohydrate53 and 
bis(2,2?:6?,2?-terpyridinium) hexakis(nitrato-O,O?)-lanthanum nitrate acetonitrile 
solvate54.
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Figure 13. An ORTEP representation (50% probability ellipsoids) of [HL9]+Cl-·H2O.
Hydrogen atoms (expect H1, H2 and H221) are omitted for clarity. The 
structure is disordered; the two structures show the two orientations of the 
naphthyl group that lead to the disorder. 
C15-C16 1.478(4) C16-C17 1.394(3) S1-C18 1.763(3) 
C20-C21 1.481(4) N2-C20 1.334(3) S1-C1 1.778(3) 
N1-C15 1.348(3) C19-C20 1.392(3)   
C14-C15 1.376(4) N3-C21 1.335(3)   
N1-C11 1.340(3) C21-C22 1.390(3)   
N2-C16 1.341(3) N3-C25 1.323(3)   
      
C11-N1-C15 123.2(2) N2-C20-C19 122.8(2) S1-C18-C19 120.5(2) 
N1-C15-C14 118.4(2) N2-C20-C21 117.9(2) S1-C18-C17 119.6(2) 
N1-C15-C16 116.4(2) C19 -C20-C21 119.3(2) C1-S1-C18 100.0(1) 
C14-C15-C16 125.1(2) N3-C21-C20 116.0(2)   
C15-C16-C17 120.8(2) C20-C21-C22 121.0(2)   
N2-C16-C15 115.0(2) N3-C21-C22 123.1(2)   
N2-C16-C17 124.1(2) C21-N3-C25 118.0(2)   
C16-N2-C20 117.4(2) C17-C18-C19 119.8(2)   
      
O1···Cl1 3.132 O1···N1 2.735 O1···C22 3.416 
O1-H2-Cl1 165.53 O1-H3-N1 143.11 O1-H221-C22 172.81 
O1···Cl1 3.141     
O1-H1-Cl1 160.78     
      
N1-C15-C16-N2 6.65 C19-C18-S1-C1 -41.49 
C22-C21-C20-N2 -7.99    
Table 6. Selected bond lengths (Å) and angles (˚) of [HL9]+Cl-·H2O. 
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The interannular C-C bonds in [HL9]+, C15-C16, 1.478(4) Å and C20-C21, 1.481(4) 
Å, are within the range reported in terpyridine ligands13 and 4?-[2-(1,3-dioxlan-2-
yl)ethylsulfanyl]-2,2?:6?,2?-terpyridine55. This is also in the case of 2,2?:6?,2?-
terpyridinium trifluoromethanesulfonate52, 2,2?:6?,2?-terpyridinium 
bis(tetraphenylborate) monohydrate53 and bis(2,2?:6?,2?-terpyridinium) 
hexakis(nitrato-O,O?)-lanthanum nitrate acetonitrile solvate54. All the other N-C, C-C 
bond lengths are within the typical range for free 2,2?:6?,2?-terpyridine ligands.13
Again, the three pyridine rings are not in the same plane and the torsion angles N1-
C15-C16-N2 and C22-C21-C20-N2 are 6.65˚ and -7.99˚ respectively.13 There are 
some differences between the bond angles in the protonated pyridine ring and the non-
protonated pyridine rings. The angle C11-N1-C15 is 123.2(2)˚, which is, 5.8(2)˚ and 
5.2(2)˚ bigger than the angles C16-N2-C20 and C21-N3-C25 respectively. The angle 
N1-C15-C14 is decreased by 5.7(2)˚, 4.4(2)˚ and 4.7(2)˚ compared to N2-C16-C17, 
N2-C20-C19 and N3-C21-C22 respectively. This is also observed in the solid-state 
structure of 2,2?:6?,2?-terpyridinium trifluoromethanesulfonate.52
The angle between C18-S1-C1 is 100.0(1)˚, which is slightly smaller than the 
corresponding angle in 4?-[2-(1,3-dioxlan-2-yl)ethylsulfanyl]-2,2?:6?,2?-terpyridine55
and 4-methyl-4?-ethylthio-2,2?:6?,2?:6?,2??-quaterpyridine56,57. The bond lengths S1-
C18 and S1-C1 are 1.763(3) Å and 1.778(3) Å respectively. The bond length S1-C18 
is typical for a Csp2-S distance.55 The torsion angle between the central pyridine and 
the S-naphthyl domain (C19-C18-S1-C1) is -41.49˚. The naphthyl domain is 
disordered and two orientations of the group that result in the disorder are shown in 
Figure 13.
The chloride ion in the structure is hydrogen-bonded to H2 of the water molecule. The 
distance of O1 and Cl1 is 3.132 Å and the angle of O1-H2-Cl1 is 165.53, which is 
typical for O-H···Cl distance.51 Also, there is another hydrogen-bonding interactions 
between the chloride ion and H1 of the water molecule. The distance of O1 and Cl1 is 
3.141 Å and the angle of O1-H1-Cl1 is 160.78, which is typical for O-H···Cl
distance.51 It is worth noting that there are no ?-? stacking interactions between the 
terpyridine and naphthyl domains. The chloride ions and water molecules form 
channels and these can be seen in the packing diagram in Figure 14.
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Figure 14. A view of the lattice of [HL9]+Cl-·H2O showing the water molecules and 
chloride ions in channels; the disorder in the naphthyl group is not shown. 
2.6 Conclusion 
In this chapter, ligands L1-L9, which contain polyethyleneoxy chains and differ from 
one another in the length of the chains, in the terminal domains or in the linkages, 
have been synthesised and characterised with 1H and 13C NMR spectroscopy, mass 
spectrometry (ES and EI), IR spectroscopy and elemental analysis. The solid-state 
structure of ligand L2 and protonated L9 ([HL9]+Cl-·H2O) were determined by X-ray 
crystallography. 
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2.7 Experimental 
? 4?-(2-Hydroxyethoxy)-2,2?:6?,2?-terpyridine (L1)
? 4?-[2-(2-Hydroxyethoxy)ethoxy]-2,2?:6?,2?-terpyridine (L2)
? 4?-{2-[2-(2-Hydroxyethoxy)ethoxy]ethoxy}-2,2?:6?,2?-terpyridine (L3)
? 4?-(Naphthalen-2-ylmethoxy)-2,2?:6?,2?-terpyridine (L4)
? 4?-[2-(Naphthalen-2-ylmethoxy)ethoxy]-2,2?:6?,2?-terpyridine (L5)
? 4?-{2-[2-(Naphthalen-2-ylmethoxy)ethoxy]ethoxy}-2,2?:6?,2?-terpyridine (L6)
? 4?-(2-{2-[2-(Naphthalen-2-ylmethoxy)ethoxy]ethoxy}ethoxy)-2,2?:6?,2?-terpyridine (L7)
? 4?-(Anthracen-9-ylmethoxy)-2,2?:6?,2?-terpyridine (L8)
? 4?-(Naphthalen-2-ylsulfanyl)-2,2?:6?,2?-terpyridine (L9)
4?-Hydroxy-2,2?:6?,2?-terpyridine (HO-terpy)36, 4?-chloro-2,2?:6?,2?-terpyridine (Cl-terpy)36
and 9-bromomethylanthracene58 were prepared as previously reported in the literature. 
? 4?-(2-Hydroxyethoxy)-2,2?:6?,2?-terpyridine (L1)
N
N
N
O
OH
Cl
OH
1. K2CO3, DMF, 70
oC
HO-terpy 4'-(2-Hydroxyethoxy)-2,2':6',2''-terpyridine (L1)
OH
N
N N
2.
T3'
T3
T4
T5
T6
S1
S2
Molecular formula: C17H15N3O2
Molecular weight: 293.32 
4?-Hydroxy-2,2?:6?,2?-terpyridine (1.50 g, 6.02 mmol) and K2CO3 (2.50 g, 18.1 mmol) 
were added to anhydrous DMF (50 mL). The reaction mixture was stirred at 70oC for 1 
hour. 2-Chloroethanol (0.485 g, 6.02 mmol) was added dropwise to the suspension and 
the mixture was stirred at 70oC for a further day. The reaction mixture was kept stirring at 
70oC throughout the reaction. Another 1 equivalent of 2-chloroethanol (0.485 g, 6.02 
mmol) was added dropwise to the reaction mixture. After 1 day, the solvent was removed 
under reduced pressure. The crude product was dissolved in CH2Cl2 (70 mL) and was 
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washed with water. The organic phase was collected, dried (MgSO4) and evaporated to 
dryness. The product L1 was collected as a white powder (1.0 g, 3.4 mmol, 56%) after 
column chromatography (Al2O3, CH2Cl2 then CH2Cl2/ 5% CH3OH).
The ligand has been made previously by a different route15,16; the sample was checked by 
spectroscopic analysis and the data below agree with those in the literature.  
1H NMR (400 MHz, CDCl3): ?H 4.04 (m, 2H, HS2), 4.37 (t, J 4.5 Hz, 2H, HS1), 7.34 (ddd, 
J 1.3, 4.8, 7.3 Hz, 2H, HT5), 7.85 (td, J 1.7, 7.7 Hz, 2H, HT4), 8.05 (s, 2H, HT3?), 8.62 (d, J
7.6 Hz, 2H, HT3), 8.69 (d, J 5.3 Hz, 2H, HT6). 
MS (ES): m/z = 316.1 [M+Na]+, 294.1 [M+H]+.
IR(solid, cm-1): 3742w, 3202br, 2955w, 2869w, 2361w, 1867w, 1744w, 1682w, 1558s, 
1450m, 1404s, 1366s, 1327m, 1258m, 1204s, 1057s, 1026s, 918m, 864m, 787s, 741s. 
Melting point: 150.2-151.5ºC (lit. m.p. 150-151ºC). 
? 4?-[2-(2-Hydroxyethoxy)ethoxy]-2,2?:6?,2?-terpyridine (L2)
Cl
O
N
N
N
O
O
OH
OH
1. K2CO3, DMF, 70
oC
4'-[2-(2-Hydroxyethoxy)ethoxy]-2,2':6',2''-
terpyridine (L2)
HO-terpy
OH
N
N N
2.
T3
T4
T5
T6
T3'
S1
S2 S3
S4
Molecular formula: C19H19N3O3
Molecular weight: 337.37 
4?-Hydroxy-2,2?:6?,2?-terpyridine (1.50 g, 6.02 mmol) and K2CO3 (2.50 g, 18.1 mmol) 
were added to anhydrous DMF (30 mL). The reaction mixture was stirred at 70oC for 30 
mins. 2-(2-Chloroethoxy)ethanol (0.750 g, 6.02 mmol) was added dropwise to the 
suspension and the mixture was stirred at 70oC for a further day. The reaction mixture 
was kept stirring at 70oC throughout the reaction. More 2-(2-chloroethoxy)ethanol (0.750 
g, 6.02 mmol) was added to the reaction mixture and the mixture was stirred for 1 day. 
The solvent was removed under reduced pressure. Water (35 mL) was added to the 
residue and aqueous NaOH (2M) was added to adjust the pH to 12. The solution was 
washed with CHCl3 (40 mL) twice. The organic layer was dried (MgSO4), filtered and 
evaporated to dryness. The product L2  was collected as a white powder (0.921 g, 2.73 
mmol, 45.3%) after column chromatography (Al2O3, CH2Cl2, then CH2Cl2/ 10% CH3OH). 
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The ligand has been made previously by a different route15,16; the sample was checked by 
spectroscopic analysis and the data below agree with those in the literature. 
1H NMR (400 MHz, CDCl3): ?H 3.68 (m, 2H, HS4), 3.77 (m, 2H, HS3), 3.93 (m, 2H, HS2), 
4.45 (m, 2H, HS1), 7.35 (ddd, J 1.0, 5.1, 7.6 Hz, 2H, HT5), 7.87 (td, J 1.7, 7.7 Hz, 2H, 
HT4), 8.13 (s, 2H, HT3?), 8.62 (d, J 7.6 Hz, 2H, HT3), 8.69 (d, J 4.0 Hz, 2H, HT6). 
MS (ES): m/z = 360 [M+Na]+.
IR (solid, cm-1): 3788w, 3252br, 2943m, 2885m, 1724w, 1659w, 1582s, 1562s, 1470m, 
1443s, 1404s, 1366m, 1323s, 1254m, 1204s, 1119s, 1038s, 988m, 895m, 860m, 787s, 
745s. 
Melting point: 109.3-111.5ºC (lit. m.p. 113-114ºC). 
? 4?-{2-[2-(2-Hydroxyethoxy)ethoxy]ethoxy}-2,2?:6?,2?-terpyridine (L3)
N
N
N
O
O
O
OH
4'-{2-[2-(2-Hydroxyethoxy)ethoxy]ethoxy}-
2,2':6',2''-terpyridine (L3)
1. K2CO3, DMF, 70
oC
HO-terpy
OH
N
N N
2.
Cl
O
O
OH
T3'
T2'
T4'
T3
T4
T5
T6
S1
S2 S3
S4
T2
S5
S6
Molecular formula: C21H23N3O4
Molecular weight: 381.43 
4?-Hydroxy-2,2?:6?,2?-terpyridine (0.50 g, 2.0 mmol) and K2CO3 (0.83 g, 6.0 mmol) were 
added to anhydrous DMF (20 mL). The reaction mixture was stirred at 70oC for 1 hour. 2-
[2-(2-Chloroethoxy)ethoxy]ethanol (0.34 g, 2.0 mmol) was added dropwise to the 
suspension and the mixture was stirred at 70oC for 1 day. The reaction mixture was kept 
stirring at 70oC throughout the reaction. Another 1 equivalent of 2-[2-(2-
chloroethoxy)ethoxy]ethanol (0.34 g, 2.0 mmol) was added dropwise to the suspension 
and the mixture was stirred for another day. The solvent was removed under reduced 
pressure. Water (15 mL) was added to the yellow oily liquid and aqueous NaOH (2M) 
was added to adjust the pH to 12 or above. The yellow solution was extracted with CHCl3
(20 mL) twice. The organic phase was dried (MgSO4), filtered and evaporated to dryness. 
All the excess 2-[2-(2-chloroethoxy)ethoxy]ethanol was removed under high vacuum. 
Then, the product L3  was collected as a pale yellow liquid (0.37 g, 0.97 mmol, 49%) after 
column chromatography (Al2O3, CH2Cl2 then CH2Cl2/ 10% CH3OH). 
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1H NMR (500 MHz, CDCl3): ?H 3.62 (m, 2H, HS5), 3.69 (m, 2H, HS4), 3.73 (m, 2H, HS6), 
3.77 (m, 2H, HS3), 3.94 (t, J 4.7 Hz, 2H, HS2), 4.42 (t, J 4.7 Hz, 2H, HS1), 7.33 (ddd, J 1.1, 
4.8, 7.5 Hz, 2H, HT5), 7.85 (td, J 1.8, 7.7 Hz, 2H, HT4), 8.05 (s, 2H, HT3?), 8.61 (d, J 8.0 
Hz, 2H, HT3), 8.68 (ddd, J 0.8, 1.7, 4.8 Hz, 2H, HT6).
13C NMR (125 MHz, CDCl3): ?C 61.8 (CS6), 67.9 (CS1), 69.5 (CS2), 70.5 (CS4), 71.1 (CS3), 
72.5 (CS5), 107.6 (CT3?), 121.5 (CT3), 123.9 (CT5), 137.0 (CT4), 148.9 (CT6), 155.8 (CT2),
156.9 (CT2?), 167.1 (CT4?). 
MS (ES): m/z = 404.2 [M+Na]+.
IR (solid, cm-1): 3757w, 3418br, 3055w, 2878m, 2885m, 1735m, 1566s, 1450m, 1412m, 
1350m, 1250m, 1203m, 1057m, 995w, 964w, 872w, 795m, 740w, 702w.  
Elemental Analysis: Found: C, 64.80; H, 6.12; N, 10.97. Calc. for C21H23N3O4·?H2O: C, 
65.10; H, 6.17; N, 10.85%. 
? 4?-(Naphthalen-2-ylmethoxy)-2,2?:6?,2?-terpyridine (L4)
N
O
N N
2.
Br
4'-(Naphthalene-2-ylmethoxy)-2,2':6',2''-
terpyridine (L4)
HO-terpy
OH
N
N N
1. K2CO3, DMF, 70
oC
T3
T4
T5
T6
T3'
S1
T2'
T2
T4'
N1
N2
N3
N4
N5
N6
N7
N8
N9
N10
Molecular formula: C26H19N3O
Molecular weight: 389.45 
4?-Hydroxy-2,2?:6?,2?-terpyridine (1.21 g, 4.85 mmol) was stirred with dry K2CO3 (2.01 g, 
14.5 mmol) in 50 mL DMF for 1 hour at 70oC under nitrogen and 2-
bromomethylnaphthalene (1.33 g, 6.02 mmol) was added to the reaction mixture. The 
reaction mixture was kept stirring at 70oC throughout the reaction. The reaction mixture 
was stirred for 1 day and then more 2-bromomethylnaphthalene (0.40 g, 1.8 mmol) was 
added. After 2 days, the reaction mixture was then filtered and the solvent was removed. 
The crude product was extracted with CH2Cl2 and water. The white powder was 
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recrystallised from methanol to give 4?-(naphthalene-2-ylmethoxy)-2,2?:6?,2?-terpyridine 
as white fine needles (0.91 g, 2.34 mmol, 48.2%). 
1H NMR (500 MHz, CDCl3) ?H 5.50 (s, 2H, HS1), 7.34 (ddd, J 1.2, 4.8, 7.5 Hz, 2H, HT5), 
7.50 (m, 2H, HN6 and HN7), 7.59 (dd, J 1.7, 8.4 Hz, 2H, HN3), 7.86 (m, 4H, HT4, HN5 and 
HN8), 7.89 (d, J 8.6 Hz, 1H, HN4), 7.97 (s, 1H, HN1), 8.17 (s, 2H, HT3?), 8.63 (dt, J 1.0, 8.0 
Hz, 2H, HT3), 8.70 (ddd, J 0.9, 1.8, 4.8 Hz, 2H, HT6).
13C NMR (125 MHz, CDCl3): ?C 70.0 (CS1), 107.7 (C T3?), 121.4 (C T3), 123.9 (CT5), 125.2 
(CN3), 126.2 (CN6/ N7), 126.3 (CN7/ N6), 126.4 (CN1), 127.8 (CN5), 128.0 (CN8), 128.5 (CN4),
133.1 (CN10), 133.3 (CN9), 133.6 (CN2), 136.8 (CT4), 149.1 (CT6), 156.1 (CT2), 157.3 (CT2?),
167.0 (CT4?).
MS (EI): m/z = 389.2 [M]+ (39.8%), 234.1 [M-OCH2Nap]
+ (18.1%), 141.1 [M-Oterpy]+
(100%). 
IR (solid, cm-1): 3101w, 3055w, 3016w, 2870w, 2546w, 1790w, 1735w, 1558s, 1443m, 
1404m, 1342s, 1258m, 1188s, 1126w, 1095w, 1003s, 926w, 903w, 864m, 825m, 787s, 
741m. 
Elemental Analysis: Found: C, 79.43; H, 4.88; N, 10.58. Calc. for C26H19N3O·¼CH3OH: 
C, 79.25; H, 5.03; N, 10.57%. 
Melting point: 186.8-188.4ºC. 
? 4?-[2-(Naphthalen-2-ylmethoxy)ethoxy]-2,2?:6?,2?-terpyridine (L5)
N
O
N N
OH
1. NaH, THF, 80oC
2.
N
O
O
N N
4'-[2-(Naphthalen-2-ylmethoxy)ethoxy]-
2,2:6',2''-terpyridine (L5)
4'-(2-Hydroxyethoxy)-2,2':6',2''-
terpyridine (L1)
Br
T3'
T2'
T4'
N2
N3
T3
T4
T5
T6
S1
T2
N4 N5
N6
N7
N8
N9
N10
N1S2 S3
Molecular formula: C28H23N3O2
Molecular weight: 433.50 
4?-(2-Hydroxyethoxy)-2,2?:6?,2?-terpyridine (0.20 g, 0.68 mmol) and NaH (60% 
suspended in oil) (48 mg, 1.2 mmol) were added to 40 mL dry THF and the mixture 
stirred at 80oC for 1 hour. The reaction mixture was kept stirring at 80oC throughout the 
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reaction. Then, 2-bromomethylnaphthalene (0.18 g, 0.82 mmol) in 5 mL of dry THF was 
added slowly to the mixture. The reaction mixture was stirred at 80oC for 2 days. 
Methanol (10 mL) and water (10 mL) were added slowly to quench the reaction. The 
solvent was removed under reduced pressure. The yellow residue was washed with 
hexane and dissolved in water. The solution was then extracted with CHCl3 twice. The 
organic layer was dried (MgSO4) and concentrated. Column chromatography (Al2O3,
CH2Cl2/ 1% CH3OH) yielded 0.20 g (0.46 mmol, 68%) of white solid L
5.
1H NMR (500 MHz, CDCl3) ?H 3.94 (t, J 4.7 Hz, 2H, HS2), 4.45 (t, J 4.7 Hz, 2H, HS1), 
4.82 (s, 2H, HS3), 7.32 (ddd, J 1.0, 4.8, 7.5 Hz, 2H, HT5), 7.46 (m, 2H, HN6 and HN7), 7.51 
(dd, J 1.7, 8.4 Hz, 1H, HN3), 7.82 (m, 6H, HN1, HN4, HN5, HN8 and HT4), 8.09 (s, 2H, HT3?),
8.62 (dt, J 1.0, 8.0 Hz, 2H, HT3), 8.69 (ddd, J 0.9, 1.8, 4.8 Hz, 2H, HT6).
13C NMR (125 MHz, CDCl3): ?C 67.8 (CS1), 68.3 (CS2), 73.5 (CS3), 107.5 (CT3?), 121.4 
(CT3), 123.8 (CT5), 125.7 (CN6/ N7), 125.9 (CN7/ N6), 126.1 (CN3), 126.5 (CN1), 127.7 (CN4/ N5/ 
N8), 127.9 (CN4/ N5/ N8), 128.3 (CN4/ N5/ N8), 133.0 (CN10), 133.3 (CN9), 135.5 (CN2), 136.8 
(CT4), 149.1 (CT6), 156.1 (CT2), 157.1 (CT2?), 167.1 (CT4?). 
MS (ES): m/z = 456.1 [M+Na]+, 434.2 [M+H]+.
IR (solid, cm-1): 3086w, 3063w, 2970w, 2847w, 1713w, 1558s, 1466m, 1404m, 1342s, 
1281m, 1250m, 1196s, 1103s, 1056s, 987s, 957s, 894m, 864s, 825m, 787s, 741s. 
Elemental Analysis: Found: C, 77.45; H, 5.37; N, 9.69. Calc. for C28H23N3O2: C, 77.58; 
H, 5.35; N, 9.69%. 
Melting point: 97.8-99.1ºC. 
? 4?-{2-[2-(Naphthalen-2-ylmethoxy)ethoxy]ethoxy}-2,2?:6?,2?-terpyridine (L6)
N
N
N
O
O
OH
N
O
NN
O
O
4'-{2-[2-(Naphthalen-2-ylmethoxy)ethoxy]
ethoxy}-2,2':6',2''-terpyridine (L6)
4'-[2-(2-Hydroxyethoxy)ethoxy]-
2,2':6',2''-terpyridine (L2)
1. NaH, THF, 80oC
2.
Br
T3
T4
T5
T6
T3'
S1
T2'
T2
T4'
N2
N3
N4
N5
N6
N7
N8
N9
N10
N1
S2 S3
S4 S5
Molecular formula: C30H27N3O3
Molecular weight: 477.55 
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4?-[2-(2-Hydroxyethoxy)ethoxy]-2,2?:6?,2?-terpyridine (0.20 g, 0.59 mmol) and NaH 
(60% suspended in oil) (71.2 mg, 1.78 mmol) were added to 20 mL dry THF and the 
mixture stirred at 80oC for 1 hour. The reaction mixture was kept stirring at 80oC
throughout the reaction. Then, 2-bromomethylnaphthalene (0.2 g, 0.9 mmol) in 5 mL of 
dry THF was added slowly to the mixture. The reaction mixture was stirred at 80oC for 1 
day. A further one-third equivalent of 2-bromomethylnaphthalene (0.07 g, 0.3 mmol) was 
added and stirred for a further day. Methanol (10 mL) and water (10 mL) were added 
slowly to quench the reaction. The solvent was removed under reduced pressure. The 
yellow residue was washed with hexane and dissolved in water. The solution was then 
extracted with CHCl3 twice. The organic layer was dried (MgSO4) and concentrated. 
Column chromatography (Al2O3, CH2Cl2/ 1% CH3OH) yielded 0.15 g (0.31 mmol, 53%) 
of colourless oily liquid L6.
1H NMR (500 MHz, CDCl3): ?H 3.71 (m, 2H, HS4), 3.81 (m, 2H, HS3), 3.95 (t, J 4.7 Hz, 
2H, HS2), 4.42 (t, J 4.7 Hz, 2H, HS1), 4.74 (s, 2H, HS5), 7.32 (ddd, J 1.2, 4.8, 7.5 Hz, 2H, 
HT5), 7.44 (m, 2H, HN6 and HN7), 7.49 (dd, J 1.6, 8.4 Hz, 1H, HN3), 7.79 (s, 1H, HN1), 7.82 
(m, 5H, HT4, HN4, HN5 and HN8), 8.08 (s, 2H, HT3?), 8.62 (dt, J 1.0, 8.0 Hz, 2H, HT3), 8.69 
(ddd, J 0.9, 1.8, 4.8 Hz, 2H, HT6).
13C NMR (125 MHz, CDCl3): ?C 67.9 (CS1), 69.5 (CS2/ S4), 69.6 (CS4/ S2), 71.1 (CS3), 73.4 
(CS5), 107.6 (CT3?), 121.4 (CT3), 123.9 (CT5), 125.80 (CN6/ N7/ N3), 125.84 (CN7/ N6/ N3), 126.0 
(CN7/ N6/ N3), 126.5 (CN1), 127.7 (CN4/ N5/ N8), 127.9 (CN4/ N5/ N8), 128.2 (CN4/ N5/ N8), 133.0 
(CN10), 133.2 (CN9), 135.8 (CN2), 136.9 (CT4), 149.0 (CT6), 155.9 (CT2), 157.0 (CT2?), 167.1 
(CT4?).
MS (ES): m/z = 500 [M+Na]+, 478 [M+H]+.
IR (solid, cm-1): 3055w, 2870br, 1566s, 1450m, 1404m, 1350m, 1250w, 1204m, 1126m, 
1095m, 1049w, 995w, 964w, 864w, 795m, 748m. 
Elemental Analysis: Found: C, 74.88; H, 5.91; N, 8.85. Calc. for C30H27N3O3·¼CH3OH: 
C, 74.83; H, 5.81; N, 8.65%. 
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? 4?-(2-{2-[2-(Naphthalen-2-ylmethoxy)ethoxy]ethoxy}ethoxy)-2,2?:6?,2?-terpyridine (L7)
N
N
N
O
O
O
OH
N
NN
O
O
O
O
4'-(2-{2-[2-(Naphthalen-2-ylmethoxy)ethoxy]
ethoxy}ethoxy)-2,2':6',2''-terpyridine (L7)
1. NaH, THF, 80oC
2.
Br
T3
T4
T5
T6
T3'
S1
T2'
T2
T4'
N2
N3
N4 N5
N6
N7
N8
N9
N10
N1S2 S3
4'-{2-[2-(2-Hydroxyethoxy)ethoxy]
ethoxy}-2,2':6',2''-terpyridine (L3)
S4 S5
S6 S7
Molecular formula: C32H31N3O4
Molecular weight: 521.61 
4?-{2-[2-(2-Hydroxyethoxy)ethoxy]ethoxy}-2,2?:6?,2?-terpyridine (0.15 g, 0.39 mmol) 
and NaH (60% suspended in oil) (19 mg, 0.47 mmol) were added to 20 mL dry THF and 
the mixture was stirred at 80oC for 1 hour. The reaction mixture was kept stirring at 80oC
throughout the reaction. Then, 2-bromomethylnaphthalene (261 mg, 1.18 mmol) was 
added slowly to the mixture. The reaction mixture was stirred at 80oC for 3 days. 
Methanol (10 mL) and water (10 mL) were added slowly to quench the reaction. The 
solvent was removed under reduced pressure. The yellow residue was washed with 
hexane and water. The solution was then extracted with CHCl3 twice. The organic layer 
was dried (MgSO4) and concentrated. The crude product was purified by column 
chromatography (Al2O3, CH2Cl2/ 1% CH3OH) to yield 0.031 g (0.060 mmol, 15%) of 
yellow oily liquid L7.
1H NMR (500 MHz, CDCl3) ?H 3.68 (m, 2H, HS6), 3.71 (m, 4H, HS4 and HS5), 3.78 (m, 
2H, HS3), 3.94 (t, J 4.7 Hz, 2H, HS2), 4.41 (t, J 4.7 Hz, 2H, HS1), 4.72 (s, 2H, HS7), 7.34 
(ddd, J 0.9, 4.9, 7.3 Hz, 2H, HT5), 7.44 (m, 2H, HN6 and HN7), 7.46 (dd, J 1.7, 8.4 Hz, 1H, 
HN3), 7.77 (s, 1H, HN1), 7.80 (m, 3H, HN4, HN5 and HN8), 7.86 (td, J 1.6, 7.7 Hz, 2H, HT4),
8.07 (s, 2H, HT3?), 8.62 (d, J 8.0 Hz, 2H, HT3), 8.69 (dd, J 0.7, 4.7 Hz, 2H, HT6). 
13C NMR (125 MHz, CDCl3): ?C 68.0 (CS1), 69.46 (CS2), 69.48 (CS6), 70.75 (CS4), 70.77 
(CS5), 71.0 (CS3), 73.3 (CS7), 107.8 (CT3?), 121.6 (CT3), 124.0 (CT5), 125.78 (CN6/ N7/ N3),
125.83 (CN7/ N6/ N3), 126.03 (CN7/ N6/ N3), 126.5 (CN1), 127.8 (CN4/ N5/ N8), 127.9 (CN4/ N5/ N8), 
128.1 (CN4/ N5/ N8), 133.0 (CN10), 133.3 (CN9), 135.8 (CN2), 137.2 (CT4), 148.7 (CT6), 155.6 
(CT2), 156.6 (CT2?), 167.2 (CT4?).
MS (ES): m/z = 544.4 [M+Na]+, 522.5 [M+H]+.
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IR (solid, cm-1): 3055w, 2870br, 1713m, 1566s, 1466m, 1404m, 1350m, 1281m, 1204m, 
1126m, 1095m, 1049w, 995w, 964w, 872m, 795m, 741w. 
Elemental Analysis: Found: C, 72.15; H, 5.94; N, 8.23. Calc. for C32H31N3O4·½H2O: C, 
72.43; H, 6.08; N, 7.92%. 
? 4?-(Anthracen-9-ylmethoxy)-2,2?:6?,2?-terpyridine (L8)
2.
HO-terpy
OH
N
N N
1. K2CO3, DMF, 70
oC
N
N
N
O
Br
4'-(Anthracen-9-ylmethoxy)-
2,2':6',2''-terpyridine (L8)
T3'
T2'
T4'
T3
T4
T5
T6
S1
T2
A1
A2
A3
A4 A5
A6
A7
A8A9
A10
A11
A12A13
A14
Molecular formula: C30H21N3O
Molecular weight: 439.51 
4?-Hydroxy-2,2?:6?,2?-terpyridine (0.50 g, 2.0 mmol) was stirred with dry K2CO3 (0.83 g, 
6.0 mmol) in 60 mL DMF for 1 hour at 70oC under nitrogen and 9-
bromomethylanthracene (0.54 mg, 2.0 mmol) was added to the reaction mixture. The 
reaction was kept at 70oC under nitrogen in the dark for 1 week. The solvent was then 
removed in vacuo and the yellow crude product was extracted with CH2Cl2 and water. 
The organic layer was collected, dried (MgSO4) and concentrated. L
8 was obtained as a 
yellow product (0.13 g, 0.30 mmol, 15%) after column chromatography (Al2O3, CH2Cl2/
hexane 3:1 and then CH2Cl2/ hexane 2:1). 
1H NMR (500 MHz, CDCl3) ?H 6.26 (s, 2H, HS1), 7.35 (ddd, J 1.2, 4.7, 7.5 Hz, 2H, HT5),
7.51 (m, 2H, H A3, A6), 7.55 (m, 2H, HA2, A7), 7.88 (td, J 1.8, 7.8 Hz, 2H, HT4), 8.07 (d, J 8.6 
Hz, 2H, HA4, A5), 8.29 (s, 2H, HT3?), 8.31 (d, J 8.6 Hz, 2H, HA1, A8), 8.57 (s, 2H, HA10), 8.66 
(dt, J 1.1, 8.0 Hz, 2H, HT3), 8.69 (ddd, J 0.9, 1.8, 4.7 Hz, 2H, HT6).
13C NMR (125 MHz, CDCl3): ?C 63.2 (CS1), 107.8 (C T3?), 121.6 (CT3), 124.0 (CT5), 124.1 
(CA1, A8), 125.3 (CA3, A6), 126.1 (CA9), 126.9 (CA2, A7), 129.3 (CA4, A5), 129.5 (CA10), 131.3 
(CA12, A13), 131.6 (CA11, A14), 137.0 (CT4), 149.2 (CT6), 156.3 (CT2), 157.6 (CT2?), 167.5 
(CT4?).
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MS (EI): m/z = 439.2 [M]+ (12.42%), 249 [M-Ant-CH2]
+ (12.11%), 191.1 [M-Oterpy]+
(100%). 
IR (solid, cm-1): 3055br, 1666w, 1558s, 1443m, 1404m, 1342m, 1250w, 1188s, 1088w, 
1057w, 995s, 926w, 872m, 787s, 725s. 
Elemental Analysis: Found: C, 80.24; H, 4.89; N, 9.28. Calc. for C30H21N3O·½H2O: C, 
80.26; H, 4.91; N, 9.36%. 
Melting point: 248.6-250.2ºC. 
? 4?-(Naphthalen-2-ylsulfanyl)-2,2?:6?,2?-terpyridine (L9)
SH
Cl-terpy
Cl
N
N N 200oC
N
S
N N
4'-(Naphthalen-2-ylsulfanyl)-
2,2';6',2''-terpyridine (L9)
T3'
T2'
T4'
N2
N3
T3
T4
T5
T6
T2
N4 N5
N6
N7
N8
N9
N10
N1
Molecular formula: C25H17N3S
Molecular weight: 391.49 
4?-Chloro-2,2?:6?,2?-terpyridine (1.16 g, 4.33 mmol) and naphthalene-2-thiol (0.694 g, 
4.33 mmol) were heated at 200oC for 2 days. The black crude product was extracted with 
CH2Cl2 and water. The organic layer was collected, dried (MgSO4) and concentrated. L
9
was obtained as a white product (1.13 g, 2.89 mmol, 66.7%) after column 
chromatography (Al2O3, DCM/ hexane 2:1). 
1H NMR (500 MHz, CDCl3) ?H 7.34 (ddd, J 1.1, 4.9, 7.4 Hz, 2H, HT5), 7.56 (m, 2H, HN6
and HN7), 7.61 (dd, J 1.8, 8.5 Hz, 1H, HN3), 7.88 (m, 4H, HT4, HN5 and HN8), 7.91 (d, J 8.7 
Hz, 1H, HN4), 8.17 (d, J 1.4 Hz, 1H, HN1), 8.27 (s, 2H, HT3?), 8.59 (d, J 8.0 Hz, 2H, HT3), 
8.65 (dd, J 0.7, 4.8 Hz, 2H, HT6).
13C NMR (125 MHz, CDCl3): ?C 119.1 (C T3?), 121.8 (CT3), 124.1 (CT5), 126.8 (CN6/ N7),
127.2 (CN7/ N6), 127.5 (CN2), 127.9 (CN5/ N8), 128.0 (CN5/ N8), 129.7 (CN4), 130.8 (CN3),
133.3 (CN10), 134.0 (CN9), 134.4 (CN1), 137.6 (CT4), 148.6 (CT6), 152.2 (CT4?), 154.8 (CT2?), 
155.1(CT2). 
MS (EI): m/z = 390.1 [M]+ (100%), 195.6 [NapSH+Cl+H]+ (11%). 
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IR (solid, cm-1): 3055w, 3009w, 1975w, 1690w, 1620w, 1151s, 1466m, 1427w, 1389m, 
1327w, 1265w, 1196w, 1119w, 1072w, 1034w, 987m, 941w, 879w, 848.6m, 810m, 
779m, 733s. 
Elemental Analysis: Found: C, 75.85; H, 4.52; N, 10.79. Calc. for C25H17N3S·¼H2O: C, 
75.83; H, 4.45; N, 10.61%. 
Melting point: 137.9-138.9ºC. 
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Chapter 3 
Synthesis of Homoleptic Mononuclear Iron(II) and Ruthenium(II) 
Complexes of 4?-Substituted-2,2?:6?,2?-Terpyridine Ligands 
Over the past 30 years, the photochemical and photophysical properties of Ru(II) 
complexes of 2,2?-bipyridine (bipy) and its derivatives have been widely 
investigated.1-16 Complexes of 2,2?-bipyridine derivatives are of particular interest 
because of their redox properties, luminescence intensities and excited state 
lifetimes.1,2,17 Although the Ru(II) complexes of 2,2?:6?,2?-terpyridine derivatives 
exhibit lower luminescence intensities and shorter excited state lifetimes at room 
temperature than those of 2,2?-bipyridine and its derivatives, complexes of 2,2?:6?,2?-
terpyridine derivatives are still of great interest. This is because of their synthetic and 
structural advantages (see Section 1.3).2,17,18 Therefore, many efforts have been made 
to design luminescent supramolecular systems that can undergo photoinduced energy-
transfer or electron-transfer process.6,12,19-37
Scheme 1. Complexation reaction between a metal centre and 2,2?:6?,2?-terpyridine 
and its derivatives.  
2,2?:6?,2?-Terpyridine derivatives (X-terpy) can form metal complexes with a variety 
of transition metal ions. The spatial properties of a complex are determined by (1) the 
coordination number and coordination geometry of the metal ion and (2) the number, 
type and distribution of the coordination sites of the ligand.38,39 Therefore, when the 
2,2?:6?,2?-terpyridine and its derivatives (X-terpy) [which act as tridentate ligands] 
N
X
N N M2+
NX
N
N
N X
N
N
M
2,2':6',2''-Terpyridine (X=H)
M = Fe or Ru
2+
[M(X-terpy)2]
2+
X-terpy
Chapter 3 
72
react with metal ions such as Fe(II) or Ru(II), achiral octahedral complexes (strictly 
D2d symmetry) are usually formed (Scheme 1).
40 Fe(II) and Ru(II) are d6 ions and in 
the low-spin state, they are kinetically inert [Ru(II) > Fe(II)]; this is a great advantage 
for synthesis as the complexes are relatively stable. 
The coordination behaviour of the mononuclear Fe(II) and Ru(II) complexes of 4?-
substituted-2,2?:6?,2?-terpyridine ligands described in Chapter 2 will be fully explored 
in this chapter (Scheme 2).
Scheme 2. Fe(II) and Ru(II) complexes of 4?-substituted-2,2?:6?,2?-terpyridine ligands 
studies in this chapter. 
3.1 Synthesis 
(a) Syntheses of homoleptic iron(II) complexes 
Homoleptic Fe(II) complexes are readily prepared by reacting 2 equivalents of ligand 
(L) and 1 equivalent of FeCl2·4H2O in methanol for 1 hour. The solution turned 
purple immediately. A purple precipitate appeared when excess aqueous NH4PF6 was 
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added. The purple precipitate was filtered and collected.23,41 The yield of 
[Fe(L)2][PF6]2 (where L = L
4-L9) complexes ranged from 74-98% (Scheme 3).
Scheme 3. The general syntheses of [Fe(L)2][PF6]2 (where L = L
4-L9).
(b) Syntheses of homoleptic ruthenium(II) complexes 
There are three methods of synthesising homoleptic Ru(II) complexes shown in 
Scheme 2. The first method involves refluxing 2 equivalents of ligand (L) and 1 
equivalent of RuCl3·3H2O in ethylene glycol and the reducing agent N-
ethylmorpholine (NEM) for 3 hour.23,31,42 The solution turns red and a red precipitate 
appears when excess aqueous NH4PF6 is added. The red precipitate [Ru(L)2][PF6]2 is 
filtered and collected. The second method involves heating 2 equivalents of ligand (L)
and 1 equivalent of RuCl3·3H2O in ethylene glycol and NEM in a microwave oven 
(600 W) for 2 minutes.36,43 Then, the same work up procedure as described in the first 
method is applied to obtain the [Ru(L)2][PF6]2 complexes. 
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Scheme 4. The general syntheses of [Ru(L)2][PF6]2 (where L = L
4-L7, L9).
The third method is most widely used to synthesise the homoleptic Ru(II) complexes 
and it was used to synthesise all the [Ru(L)2][PF6]2 complexes in this chapter except 
for [Ru(L8)2][PF6]2. The homoleptic Ru(II) complexes are synthesised in a stepwise 
manner.24,26,29 Firstly, 1 equivalent of ligand (L) and 1 equivalent of RuCl3·3H2O were 
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refluxed in methanol for 3 hours. Then, the dark brown insoluble [RuLCl3] was 
collected and washed well with water. Secondly, 1 equivalent of [RuLCl3] and 1 
equivalent of ligand (L) were refluxed in methanol and few drops of the reducing 
agent N-ethylmorpholine (NEM) for another 3 hours. By adding excess aqueous 
NH4PF6, a red precipitate of the product appeared. Then, the red precipitate 
[Ru(L)2][PF6]2 was filtered, collected and washed well with water. The overall yield 
of [Ru(L)2][PF6]2 (where L = L
4-L7, L9) ranged from 35-69% (Scheme 4).
An attempt to synthesise [Ru(L8)2][PF6]2 using the above three methods failed. 
Therefore, another procedure was used (Scheme 5).42 [Ru(HO-Terpy)2][PF6]2, which 
is synthesised in two steps by the previously described procedure, and dry K2CO3
were stirred in dry acetonitrile at 70ºC for 2 hours. The reaction mixture was kept at 
70ºC throughout the reaction. Then, 9-bromomethylanthracene was added to the 
reaction mixture and the mixture was stirred for 1 day. Excess aqueous NH4PF6 was 
added to the solution. The dark brown precipitate was filtered and collected. The 
crude product was purified by column chromatography (silica, A sol). The yield of 
[Ru(L8)2][PF6]2 is 71%. 
Scheme 5. The synthesis of [Ru(L8)2][PF6]2.
3.2
1
H NMR spectroscopic characterisation 
All the complexes were characterised by 1H NMR spectroscopy in CD3CN solution. 
The 1H NMR spectra of the complexes were similar to those of other related 
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bis(terpyridine) systems. The terpyridine proton signals are similar in all complexes 
with the exception of the signals HT6 and HT3? which are subject to the influence of the 
metal centre and of the 4?-substituents attached to the terpyridine domain (Table 
1).41,42
Proton resonance (?)
HT5 HT6 HT4 HT3 HT3?
[Fe(poterpy)2][PF6]2
*,41 7.08 (td)  
J 1.2, 6.0 Hz 
7.14 (d)  
J 4.2 Hz 
7.87 (td)  
J 1.8, 7.4 
Hz
8.43 (d)  
J 8.1 Hz 
8.50 (s) 
[Fe(L4)2][PF6]2
7.08 (ddd) 
J 1.3, 5.6, 7.5 
Hz
7.17 (ddd) 
J 0.7, 1.4, 5.6 
Hz 
7.87 (td)  
J 1.5, 7.8 
Hz
8.44 (ddd) 
J 0.8, 1.2, 
8.0 Hz 
8.60 (s) 
[Fe(L5)2][PF6]2 6.99 (m) 
7.09 (dd) 
J 0.6, 5.6 Hz 
7.79 (m) 
8.36 (d) 
J 8.0 Hz 
8.49 (s) 
[Fe(L6)2][PF6]2
7.00 (t) 
J 7.1 Hz 
7.11 (d) 
J 5.6 Hz 
7.81 (m) 
8.37 (d) 
J 8.1 Hz 
8.46 (s) 
[Fe(L7)2][PF6]2
7.00 (t) 
J 6.3 Hz 
7.11 (d) 
J 5.1 Hz 
7.81 (m) 
8.36 (d) 
J 8.1 Hz 
8.44 (s) 
[Fe(L8)2][PF6]2
7.15 (ddd), 
J 1.3, 5.6, 7.5 
Hz
7.27 (ddd) 
J 0.7, 1.4, 
5.6Hz 
7.90 (td)  
J 1.4, 7.8 
Hz
8.45 (dt) 
J 1.0, 8.0 
Hz
8.73 (s) 
[Fe(L9)2][PF6]2
7.06 (ddd) 
J 1.3, 5.6, 7.6 
Hz
7.14 (ddd) 
J 0.7, 1.4, 5.6 
Hz 
7.77 (td)  
J 1.5, 7.8 
Hz
8.20 (m) 8.56 (s) 
J J34 8.0 Hz; J45 7.5 Hz; J46 1.4 Hz; J53 1.3 Hz; J56 5.6 Hz; J63 0.7 Hz 
[Ru(poterpy)2][PF6]2
*,42 7.16 (td)  
J 1.3, 7.0 Hz 
7.38 (dd)  
J 1.1, 5.0 Hz 
7.90 (td)  
J 1.4, 8.0 
Hz
8.47 (d)
J 8.0 Hz 
8.35 (s) 
[Ru(L4)2][PF6]2
7.16 (ddd) 
J 1.4, 5.7, 7.5 
Hz
7.39 (ddd) 
J 0.6, 1.4, 5.6 
Hz
7.90 (td)  
J 1.5, 7.9 
Hz
8.47 (dt) 
J 0.9, 8.1 
Hz
8.45 (s) 
[Ru(L5)2][PF6]2
7.08 (ddd) 
J 1.4, 5.7, 7.5 
Hz
7.33 (ddd) 
J 0.6, 1.4, 5.6 
Hz
7.83 (m) 
8.39 (dt) 
J 0.8, 8.1 
Hz
8.33 (s) 
[Ru(L6)2][PF6]2
7.08 (ddd) 
J 1.6, 5.7, 7.5 
Hz
7.34 (d) 
J 5.1 Hz 
7.82 (m) 
8.40 (d) 
J 8.1 Hz 
8.31 (s) 
[Ru(L7)2][PF6]2
7.08 (t) 
J 6.6 Hz 
7.34 (d) 
J 5.1 Hz 
7.82 (m) 
8.39 (d) 
J 8.1 Hz 
8.29 (s) 
[Ru(L8)2][PF6]2
7.22 (ddd), 
J 1.3, 5.6, 7.5 
Hz
7.47 (ddd) 
J 0.7, 1.5, 
5.6Hz 
7.93 (ddd) 
J 1.5, 7.6, 
8.1 Hz 
8.47 (ddd) 
J 0.8, 1.3, 
8.1 Hz 
8.56 (s) 
[Ru(L9)2][PF6]2
7.14 (ddd) 
J 1.3, 5.6, 7.6 
Hz
7.38 (ddd) 
J 0.7, 1.5, 5.6 
Hz
7.81 (ddd) 
J 1.5, 7.7, 
8.1 Hz 
8.22 (ddd)  
J 0.8, 1.3, 
8.2 Hz 
8.43 (s) 
J J34 8.1 Hz; J45 7.6 Hz; J46 1.5 Hz; J53 1.3 Hz; J56 5.6 Hz; J63 0.7 Hz 
Table 1.
1H NMR spectroscopic data (500 MHz) for the 5 terpyridine proton signals 
of the 12 complexes in CD3CN solution at room temperature (except 
[M(L6)2][PF6]2 and [M(L
7)2][PF6]2 were measured at 400 MHz, where M = 
Fe or Ru). (* poterpy = 4?-(2-propynyl-1-oxy)-2,2?:6?,2?-terpyridine) 
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Proton resonance (?)
HN6, N7 HN3 HN5 HN8 HN4 HN1
[Fe(L4)2][PF6]2 7.63 (m) 
7.83 (dd) 
J 1.8, 8.4 Hz 
8.01 (m) 8.05 (m) 
8.10 (d) 
J 8.4 Hz 
8.24 (s) 
[Fe(L5)2][PF6]2 7.45 (m) 
7.60 (dd) 
J 1.6, 8.4 Hz 
7.79 (m) 
7.85 (d) 
J 8.1 Hz 
7.87 (d) 
J 8.5 Hz 
7.94 (s) 
[Fe(L6)2][PF6]2 7.44 (m) 
7.51 (d) 
J 8.6 Hz 
7.81 (m) 
[Fe(L7)2][PF6]2 7.43 (m) 
7.48 (d) 
J 8.6 Hz 
7.81 (m) 
[Fe(L9)2][PF6]2 7.71 (m) 
7.94 (dd) 
J 1.8, 8.6 Hz 
8.09 (m) 8.20 (m) 
8.53 (d)
J 1.5 Hz 
[Ru(L4)2][PF6]2 7.62 (m) 
7.79 (dd) 
J 1.8, 8.4 Hz 
8.00 (m) 8.03 (m) 
8.08 (d)  
J 8.5 Hz 
8.20 (s) 
[Ru(L5)2][PF6]2 7.45 (m) 
7.59 (dd) 
J 1.7, 8.4 Hz 
7.83 (m) 
7.88 (d)  
J 8.5 Hz 
7.92 (s) 
[Ru(L6)2][PF6]2 7.44 (m) 
7.50 (dd) 
J 1.3, 8.3 Hz 
7.82 (m) 
[Ru(L7)2][PF6]2 7.43 (m) 
7.47 (dd) 
J 1.5, 8.6 Hz 
7.82 (m) 
[Ru(L9)2][PF6]2 7.66 (m) 
7.85 (dd) 
J 1.9, 8.6 Hz 
8.07 (m) 
8.16 (d)  
J 8.6 Hz 
8.46 (d) 
J 1.6 Hz 
Proton resonance (?)
HS1 (s) HA3, A6 (ddd) HA2, A7 (ddd) HA4, A5 (dt) HA1, A8 (dd) HA10 (s) 
[Fe(L8)2][PF6]2 6.70 
7.67
J 0.9, 6.5, 8.5 
Hz
7.77  
J 1.3, 6.5, 
9.0 Hz 
8.26
J 0.6, 8.5 Hz 
8.63
J 0.9, 9.0 Hz 
8.83
[Ru(L8)2][PF6]2 6.63 
7.67
J 0.9, 6.5, 8.4 
Hz
7.75  
J 1.3, 6.5, 
8.9 Hz 
8.24
J 0.6, 8.5 Hz 
8.59
J 0.9, 9.0 Hz 
8.80
Table 2.
1H NMR spectroscopic data (500 MHz) for the naphthyl or the anthryl 
proton signals of the 12 complexes in CD3CN solution at room temperature 
(except [M(L6)2][PF6]2 and [M(L
7)2][PF6]2 were measured at 400 MHz, 
where M = Fe or Ru). 
The 1H NMR spectrum of [Fe(L4)2][PF6]2 in CD3CN solution is shown in Figure 1.
Five terpyridine proton signals were found as expected by comparison to a similar 
Fe(II) system;41 the rest of the proton signals belonging to the naphthyl rings and the 
methylene group were further identified by NOESY and COSY techniques. The 
singlet at ? 5.87, which exhibits an NOE signal (Figure 2a) to HT3? singlet at ? 8.60, is 
assigned to HS1. The signal for HS1 also exhibits NOE signals to a singlet HN1 and a 
doublet of doublets HN3 at ? 8.24 and ? 7.83 respectively (Figure 2a). The signal for 
HN1 exhibits an NOE signal to a signal at ? 8.05, which is assigned to HN8 (Figure
2b). The signal for HN8 gives a COSY cross peak to HN7 at ? 7.63 (Figure 3). Also, 
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the signal for HN3 gives a COSY cross peak to a doublet at ? 8.10, and is therefore 
assigned to HN4. The signal for HN4 exhibits an NOE signal to a signal at ? 8.01, 
which is assigned to HN5 (Figure 2b). The signal for HN5 gives a COSY cross peak to 
the signal assigned to HN6 at ? 7.63 (Figure 3).
Figure 1. 
1H NMR (500 MHz) spectrum of [Fe(L4)2][PF6]2 in CD3CN solution at 
room temperature. 
(a) (b) 
Figure 2. NOESY spectra (500 MHz) of [Fe(L4)2][PF6]2 in CD3CN solution at room 
temperature. 
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Figure 3. COSY spectrum (500 MHz) of [Fe(L4)2][PF6]2 in CD3CN solution at room 
temperature.
(a) (b) 
Figure 4. COSY spectrum (500 MHz) of [Fe(L5)2][PF6]2 in CD3CN solution at room 
temperature.
The five terpyridine signals and the naphthyl signals of [Fe(L5)2][PF6]2 are assigned as 
in [Fe(L4)2][PF6]2 and these are confirmed by a COSY spectrum (Figure 4a). The rest 
of the ethyleneoxy chain signals are assigned by using a COSY spectrum (Figure 4b).
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The signal for HS1 is expected to be at a higher chemical shift than HS2. Therefore, the 
triplet at ? 4.83 is assigned as HS1 and the one at ? 4.18 is assigned as HS2.
The 1H NMR spectra of [Fe(L6)2][PF6]2 and [Fe(L
7)2][PF6]2 in CD3CN solution are 
assigned according to the spectrum for [Fe(L5)2][PF6]2. There is not much difference 
in the chemical shifts of the terpyridine signals or of the naphthyl signals as the length 
of the ethyleneoxy chain varies. However, the proton signals in the spectrum of 
[Fe(L4)2][PF6]2, which has the shortest distance between the terpyridine and naphthyl 
domain, shifted to lower field (Table 1 and Table 2).
The 1H NMR spectrum of [Fe(L8)2][PF6]2 in CD3CN solution exhibits ten signals 
from the terpyridine and the anthryl domains (Figure 5). The 5 terpyridine signals are 
assigned as before. The singlet signal at ? 6.70 is assigned to HS1. The signal for HS1
gives NOE signals to a singlet at ? 8.73 and a doublet of doublets at ? 8.63, which are 
assigned to HT3? and HA1, A8 respectively (Figure 6). From the COSY spectrum 
(Figure 7), HA1, A8 gives a COSY cross peak to a signal at ? 7.77, which is then 
assigned to HA2, A7. The singlet at ? 8.83, which has half of the relative integral of the 
signal for HS1, is assigned to HA10. HA10 gives an NOE signal to a triplet of doublets at 
? 8.26; the signal is assigned to HA4, A5 (Figure 6). From the COSY spectrum (Figure 
7), HA4, A5 gives a COSY cross peak to a signal at ? 7.67, which is assigned to HA3, A6.
Figure 5. 
1H NMR (500 MHz) spectrum of [Fe(L8)2][PF6]2 in CD3CN solution at 
room temperature. 
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Figure 6. NOESY spectrum (500 MHz) of [Fe(L8)2][PF6]2 in CD3CN solution at room 
temperature.
Figure 7. COSY spectrum (500 MHz) of [Fe(L8)2][PF6]2 in CD3CN solution at room 
temperature. 
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The 1H NMR spectrum of [Fe(L9)2][PF6]2 in CD3CN solution is shown in Figure 8b.
By comparing the spectrum to that of [Fe(L4)2][PF6]2, there are very different 
chemical shifts for the naphthyl ring when the linkage was changed from OCH2 to S 
between the terpyridine and naphthyl domain (Figure 8). Five terpyridine signals 
were assigned as previously described. The rest of the signals belonging to the 
naphthyl ring were further identified by NOESY and COSY techniques. The doublet 
with a coupling constant of 1.5 Hz at ? 8.53 is assigned to HN1. The signal for HN1
exhibits NOE signals to signals at ? 8.09 and ? 7.94, which are assigned to HN8 and 
HN3 respectively (Figure 9). Then, the signal for HN8 gives a COSY cross peak to the 
signal at ? 7.71, and is therefore assigned to HN7. Also, the signal for HN3 gives a 
COSY cross peak to a signal at ? 8.20, and is then assigned to HN4 (Figure 10). The 
signal for HN4 exhibits an NOE signal to a signal at ? 8.09, which is assigned to HN5
(Figure 9). HN5 gives a COSY cross peak to HN6 signal at ? 7.71 (Figure 10).
Within the series of [Fe(L)2][PF6]2 complexes (L = L
4-L7), the terpyridine signals in 
the 1H NMR spectra vary, especially the HT3? signal, as the end domain is varied. It is 
worth noting that there are no significant differences when the length of the 
ethyleneoxy linkage is varied in the case of [Fe(L)2][PF6]2 (L = L
5-L7).
Figure 8. 
1H NMR (500 MHz) spectra of (a) [Fe(L4)2][PF6]2 and (b) [Fe(L
9)2][PF6]2
in CD3CN solution at room temperature. 
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Figure 9. NOESY spectrum (500 MHz) of [Fe(L9)2][PF6]2 in CD3CN solution at room 
temperature. 
Figure 10. COSY spectrum (500 MHz) of [Fe(L9)2][PF6]2 in CD3CN solution at room 
temperature.
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The 1H NMR spectrum of [Ru(L4)2][PF6]2 in CD3CN solution is shown in Figure 11.
The five terpyridine signals were found as expected by comparison to a similar Ru(II) 
system;42 the rest of the signals belonging to the naphthyl ring and methylene protons 
were further assigned by NOESY and COSY experiments. The singlet at ? 5.79, 
which exhibits an NOE signal to the signal for HT3? at ? 8.45, is assigned to HS1
(Figure 12a). The signal for HS1 also exhibits NOE signals to signals for HN1 and HN3
at ? 8.20 and ? 7.79 respectively (Figure 12a). The signal for HN1 exhibits an NOE 
signal to a signal at ? 8.03, which is assigned to HN8 (Figure 12b). The signal for HN8
gives a COSY cross peak to the signal for HN7 at ? 7.62 (Figure 13). In the COSY 
spectrum (Figure 13), the signal for HN3 gives a COSY cross peak to the signal at ?
8.08, and this is therefore assigned to HN4. The signal for HN4 exhibits an NOE signal 
to the signal at ? 8.00, which is assigned to HN5 (Figure 12b). The signal for HN5
gives a COSY cross peak to the signal for HN6 at ? 7.62 (Figure 13).
Figure 11. 
1H NMR (500 MHz) spectrum of [Ru(L4)2][PF6]2 in CD3CN solution at 
room temperature. 
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(a) (b) 
Figure 12. NOESY spectra (500 MHz) of [Ru(L4)2][PF6]2 in CD3CN solution at room 
temperature. 
Figure 13. COSY spectrum (500 MHz) of [Ru(L4)2][PF6]2 in CD3CN solution at room 
temperature. 
The 1H NMR spectrum of [Ru(L5)2][PF6]2 in CD3CN solution is shown in Figure 14.
The five terpyridine signals and the naphthyl signals have been assigned in the same 
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way as for [Ru(L4)2][PF6]2 and the assignments were confirmed by COSY and 
NOESY. 
Figure 14. 1H NMR (500 MHz) spectrum of [Ru(L5)2][PF6]2 in CD3CN solution at 
room temperature. 
The 1H NMR spectra of [Ru(L6)2][PF6]2 and [Ru(L
7)2][PF6]2 in CD3CN solution were 
assigned by a comparison of the spectra to that of [Ru(L5)2][PF6]2. There are no 
significant differences between the chemical shifts of the terpyridine signals and 
naphthyl signals in this series of compounds even though the length of the 
ethyleneoxy chain varies (Table 1 and Table 2).
The 1H NMR spectrum of [Ru(L8)2][PF6]2 in CD3CN solution exhibits ten signals 
from the terpyridine and the anthryl domains (Figure 15). The five terpyridine signals 
were assigned as previously described. The singlet at ? 6.63 is assigned to HS1. The 
signal for HS1 gives NOE signals to a singlet at ? 8.56 and a doublet of doublets at ?
8.59 (Figure 16). These signals are therefore assigned to HT3? and HA1, A8 respectively. 
In the COSY spectrum (Figure 17), HA1, A8 gives a cross peak to the signal at ? 7.75, 
and this signal is assigned to HA2, A7. The singlet at ? 8.80, which has half of the 
relative integral of the signal for HS1, is assigned to HA10. The signal for HA10 gives an 
NOE signal to a signal at ? 8.24, which is assigned to HA4, A5 (Figure 16). In the 
COSY spectrum (Figure 17), HA4, A5 gives a cross peak to a signal at ? 7.67, and this 
signal is assigned to HA3, A6. Interestingly, there are no significant differences in the 
anthryl signals when the metal centre changes from Fe(II) to Ru(II) (Table 2).
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Figure 15.
1H NMR spectrum (500 MHz) of [Ru(L8)2][PF6]2 in CD3CN solution at 
room temperature. 
Figure 16. NOESY spectrum (500 MHz) of [Ru(L8)2][PF6]2 in CD3CN solution at 
room temperature. 
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Figure 17. COSY spectrum (500 MHz) of [Ru(L8)2][PF6]2 in CD3CN solution at room 
temperature. 
Figure 18. 1H NMR spectra (500 MHz) of (a) [Ru(L4)2][PF6]2 and (b) [Ru(L
9)2][PF6]2
in CD3CN solution at room temperature. 
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The 1H NMR spectrum of [Ru(L9)2][PF6]2 in CD3CN solution is shown in Figure
18b. Comparing this with the spectrum for [Ru(L4)2][PF6]2 shows that there is a 
significant change in the chemical shifts for the naphthyl ring protons when the 
linkage between the terpyridine and naphthyl domain is changed from OCH2 to S 
(Figure 18). The five terpyridine signals were assigned as previously described. The 
signals belonging to the naphthyl rings were further identified by NOESY and COSY 
experiments. 
In conclusion, with the exception of the signal for HT3?, there are only slight 
differences in the terpyridine signals when the terminal domain is altered within a 
series of complexes for a given metal centre. It is also worth noting that there are no 
significant differences when the length of the ethyleneoxy linkage varies in the case of 
[Ru(L)2][PF6]2 (L = L
5-L7). In addition, varying the metal centre from Fe(II) to Ru(II) 
does not lead to major differences in the signals for the substituents in the 1H NMR 
spectra of [M(L)2][PF6]2 (where M = Fe or Ru and L = L
4-L9) (Table 2).
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3.3 Mass spectrometric characterisation 
Electrospray ionisation mass spectrometry (ES-MS) was used to characterise the new 
complexes. The mass spectrum shows peaks for ions with particular mass to charge 
ratios (m/z). Each signal has a unique combination of the isotopes of the elements in 
the complexes. The difference between each of the signals of the isotope pattern is the 
reciprocal of the charge on the fragment from which the signal originates; e.g. if z = 2, 
the separation between peaks in an envelope will be 0.5 mass units. Normally, ES-MS 
is a relatively soft ionisation method and, [M-PF6]
+ and [M-2PF6]
2+ peaks are found as 
the major peaks for mononuclear Fe(II) and Ru(II) complexes. However, if the 
voltage used to ionise the samples is relatively high, some other fragments are 
observed in the spectra (Table 3).
m/z
[M-PF6]
+ [M-PF6-PF5]
+ [M-2PF6]
2+ Others 
[Fe(L4)2][PF6]2 979.0 853.1  1147.0, 693.4, 552.3, 464.1 
[Fe(L5)2][PF6]2 1067.1 940.9 461.5 737.4, 552.3, 508.3 
[Fe(L6)2][PF6]2 1154.9  505.2 781.2 
[Fe(L7)2][PF6]2 1243.0  549.2 825.3 
[Fe(L8)2][PF6]2 1079.0 953.0  743.2, 552.3, 191.4 
[Fe(L9)2][PF6]2   419.6 466.4 
[Ru(L4)2][PF6]2 1025.1 899.1  739.1, 598.1 
[Ru(L5)2][PF6]2 1113.2  484.1 783.3 
[Ru(L6)2][PF6]2 1201.1  528.1 827.2 
[Ru(L7)2][PF6]2 1289.1  572.1  
[Ru(L8)2][PF6]2 1125.1   
1189.1, 1157.0, 821.1, 
598.1, 191.1 
[Ru(L9)2][PF6]2 1029.0  442.1  
Table 3. The ES-MS data of the twelve complexes. 
In the ES-MS spectrum of [Fe(L6)2][PF6]2, which is shown in Figure 19, a peak at m/z
505.2 assigned to [M-2PF6]
2+ was the major signal. The other 2 minor signals at m/z
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1154.9 and 781.2 correspond to [M-PF6]
+ and [M-2PF6-O(CH2CH2O)2CH2Nap]
+
respectively. 
Figure 19. The ES-MS spectrum of [Fe(L6)2][PF6]2.
In Figure 20, the ES-MS spectrum of [Ru(L9)2][PF6]2 is shown. Two major signals 
were recorded at m/z 1029.0 and 442.1 which correspond to [M-PF6]
+ and [M-2PF6]
2+
respectively. The isotope patterns match those of the simulated spectra.  
Figure 20. The ES-MS spectrum of [Ru(L9)2][PF6]2. 
[M-PF6]
+[M-2PF6-
O(CH2CH2O)2
CH2Nap]
+
[M-2PF6]
2+
[M-PF6]
+[M-2PF6]
2+
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3.4 Absorption spectroscopic characterisation 
The electronic spectra of the homoleptic Fe(II) and Ru(II) complexes were recorded 
in HPLC grade acetonitrile solution. The absorption spectra of these complexes are 
similar to the sum of the spectra of [M(terpy)2]
2+, where M is Fe(II) or Ru(II), and 
those of the substituents. The absorption data for these twelve homoleptic complexes 
are summarised in Table 4.
?max, nm (?/ 103, M-1cm-1)
LC  MLCT 
[Fe(terpy)2][PF6]2 270 (39.9), 278 (35.2), 317 (52.2) 549 (11.6) 
[Fe(L4)2][PF6]2 223 (195), 245 (60.7), 273 (71.0), 315 (33.5) 556 (10.5) 
[Fe(L5)2][PF6]2 224 (241), 244 (59.7), 272(68.1), 315 (38.8) 556 (11.7) 
[Fe(L6)2][PF6]2 224 (289), 241 (74.7), 274 (74.0), 315 (31.8) 554 (8.41) 
[Fe(L7)2][PF6]2 224 (236), 241 (65.6), 272 (70.1), 315 (43.1) 557 (12.8) 
[Fe(L8)2][PF6]2
254 (333), 272 (75.9), 316 (48.2), 349 (20.8), 366 
(28.0), 386 (23.8) 
557 (15.9) 
[Fe(L9)2][PF6]2 221 (151), 283 (84.3), 314 (54.9) 566 (23.1) 
[Ru(terpy)2][PF6]2 268 (66.9), 305 (111.1) 473 (25.4) 
[Ru(L4)2][PF6]2 223(241), 242 (77.5), 269 (90.7), 304 (73.5) 485 (21.2) 
[Ru(L5)2][PF6]2 227 (236), 245 (60.8), 270 (68.1), 307 (67.4) 488 (19.0) 
[Ru(L6)2][PF6]2 224 (31.4), 241 (8.08), 267 (8.86), 304 (9.16) 486 (1.71) 
[Ru(L7)2][PF6]2 224 (213), 241 (61.6), 267 (62.1), 304 (63.5) 485 (16.9) 
[Ru(L8)2][PF6]2
251 (261), 267 (55.3), 302 (49.9), 346 (16.4), 363 
(18.9), 384 (16.5) 
483 (16.0) 
[Ru(L9)2][PF6]2 222 (129), 280 (76.0), 301 (66.6) 490 (26.3) 
Table 4. Electronic spectroscopic data for the complexes in acetonitrile solution.
The very intense bands in the UV region are assigned to the ligand-centred ?*??
transitions. The Fe(II) complexes and Ru(II) complexes exhibit a low energy metal-
to-ligand charge transfer (MLCT) transition with ?max between 554 to 566 nm and 
with ?max between 483 to 490 nm respectively. The MLCT transitions occur when an 
electron is transferred from the metal-centred d orbital to an unfilled ligand-centred ?*
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orbital. The data in Table 4 indicate that substitution in the 4?-position of the 
terpyridine ligand causes a dramatic red shift compared to the 2,2?:6?,2?-terpyridine 
ligand. Balzani and Constable et al.44 have reported that there is a red shift of the 
MLCT band of Ru(II) complexes irrespective of whether the substituent at the 4?-
position of the terpyridine ligand is electron-donating or electron-accepting. This 
indicates that, in spite of the electron-donating or electron-withdrawing nature of the 
substituents at the 4?-position, the energy of the absorption maximum decreases. 
A red shift of the MLCT band is observed when the linkage between the terpyridine 
ligand and the substituent is changed from OCH2 to S. It seems that there is no 
influence on the absorption data when the length of the linkage chain is changed, nor 
when the nature of the terminal domain is altered. 
3.5 Electrochemical studies 
The new complexes are redox active and were studied by cyclic voltammetry in 
acetonitrile solution. The redox potential data (vs. Fc/Fc+) are presented in Table 5.
Except for [Fe(L8)2][PF6]2, [Fe(L
9)2][PF6]2, [Ru(L
8)2][PF6]2 and [Ru(L
9)2][PF6]2, the 
processes of these complexes are reversible and they exhibit a M(II)/M(III) process 
and two reversible ligand-centred reductions.  
The observed Ru(II)/Ru(III) redox potentials for [Ru(L)2][PF6]2 (where L = L
4-L8) are 
the same as the corresponding potential for [Ru(EtO-terpy)2][PF6]2 (+0.74 V), where 
EtO-terpy = 4?-ethoxy-2,2?:6?,2?-terpyridine.44-46 This indicates that the electronic 
character of the substituents in the 4?-position of the terpyridine ligand is not 
influenced by the length of the chain or the end terminal domain. There are two and 
one non-reversible ligand-centred oxidation processes observed in [Ru(L8)2][PF6]2
and [Ru(L9)2][PF6]2. The Ru(II)/Ru(III) redox potential for [Ru(L
9)2][PF6]2 are more 
positive than others. This indicates that the S-2-naphthyl substituent has less electron-
donating power than all the other OCH2 substituents.  
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The electronic character of substituents in the 4?-position of the terpyridine ligands 
can be quantified by the use of a Hammett ?+ parameter. The Hammett ?+ parameter 
can be defined by using the formula Eox(Ru) = 0.245?+ + 0.944.45,47,48 The ?+
parameters for all the OCH2 linkage substituents are -0.87 (Eox(Ru) = 0.73 V) and -
0.83 (Eox(Ru) = 0.74 V). By substituting the ?+ value obtained from the formula of 
Eox(Ru) into the following formula, Eox(Fe) = 0.212?+ + 0.755, the Eox(Fe) value for 
iron complexes with OCH2 linked 4?-substituent terpyridine can be calculated. The 
calculated Eox(Fe) values, which are +0.57 V and +0.58 V, correspond well to the 
observed potential (+0.59 V). The ?+ parameter for the S-2-naphthyl substituent is -
0.42 which obtained from the formula of Eox(Ru) and the calculated Eox(Fe) potential 
(+0.67 V) is comparable to the observed value (+0.68 V). 
Ered (V) 
2nd reduction 
Ered (V) 
1st reduction 
Eox (V) 
Ru(II/III)
Eox (V) Eox (V)
[Fe(terpy)2][PF6]2 -1.85 -1.65 0.77   
[Fe(L4)2][PF6]2 -1.86 -1.72 0.59   
[Fe(L5)2][PF6]2 -1.90 -1.74 0.59   
[Fe(L6)2][PF6]2 -1.87 -1.73 0.59   
[Fe(L7)2][PF6]2 -1.90 -1.73 0.59   
[Fe(L8)2][PF6]2 -1.65* -1.62* 0.59 0.73* 0.95* 
[Fe(L9)2][PF6]2 -1.69 -1.58 0.68 0.84*  
[Ru(terpy)2][PF6]2 -1.92 -1.67 0.92   
[Ru(L4)2][PF6]2 -1.89 -1.71 0.74   
[Ru(L5)2][PF6]2 -1.91 -1.73 0.74   
[Ru(L6)2][PF6]2 -1.92 -1.72 0.73   
[Ru(L7)2][PF6]2 -1.91 -1.72 0.74   
[Ru(L8)2][PF6]2 -1.64  0.73  0.97* 
[Ru(L9)2][PF6]2  -1.58 0.84   
Table 5. Cyclic voltammetry data for the complexes in acetonitrile solution, with 
0.1M [tBu4N][PF6] as supporting electrolyte and Fc/Fc
+ as reference. Redox 
potentials marked * are non-reversible ligand-centred oxidation processes.
In conclusion, these complexes show an M(II)/(III) process at lower potential than 
those for [M(terpy)2]
2+. This indicates that these substituents in the 4?-position of the 
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terpyridine ligand (L4-L9) have higher electron donating properties than a proton in 
the 4?-position of 2,2?:6?,2?-terpyridine. 
3.6 Crystal structures of [M(L
4
)2][PF6]2·CH3CN and [M(L
5
)2][PF6]2
(where M = Fe and Ru) 
(a) Crystal structure of [Fe(L
4
)2][PF6]2·CH3CN 
Figure 21. An ORTEP representation (50% probability ellipsoids) of the [Fe(L4)2]
2+
cation in [Fe(L4)2][PF6]2·CH3CN. Hydrogen atoms are omitted for clarity. 
Crystals of [Fe(L4)2][PF6]2·CH3CN were obtained by slow diffusion of diethyl ether 
vapour into an acetonitrile solution of [Fe(L4)2][PF6]2. The crystals were of X-ray 
quality and the molecular structure of [Fe(L4)2][PF6]2·CH3CN was determined. The 
structure of the [Fe(L4)2]
2+ cation is presented in Figure 21. Crystallographic data are 
given in Appendix II and selected bond lengths and angles are given in Table 6. As 
expected, the tridentate ligands exhibit the cisoid conformation about the interannular 
C-C bonds, which is necessary for the adoption of the chelating mode. The 
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coordination sphere of the Fe(II) centre is similar to those in other complexes 
containing tridentate 2,2?:6?,2?-terpyridine ligands. The three pyridine rings in each 
ligand are close to being coplanar and the torsion angles N1-C5-C6-N2, N2-C10-C11-
N3, N4-C20-C21-N5 and N5-C25-C26-N6 are 2.59˚, -5.48˚, 1.73˚ and -0.58˚. The 
angle between the planes containing atoms N1, N2, N3 and N4, N5, N6 is 88.9˚.49-52
Fe1-N1 1.983(1) N1-C1 1.337(2) C5-C6 1.466(2) 
Fe1-N2 1.887(1) N1-C5 1.364(2) C10-C11 1.470(2) 
Fe1-N3 1.972(1) N2-C6 1.346(2) C20-C21 1.469(2) 
Fe1-N4 1.971(1) N2-C10 1.340(2) C25-C26 1.466(2) 
Fe1-N5 1.882(1) N3-C11 1.361(2)   
Fe1-N6 1.981(1) N3-C15 1.341(2) C8-O1 1.340(2) 
  N4-C16 1.344(2) C31-O1 1.429(2) 
  N4-C20 1.361(2) C23-O2 1.347(2) 
  N5-C21 1.349(2) C42-O2 1.454(2) 
  N5-C25 1.344(2)   
  N6-C26 1.361(2)   
  N6-C30 1.343(2)   
      
N1-Fe1-N2 80.54(5) N4-Fe1-N5 80.83(5) C7-C8-O1 115.3(1) 
N1-Fe1-N3 160.99(4) N4-Fe1-N6 161.21(4) C9-C8-O1 124.4(1) 
N2-Fe1-N3 80.61(5) N5-Fe1-N6 80.55(5) C8-O1-C31 117.6(1) 
N1-Fe1-N4 92.99(5) N3-Fe1-N6 92.10(5) C22-C23-O2 115.4(1) 
N2-Fe1-N4 100.92(5) N1-Fe1-N5 100.54(5) C24-C23-O2 124.6(1) 
N3-Fe1-N4 88.14(5) N1-Fe1-N6 92.85(5) C23-O2-C42 116.7(1) 
N3-Fe1-N5 98.38(5) N2-Fe1-N6 97.65(5)   
  N2-Fe1-N5 177.92(5)   
Table 6. Selected bond lengths (Å) and angles (˚) of the [Fe(L4)2]
2+ cation in 
[Fe(L4)2][PF6]2·CH3CN. 
All the bond lengths of the interannular C-C bonds and N-C bonds are comparable to 
the corresponding bond lengths of other Fe(II) complexes containing tridentate 
2,2?:6?,2?-terpyridine ligands.49,50,52 The Fe-N contacts to the central ring of the 4?-
(naphthalen-2-ylmethoxy)-2,2?:6?,2?-terpyridine ligand (Fe1-N2 and Fe1-N5) are 
shorter than those to the terminal rings (Fe1-N1, Fe1-N3, Fe1-N4 and Fe1-N6), which 
are within the reported range of Fe(II) complexes with 2,2?:6?,2?-terpyridine 
ligands.49-52 The methyleneoxy chain is nearly coplanar with the central pyridine ring. 
The torsion angles C9-C8-O1-C31 and C24-C23-O2-C42 are -2.09˚ and -8.06˚. The 
bond lengths O1-C8 and O2-C23 are 1.340(2) Å and 1.347(2) Å respectively which 
are similar to the corresponding distances in bis[4?-(2-propynyl-1-oxy)-2,2?:6?,2?-
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terpyridine]-ruthenium bis(hexafluorophosphate) acetone solvate 
([Ru(poterpy)2][PF6]2·(CH3)2CO)
42. The bond angles C7-C8-O1, C9-C8-O1, C22-
C23-O2 and C24-C23-O2 are within the range reported in the [Ru(poterpy)2]
2+ cation 
in the solid-state structure of [Ru(poterpy)2][PF6]2·(CH3)2CO. Also the bond angles 
C8-O1-C31 and C23-O2-C42 are 117.6(1)˚ and 116.7(1)˚ respectively which, within 
experimental error, are comparable to the corresponding angles in ([Ru(poterpy)2]
2+
cation (117.5(3)˚ and 118.1(3)˚).42
Figure 22. Packing of the [Fe(L4)2]
2+ cations that shows the face-to-face naphthyl-
pyridrine (blue line and green line), naphthyl-naphthyl (brown line) and 
face-to-edge (red line) interactions between the naphthyl rings and the 
pyridine rings. Hydrogen atoms are omitted for clarity. 
The dihedral angles of the planes of 2,2?:6?,2?-terpyridine and the naphthyl ring i.e. 
the planes containing N4, N5, N6 and C43, C46, C49, and N1, N2, N3 and C32, C36, 
C39 are 79.2˚ and 13.8˚ respectively. The two dihedral angles are very different. This 
is because of the intermolecular interactions between the naphthyl rings and pyridine 
rings between the molecules. The distance from the centroid of the pyridine N3 ring to 
the C40 atom of the naphthyl ring is 3.441 Å. The closest separation (C14 to C40) is 
3.433 Å. The other pair is from the naphthyl to the pyridine N1 ring. The distance 
Chapter 3 
98
from the centroid of the pyridine N1 ring to the C51 atom of the naphthyl ring is 
3.522 Å. The closest distance (C3 to C51) is 3.525 Å. In addition, there are naphthyl-
naphthyl ?-? stacking interactions in the lattice. The distance from the centroid of one 
naphthyl ring (C32-C34, C39-C41) to the C52 atom of the other naphthyl ring is 
3.443 Å. The shortest distance between two atoms of two rings (C32 to C52) is 3.481 
Å. Also, there are face-to-edge interactions between the naphthyl rings and the 
pyridine rings. The closest separation between CH···?, that is from the centroid of 
pyridine N6 ring to C40 atom of naphthyl ring, is 3.918 Å. The intermolecular 
interactions can be seen in the packing diagram presented in Figure 22.
(b) Crystal structure of [Ru(L
4
)2][PF6]2·CH3CN
Figure 23. An ORTEP representation (50% probability ellipsoids) of the [Ru(L4)2]
2+
cation in [Ru(L4)2][PF6]2·CH3CN. Hydrogen atoms are omitted for clarity. 
X-ray quality crystals of [Ru(L4)2][PF6]2·CH3CN were also obtained by slow diffusion 
of diethyl ether vapour into an acetonitrile solution of [Ru(L4)2][PF6]2. The structure 
of the [Ru(L4)2]
2+ cation is presented in Figure 23 and the crystallographic data are 
given in Appendix II. The structure is very similar to that of [Fe(L4)2][PF6]2·CH3CN 
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described above. The tridentate ligands exhibit the cisoid conformation about the 
interannular C-C bonds to adopt the chelating mode.40,42,45 The three pyridine rings in 
each ligand are close to being coplanar and the torsion angles N1-C5-C6-N2, N2-C10-
C11-N3, N4-C20-C21-N5 and N5-C25-C26-N6 are 4.13˚, -5.72˚, 2.67˚ and -1.02˚.
The angle between the planes containing atoms N1, N2, N3 and N4, N5, N6 is 
88.8˚.42,45
Ru1-N1 2.080(2) N1-C1 1.342(3) C5-C6 1.469(3) 
Ru1-N2 1.981(2) N1-C5 1.372(2) C10-C11 1.471(3) 
Ru1-N3 2.058(2) N2-C6 1.349(2) C20-C21 1.468(3) 
Ru1-N4 2.064(2) N2-C10 1.344(2) C25-C26 1.471(3) 
Ru1-N5 1.973(2) N3-C11 1.370(2)   
Ru1-N6 2.066(2) N3-C15 1.343(3) C8-O1 1.342(2) 
  N4-C16 1.340(3) C31-O1 1.428(2) 
  N4-C20 1.367(2) C23-O2 1.349(2) 
  N5-C21 1.354(2) C42-O2 1.454(2) 
  N5-C25 1.339(2)   
  N6-C26 1.366(2)   
  N6-C30 1.345(3)   
      
N1-Ru1-N2 78.73(6) N4-Ru1-N5 79.23(7) C7-C8-O1 115.0(2) 
N1-Ru1-N3 157.34(6) N4-Ru1-N6 157.66(6) C9-C8-O1 124.3(2) 
N2-Ru1-N3 78.72(7) N5-Ru1-N6 78.63(7) C8-O1-C31 117.7(2) 
N1-Ru1-N4 94.27(6) N3-Ru1-N6 92.32(7) C22-C23-O2 115.1(2) 
N2-Ru1-N4 102.55(7) N1-Ru1-N5 103.09(6) C24-C23-O2 124.6(2) 
N3-Ru1-N4 88.47(6) N1-Ru1-N6 93.54(6) C23-O2-C42 116.7(2) 
N3-Ru1-N5 99.53(7) N2-Ru1-N6 99.50(7)   
  N2-Ru1-N5 177.42(7)   
Table 7. Selected bond lengths (Å) and angles (˚) of the [Ru(L4)2]
2+ cation in 
[Ru(L4)2][PF6]2·CH3CN. 
Selected bond lengths and angles are given in Table 7. All the bond lengths of the 
interannular C-C bonds and N-C bonds are comparable to the corresponding bond 
lengths of other Ru(II) complexes containing tridentate 2,2?:6?,2?-terpyridine 
ligands.42,45 The Ru-N contacts to the central ring of the 4?-(naphthalen-2-ylmethoxy)-
2,2?:6?,2?-terpyridine ligand (Ru1-N2 and Ru-N5) are shorter than those to the 
terminal rings (Ru1-N1, Ru1-N3, Ru1-N4 and Ru1-N6), which are within the reported 
range for Ru(II) complexes with 2,2?:6?,2?-terpyridine ligands.42,45 The methyleneoxy 
chain is nearly coplanar with the central pyridine ring. The torsion angles C9-C8-O1-
C31 and C24-C23-O2-C42 are -2.44˚ and -8.23˚. The bond lengths O1-C8 and O2-
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C23 are 1.342(2) Å and 1.349(2) Å respectively which, within experimental error, are 
the similar to the corresponding bond lengths in the [Ru(poterpy)2]
2+ cation of 
[Ru(poterpy)2][PF6]2·(CH3)2CO.
42 The bond angles C7-C8-O1, C9-C8-O1, C22-C23-
O2 and C24-C23-O2 are within the range reported in the solid-state structure of 
[Ru(poterpy)2][PF6]2·(CH3)2CO. Also the bond angles C8-O1-C31 and C23-O2-C42 
are 117.7(2)˚ and 116.7(2)˚ respectively, which is comparable to the corresponding 
angles in the [Ru(poterpy)2]
2+ cation (117.5(3)˚ and 118.1(3)˚).42
Figure 24. Packing of the [Ru(L4)2]
2+ cations that shows the face-to-face naphthyl-
pyridine (blue line and green line), naphthyl-naphthyl (brown line) and 
face-to-edge (red line) interactions between the naphthyl rings and the 
pyridine rings. Hydrogen atoms are omitted for clarity. 
The dihedral angles of the planes of 2,2?:6?,2?-terpyridine and the naphthyl ring i.e. 
the planes containing N4, N5, N6 and C43, C46, C49, and N1, N2, N3 and C32, C36, 
C39 are 79.8˚ and 13.4˚ respectively. The two dihedral angles are very different. Just 
as in the Fe(II)-containing structure described above, this is due to a consequence of 
intermolecular interactions between the pyridine and naphthyl rings between 
molecules. The separation from the centroid of the pyridine N3 ring to the C40 atom 
of the naphthyl ring is 3.449 Å and the closest separation (C14 to C40) is 3.409 Å. 
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The other pair is from the naphthyl to the pyridine N1 ring. The distance from the 
centroid of the pyridine N1 ring to the C51 atom of the naphthyl ring is 3.516 Å. The 
closest distance (C3 to C51) is 3.539 Å. In addition, there are naphthyl-naphthyl ?-?
stacking interactions in the lattice. The distance from the centroid of one naphthyl ring 
(C32-C34, C39-C40) to the C52 atom in the other naphthyl ring is 3.479 Å. The 
shortest distance between two atoms of two rings (C32 to C52) is 3.479 Å. Again, 
there are face-to-edge interactions between the naphthyl rings and the pyridine rings. 
The closest separation of CH···? interactions, that is from the centroid of the plane 
C26, C28, C30 to C40, is 3.969 Å. These intermolecular interactions are shown in 
Figure 24.
(c) Crystal structure of [Fe(L
5
)2][PF6]2
The purple crystals of this iron complex, which were suitable for X-ray 
crystallographic analysis, were obtained by slow diffusion of diethyl ether vapour into 
acetonitrile solution of [Fe(L5)2][PF6]2. The lattice contains two non-equivalent, but 
very similar, [Fe(L5)2]
2+ cations (Figure 25). Crystallographic data are given in 
Appendix II.
The expected six-coordinate structure is confirmed. As described before, the tridentate 
ligands exhibit the cisoid conformation about the interannular C-C bonds in order to 
chelating to the metal. The three pyridine rings in each ligand are close to being 
coplanar and the torsion angles N1-C5-C6-N2, N2-C10-C11-N3, N4-C20-C21-N5 
and N5-C25-C26-N6 in molecule A and the corresponding angles in molecule B are 
within 4˚ of each other. The angle between the planes containing atoms N1, N2, N3 
and N4, N5, N6 is 88.0˚ for molecule A and that between the corresponding planes in 
molecule B is 88.9˚.49-52
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Figure 25. The crystal structure of the two independent [Fe(L5)2]
2+ cations in 
[Fe(L5)2][PF6]2 by an ORTEP representation (50% probability 
ellipsoids). The upper one is molecule A and the bottom one is molecule 
B. Hydrogen atoms are omitted for clarity. Carbon atoms are numbered 
sequentially around each ring. 
Selected bond lengths and angles of the two independent molecules (A and B) are 
given in Table 8. All the bond lengths of the interannular C-C bonds and N-C bonds 
which, within experimental error, are comparable to the corresponding bond lengths 
of other Fe(II) complexes containing tridentate 2,2?:6?,2?-terpyridine ligands.49,50,52
The Fe-N contacts to the central ring of the 4?-[2-(naphthalen-2-ylmethoxy)ethoxy]-
2,2?:6?,2?-terpyridine ligand (Fe1-N2 and Fe-N5) are shorter than those to the terminal 
rings (Fe1-N1, Fe1-N3, Fe1-N4 and Fe1-N6), which are within the reported range of 
Fe(II) complexes with 2,2?:6?,2?-terpyridine ligands.49-52 
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Molecule A  Molecule B  
Fe1-N1 1.972(6) Fe2-N7 1.976(5) 
Fe1-N2 1.887(5) Fe2-N8 1.884(5) 
Fe1-N3 1.989(5) Fe2-N9 1.979(5) 
Fe1-N4 1.967(6) Fe2-N10 1.986(6) 
Fe1-N5 1.878(5) Fe2-N11 1.889(5) 
Fe1-N6 1.975(6) Fe2-N12 1.959(6) 
O1-C8 1.345(8) O21-C108 1.325(7) 
O1-C51 1.41(1) O21-C151 1.442(9) 
O11-C23 1.341(8) O31-C123 1.344(8) 
O11-C61 1.438(8) O31-C161 1.48(1) 
    
N1-Fe1-N2 81.3(2) N7-Fe2-N8 81.1(2) 
N1-Fe1-N3 161.4(2) N7-Fe2-N9 161.6(2) 
N2-Fe1-N3 80.2(2) N8-Fe2-N9 80.5(2) 
N1-Fe1-N4 89.9(2) N7-Fe2-N10 92.8(2) 
N2-Fe1-N4 97.9(2) N8-Fe2-N10 99.0(2) 
N3-Fe1-N4 92.9(2) N9-Fe2-N10 91.2(2) 
N3-Fe1-N5 98.5(2) N7-Fe2-N11 99.1(2) 
N4-Fe1-N5 80.3(2) N10-Fe2-N11 80.4(2) 
N4-Fe1-N6 161.1(2) N10-Fe2-N12 161.8(2) 
N5-Fe1-N6 80.8(2) N11-Fe2-N12 81.4(2) 
N3-Fe1-N6 89.1(2) N9-Fe2-N12 92.4(2) 
N1-Fe1-N5 100.1(2) N7-Fe2-N11 99.1(2) 
N1-Fe1-N6 94.1(2) N7-Fe2-N12 89.5(2) 
N2-Fe1-N6 101.0(2) N8-Fe2-N12 99.2(2) 
N2-Fe1-N5 177.7(2) N8-Fe2-N11 179.4(2) 
O1-C8-C7 116.6(7) O21-C108-C107 124.1(6) 
O1-C8-C9 122.7(7) O21-C108-C109 115.8(6) 
C8-O1-C51 119.6(6) C108-O21-C151 116.5(5) 
O11-C23-C22 115.8(6) O31-C123-C122 114.9(6) 
O11-C23-C24 124.0(6) O31-C123-C124 124.8(6) 
C23-O11-C61 118.4(5) C123-O31-C161 117.9(6) 
Table 8. Selected bond lengths (Å) and angles (˚) of the two independent [Fe(L5)2]
2+
cations in [Fe(L5)2][PF6]2.
The ethyleneoxy chains in a given molecule are very different from each other and 
adopt different conformations. The bond lengths between the O atoms to the directly 
connected C atoms of central pyridine rings are range from 1.325(7)-1.345(8) Å 
which, within experimental error, are the same as that in the [Ru(poterpy)2]
2+ cation in 
the solid-state structure of [Ru(poterpy)2][PF6]2·(CH3)2CO
42. The bond angles C7-C8-
O1, C9-C8-O1, C22-C23-O11 and C24-C23-O11 in molecule A and C107-C108-
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O21, C109-C108-C21, C122-C123-O31 and C124-C123-O31 in molecule B are 
within the range reported in the solid-state structure of 
[Ru(poterpy)2][PF6]2·(CH3)2CO.
42 Also the bond angles C8-O1-C51 and C23-O11-
C61 in molecule A are 119.6(6)˚ and 118.4(5)˚ and C108-O21-C151 and C123-O31-
C161 in molecule B are 116.5(5)˚ and 117.9(6)˚, which is comparable to the 
corresponding angles in [Ru(poterpy)2]
2+ cation (117.5(3)˚ and 118.1(3)˚). Along the 
ethyleneoxy chain, the C-C and C-O bond lengths are different in the two molecules 
(Table 7). The C-C and C-O bond lengths are range from 1.46(1)-1.63(2) Å and 
1.33(1)-1.48(1) Å respectively. 
There are 2 pairs of face-to-face ?-? stacking interactions between the pyridine rings 
in the unit cell. One pair is between the pyridine N3 and N7 ring and the other one is 
between the pyridine N1 and N10 ring. The distance between the centroid of the 
pyridine N7 ring and C14 atom of the pyridine N3 ring is 3.537 Å, and the distance 
between the centroid of the pyridine N10 ring and C3 atom of the pyridine N1 ring is 
3.578 Å. The packing diagram is shown in Figure 26.
Figure 26. Packing of the [Fe(L5)2]
2+ cations that shows the face-to-face ?-? stacking 
interactions between the pyridine rings. Blue line is from pyridine ring N3 
to N7; red line is from pyridine ring N1 to N10. Hydrogen atoms are 
omitted for clarity. 
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(d) Crystal structure of [Ru(L
5
)2][PF6]2
By slow diffusion of diethyl ether vapour into an acetonitrile solution of 
[Ru(L5)2][PF6]2, red crystals of this ruthenium complex were obtained. The lattice 
contains two non-equivalent, but very similar, [Ru(L5)2]
2+ cations A and B (Figure 
27). Crystallographic data are given in Appendix II. As in the three crystal structures 
described above, the tridentate ligands exhibit the cis-cis conformation about the 
interannular C-C bonds.40,42,45 The three pyridine rings in each ligand are close to 
being coplanar and the torsion angles N1-C5-C6-N2, N2-C10-C11-N3, N4-C20-C21-
N5 and N5-C25-C26-N6 in molecule A are -1.79˚, 1.95˚, -0.20˚, -1.86˚ and those 
corresponding to molecule B are -3.21˚, 2.88˚, 0.89˚, -0.01˚. The angle between the 
planes containing atoms N1, N2, N3 and N4, N5, N6 is 88.3˚ for molecule A and that 
between the corresponding planes in molecule B is 88.6˚.42,45
Figure 27. The crystal structure of the two independent [Ru(L5)2]
2+ cations in 
[Ru(L5)2][PF6]2 by an ORTEP representation (50% probability 
ellipsoids). The upper one is molecule A and the bottom one is molecule 
B. Hydrogen atoms are omitted for clarity. Carbon atoms are numbered 
sequentially around each ring. 
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Molecule A  Molecule B  
Ru1-N1 2.065(3) Ru2-N7 2.065(3) 
Ru1-N2 1.981(2) Ru2-N8 1.978(2) 
Ru1-N3 2.069(3) Ru2-N9 2.059(3) 
Ru1-N4 2.070(3) Ru2-N12 2.051(3) 
Ru1-N5 1.976(2) Ru2-N11 1.971(2) 
Ru1-N6 2.057(3) Ru2-N10 2.062(3) 
O1-C8 1.357(3) O21-C108 1.348(4) 
O1-C51 1.447(4) O21-C151 1.427(5) 
O11-C23 1.340(4) O31-C123 1.349(4) 
O11-C61 1.464(5) O31-C161 1.433(4) 
    
N1-Ru1-N2 78.9(1) N7-Ru2-N8 78.8(1) 
N1-Ru1-N3 157.83(9) N7-Ru2-N9 157.9(1) 
N2-Ru1-N3 78.9(1) N8-Ru2-N9 79.1(1) 
N1-Ru1-N4 93.7(1) N7-Ru2-N12 91.1(1) 
N2-Ru1-N4 100.5(1) N8-Ru2-N12 98.4(1) 
N3-Ru1-N4 91.0(1) N9-Ru2-N12 92.6(1) 
N3-Ru1-N5 100.3(1) N9-Ru2-N11 98.8(1) 
N4-Ru1-N5 79.0(1) N11-Ru2-N12 79.1(1) 
N4-Ru1-N6 157.8(1) N10-Ru2-N12 157.8(1) 
N5-Ru1-N6 78.8(1) N10-Ru2-N11 78.7(1) 
N3-Ru1-N6 93.8(1) N9-Ru2-N10 90.3(1) 
N1-Ru1-N5 101.9(1) N7-Ru2-N11 103.2(1) 
N1-Ru1-N6 89.9(1) N7-Ru2-N10 94.5(1) 
N2-Ru1-N6 101.7(1) N8-Ru2-N10 103.8(1) 
N2-Ru1-N5 179.1(1) N8-Ru2-N11 176.7(1) 
O1-C8-C7 123.4(3) O21-C108-C107 116.0(3) 
O1-C8-C9 115.5(3) O21-C108-C109 123.5(3) 
C8-O1-C51 116.2(3) C108-O21-C151 118.9(3) 
O11-C23-C22 114.8(3) O31-C123-C124 115.1(3) 
O11-C23-C24 124.7(3) O31-C123-C122 124.4(3) 
C23-O11-C61 118.3(3) C123-O31-C161 116.6(3) 
Table 9. Selected bond lengths (Å) and angles (˚) of the two independent [Ru(L5)2]
2+
cations in [Ru(L5)2][PF6]2.
Selected bond lengths and angles of the two independent molecules (A and B) are 
given in Table 9. All the bond lengths of the interannular C-C bonds and N-C bonds 
are, within experimental error, comparable to the corresponding bond lengths of other 
Ru(II) complexes containing tridentate 2,2?:6?,2?-terpyridine ligands.42,45 The Ru-N 
distances show the typical trend for 2,2?:6?,2?-terpyridine containing complexes with 
bonds to the central terpyridine ring (1.971(2)-1.981(2) Å) being significantly shorter 
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than those to the terminal rings (2.051(3)-2.070(3) Å). All bond lengths and angles 
within the [Ru(terpy)2] moiety are normal.
42,45
The ethyleneoxy chains are very different from each other. They adopt different 
conformations, like those in the case of [Fe(L5)2][PF6]2. The bond lengths of the O 
atoms to the directly connected C atoms of central pyridine rings are range from 
1.340(4)-1.357(3) Å which, within experimental error, are the same as that in the 
[Ru(poterpy)2][PF6]2·(CH3)2CO.
42 The bond angles C7-C8-O1, C9-C8-O1, C22-C23-
O11 and C24-C23-O11 in molecule A and C107-C108-O21, C109-C108-C21, C124-
C123-O31 and C122-C123-O31 in molecule B are within the range reported in the 
solid-state structure of [Ru(poterpy)2][PF6]2·(CH3)2CO.
42 Also the bond angles C8-
O1-C51 and C23-O11-C61 in molecule A are 116.2(3)˚ and 118.3(3)˚ and C108-O21-
C151 and C123-O31-C161 in molecule B are 118.9(3)˚ and 116.6(3)˚, which is 
comparable to the corresponding angles in [Ru(poterpy)2]
2+ cation (117.5(3)˚ and 
118.1(3)˚).42 Along the ethyleneoxy chain, the C-C and C-O bond lengths are different 
in the two molecules (Table 8).
Figure 28. Packing of the [Ru(L5)2]
2+ cations that shows the face-to-face ?-? stacking 
interactions between the pyridine rings. Blue line is from pyridine ring N4 
to N7; red line is from pyridine ring N1 to N9. Hydrogen atoms are 
omitted for clarity. 
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There are 2 pairs of face-to-face ?-? stacking interactions between the pyridine rings 
in the unit cell. One pair is between pyridine ring N1 and N9 and the other one is 
between pyridine ring N4 and N7. The closest separation between the centroid of the 
pyridine N1 ring and C114 atom of the pyridine N9 ring is 3.550 Å. The other pair of 
?-? stacking interactions are between the pyridine N4 ring and N7 ring. The closest 
distance between the centroid of pyridine N4 ring and C103 atom of N7 ring is 3.523 
Å. The packing diagram is shown in Figure 28.
3.7 Conclusion 
The mononuclear Fe(II) and Ru(II) complexes of different 4?-substituted-2,2?:6?,2?-
terpyridine ligands L4-L9, which contain polyethyleneoxy chains and differ from one 
another in the length of the chains, in the terminal domains or in the linkages, have 
been synthesised. The complexes have been characterised with 1H NMR 
spectroscopy, mass spectrometry (ES), UV/VIS spectroscopy, cyclic voltammetry and 
elemental analysis. The solid-state structures of [M(L4)2][PF6]2 and [M(L
5)2][PF6]2
(where M = Fe and Ru) were determined by X-ray crystallography. 
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3.8 Experimental 
? [Fe(L4)2][PF6]2 ? [Ru(L4)2][PF6]2
? [Fe(L5)2][PF6]2 ? [Ru(L5)2][PF6]2
? [Fe(L6)2][PF6]2 ? [Ru(L6)2][PF6]2
? [Fe(L7)2][PF6]2 ? [Ru(L7)2][PF6]2
? [Fe(L8)2][PF6]2 ? [Ru(L8)2][PF6]2
? [Fe(L9)2][PF6]2 ? [Ru(L9)2][PF6]2
where L4 4?-(Naphthalen-2-ylmethoxy)-2,2?:6?,2?-terpyridine 
L
5
4?-[2-(Naphthalen-2-ylmethoxy)ethoxy]-2,2?:6?,2?-terpyridine 
L
6
4?-{2-[2-(Naphthalen-2-ylmethoxy)ethoxy]ethoxy}-2,2?:6?,2?-terpyridine 
L
7
4?-(2-{2-[2-(Naphthalen-2-ylmethoxy)ethoxy]ethoxy}ethoxy)-2,2?:6?,2?-
terpyridine 
L
8
4?-(Anthracen-9-ylmethoxy)-2,2?:6?,2?-terpyridine 
L
9
4?-(Naphthalen-2-ylsulfanyl)-2,2?:6?,2?-terpyridine 
[Ru(HO-terpy)2][PF6]2
45 and 9-bromomethylanthracene53 were prepared as previously 
reported in the literature. L4, L5, L6, L7, L8 and L9 were prepared as in Chapter 2. 
(a) General method for synthesising iron(II) complexes 
FeCl2·4H2O (1 equivalent) and L (2 equivalents) were added into 5 mL CH3OH. The purple 
solution was stirred at room temperature for about 1 hour. Excess aqueous NH4PF6 was added 
N
Y
N N
NY
N
N
N Y
N
N
Fe [PF6]2
N
O
NN
O
O
N
O
NN
O
O
N
O
NN
O
O
Fe [PF6]2
L
1. FeCl2
.4H2O, MeOH
2. Excess aqueous NH4PF6
L
1. FeCl2
.4H2O, MeOH
2. Excess aqueous NH4PF6
L5    n = 0 
L6    n = 1
L7    n = 2
n
n
n
L4   Y = O-CH2-2-naphthyl 
L8   Y = O-CH2-9-anthryl
L9    Y = O-S-2-naphthyl
[Fe(L)2][PF6]2   (L = L
4, L8, L9)
[Fe(L)2][PF6]2   (L = L
5-L7)
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to the solution. The purple precipitate was filtered, washed with water and collected without 
purification to give a purple powder.23,41
? [Fe(L4)2][PF6]2
Molecular formula: 
C52H38N6O2FeP2F12 
Molecular weight: 1124.67 
L
4 (40 mg, 0.10 mmol) and FeCl2·4H2O (10 mg, 0.050 mmol) were used. A purple 
powder (54.8 mg, 97.4%) was obtained. 
1H NMR (500 MHz, CD3CN): ?H 5.87 (s, 4H, HS1), 7.08 (ddd, J 1.3, 5.6, 7.5 Hz, 4H, 
HT5), 7.17 (ddd, J 0.7, 1.4, 5.6 Hz, 4H, HT6), 7.63 (m, 4H, HN7 and HN6), 7.83 (dd, J 1.8, 
8.4 Hz, 2H, HN3), 7.87 (td, J 1.5, 7.8 Hz, 4H, HT4), 8.01 (m, 2H, HN5), 8.05 (m, 2H, HN8), 
8.10 (d, J 8.4 Hz, 2H, HN4), 8.24 (s, 2H, HN1), 8.44 (ddd, J 0.8, 1.2, 8.0 Hz, 4H, HT3), 8.60 
(s, 4H, HT3?).
MS (ES): m/z = 1147.0 [M+Na]+, 979.0 [M-PF6]
+, 853.1 [M-PF6-PF5]
+, 693.4 [M-2PF6-
CH2Nap]
+, 552.3 [M-2PF6-2CH2Nap]
+, 464.1 [L4+ Fe+ F]+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 223 (195 x 103), 245 (60.7 x 103), 273 (71.0 x 
103), 315 (33.5 x 103), 556 (10.5 x 103). 
Cyclic voltammetry data (CH3CN, 0.1 M [
tBu4N]PF6, Fc/Fc
+): +0.59 V, -1.72 V, -1.86 V. 
Found: C, 55.19; H, 3.48; N, 8.07. Calc. for C52H38N6O2P2F12Fe·½CH3CN: C, 55.58; H, 
3.48; N, 7.95%. 
? [Fe(L5)2][PF6]2
Molecular formula: C56H46N6O4FeP2F12
Molecular weight: 1212.78 
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L
5 (17 mg, 0.040 mmol) and FeCl2·4H2O (4.0 mg, 0.020 mmol) were used. A purple 
powder (24.8 mg, 98.0%) was obtained. 
1H NMR (500 MHz, CD3CN): ?H 4.18 (m, 4H, HS2), 4.83 (m, 4H, HS1), 4.91 (s, 4H, HS3), 
6.99 (m, 4H, HT5), 7.09 (dd, J 0.6, 5.6 Hz, 4H, HT6), 7.45 (m, 4H, HN7 and HN6), 7.60 (dd, 
J 1.6, 8.4 Hz, 2H, HN3), 7.79 (m, 6H, HT4 and HN5), 7.85 (d, J 8.1 Hz, 2H, HN8), 7.87 (d, J
8.5 Hz, 2H, HN4), 7.94 (s, 2H, HN1), 8.36 (d, J 8.0 Hz, 4H, HT3), 8.49 (s, 4H, HT3?).
13C NMR (125 MHz, CD3CN): ?C 69.6 (CS2), 71.0 (CS1), 74.0 (CS3), 112.5 (CT3?), 124.5 
(CT3), 126.9 (CN3), 127.0 (CN6/ N7/ N1), 127.25 (CN6/ N7/ N1), 127.27 (CN6/ N7/ N1), 128.1 (CT5), 
128.6 (CN5/ N8), 128.7 (CN8/ N5), 129.1 (CN4), 133.9 (CN10), 134.2 (CN9), 137.1 (CN2), 139.4 
(CT4), 154.2 (CT6), 159.0 (CT2), 161.7 (CT2?), 168.9 (CT4?). 
MS (ES): m/z = 1067.1 [M-PF6]
+, 940.9 [M-PF6-PF5]
+, 737.4 [M-2PF6-
CH2CH2OCH2Nap]
+, 552.3 [M-2PF6-2CH2CH2OCH2Nap]
+, 508.3 [L5+Fe+F]+, 461.5 [M-
2PF6]
2+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 224 (241 x 103), 244 (59.7 x 103), 272 (68.1 x 
103), 315 (38.8 x 103), 556 (11.7 x 103). 
Cyclic voltammetry data (CH3CN, 0.1 M [
tBu4N]PF6, Fc/Fc
+): +0.59 V, -1.74 V, -1.90 V. 
Found: C, 54.91; H, 4.04; N, 6.64. Calc. for C56H46N6O4P2F12Fe·½H2O: C, 55.05; H, 3.88; 
N, 6.88%. 
? [Fe(L6)2][PF6]2
Molecular formula: C60H54N6O6FeP2F12
Molecular weight: 1300.78 
L
6 (59.5 mg, 0.125 mmol) and FeCl2·4H2O (12.4 mg, 0.0625 mmol) were used. A purple 
powder (69.4 mg, 85.7%) was obtained. 
1H NMR (400 MHz, CD3CN): ?H 3.79 (m, 4H, HS4), 3.88 (m, 4H, HS3), 4.12 (m, 4H, HS2), 
4.75 (s, 4H, HS5), 4.76 (m, 4H, HS1), 7.00 (t, J 7.1 Hz, 4H, HT5), 7.11 (d, J 5.6 Hz, 4H, 
HT6), 7.44 (m, 4H, HN6 and HN7), 7.51 (d, J 8.6 Hz, 2H, HN3), 7.81 (m, 12H, HN5, HN8, HT4,
HN4 and HN1), 8.37 (d, J 8.1 Hz, 4H, HT3), 8.46 (s, 4H, HT3?). 
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MS (ES): m/z = 1154.9 [M-PF6]
+, 781.2 [M-2PF6-O(CH2CH2O)2CH2Nap]
+, 505.2 [M-
2PF6]
2+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 224 (289 x 103), 241 (74.7 x 103), 274 (74.0 x 
103), 315 (31.8 x 103), 554 (8.41 x 103). 
Cyclic voltammetry data (CH3CN, 0.1 M [
tBu4N]PF6, Fc/Fc
+): +0.59 V, -1.73 V, -1.87 V. 
Found: C, 55.21; H, 4.21; N, 6.41. Calc. for C60H54N6O6P2F12Fe: C, 55.39; H, 4.18; N, 
6.46%.
? [Fe(L7)2][PF6]2
Molecular formula: 
C64H62N6O8FeP2F12 
Molecular weight: 1388.99 
L
7 (40 mg, 0.077 mmol) and FeCl2·4H2O (7.65 mg, 0.0385 mmol) were used. The purple 
powder (42.6 mg, 79.7%) was obtained. 
1H NMR (400 MHz, CD3CN): ?H 3.72 (m, 12H, HS4, HS5 and HS6), 3.82 (t, J 4.2 Hz, 4H, 
HS3), 4.11 (t, J 4.0 Hz, 4H HS2), 4.69 (s, 4H, HS7), 4.74 (t, J 4.0 Hz, 4H, HS1), 7.00 (t, J 6.3 
Hz, 4H, HT5), 7.11 (d, J 5.1 Hz, 4H, HT6), 7.43 (m, 4H, HN6 and HN7), 7.48 (d, J 8.6 Hz, 
2H, HN3), 7.81 (m, 12H, HN5, HN8, HT4, HN4 and HN1), 8.36 (d, J 8.1 Hz, 4H, HT3), 8.44 (s, 
4H, HT3?). 
MS (ES): m/z = 1243.0 [M-PF6]
+, 825.3 [M-2PF6-(CH2CH2O)3CH2Nap]
+, 549.2 [M-
2PF6]
2+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 224 (236 x 103), 241 (65.6 x 103), 272 (70.1 x 
103), 315 (43.1 x 103), 557 (12.8 x 103). 
Cyclic voltammetry data (CH3CN, 0.1 M [
tBu4N]PF6, Fc/Fc
+): +0.59 V, -1.73 V, -1.90 V. 
Found: C, 54.53; H, 4.47; N, 6.02. Calc. for C64H62N6O8P2F12Fe·H2O: C, 54.63; H, 4.59; 
N, 5.97%. 
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? [Fe(L8)2][PF6]2
Molecular formula: 
C60H42N6O2FeP2F12 
Molecular weight: 1224.79 
L
8 (35 mg, 0.080 mmol) and FeCl2·4H2O (7.9 mg, 0.040 mmol) were used. A purple 
powder (36.3 mg, 74.0%) was obtained. 
1H NMR (500 MHz, CD3CN): ?H 6.70 (s, 4H, HS1), 7.15 (ddd, J 1.3, 5.6, 7.5 Hz, 4H, 
HT5), 7.27 (ddd, J 0.7, 1.4, 5.6 Hz, 4H, HT6), 7.67 (ddd, J 0.9, 6.5, 8.5 Hz, 4H, HA3, A6),
7.77 (ddd, J 1.3, 6.5, 9.0 Hz, 4H, HA2, A7), 7.90 (td, J 1.4, 7.8 Hz, 4H, HT4), 8.26 (dt, J 0.6, 
8.5 Hz, 4H, HA4, A5), 8.45 (dt, J 1.0, 8.0 Hz, 4H, HT3), 8.63 (dd, J 0.9, 9.0 Hz, 4H, HA1, A8), 
8.73 (s, 4H, HT3?), 8.83 (s, 2H, HA10).
MS (ES): m/z = 1079.0 [M-PF6]
+, 953.0 [M-PF6-PF5]
+, 743.2 [M-2PF6-CH2Ant]
+, 552.3 
[M-2PF6-2CH2Ant]
+, 191.4 [CH2Ant]
+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 254 (333 x 103), 272 (75.9 x 103), 316 (48.2 x 
103), 349 (20.8 x 103), 366 (28.0 x 103), 386 (23.8 x 103), 557 (15.9 x 103).
Cyclic voltammetry data (CH3CN, 0.1 M [
tBu4N]PF6, Fc/Fc
+): +0.95 V, +0.73 V, +0.59 
V, -1.62 V, -1.65 V. 
Found: C, 57.79; H, 3.73; N, 6.72. Calc. for C60H42N6O2P2F12Fe·H2O: C, 57.98; H, 3.57; 
N, 6.76%.
? [Fe(L9)2][PF6]2
Molecular formula: C50H34N6S2FeP2F12
Molecular weight: 1128.75 
L
9 (40 mg, 0.10 mmol) and FeCl2·4H2O (9.9 mg, 0.050 mmol) were used. A purple 
powder (51.2 mg, 90.8%) was obtained. 
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1H NMR (500 MHz, CD3CN): ?H 7.06 (ddd, J 1.3, 5.6, 7.6 Hz, 4H, HT5), 7.14 (ddd, J 0.7, 
1.4, 5.6 Hz, 4H, HT6), 7.71 (m, 4H, HN6 and HN7), 7.77 (td, J 1.5, 7.8 Hz, 4H, HT4), 7.94 
(dd, J 1.8, 8.6 Hz, 2H, HN3), 8.09 (m, 4H, HN5 and HN8), 8.20 (m, 6H, HT3 and HN4), 8.53 
(d, J 1.5 Hz, 2H, HN1), 8.56 (s, 4H, HT3?).
MS (ES): m/z = 466.4 [L9+Fe+F]+, 419.6 [M-2PF6]
2+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 221 (151 x 103), 283 (84.3 x 103), 314 (54.9 x 
103), 566 (23.1 x 103).
Cyclic voltammetry data (CH3CN, 0.1 M [
tBu4N]PF6, Fc/Fc
+): +0.84 V, +0.68 V, -1.58 V, 
-1.69 V. 
Found: C, 53.21; H, 3.16; N, 7.21. Calc. for C50H34N6S2P2F12Fe: C, 53.20; H, 3.04; N, 
7.45%. 
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(b) General method for synthesising ruthenium(II) complexes 
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Step 1 
RuCl3·3H2O (1 equivalent) and L (1 equivalent) were added to 10 mL CH3OH. The solution 
was heated to reflux for 3 hours. Then, the brownish yellow precipitate which had formed was 
filtered off and air dried to give [RuLCl3]. The product was used without any purification. 
Step 2 
The complex [RuLCl3] (1 equivalent) and L (1 equivalent) were suspended in CH3OH (10 
mL). N-Ethylmorpholine (NEM) (2 drops) was added and the mixture was heated to reflux for 
3 hours. Then, the resulting dark solution was allowed to cool, and excess aqueous NH4PF6
was added to the solution. The dark red precipitate was filtered and washed with water. The 
dark red precipitate was collected without purification to give a red powder.24,26,29
? [Ru(L4)2][PF6]2
Molecular formula: 
C52H38N6O2RuP2F12 
Molecular weight: 1169.90 
RuCl3·3H2O (17 mg, 0.064 mmol) and L
4 (25 mg, 0.064 mmol) were used for step 1 and 
30.3 mg of [RuL4Cl3] was obtained. Then, another 1 equivalent of L
4 (20 mg, 0.051 
mmol) was used for the second step. A reddish brown powder (41.2 mg, 55.0%) was 
obtained. 
1H NMR (500 MHz, CD3CN): ?H 5.79 (s, 4H, HS1), 7.16 (ddd, J 1.4, 5.7, 7.5 Hz, 4H, 
HT5), 7.39 (ddd, J 0.6, 1.4, 5.6 Hz, 4H, HT6), 7.62 (m, 4H, HN7 and HN6), 7.79 (dd, J 1.8, 
8.4 Hz, 2H, HN3), 7.90 (td, J 1.5, 7.9 Hz, 4H, HT4), 8.00 (m, 2H, HN5), 8.03 (m, 2H, HN8), 
8.08 (d, J 8.5 Hz, 2H, HN4), 8.20 (s, 2H, HN1), 8.45 (s, 4H, HT3?), 8.47 (dt, J 0.9, 8.1 Hz, 
4H, HT3).
MS (ES): m/z = 1025.1 [M-PF6]
+, 899.1 [M-PF6-PF5]
+, 739.1 [M-2PF6-CH2Nap]
+, 598.1 
[M-2PF6-2CH2Nap]
+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 223 (241 x 103), 242 (77.5 x 103), 269 (90.7 x 
103), 304 (73.5 x 103), 485 (21.2 x 103). 
Cyclic voltammetry data (CH3CN, 0.1 M [
tBu4N]PF6, Fc/Fc
+): +0.74 V, -1.71 V, -1.89 V. 
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Found: C, 52.91; H, 3.35; N, 7.09. Calc. for C52H38N6O2P2F12Ru·½H2O: C, 52.97; H, 
3.33; N, 7.13%. 
? [Ru(L5)2][PF6]2
Molecular formula: C56H46N6O4RuP2F12 
Molecular weight: 1258.00 
RuCl3·3H2O (21 mg, 0.080 mmol) and L
5 (35 mg, 0.080 mmol) were used for step 1 and 
26.4 mg of [RuL5Cl3] was obtained. Then, another 1 equivalent of L
5 (16 mg, 0.037 
mmol) was used for the second step. A reddish brown powder (35.5 mg, 35.3%) was 
obtained. 
1H NMR (500 MHz, CD3CN): ?H 4.14 (m, 4H, HS2), 4.75 (m, 4H, HS1), 4.88 (s, 4H, HS3), 
7.08 (ddd, J 1.4, 5.7, 7.5 Hz, 4H, HT5), 7.33 (ddd, J 0.6, 1.4, 5.6 Hz, 4H, HT6), 7.45 (m, 
4H, HN7 and HN6), 7.59 (dd, J 1.7, 8.4 Hz, 2H, HN3), 7.83 (m, 8H, HN8, HT4 and HN5), 7.88 
(d, J 8.5 Hz, 2H, HN4), 7.92 (s, 2H, HN1), 8.33 (s, 4H, HT3?), 8.39 (dt, J 0.8, 8.1 Hz, 4H, 
HT3).
13C NMR (125 MHz, CD3CN): ?C 69.6 (CS2), 70.7 (CS1), 74.0 (CS3), 112.1 (CT3?), 125.2 
(CT3), 126.9 (CN3), 127.0 (CN6/ N7), 127.2 (CN1 and CN6/ N7), 128.3 (CT5), 128.6 (CN5/ N8), 
128.7 (CN8/ N5), 129.1 (CN4), 133.9 (CN10), 134.2 (CN9), 137.1 (CN2), 138.6 (CT4), 153.4 
(CT6), 157.3 (CT2), 159.2 (CT2?), 166.9 (CT4?).
MS (ES): m/z = 1113.2 [M-PF6]
+, 783.3 [M-2PF6-CH2CH2OCH2Nap]
+, 484.1 [M-2PF6]
2+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 227 (236 x 103), 245 (60.8 x 103), 270 (68.1 x 
103), 307 (67.4 x 103), 488 (19.0 x 103). 
Cyclic voltammetry data (CH3CN, 0.1 M [
tBu4N]PF6, Fc/Fc
+): +0.74 V, -1.73 V, -1.91 V. 
Found: C, 53.09; H, 3.79; N, 6.49. Calc. for C56H46N6O4P2F12Ru·½H2O: C, 53.08; H, 
3.74; N, 6.63%. 
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? [Ru(L6)2][PF6]2
Molecular formula: 
C60H54N6O6RuP2F12 
Molecular weight: 1346.11 
RuCl3·3H2O (37 mg, 0.14 mmol) and L
6 (68 mg, 0.14 mmol) were used for step 1 and 
88.0 mg of [RuL6Cl3] was obtained. Then, another 1 equivalent of L
6 (62 mg, 0.13 mmol) 
was used for the second step. A reddish brown powder (77.3 mg, 41.0%) was obtained 
after recrystallisation with ethanol. 
1H NMR (400 MHz, CD3CN): ?H 3.77 (m, 4H, HS4), 3.85 (m, 4H, HS3), 4.07 (t, J 4.3 Hz, 
4H, HS2), 4.68 (t, J 4.3 Hz, 4H, HS1), 4.73 (s, 4H, HS5), 7.08 (ddd, J 1.6, 5.7, 7.5 Hz, 4H, 
HT5), 7.34 (d, J 5.1 Hz, 4H, HT6), 7.44 (m, 4H, HN6 and HN7), 7.50 (dd, J 1.3, 8.3 Hz, 2H, 
HN3), 7.82 (m, 12H, HN8, HT4, HN5, HN4 and HN1), 8.31 (s, 4H, HT3?), 8.40 (d, J 8.1 Hz, 4H, 
HT3).
MS (ES): m/z = 1201.1 [M-PF6]
+, 827.2 [M-2PF6-(CH2CH2O)2CH2Nap]
+, 528.1 [M-
2PF6]
2+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 224 (31.4 x 103), 241 (8.08 x 103), 267 (8.86 
x 103), 304 (9.16 x 103), 486 (1.71 x 103).
Cyclic voltammetry data (CH3CN, 0.1 M [
tBu4N]PF6, Fc/Fc
+): +0.73 V, -1.72 V, -1.92 V. 
Found: C, 53.07; H, 3.85; N, 6.25. Calc. for C60H54N6O6P2F12Ru·½H2O: C, 53.17; H, 
4.09; N, 6.20%. 
? [Ru(L7)2][PF6]2
Molecular formula: 
C64H62N6O8RuP2F12 
Molecular weight: 1434.21 
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RuCl3·3H2O (14 mg, 0.052 mmol) and L
7 (27 mg, 0.052 mmol) were used for step 1 and 
21.3 mg of [RuL7Cl3] was obtained. Then, another 1 equivalent of L
7 (15 mg, 0.029 
mmol) was used for the second step. A reddish brown powder (39.8 mg, 53.5%) was 
obtained. 
1H NMR (400 MHz, CD3CN): ?H 3.70 (m, 12H, HS4, HS5 and HS6) 3.79 (m, 4H, HS3), 4.06 
(t, J 4.3 Hz, 4H, HS2), 4.66 (t, J 4.3 Hz, 4H, HS1), 4.68 (s, 4H, HS7), 7.08 (t, J 6.6 Hz, 4H, 
HT5), 7.34 (d, J 5.1 Hz, 4H, HT6), 7.43 (m, 4H, HN7 and HN6), 7.47 (dd, J 1.5, 8.6 Hz, 2H, 
HN3), 7.82 (m, 12H, HN8, HT4, HN5, HN4 and HN1), 8.29 (s, 4H, HT3?), 8.39 (d, J 8.1 Hz, 4H, 
HT3).
MS (ES): m/z = 1289.1 [M-PF6]
+, 572.1 [M-2PF6]
2+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 224 (213 x 103), 241 (61.6 x 103), 267 (62.1 x 
103), 304 (63.5 x 103), 485 (16.9 x 103). 
Cyclic voltammetry data (CH3CN, 0.1 M [
tBu4N]PF6, Fc/Fc
+): +0.74 V, -1.72 V, -1.91 V. 
Found: C, 52.65; H, 4.44; N, 5.91. Calc. for C64H62N6O8P2F12Ru·H2O: C, 52.93; H, 4.44; 
N, 5.79%. 
? [Ru(L9)2][PF6]2
Molecular formula: C50H34N6S2RuP2F12 
Molecular weight: 1173.97 
RuCl3·3H2O (20 mg, 0.077 mmol) and L
9 (30 mg, 0.077 mmol) were used for step 1 and 
39.6 mg of [RuL9Cl3] was obtained. Then, another 1 equivalent of L
9 (26 mg, 0.066 
mmol) was used for the second step. A reddish brown powder (62.5 mg, 69.1%) was 
obtained after recrystallisation with ethanol. 
1H NMR (500 MHz, CD3CN): ?H 7.14 (ddd, J 1.3, 5.6, 7.6 Hz, 4H, HT5), 7.38 (ddd, J 0.7, 
1.5, 5.6 Hz, 4H, HT6), 7.66 (m, 4H, HN6 and HN7), 7.81 (ddd, J 1.5, 7.7, 8.1 Hz, 4H, HT4), 
7.85 (dd, J 1.9, 8.6 Hz, 2H, HN3), 8.07 (m, 4H, HN5 and HN8), 8.16 (d, J 8.6 Hz, 2H, HN4), 
8.22 (ddd, J 0.8, 1.3, 8.2 Hz, 4H, HT3), 8.43 (s, 4H, HT3?), 8.46 (d, J 1.6 Hz, 2H, HN1). 
MS (ES): m/z = 1029.0 [M-PF6]
+, 442.1 [M-2PF6]
2+.
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UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 222 (129 x 103), 280 (76.0 x 103), 301 (66.6 x 
103), 490 (26.3 x 103).
Cyclic voltammetry data (CH3CN, 0.1 M [
tBu4N]PF6, Fc/Fc
+): +0.84 V, -1.58 V. 
Found: C, 51.10; H, 2.97; N, 7.08. Calc. for C50H34N6S2P2F12Ru: C, 51.15; H, 2.92; N, 
7.16%. 
? [Ru(L8)2][PF6]2
Molecular formula: 
C60H42N6O2RuP2F12 
Molecular weight: 1270.01 
Since the attempt to use the above method to synthesise [Ru(L8)2][PF6]2 was not 
successful, the following method is used to synthesise [Ru(L8)2][PF6]2.
42
[Ru(HO-Terpy)2][PF6]2 (89 mg, 0.10 mmol), which was synthesised in two steps as in the 
literature45, and dry K2CO3 (0.426 g, 3.08 mmol) were stirred in dry CH3CN (20 mL) at 
70ºC for 2 hours. The reaction mixture was kept at 70
ºC throughout the reaction. Then, 9-
bromomethylanthracene (66 mg, 0.30 mmol) was added to the reaction mixture. The 
reaction mixture was kept at 70ºC for 1 day. Excess methanolic NH4PF6 was added to the 
solution. The dark brown precipitate was filtered and collected. The crude product was 
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purified by column chromatography (SiO2, CH3CN: saturated aqueous KNO3: H2O
14:2:1). A red product (90.6 mg, 71.3%) was obtained. 
1H NMR (500 MHz, CD3CN): ?H 6.63 (s, 4H, HS1), 7.22 (ddd, J 1.3, 5.6, 7.5 Hz, 4H, 
HT5), 7.47 (ddd, J 0.7, 1.5, 5.6 Hz, 4H, HT6), 7.67 (ddd, J 0.9, 6.5, 8.4 Hz, 4H, HA3, A6),
7.75 (ddd, J 1.3, 6.5, 8.9 Hz, 4H, HA2, A7), 7.93 (ddd, J 1.5, 7.6, 8.1 Hz, 4H, HT4), 8.24 (dt, 
J 0.6, 8.5 Hz, 4H, HA4, A5), 8.47 (ddd, J 0.8, 1.3, 8.1 Hz, 4H, HT3), 8.56 (s, 4H, HT3?), 8.59 
(dd, J 0.9, 9.0 Hz, 4H, HA1, A8), 8.80 (s, 2H, HA10). 
MS (ES): m/z =1189.1 [M-PF6+2CH3OH]
+, 1157.0 [M-PF6+CH3OH]
+, 1125.1 [M-PF6]
+,
821.1 [M-PF6-PF5-Ant]
+, 598.1 [M-2PF6-2CH2Ant]
+, 191.1 [CH2Ant]
+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 251 (261 x 103), 267 (55.3 x 103), 302 (49.9 x 
103), 346 (16.4 x 103), 363 (18.9 x 103), 384 (16.5 x 103), 483 (16.0 x 103).
Cyclic voltammetry data (CH3CN, 0.1 M [
tBu4N]PF6, Fc/Fc
+): +0.97V, +0.73, -1.64 V. 
Found: C, 58.04; H, 3.74; N, 6.28. Calc. for C60H42N6O2Ru·(PF6)1.6·(SiF6)0.2: C, 58.09; H, 
3.41; N, 6.78%. 
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Chapter 4 
Synthesis of Homoleptic Mononuclear Cobalt(II) Complexes of 4?-
Substituted-2,2?:6?,2?-Terpyridine Ligands 
As discussed in the previous chapter, when 2,2?:6?,2?-terpyridine and its derivatives 
react with Co(II) ions, achiral octahedral complexes (strictly D2d symmetry) are 
formed.
1-5
 In contrast to kinetically inert low spin d
6
 transition metal ions, Co(II) 
[which is a labile metal centre] allows equilibrium to be reached rapidly.
6,7
Studies of mononuclear Co(II) complexes of 4?-substituted-2,2?:6?,2?-terpyridine
ligands described in Chapter 2 will be fully presented in this chapter (Scheme 1).
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Scheme 1. Co(II) complexes of 4?-substituted-2,2?:6?,2?-terpyridine ligands studied in 
this chapter. 
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As mentioned before, Co(II) complexes are very labile
8-14
 (e.g. exchange rate of 
[Co(H2O)6]
3+
 and [Co(H2O)6]
2+
 is ? 0.75 M-1s-1)11,12 and this makes it an ideal metal 
centre for the self-assembly of molecular architectures. The exchange processes of 
5,5?-disubstituted-2,2?:6?,2?-terpyridine ligands15 and 4?-substituted-2,2?:6?,2?-
terpyridine ligands
6
 have been studied by the groups of Lehn and Constable. In this 
chapter, some preliminary studies of the combinatorial library which is formed when 
two or more [Co(L)2]
2+
 complexes are mixed, are discussed.  
4.1 Synthesis 
Scheme 2. The general syntheses of [Co(L)2][PF6]2 (where L = L
1
-L
9
, terpy).
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The homoleptic Co(II) complexes were easily prepared by reacting 2 equivalents of 
ligand (L) with 1 equivalent of Co(OAc)2·4H2O in methanol for 0.5 hour. The 
solution turned brown immediately. A brown precipitate appeared when excess 
methanolic NH4PF6 was added. The brown precipitate was filtered and collected.
4-7,15-
20
 The yield of [Co(L)2][PF6]2 (where L = L
1
-L
9
, terpy) complexes ranged from 47-
87% (Scheme 2).
4.2
1
H NMR spectroscopic characterisation 
Cobalt(II) is a d
7
 transition metal ion which provides some practical handles.
21
Octahedral Co(II) complexes possess either one (low-spin) or three (high-spin) 
unpaired electron(s) (Figure 1).
Figure 1. The two possibilities for the arrangement of electrons for an octahedral 
Co(II) metal ion. 
This has two effects on the 
1
H NMR spectra of Co(II) complexes, namely, 
paramagnetically shifted signals and broadened signals.
6,7
 The shifting is caused by a 
significant difference between the local magnetic field at the protons and the applied 
field, in which the difference is due to the association of magnetic field and the 
unpaired electrons. The broadened signals result from an efficient relaxation 
mechanism, which arises from coupling between the electronic and magnetic spin. 
Low-spin cobalt(II) bis(terpyridine) complexes exhibit resonances down to around ?
110 
22,23
 while high-spin cobalt(II) bis(terpyridine) complexes can exhibit even lower 
field resonances in the ? 200-250 region24. Constable and coworkers synthesised high-
t2g
eg
t2g
eg
Low-spin d
7 High-spin d
7
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spin [Co(6-Br-terpy)2][PF6]2 and in CD3CN solution, this gave 
1
H NMR signals with 
the lowest field signal at ? 250.24
For Co(II) complexes, the 
1
H NMR signals are broad and coupling patterns cannot be 
used to aid assignments. In the past, we assumed the 
1
H nuclei in closest proximity to 
the Co(II) centre should be affected the most and show the greatest paramagnetic 
shifting. Recently, we established a method for assigning the broadened terpyridine 
proton signals. We found that the chemical exchange between Co(II) and Co(III) 
species could be used to assign the terpyridine proton signals. The assignment of the 
protons of the Co(II) complexes are made by a range of NMR techniques including 
COSY and chemical exchange difference spectroscopy (EXSY) experiments. 
A mixture of [Co(terpy)2]
3+
 and [Co(terpy)2]
2+
 is a classical self-exchange system and 
the rate of electron transfer is ? 50 M-1s-1 at room temperature.12,13 The exchange rates 
are within the medium to slow range of chemical exchange on the NMR time scale. 
Therefore, the electron transfer reaction interconverts Co(II) and Co(III) complexes 
and can be detected by NMR spectroscopy as an apparent chemical exchange of 
Co(II) and Co(III) cations.  
The
1
H NMR spectrum of a roughly 5:1 mixture of [Co(L
7
)2][PF6]2 and 
[Co(L
7
)2][PF6]3 complexes in CD3CN solution exhibits two subspectra (Figure 2).
The chemical exchange between the Co(II) and Co(III) complexes is slow on the 
NMR time scale and therefore the terpyridine proton signals can now be assigned by 
EXSY experiments. Irradiating the proton signals of the low spin Co(II) d
7
 species at 
? 112, 75, 71, 35 and 15 gives exchange peaks to the signals in the "normal" range (?
3.5-9). The latter are the corresponding proton signals for the Co(III) low-spin d
6
species. For example, irradiating the Co(II) proton signal at ? 112 gives an exchange 
peak to a doublet signal at ? 7.3, which is the HT6 signal (see Figure 2 for the atom 
labelling scheme) of the Co(III) species (Figure 4). Therefore, the signal at ? 112 is 
the H
T6
 signal of Co(II) species. Similarly, the signals at ? 75, 71, 35 and 15 are 
assigned to H
T3?
, H
T3
, H
T5
 and H
S1
 of the Co(II) species (Figure 4). The signal for 
Co(II) H
T5
 at ? 35 gives a cross peak to a signal at ? 6.4, which is assigned to Co(II) 
H
T4
 (Figure 3). All the terpyridine proton signals are now assigned. The rest of the 
signals were assigned by using the COSY and NOESY techniques. 
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Figure 2.
1
H NMR (500 MHz) spectrum of a 5:1 mixture of [Co(L
7
)2][PF6]2 and 
[Co(L
7
)2][PF6]3 in CD3CN solution at room temperature. In the inset 
spectrum (? 3.5-10), the signals in the dash-lined boxes are the 
subspectrum of the [Co(L
7
)2][PF6]3 species. 
Figure 3. COSY spectrum (500 MHz) of a mixture of [Co(L
7
)2][PF6]2 and 
[Co(L
7
)2][PF6]3 in CD3CN solution at room temperature. 
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Figure 4. The spectra of the exchange peaks between the mixture of [Co(L
7
)2][PF6]2 and [Co(L
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)2][PF6]3 species were measured at 500 MHz. 
The signals with dash-lined boxes are the Co(III) species; all the rest are the signals of Co(II) species. 
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Proton resonance (?)
HT6 (br) HT3? (s) HT3 (s) HT5 (s) HT4 (s) HT4? (s) 
[Co(terpy)2][PF6]2
(without Co(III) 
species, measured 
at 250 MHz) 
99.2 48.1 57.1 34.5 8.94 21.9 
[Co(terpy)2][PF6]2
(with 20% Co(III) 
species, measured 
at 500 MHz) 
97.5 45.9 56.0 34.1 9.12 22.0 
[Co(L1)2][PF6]2 112.1 75.2 70.7 34.7 6.42  
[Co(L2)2][PF6]2 111.8 74.6 70.5 34.7 6.47  
[Co(L3)2][PF6]2 111.9 74.6 70.5 34.7 6.46  
[Co(L4)2][PF6]2 113.6 76.3 71.5 35.1 6.35  
[Co(L5)2][PF6]2 111.4 74.6 70.2 34.6 6.38  
[Co(L6)2][PF6]2 111.2 74.5 70.1 34.5 6.35  
[Co(L7)2][PF6]2 111.8 74.6 70.4 34.7 6.42  
[Co(L8)2][PF6]2 110.9 73.8 69.7 34.7 6.56  
[Co(L9)2][PF6]2 102.8 55.9 61.6 34.1 8.08  
HS1 HS2 HS3 HS4 HS5 HS6  OH 
[Co(L1)2][PF6]2 14.98 (s) 9.49 (s)     
8.00 (t)
J 5.9 Hz 
[Co(L2)2][PF6]2 14.90 (s) 9.43 (s) 
7.09 (t)
J 5.0 Hz 
6.12 (t) 
J 5.0 Hz 
5.17 (t)
J 5.0 Hz 
[Co(L3)2][PF6]2 14.89 (s) 9.38 (s) 7.07 (s) 6.04 (s) 
5.06 (t) 
J 5.0 Hz 
4.60 (s) 3.97 (s) 
 HS1 HS2 HS3 HS4 HS5 HS6 HS7
[Co(L4)2][PF6]2 16.25 (s)       
[Co(L5)2][PF6]2 14.90 (s) 9.54 (s) 8.14 (s)     
[Co(L6)2][PF6]2 14.90 (s) 9.44 (s) 7.16 (m) 6.10 (m)   
[Co(L7)2][PF6]2 15.01 (s) 9.46 (s) 
7.15 (t)
J 4.6 Hz 
6.11 (t) 
J 4.4 Hz 
5.21 (t) 
J 4.5 Hz 
4.59 (t) 
J 4.5 Hz 
5.12 (s) 
[Co(L8)2][PF6]2 16.77 (s)       
Table 1.
1
H NMR spectroscopic data for terpyridine proton and the linkage CH2
proton signals of [Co(L)2][PF6]2 (L = L
1
-L
9
, terpy) in CD3CN solution at 
room temperature. The 
1
H NMR spectra for [Co(L)2][PF6]2 (L = L
1
-L
3
)
were measured at 250 MHz, for [Co(L)2][PF6]2 (L = L
5
, L
6
) were measured 
at 400 MHz and all the others were measured at 500 MHz. 
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Proton resonance (?)
HN1 (s) HN3 (d) HN4 (d) HN5 (d) HN6 (t) HN7 (t) HN8 (d) 
[Co(L4)2][PF6]2 13.48 
13.10
J 7.4 Hz 
10.55
J 7.4 Hz 
9.39
J 8.4 Hz 
8.55
J 7.7 Hz 
8.67
J 6.9 Hz 
10.18
J 7.3 Hz 
[Co(L5)2][PF6]2 10.16 
9.99
J 7.9 Hz 
8.10
J 7.9 Hz 
7.44
J 8.7 Hz 
6.99
J 7.5 Hz 
6.72
J 7.5 Hz 
7.28
J 7.9 Hz 
[Co(L6)2][PF6]2 8.58
8.38
J 7.9 Hz 
7.53
J 7.9 Hz 
7.16 (m) 
6.86 (t)
J 7.5 Hz 
6.77 (t)
J 7.1 Hz 
7.66
J 7.9 Hz 
Co(L7)2][PF6]2 7.93 
7.67
J 7.7 Hz 
7.48
J 8.2 Hz 
6.99
J 8.1 Hz 
6.60
J 7.4 Hz 
6.77
J 7.3 Hz 
7.55
J 8.0 Hz 
Co(L9)2][PF6]2 12.37 
12.67
J 8.3 Hz 
10.15
J 8.3 Hz 
9.13
J 8.4 Hz 
8.36
J 7.8 Hz 
8.47
J 7.7 Hz 
9.63
J 8.4 Hz 
 HA1, A8 (d) HA10 (s) HA2, A7 (m) HA4, A5 (d) HA3, A6 (m) 
[Co(L8)2][PF6]2
14.63
J 8.9 Hz 
10.63 10.13 
9.84
J 8.8 Hz 
9.13 
Table 2.
1
H NMR spectroscopic data for the naphthyl and anthryl proton signals of 
[Co(L)2][PF6]2 (L = L
4
-L
9
) in CD3CN solution at room temperature. The 
1
H
NMR spectra for [Co(L)2][PF6]2 (L = L
5
, L
6
) were measured at 400 MHz 
and all the others were measured at 500 MHz. 
It was found that all the [Co(L)2][PF6]2 species in which the 4?-position of the 
2,2?:6?,2?-terpyridine domain has an oxygen linker to another domain, have very 
similar chemical shifts for the signals in the range ? 35-115. Therefore, the terpyridine 
proton signals of the other [Co(L)2][PF6]2 complexes (where L = L
1
-L
6
, L
8
) described 
in this chapter are assigned according to [Co(L
7
)2][PF6]2. Table 1 shows the chemical 
shifts of all the terpyridine protons of [Co(L)2][PF6]2 in CD3CN solution at room 
temperature. Now, the assignment of all the Co(II) complexes in which the 4?-
substituted-2,2?:6?,2?-terpyridine ligands contain an oxygen linker is clear. 
The assignment of the ethyleneoxy CH2 linkage of [Co(L)2][PF6]2 complexes (where 
L = L
1
-L
3
) was made by the use of a COSY spectrum (? 0-16, 250 MHz) and the 
chemical shifts of the terpyridine domain protons are compatible with those of 
[Co(L
7
)2][PF6]2. The 
1
H NMR spectrum of [Co(L
3
)2][PF6]2 in CD3CN solution and the 
COSY spectrum (? 0-16, 250 MHz) are shown in Figure 5 and Figure 6 respectively.  
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Figure 5. The full 
1
H NMR (250 MHz) spectrum of [Co(L
3
)2][PF6]2 in CD3CN 
solution at room temperature. (* is the signal for CH3CN) 
The 5 terpyridine signals are assigned as those in [Co(L
7
)2][PF6]2. The proton signals 
of the CH2 linkages were assigned by COSY spectrum (? 0-16, 250 MHz). A singlet 
at ? 3.97 which has half of the relative integral of the signal for HT4 at ? 6.46 is 
assigned to OH. The OH signal gives a COSY cross peak to a singlet at ? 4.60 and is 
assigned to H
S6
. The signal for H
S6
 gives a cross peak to a signal at ? 5.06 and is 
assigned to H
S5
. The other two pairs of cross peaks at ? 14.89, 9.38 and ? 7.07, 6.04 
are assigned to H
S1
, H
S2
 and H
S3
, H
S4
respectively as they are compatible with those 
proton chemical shifts of [Co(L
7
)2][PF6]2. Protons in the ethyleneoxy chains which are 
closest to the Co(II) metal centre give rise to 
1
H NMR signals that are shifted to the 
lowest field (Table 1). An experiment was set up on a 500 MHz spectrometer to 
measure the T1 relaxation time via an inversion recovery sequence.
25
 The 
approximated T1 values of the five terpyridine proton signals (H
T6
, H
T3?
, H
T3
, H
T5
 and 
H
T4
) are shorter than those of the ethyleneoxy linkage proton signals (Table 3).
Constable et al.
7
 had been reported the T1 relaxation times of the six protons of 
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[Co(terpy)2][PF6]2 in CD3CN solution by the inversion recovery technique. The T1
values of the terpyridine protons of [Co(L
3
)2][PF6]2 were found to vary from 1.5 ms to 
75 ms, which compares well with those values of [Co(terpy)2][PF6]2 (vary from 1.54 
ms to 76.0 ms).
7
 HT6 (br) HT3? (s) HT3 (s) HT5 (s) HT4 (s)   
T1 1.5 ms 13.9 ms 18.8 ms 34.6 ms 75 ms   
 HS1 HS2 HS3 HS4 HS5 HS6 OH 
T1 92.4 ms 222.2 ms 432.9 ms 476.2 ms 533.9 ms 447.3 ms 1.6 s 
Table 3. The relaxation times T1 of the proton signals of [Co(L
3
)2][PF6]2 in CD3CN 
solution at room temperature. The spectrum was measured at 500 MHz. 
Figure 6. The COSY (? 3.5-15.5, 250 MHz) spectrum of [Co(L3)2][PF6]2 in CD3CN 
solution at room temperature. 
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The
1
H NMR spectrum of [Co(L
4
)2][PF6]2 in CD3CN solution exhibits thirteen signals 
from the terpyridine and the naphthyl domains (Figure 7). The 5 terpyridine signals 
are assigned as before. The COSY spectrum in Figure 8 shows the cross peak 
between H
T3
 (? 71.5), HT4 (? 6.35) and HT5 (? 35.1). The singlet signal at ? 16.25, 
which has the same relative integral of the signal for H
T4
 at ? 6.35, is assigned to HS1.
The singlet at ? 13.48, which has half of the relative integral of the signal for HS1, is 
assigned to H
N1
.
Figure 7.
1
H NMR (500 MHz) spectrum of [Co(L
4
)2][PF6]2 in CD3CN solution at 
room temperature. (* is the signal for CH3CN) 
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Figure 8. COSY spectrum (? 0-80, 500 MHz) of [Co(L4)2][PF6]2 in CD3CN solution 
at room temperature. (* is the signal for CH3CN) 
By using NOE difference experiments, the rest of the naphthyl proton signals were 
assigned (Figure 9). Irradiating the H
N1
 singlet at ? 13.5 gives an exchange peak to a 
doublet at ? 10.2. This is therefore assigned to HN8 (Figure 9e). Then, irradiating the 
signal for H
N8
 gives exchange peaks to a singlet at ? 13.5 and a triplet at ? 8.7. These 
signals correspond to H
N1
 and H
N7
 respectively (Figure 9c). In the COSY spectrum 
(Figure 10), there is a cross peak from H
N7
 at ? 8.7 to a triplet at ? 8.6, which is 
assigned to H
N6
. The signal for H
N6
 gives a cross peak to a doublet at ? 9.4 which is 
assigned to H
N5
. Finally, irradiating the signal for H
N5
 at ? 9.4 gives exchange peaks 
to a doublet at ? 10.6 and a triplet at ? 8.6, which are assigned to HN4 and HN6
respectively (Figure 9b). The signal for H
N4
 gives a cross peak to H
N3
 at ? 13.1. With 
the help of COSY and NOE difference experiments, all the naphthyl proton signals 
were therefore assigned. 
*
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Figure 9. Spectra (500 MHz) showing the NOE difference experiments of 
[Co(L
4
)2][PF6]2 in CD3CN solution at room temperature.  
Figure 10. COSY spectrum (? 6-17, 500 MHz) of [Co(L4)2][PF6]2 in CD3CN solution 
at room temperature. 
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The proton signals of [Co(L)2][PF6]2 (where L = L
5
-L
6
) were fully assigned with the 
help of COSY and NOE difference experiments. The chemical shifts for the 
ethyleneoxy chain CH2 signals and the naphthyl signals are shown in Table 1 and 
Table 2. The sequence of the chemical shifts for the CH2 proton signals of the 
ethyleneoxy chain seem to be predictable but this is not true for the chemical shifts of 
the naphthyl ring signals. The proton signals of [Co(L
8
)2][PF6]2 were assigned by 
using COSY techniques. The proton signals of the terpyridine ring are comparable 
with those of [Co(L
7
)2][PF6]2 (Table 1).
The
1
H NMR spectrum of [Co(L
9
)2][PF6]2 in CD3CN solution is shown in Figure 11.
The five terpyridine signals are different from those of [Co(L)2][PF6]2 (where L = L
1
-
L
8
), except the signal at around ? 34. Assuming the signal at ? 34 is still HT5. The 
COSY spectrum in Figure 12 shows the cross peak between H
T5
 (? 34.1) to HT4 (?
8.08) and H
T4
 (? 8.08) to HT3 (? 61.6). The signals at ? 102.8 and ? 55.9 are HT6 and 
H
T3?
respectively.
Figure 11.
1
H NMR (500 MHz) spectrum of [Co(L
9
)2][PF6]2 in CD3CN solution at 
room temperature. (* is the signal for CH3CN) 
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Figure 12. COSY spectrum (? 5-65, 500 MHz) of [Co(L9)2][PF6]2 in CD3CN solution 
at room temperature. 
The singlet at ? 12.37, which has half of the relative integral of the signal for HT4, is 
assigned to H
N1
. The rest of the naphthyl proton signals were assigned by COSY and 
long-range COSY techniques. In the long-range COSY spectrum (Figure 13), there is 
a cross peak from the signal for H
N1
 at ? 12.37 to a doublet at ? 9.13, which is 
assigned to H
N5
. The signal for H
N5
 gives a cross peak to a triplet at ? 8.36 which is 
assigned to H
N6
. The signal for H
N6
 gives a cross peak to a triplet at ? 8.47 which is 
assigned to H
N7
. Finally, H
N7
 gives a cross peak to a doublet at ? 9.63 which is 
assigned to H
N8
. The signal for H
N8
 gives a cross peak to H
N4
 at ? 10.15. Then, the 
signal for H
N4
 gives a cross peak to a doublet at ? 12.67 which is assigned to HN3.
T3 
T3? T5 
T4 
Naphthyl ring 
signals 
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Figure 13. The long-range COSY spectrum (500 MHz) of [Co(L
9
)2][PF6]2 in CD3CN
solution at room temperature. 
Constable et al.
7
 have reported the 
1
H NMR spectrum and the T1 relaxation times of 
[Co(terpy)2][PF6]2 in CD3CN solution. Since the resonances were so broad that no 
coupling was observed in a wide range of techniques, it was not possible to give an 
unambiguous assignment of the spectrum at that time. Recently, by applying the 
EXSY difference experiments to a mixture of [Co(terpy)2]
2+
 and [Co(terpy)2]
3+
, the 
proton signals of [Co(terpy)2]
2+
 in CD3CN solution were assigned. Figure 14 shows 
the COSY spectrum in the chemical shift range for the [Co(terpy)2]
3+
. The six 
terpyridine protons of the [Co(terpy)2]
3+
 in D2O solution have been fully assigned and 
reported in the literature.
26
 The order of the terpyridine proton signals is the same in 
both D2O and CD3CN solution (H
T6
, H
T5
, H
T4
, H
T3
, H
T4? & T3?
, from higher to lower 
field). Since the terpyridine signals of the Co(III) species are known, the assignment 
of the terpyridine signals of Co(II) species can be done by applying the EXSY 
difference experiment to each terpyridine signals of the Co(II) species in the 
T4 
N6 N7 N5 N8 
N4 
N1 
N3 
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paramagnetic range. Irradiating the Co(II) proton signal at ? 97.5 gives an exchange 
peak to a doublet at ? 7.24, which is the HT6 signal of Co(III) species. Therefore, the 
signal at ? 97.5 is assigned to the HT6 signal of Co(II) species. Similarly, the signals at 
? 56.0, 45.9, 34.1, 22.0 and 9.12 are assigned to HT3, HT3?, HT5, HT4? and HT4 of Co(II) 
species (Figure 15). The chemical shifts of the proton signals are shown in Table 1.
Figure 14. COSY spectrum (? 7-9.5, 500 MHz) of mixture of [Co(terpy)2][PF6]2 and 
[Co(terpy)2][PF6]3 in CD3CN solution at room temperature. Only the 
signal at ? 9.12 belongs to Co(II) species; all the rest belong to Co(III) 
species. 
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Figure 15. The exchange spectra (500 MHz) of [Co(terpy)2][PF6]2 and 
[Co(terpy)2][PF6]3 in CD3CN solution. 
The
1
H NMR spectra of [Co(L)2][PF6]2 where L = L
1
-L
9
, terpy were fully assigned. 
The terpyridine proton signals of [Co(L)2][PF6]2 (where L = L
1
-L
8
), in which the 
terpyridine domain is linked to the end domain with an oxygen bridge, are very 
similar. However, the one with the sulfur linked between the terpyridine and naphthyl 
domain is very different from the rest. The terpyridine proton signals are in the order 
H
T6
, H
T3?
, H
T3
, H
T5
, H
T4
 (from lower to higher field) in the case of [Co(L)2][PF6]2
(where L = L
1
-L
8
); the sequential order of [Co(L
9
)2][PF6]2 and also [Co(terpy)2][PF6]2
is H
T6
, H
T3
, H
T3?
, H
T5
, H
T4
 (from lower to higher field). The H
T3?
 signals are influenced 
by the substituent at the 4?-position of the 2,2?:6?,2?-terpyridine ligand. 
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Co(III)
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HT5 Co(III) HT4 Co(III) HT3 Co(III) 
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4.3
13
C NMR spectroscopic characterisation of [Co(L
7
)2][PF6]2 and 
[Co(L
9
)2][PF6]2
In addition to the 1H NMR spectra of the paramagnetic Co(II) complexes being 
paramagnetically shifted, we also observed that the 13C NMR spectra of the Co(II) 
complexes were shifted and signals ranged from ? -150 to 500 compared to the 
Co(III) complexes in the "normal" range (? 0-200). Except for the 13C NMR signals of 
the Co(II) terpyridine protons (T5, T3, T3?, T4?, T6, T2? and T2), all the rest of the 
signals are still in the "normal" range (? 0-200). The 13C NMR signals in the range ?
0-200 can be assigned by using HMQC and HMBC techniques. The assignment of 
13C NMR signals outside this range is not possible using routine experimental 
conditions for the HMQC and HMBC experiments. Therefore, selective proton 
decoupling experiments were applied to make the assignments.  
Figure 16. The 13C NMR spectrum (125 MHz, ? 69-81) of the mixture of 
[Co(L7)2][PF6]2 and [Co(L
7)2][PF6]3 in CD3CN solution at room 
temperature.  
The 13C NMR spectrum of a [Co(L7)2][PF6]2 and [Co(L
7)2][PF6]3 mixture (5:1) were 
measured in CD3CN solution. A total of thirteen singlet signals in ? 69-81 region 
(Figure 16) was found for seven pairs of the symmetric CH2 carbon of the 
ethyleneoxy chains in each of the Co(II) and Co(III) analogous and were assigned by 
the use of 1H-13C correlation HMQC and HMBC spectra. Table 4 shows the chemical 
shifts of the 13C NMR signals of the ethyleneoxy chains of Co(II) and Co(III) species. 
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The signals of the Co(II) species are shifted to lower field than those of the Co(III) 
species. When one compares analogous Co(II) and Co(III) complexes, there is 0.5-10 
ppm difference between the signals for a particular proton (Table 4).
13C resonance (?)
CS1 CS2 CS3 CS4 CS5 CS6 CS7
[Co(L7)2]
2+ 80.4 78.9 75.3 74.0 72.9 71.7 74.1 
[Co(L7)2]
3+ 72.5 69.6 71.6 71.2 70.6 73.6 
difference 7.9 9.3 3.7 2.8 1.7 1.1 0.5 
Table 4.
13C NMR spectroscopic data for the ethyleneoxy chains signals of 
[Co(L7)2][PF6]2 and [Co(L
7)2][PF6]3 in CD3CN solution at room 
temperature. The spectra were measured at 125 MHz. 
Figure 17. The 13C NMR spectrum (125 MHz, ? 115-175) of the mixture of 
[Co(L7)2][PF6]2 and [Co(L
7)2][PF6]3 in CD3CN solution at room 
temperature.
The 13C NMR spectrum in the normal aromatic region is shown in Figure 17. All the 
Co(II) and Co(III) naphthyl signals can be assigned by the use of HMQC and HMBC 
techniques. However, most of the proton signals of the Co(III) species are not well 
separated. It is not possible to fully assign the carbon signals of the Co(III) species. 
There is no significant difference (within 1 ppm) between the Co(II) and Co(III) 
naphthyl carbon signals. With the help of selective proton decoupling experiments, 
the terpyridine carbon signals of the Co(II) species were assigned. Irradiating the 
proton signal at ? 112 (i.e. HT6 of Co(II) species), the carbon signal at ? -74.6 is 
decoupled. Therefore, the carbon signal at ? -74.6 is CT6 of the Co(II) species (Figure 
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19). By using the same method, the carbon signals at ? 383.2, 353.6 and 499.4 are 
assigned to the CT3?, CT3 and CT5 signals of the Co(II) species, respectively. The 
carbon signal at ? 161.7 is assigned to CT4 of Co(II) because there is a cross peak 
between the HT4 signal of Co(II) at ? 6.42 and the signal at ? 161.7 in the HMQC 
spectrum (Figure 18). There are three quaternary carbon signals at ? 304.8, -49.1 and 
-127.7 (Figure 19). By looking at the relative integrals, we found that the integral for 
the signal at ? 304.8 is roughly half of those for the two signals at ? -49.1 and ? -
127.7. Therefore, the signal at ? 304.8 belongs to CT4? but the two signals at ? -49.1 
and ? -127.7 can only be assigned to CT2? and CT2, and not unambiguously to one or 
other of these carbon centres. Table 5 shows the 13C NMR signals of the terpyridine 
carbon of Co(II) and Co(III) species. The terpyridine carbon NMR signals of Co(III) 
species was assigned by using the HMBC and HMQC techniques. 
Figure 18. The HMQC spectrum of the mixture of [Co(L7)2][PF6]2 and 
[Co(L7)2][PF6]3 in CD3CN solution at room temperature. The spectrum 
was measured at 125 MHz. 
13C resonance (?)
CT2? CT2 CT6 CT4 CT4? CT3 CT3? CT5
[Co(L7)2]
2+ -49.1, -127.7 -74.6 161.7 304.8 353.6 383.2 499.4 
[Co(L7)2]
3+ 157.8 157.1 153.2 144.0 173.7 127.7 115.7 131.7 
Table 5. 13C NMR spectroscopic data for the terpyridine signals of [Co(L7)2][PF6]2
and [Co(L7)2][PF6]3 in CD3CN solution at room temperature. The spectra 
were measured at 125 MHz. 
HT4 Co(II) 
CT4 Co(II) 
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Figure 19. The 13C selective proton decoupling spectra (125 MHz) of the mixture of [Co(L7)2][PF6]2 and [Co(L
7)2][PF6]3 in CD3CN solution at 
room temperature. (The carbon signals in the dash-lined box are the quaternary carbon signals) 
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The 13C NMR spectrum of [Co(L9)2][PF6]2 was measured in CD3CN solution. There 
are twenty signals in total, including the two signals of CD3CN. In the range ? 120-
160, there are eleven carbon signals. With the help of HMQC and HMBC 
experiments, these 13C NMR signals at ? 120-160 were assigned to the carbon signals 
for naphthyl ring and the carbon signal for CT4 (Figure 20).
Figure 20. The 13C NMR spectrum (125 MHz, ? 120-160) of [Co(L9)2][PF6]2 in 
CD3CN solution at room temperature. 
The rest of 13C NMR signals were assigned by using selective proton decoupling 
experiments. Irradiating the proton at ? 102.8 (i.e. HT6 of Co(II) species), the carbon 
signal at ? -55.5 is decoupled. Therefore, the carbon signal at ? -55.5 is CT6 of the 
Co(II) species (Figure 21). By using the same method, the carbon signals at ? 336.5, 
339.0 and 464.5 are assigned to CT3?, CT3 and CT5 of the Co(II) species respectively. In 
the HMQC spectrum (Figure 22), there is a cross peak between the HT4 signal of 
Co(II) at ? 8.08 and the ? 158.2 of the 13C NMR signal. Therefore, the signal at ?
158.2 is assigned to CT4. There are three quaternary carbon signals at ? 247.0, -11.7 
and -85.8. The relative integral for the signal at ? 247.0 is roughly half of those for the 
two signals at ? -11.7 and ? -85.5. Therefore, the signal at ? 247.0 is assigned to CT4?.
An HMBC experiment was done attempting to distinguish CT2? and CT2 since we 
know that HT4 is at ? 8.08. However, no cross peak was observed. Therefore, the two 
signals at ? -49.1 and ? -127.7 could not be unambiguously assigned. 
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Figure 21. The 13C selective proton decoupling spectra (125 MHz) of [Co(L9)2]
2 in CD3CN solution at room temperature. (The carbon signals in 
the dash-lined box are the quaternary carbon signals) 
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Figure 22. The HMQC spectrum (125 MHz) of [Co(L9)2][PF6]2 in CD3CN solution at 
room temperature. 
The carbon NMR spectra of [Co(L7)2][PF6]2 and [Co(L
9)2][PF6]2 were fully assigned 
except the signals for CT2? and CT2 could not be distinguished. It is worth nothing that 
there were significant differences in the 13C chemical shifts for the terpyridine unit in 
[Co(L7)2][PF6]2 and [Co(L
9)2][PF6]2 (Table 6). This includes the C
T6 which is the 
furthest away form the 4?-substitution position of the terpyridine ligand. 
13C resonance (?)
CT2? CT2 CT6 CT4 CT4? CT3 CT3? CT5
[Co(L7)2]
2+ -49.1, -127.7 -74.6 161.7 304.8 353.6 383.2 499.4 
[Co(L9)2]
2+ -85.8, -11.7 -55.5 158.2 247.0 339.0 336.5 464.5 
Table 6. 13C NMR spectroscopic data for terpyridine signals of [Co(L7)2][PF6]2 and 
[Co(L9)2][PF6]2 in CD3CN solution at room temperature. The spectra were 
measured at 125 MHz. 
HN3
HN1
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HN8 H
N5
HN7 HN6 HT4
CT4
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4.4 Mass spectrometric characterisation 
Electrospray ionisation mass spectrometry (ES-MS) was used to characterise the 
complexes. The mass spectrum shows peaks for ions with particular mass to charge 
ratios (m/z). Each signal has a unique combination of the isotopes of the elements in 
the complexes. And the difference between each of the signals of the isotope pattern is 
the reciprocal of the charge on the fragment from which the signal originates. 
Normally, ES-MS is a relatively soft ionisation method. Therefore, [M-PF6]
+ and [M-
2PF6]
2+ peaks are found as the major peaks for mononuclear Co(II) complexes. 
However, the voltage used to ionise the samples is rather high for these complexes, 
and some other fragments are observed in the spectra (Table 7).
m/z
[M-PF6]
+ [M-PF6-PF5]
+ [M-2PF6]
2+ Others 
[Co(L1)2][PF6]2 790.3  322.6 644.2, 300.6, 278.6 
[Co(L2)2][PF6]2 878.3  366.6 
1062.2, 1046.3, 732.3, 
644.2, 556.2, 322.6, 278.6 
[Co(L3)2][PF6]2 965.9  410.6 1007.9, 431.6 
[Co(L4)2][PF6]2 982.0 856.0  696.4, 555.5, 467.3 
[Co(L5)2][PF6]2 1070.3  462.7 740.2, 493.3 
[Co(L6)2][PF6]2 1158.3  506.6 784.2, 500.2 
[Co(L7)2][PF6]2 1246.2  551.7 828.5, 599.4 
[Co(L8)2][PF6]2 1083.2 956.2  
876.1, 746.3, 555.5, 540.6, 
517.1, 191.4 
[Co(L9)2][PF6]2 985.9   421.2  
[Co(terpy)2][PF6]2 669.9 544.0 262.9  
Table 7. The ES-MS data of the ten Co(II) complexes. 
In contrast to Fe and Ru, Co has only one isotope. Therefore, the isotopic pattern is 
mainly because of the presence of 12C/13C. In the ES-MS spectrum of [Co(L7)2][PF6]2
(Figure 23), m/z 599.4 was the major signal. This corresponds to [L7+Co+F]+. The 
other signals at m/z 1246.0, 828.4 and 551.2 correspond to [M-PF6]
+, [M-PF6-
(CH2CH2O)2OCH2Nap]
+, [M-2PF6]
2+ respectively. Traces of [Co(L7)2][PF6]3 were 
detected. [M-PF6]
+ and [M-3PF6]
3+ peaks are found less than 20% of relative 
abundance at m/z 1391 and 367. 
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Figure 23. The ES-MS spectrum of [Co(L7)2][PF6]2 (the peaks marked * are belong to 
[Co(L7)2][PF6]3 complex). 
In the ES-MS spectrum of [Co(L9)2][PF6]2 (Figure 24), a peak assigned to [M-2PF6]
2+
at m/z 421.2 was the major signal. The other minor signal at m/z 985.9 corresponds to 
[M-PF6]
+.
Figure 24. The ES-MS spectrum of [Co(L9)2][PF6]2.
[M-PF6]
+
[M-2PF6]
2+
[L7+Co+F]+
[M-2PF6]
2+
[M-PF6-
(CH2CH2O)2
OCH2Nap]
+
[M-PF6]
+
*
*
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4.5 Absorption spectroscopic characterisation 
The electronic spectra of the homoleptic Co(II) complexes were recorded in HPLC 
grade acetonitrile solution. The absorption spectra of these complexes are similar to 
the sum of the spectra of [Co(terpy)2]
2+ and the substituents. The absorption data for 
these ten homoleptic complexes are summarised in Table 8.
?max, nm ( ? / 103, M-1cm-1)
LC
[Co(L1)2][PF6]2 242 (52.0), 270 (44.4), 303 (22.9)
[Co(L2)2][PF6]2 244 (55.3), 270 (46.9), 302 (25.0)
[Co(L3)2][PF6]2 242 (58.6), 270 (49.8), 301 (26.5)
[Co(L4)2][PF6]2 223 (221), 249 (71.5), 273 (66.2), 311 (23.7)
[Co(L5)2][PF6]2 222 (251), 244 (64.1), 270 (61.5), 303 (27.9)
[Co(L6)2][PF6]2 222 (233), 241 (60.4), 270 (57.3), 303 (27.2)
[Co(L7)2][PF6]2 224 (260), 241 (63.1), 272 (63.7), 305 (29.4)
[Co(L8)2][PF6]2 254 (298), 281 (45.1), 315 (21.5), 348 (16.0), 366 (21.1), 386 (19.3)
[Co(L9)2][PF6]2 221 (146), 283 (74.0), 310 (49.7)
[Co(terpy)2][PF6]2 280 (44.1), 314 (36.7) 
Table 8. Electronic spectroscopic data for the complexes in acetonitrile solution.
The very intense bands in the UV region are assigned to the ligand-centred ?*??
transitions. But the low energy metal-to-ligand charge transfer (MLCT) transition 
band is not intense enough to detect in dilute solution (~10-6 M) for the UV/VIS 
measurement. The MLCT transitions of the Co(II) terpyridine type normally occur at 
450-510 nm in a more concentrated sample (~10-4 M).27,28
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4.6 Crystal structures of [Co(L
4
)2][PF6]2 and 
[Co(L
8
)2][PF6]2·1¾CH3CN
(a) Crystal structure of [Co(L
4
)2][PF6]2
Figure 25. An ORTEP representation (50% probability ellipsoids) of the [Co(L4)2]
2+
cation in [Co(L4)2][PF6]2. Hydrogen atoms are omitted for clarity. Carbon 
atoms are numbered sequentially around each ring. 
Crystals of [Co(L4)2][PF6]2 were obtained by slow diffusion of diethyl ether vapour 
into an acetonitrile solution of [Co(L4)2][PF6]2. The crystals were of X-ray quality and 
the molecular structure of [Co(L4)2][PF6]2 was determined. The structure of the 
[Co(L4)2]
2+ cation is presented in Figure 25. Crystallographic data are given in 
Appendix III and selected bond lengths and angles are given in Table 9. As 
expected, the tridentate ligands exhibit the cisoid conformation about the interannular 
C-C bonds, which is necessary for the adoption of the chelating mode. The 
coordination sphere of the Co(II) centre is similar to those in other complexes 
containing tridentate 2,2?:6?,2?-terpyridine ligands. The three pyridine rings in each 
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ligand are close to being coplanar and the torsion angles N1-C5-C6-N2, N2-C10-C11-
N3, N4-C31-C32-N5 and N5-C36-C37-N6 are 6.76˚, -4.30˚, -5.82˚ and 3.03˚. The 
angle between the planes containing atoms N1, N2, N3 and N4, N5, N6 is 86.4˚.29-33
Table 9. Selected bond lengths (Å) and angles (˚) of the [Co(L4)2]
2+ cation in 
[Co(L4)2][PF6]2.
All the bond lengths of the interannular C-C bonds and N-C bonds are comparable to 
the corresponding bond lengths of other Co(II) complexes containing tridentate 
2,2?:6?,2?-terpyridine ligands.29-33 The Co-N contacts to the central ring of the 4?-
(naphthalen-2-ylmethoxy)-2,2?:6?,2?-terpyridine ligand (Co1-N2 and Co1-N5) are 
shorter than those to the terminal rings (Co1-N1, Co1-N3, Co1-N4 and Co1-N6), 
which are within the reported range of Co(II) complexes with 2,2?:6?,2?-terpyridine 
ligands.29-33 The methyleneoxy chains are nearly coplanar with the central pyridine 
rings. The torsion angles C9-C8-O1-C16 and C35-C34-O2-C42 are -3.96˚ and 12.38˚.
The bond lengths O1-C8 and O2-C34 are 1.345(4) Å and 1.342(4) Å respectively 
which are similar to the corresponding distances in [Ru(poterpy)2][PF6]2·(CH3)2CO.
34
The bond angles C7-C8-O1, C9-C8-O1, C33-C34-O2 and C35-C34-O2 are within the 
range reported in the [Ru(poterpy)2]
2+ cation in the solid-state structure of 
Co1-N1 2.161(3) N1-C1 1.335(4) C5-C6 1.481(5) 
Co1-N2 2.005(3) N1-C5 1.341(4) C10-C11 1.477(4) 
Co1-N3 2.126(3) N2-C6 1.339(4) C31-C32 1.477(4) 
Co1-N4 2.126(3) N2-C10 1.338(4) C36-C37 1.481(4) 
Co1-N5 2.010(3) N3-C11 1.345(4)   
Co1-N6 2.110(3) N3-C15 1.338(4) C8-O1 1.345(4) 
  N4-C27 1.335(4) C16-O1 1.447(4) 
  N4-C31 1.344(4) C34-O2 1.342(4) 
  N5-C32 1.345(4) C42-O2 1.449(5) 
  N5-C36 1.329(4)   
  N6-C37 1.350(4)   
  N6-C41 1.324(4)   
      
N1-Co1-N2 77.2(1) N4-Co1-N5 76.5(1) C7-C8-O1 115.0(3) 
N1-Co1-N3 154.2(1) N4-Co1-N6 152.3(1) C9-C8-O1 124.6(3) 
N2-Co1-N3 77.0(1) N5-Co1-N6 76.8(1) C8-O1-C16 118.3(3) 
N1-Co1-N4 99.3(1) N3-Co1-N6 91.4(1) C33-C34-O2 116.2(3) 
N2-Co1-N4 110.2(1) N1-Co1-N5 95.3(1) C35-C34-O2 124.6(3) 
N3-Co1-N4 90.7(1) N1-Co1-N6 90.6(1) C34-O2-C42 118.3(3) 
N3-Co1-N5 110.2(1) N2-Co1-N6 97.2(1)   
  N2-Co1-N5 170.5(1)   
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[Ru(poterpy)2][PF6]2·(CH3)2CO. Also the bond angles C8-O1-C16 and C34-O2-C42 
are both 118.3(3)˚ which, within experimental error, are comparable with the 
corresponding angles in ([Ru(poterpy)2]
2+ cation (117.5(3)˚ and 118.1(3)˚).30
The dihedral angles of the planes of 2,2?:6?,2?-terpyridine and the naphthyl ring i.e. 
the planes containing N4, N5, N6 and C43, C47, C50, and N1, N2, N3 and C17, C21, 
C24 are 85.0˚ and 63.4˚ respectively. There are two pairs of intermolecular 
interactions between the naphthyl rings and pyridine rings between the molecules. 
The distance between the centroid of the pyridine N4 ring and the C38 atom of the 
pyridine N6 ring is 3.847 Å. The closest separation (C29 to C38) is 3.796 Å. The 
other pair is from the pyridine N1 ring to the naphthyl C43 ring. The distance between 
the centroid of the pyridine N1 ring and the C44 atom of the naphthyl ring is 3.661 Å. 
The closest distance (C2 to C44) is 3.725 Å. The intermolecular interactions can be 
seen in the packing diagram presented in Figure 26.
Figure 26. Packing of the [Co(L4)2]
2+ cations that shows the face-to-face pyridine-
pyridrine and pyridine-naphthyl interactions between the naphthyl rings 
and the pyridine rings. Hydrogen atoms are omitted for cl
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(b) Crystal structure of [Co(L
8
)2][PF6]2·1¾CH3CN
Crystals of [Co(L8)2][PF6]2·1¾CH3CN were obtained by slow diffusion of diethyl 
ether vapour into an acetonitrile solution of [Co(L8)2][PF6]2. The brown crystals were 
of X-ray quality and the molecular structure of [Co(L8)2][PF6]2 was determined. The 
structure of the [Co(L8)2]
2+ cation is presented in Figure 27. Crystallographic data are 
given in Appendix III. The expected six-coordinate metal environment is shown. As 
described before, the tridentate ligands exhibit the cisoid conformation about the 
interannular C-C bonds in order to chelate to the metal. The coordination sphere of the 
Co(II) centre is similar to those in other complexes containing tridentate 2,2?:6?,2?-
terpyridine ligands. The three pyridine rings in each ligand are close to being coplanar 
and the torsion angles N1-C5-C6-N2, N2-C10-C11-N3, N4-C35-C36-N5 and N5-
C40-C41-N6 are 2.40˚, 1.17˚, -7.00˚ and 5.78˚. The angle between the planes 
containing atoms N1, N2, N3 and N4, N5, N6 is 87.8˚.29-33 
Figure 27. An ORTEP representation (50% probability ellipsoids) of the [Co(L8)2]
2+
cation in [Co(L8)2][PF6]2·1¾CH3CN. Hydrogen atoms are omitted for 
clarity. Carbon atoms are numbered sequentially around each ring. 
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Selected bond lengths and angles of the [Co(L8)2]
2+ cation are given in Table 10. All 
the bond lengths of the interannular C-C bonds and N-C bonds which, within 
experimental error, are comparable to the corresponding bond lengths of other Co(II) 
complexes containing tridentate 2,2?:6?,2?-terpyridine ligands.29-33 The Co-N distances 
show the typical trend for 2,2?:6?,2?-terpyridine containing complexes with bonds to 
the central terpyridine ring (1.995(4)-1.998(3) Å) being significantly shorter than 
those to the terminal rings (2.102(4)-2.132(4) Å). All bond lengths and angles within 
the [Co(terpy)2] moiety are normal.
29-33 
Table 10. Selected bond lengths (Å) and angles (˚) of the [Co(L8)2]
2+ cation in 
[Co(L8)2][PF6]2·1¾CH3CN.
The methyleneoxy chains are nearly coplanar with the central pyridine rings. The 
torsion angles C7-C8-O1-C16 and C37-C38-O2-C46 are 6.33˚ and -2.68˚. The bond 
lengths O1-C8 and O2-C38 are 1.348(5) Å and 1.340(6) Å respectively which are 
similar to the corresponding distances in [Ru(poterpy)2][PF6]2·(CH3)2CO
34. The bond 
angles C7-C8-O1, C9-C8-O1, C37-C38-O2 and C39-C38-O2 are within the range 
reported in the [Ru(poterpy)2]
2+ cation in the solid-state structure of 
[Ru(poterpy)2][PF6]2·(CH3)2CO. Also the bond angles C8-O1-C16 and C38-O2-C46 
Co1-N1 2.132(4) N1-C1 1.325(6) C5-C6 1.462(6) 
Co1-N2 1.998(3) N1-C5 1.355(5) C10-C11 1.477(6) 
Co1-N3 2.122(4) N2-C6 1.334(6) C35-C36 1.477(7) 
Co1-N4 2.121(4) N2-C10 1.352(6) C40-C41 1.480(6) 
Co1-N5 1.995(4) N3-C11 1.341(6)   
Co1-N6 2.102(4) N3-C15 1.335(6) C8-O1 1.348(5) 
  N4-C31 1.341(6) C16-O1 1.424(6) 
  N4-C35 1.351(6) C38-O2 1.340(6) 
  N5-C36 1.330(5) C46-O2 1.446(6) 
  N5-C40 1.344(6)   
  N6-C41 1.352(6)   
  N6-C45 1.337(6)   
      
N1-Co1-N2 76.9(1) N4-Co1-N5 77.1(1) C7-C8-O1 124.6(4) 
N1-Co1-N3 153.2 (1) N4-Co1-N6 154.2 (2) C9-C8-O1 115.8(4) 
N2-Co1-N3 77.1(2) N5-Co1-N6 77.4(1) C8-O1-C16 116.8(4) 
N1-Co1-N4 94.4(2) N3-Co1-N6 88.6(2) C37-C38-O2 125.1(4) 
N2-Co1-N4 97.6(2) N1-Co1-N5 101.1(1) C39-C38-O2 115.9(4) 
N3-Co1-N4 94.9 (2) N1-Co1-N6 93.8(1) C38-O2-C46 118.5(4) 
N3-Co1-N5 105.5(2) N2-Co1-N6 108.0(2)   
  N2-Co1-N5 174.2(2)   
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are 116.8(4) and 118.5(4)˚ respectively which, within experimental error, are 
comparable with the corresponding angles in ([Ru(poterpy)2]
2+ cation (117.5(3)˚ and 
118.1(3)˚).34
Figure 28. Packing of the [Co(L8)2]
2+ cations that shows anthryl-pyridine (green 
lines) interactions between the anthryl rings and the pyridine rings in the 
unit cell. Hydrogen atoms are omitted for clarity. 
The dihedral angles of the planes of 2,2?:6?,2?-terpyridine and the anthryl ring (i.e. the 
planes containing N1, N2, N3 and C17, C21, C27, and N4, N5, N6 and C47, C51, 
C57) are 81.3˚ and 85.3˚ respectively. There are three pairs of intermolecular 
interactions between the anthryl rings and pyridine rings in the molecules. The 
distance from the centroid of the pyridine N4 ring to the C51 atom of the anthryl ring 
is 3.687 Å (Figure 28). The closest separation (C32 to C51) is 3.873 Å. Interestingly, 
2 pairs of anthryl-anthryl ?-? stacking interactions are found in the packing of the 
[Co(L8)2]
2+ cations (Figure 29). The plane-to-plane distances are around 3.7 Å 
between the 2 anthryl rings. The shortest distance between the C57 atom of one 
anthryl ring to C29 atom of the other one is 3.419 Å. The other pair which has a 
shortest distance between C23 atom of one anthryl ring to C20 atom of the other one 
is 3.549 Å.
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Figure 29. A diagram to show the anthryl-anthryl ?-? stacking interactions between 
three anthryl rings of the [Co(L8)2]
2+ cations. Hydrogen atoms are omitted 
for clarity. 
?-? stacking interactions 
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4.7
1
H NMR spectroscopic exchange experiments of the Co(II) 
complexes  
Equal molar amounts of homoleptic [Co(A)2][PF6]2 and [Co(B)2][PF6]2 were mixed in 
CD3CN and the heteroleptic complex, [Co(A)(B)]
2+ resulted.6,7,35 The exchange 
reactions were monitored by 1H NMR spectroscopy. The proton resonances of Co(II) 
complexes (which contain paramagnetic d7 ions) shift to low field and are well 
separated. This allows the intensity of each signal to be followed easily in the 
exchange process by using 1H NMR spectroscopy (see Section 4.2 for details). 
Several combinations of two homoleptic Co(II) complexes were chosen to study the 
exchange reactions. The results are summarised in Table 11.
Combination [Co(A)2][PF6]2 [Co(B)2][PF6]2
Time for the equilibrium 
reached 
(a) [Co(L1)2][PF6]2 [Co(L
2)2][PF6]2 Immediately after mixing 
(b) [Co(L4)2][PF6]2 [Co(L
9)2][PF6]2 Immediately after mixing 
(c) [Co(L8)2][PF6]2 [Co(L
9)2][PF6]2 Immediately after mixing 
(d) [Co(L4)2][PF6]2 [Co(L
8)2][PF6]2 5 hr after mixing 
(e) [Co(terpy)2][PF6]2 [Co(L
8)2][PF6]2 45 mins after mixing 
(f) [Co(Fc-terpy)2][PF6]2 [Co(L
8)2][PF6]2 Immediately after mixing 
Table 11. The combination of homoleptic Co(II) complexes with different 4?-
substituted-2,2?:6?,2?-terpyridine used for the studies of the exchange 
reactions. 
In the equilibrium mixture of [Co(L1)2]
2+, [Co(L1)(L2)]2+ and [Co(L2)2]
2+, there are 
four resonances: two belong to the homoleptic complexes and the remaining two 
belong to the heteroleptic complex. From the 1H NMR spectrum (Figure 30), the 
number of resonances doubled and this indicated the formation of [Co(L1)(L2)]2+
cation. The exchange reaction mixture equilibrates immediately after mixing. The rate 
of the exchange reaction between the two complexes is faster than the 5-substituted 
2,2?:6?,2?-terpyridine previously studied by Constable et al.7. Since the resonances at ?
74 and ? 34 revealed the distribution of [Co(L1)2]2+, [Co(L1)(L2)]2+ and [Co(L2)2]2+
was 1:2:1 ratio, it was concluded that the product distribution is statistical. 
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Figure 30. 1H NMR spectroscopic data (250 MHz) for the mixture of [Co(L1)2][PF6]2
and [Co(L2)2][PF6]2 in CD3CN solution at room temperature. (A = 
[Co(L1)2]
2+, B = [Co(L2)2]
2+, C = [Co(L1L2)]2+)
For the exchange experiment of [Co(L4)2][PF6]2 and [Co(L
8)2][PF6]2, the exchange 
reaction took around 5 hours to reach equilibrium after mixing the equal molar Co(II) 
complexes together (Figure 31). As mentioned before, four resonances are observed 
in a 1:1:1:1 ratio when the mixture reaches equilibrium. The spectra (? 30-78) 
measured at different time intervals of the exchange experiment are shown in Figure 
32.
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Figure 31. 1H NMR spectroscopic data (250 MHz) for the mixture of [Co(L4)2][PF6]2
and [Co(L8)2][PF6]2 in CD3CN solution at room temperature. (A = 
[Co(L4)2]
2+, B = [Co(L8)2]
2+, C = [Co(L4L8)]2+)
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Figure 32. 1H NMR spectra (? 30-78, 250 MHz) for the mixture of [Co(L4)2][PF6]2
and [Co(L8)2][PF6]2 in CD3CN solution at room temperature measured at 
different time intervals. (A = [Co(L4)2]
2+, B = [Co(L8)2]
2+, C = 
[Co(L4L8)]2+)
The equilibrium between two Co(II) complexes was attained very rapidly in most 
cases. It is not possible to predict which combination will take the longest time to 
reach equilibrium. The Constable group has investigated the electronic effects 
associated with the 4?-substituted-2,2?:6?,2?-terpyridine; however, changes in the 
nature of the 4?-substituent did not influence the position of equilibrium.7
Some preliminary 1H NMR experiments were done, for example adding substrates 
(C6F6, C60, cyclodextrin) to [Co(L)2][PF6]2 (L = L
5-L7) for exploring the possibility of 
reequilibration of [Co(A)2][PF6]2 and [Co(B)2][PF6]2. However, there is solubility 
problem between the substrate and the Co(II) complexes in mixture of solvent 
(CD3CN, CD3OD, D2O). There is no significant shifting for the signals of the Co(II) 
complexes by adding the substrate to the NMR tube. 
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4.8 Conclusion
The mononuclear Co(II) complexes of different 4?-substituted-2,2?:6?,2?-terpyridine
ligands L1-L9, which contain polyethyleneoxy chains and differ from one another in 
the length of the chains, in the terminal domains or in the linkages, have been 
synthesised. The complexes have been characterised with 1H NMR spectroscopy, 
mass spectrometry (ES), UV/VIS spectroscopy and elemental analysis. A newly 
established method for the assignment of Co(II) complexes using the EXSY 
difference experiment were presented. This is based on the self exchange system 
between Co(II) and Co(III) species, which is slow enough on the NMR time scale. 
The solid-state structures of [Co(L4)2][PF6]2 and [Co(L
8)2][PF6]2 were determined by 
X-ray crystallography. Finally, some preliminary studies of the combinatorial library 
were discussed.  
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4.9 Experimental 
? [Co(L1)2][PF6]2
? [Co(L2)2][PF6]2
? [Co(L3)2][PF6]2
? [Co(L4)2][PF6]2
? [Co(L5)2][PF6]2
? [Co(L6)2][PF6]2
? [Co(L7)2][PF6]2
? [Co(L8)2][PF6]2
? [Co(L9)2][PF6]2
? [Co(terpy)2][PF6]2
where L1 4?-(2-Hydroxyethoxy)-2,2?:6?,2?-terpyridine 
L
2
4?-[2-(2-Hydroxyethoxy)ethoxy]-2,2?:6?,2?-terpyridine 
L
3
4?-{2-[2-(2-Hydroxyethoxy)ethoxy]ethoxy}-2,2?:6?,2?-terpyridine 
L
4
4?-(Naphthalen-2-ylmethoxy)-2,2?:6?,2?-terpyridine 
L
5
4?-[2-(Naphthalen-2-ylmethoxy)ethoxy]-2,2?:6?,2?-terpyridine 
L
6
4?-{2-[2-(Naphthalen-2-ylmethoxy)ethoxy]ethoxy}-2,2?:6?,2?-terpyridine 
L
7
4?-(2-{2-[2-(Naphthalen-2-ylmethoxy)ethoxy]ethoxy}ethoxy)-2,2?:6?,2?-
terpyridine 
L
8
4?-(Anthracen-9-ylmethoxy)-2,2?:6?,2?-terpyridine 
L
9
4?-(Naphthalen-2-ylsulfanyl)-2,2?:6?,2?-terpyridine 
terpy 2,2?:6?,2?-terpyridine 
L
1
, L
2
, L
3
, L
4
, L
5
, L
6
, L
7
, L
8
 and L
9
 were prepared as in Chapter 2. 4?-Ferrocenyl-2,2?:6?,2?-
terpyridine (Fc-terpy) were prepared as in the literature.36
General method for synthesising cobalt(II) complexes 
A solution of Co(OAc)2·4H2O (1 equivalent) in 10 mL CH3OH was treated with the 
appropriate ligand L (2 equivalents) and the mixture stirred for 0.5 hour at room temperature 
during which period a brown colour developed. Excess methanolic NH4PF6 was added to the 
solution. The resultant brown precipitate was collected by filtration, washed with diethyl ether 
and dried.4-7,16-20
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L
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    n = 0 
L
6
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L
7
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n
n
n
L
4
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L
8
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L
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2
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3
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n
n
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1
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3
)
? [Co(L1)2][PF6]2
Molecular formula: C34H30N6O4CoP2F12 
Molecular weight: 935.50 
L
1 (50 mg, 0.17 mmol) and Co(OAc)2·4H2O (21 mg, 0.085 mmol) were used. A brown 
powder (38.6 mg, 48.6%) was obtained. 
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1H NMR (250 MHz, CD3CN): ?H 6.42 (s , 4H, HT4), 8.00 (t, J 5.9 Hz, 2H, OH), 9.49 (s, 
4H, HS2), 14.98 (s, 4H, HS1), 34.7 (s, 4H, HT5), 70.7 (s, 4H, HT3), 75.2 (s, 4H, HT3?), 112.1 
(br, 4H, HT6).
MS (ES): m/z = 790.3 [M-PF6]
+, 644.2 [M-2PF6-H]
+, 322.6 [M-2PF6]
2+, 300.6 [M-2PF6-
CH2CH2O]
2+, 278.6 [M-2PF6-2CH2CH2O]
2+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 242 (52.0 x 103), 270 (44.4 x 103), 303 (22.9 
x 103).
Found: C, 43.51; H, 3.33; N, 8.88. Calc. for C34H30N6O4P2F12Co: C, 43.65; H, 3.23; N, 
8.98%. 
? [Co(L2)2][PF6]2
Molecular formula: C38H38N6O6CoP2F12 
Molecular weight: 1023.61 
L
2
 (50 mg, 0.15 mmol) and Co(OAc)2·4H2O (19 mg, 0.075 mmol) were used. A brown 
powder (44.2 mg, 57.6%) was obtained. 
1H NMR (250 MHz, CD3CN): ?H 5.17 (t, J 5.0 Hz, 2H, OH), 6.12 (t, J 5.0 Hz, 4H, HS4),
6.47 (s, 4H, HT4), 7.09 (t, J 5.0 Hz, 4H, HS3), 9.43 (s, 4H, HS2), 14.90 (s, 4H, HS1), 34.7 (s, 
4H, HT5), 70.5 (s, 4H, HT3), 74.6 (s, 4H, HT3?), 111.8 (br, 4H, HT6).
MS (ES): m/z = 1062.2 [M+K]+, 1046.3 [M+Na]+, 878.3 [M-PF6]
+, 732.3 [M-2PF6-H]
+,
644.2 [M-2PF6-(CH2CH2O)2H]
+, 556.2 [M-2PF6-2(CH2CH2O)2H]
+, 366.6 [M-2PF6]
2+,
322.6 [M-2PF6-(CH2CH2O)2]
2+, 278.6 [M-2PF6-2(CH2CH2O)2]
2+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 244 (55.3 x 103), 270 (46.9 x 103), 302 (25.0 
x 103).
Found: C, 43.95; H, 3.86; N, 7.96. Calc. for C38H38N6O6P2F12Co·CH3OH: C, 44.37; H, 
4.01; N, 7.96% 
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? [Co(L3)2][PF6]2
Molecular formula: C42H46N6O8CoP2F12 
Molecular weight: 1111.71 
L
3 (57 mg, 0.15 mmol) and Co(OAc)2·4H2O (19 mg, 0.075 mmol) were used. A brown 
powder (50.7 mg, 60.8%) was obtained. 
1H NMR (250 MHz, CD3CN): ?H 3.97 (s, 2H, OH), 4.60 (s, 4H, HS6), 5.06 (t, J 5.0 Hz, 
4H, HS5), 6.04 (s, 4H, HS4), 6.46 (s, 4H, HT4), 7.07 (s, 4H, HS3), 9.38 (s, 4H, HS2), 14.89 (s, 
4H, H
S1
), 34.7 (s, 4H, H
T5
), 70.5 (s, 4H, H
T3
), 74.6 (s, 4H, H
T3?
), 111.9 (br, 4H, H
T6
).
MS (ES): m/z = 1007.9 [M-PF6+CH3CN]
+, 965.9 [M-PF6]
+, 431.6 [M-2PF6+CH3CN]
2+,
410.6 [M-2PF6]
2+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 242 (58.6 x 103), 270 (49.8 x 103), 301 (26.5 
x 103).
Found: C, 45.11; H, 4.25; N, 7.42. Calc. for C42H46N6O8P2F12Co: C, 45.38; H, 4.17; N, 
7.56%. 
? [Co(L4)2][PF6]2
Molecular formula: 
C52H38N6O2CoP2F12 
Molecular weight: 1127.76 
L
4
 (50 mg, 0.13 mmol) and Co(OAc)2·4H2O (16 mg, 0.065 mmol) were used. The brown 
powder (63.9 mg, 87.2%) was obtained. 
1H NMR (500 MHz, CD3CN): ?H 6.35 (s, 4H, HT4), 8.55 (t, J 7.7 Hz, 2H, HN6), 8.67 (t, J
6.9 Hz, 2H, HN7), 9.39 (d, J 8.4 Hz, 2H, HN5), 10.18 (d, J 7.3 Hz, 2H, HN8), 10.55 (d, J 7.4 
Hz, 2H, H
N4
), 13.10 (d, J 7.4 Hz, 2H, H
N3
), 13.48 (s, 2H, H
N1
), 16.25 (s, 4H, H
S1
), 35.1 (s, 
4H, HT5), 71.5 (s, 4H, HT3), 76.3 (s, 4H, HT3?), 113.6 (br, 4H, HT6).
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MS (ES): m/z = 982.0 [M-PF6]
+, 856.0 [M-PF6-PF5]
+, 696.4 [M-2PF6-CH2Nap]
+, 555.5 
[M-2PF6-2CH2Nap]
+, 467.3 [L4+Co+F]+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 223 (221 x 103), 249 (71.5 x 103), 273 (66.2 x 
103), 311 (23.7 x 103).
Found: C, 55.26; H, 3.52; N, 7.55. Calc. for C52H38N6O2P2F12Co: C, 55.38; H, 3.40; N, 
7.45%. 
? [Co(L5)2][PF6]2
Molecular formula: 
C56H46N6O4CoP2F12 
Molecular weight: 1215.86 
L
5 (50.0 mg, 0.12 mmol) and Co(OAc)2·4H2O (15 mg, 0.060 mmol) were used. A brown 
powder (42.9 mg, 58.8%) was obtained. 
1H NMR (400 MHz, CD3CN): ?H 6.38 (s, 4H, HT4), 6.72 (t, J 7.5 Hz, 2H, HN7), 6.99 (t, J
7.5 Hz, 2H, HN6), 7.28 (d, J 7.9 Hz, 2H, HN8), 7.44 (d, J 8.7 Hz, 2H, HN5), 8.10 (d, J 7.9 
Hz, 2H, HN4), 8.14 (s, 4H, HS3), 9.54 (s, 4H, HS2), 9.99 (d, J 7.9 Hz, 2H, HN3), 10.16 (s, 
2H, HN1), 14.90 (s, 4H, HS1), 34.6 (s, 4H, HT5), 70.2 (s, 4H, HT3), 74.6 (s, 4H, HT3?), 111.4 
(br, 4H, HT6). 
MS (ES): m/z = 1070.3 [M-PF6]
+, 740.2 [M-2PF6-CH2CH2OCH2Nap]
+, 493.3 
[L5+Co+H]+, 462.7 [M-2PF6]
2+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 222 (251 x 103), 244 (64.1 x 103), 270 (61.5 x 
103), 303 (27.9 x 103).
Found: C, 55.16; H, 3.71; N, 6.88. Calc. for C56H46N6O4P2F12Co: C, 55.32; H, 3.81; N, 
6.91%. 
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? [Co(L6)2][PF6]2
Molecular formula: C60H54N6O6CoP2F12 
Molecular weight: 1303.97 
L
6 (61 mg, 0.13 mmol) and Co(OAc)2·4H2O (16 mg, 0.065 mmol) were used. A brown 
powder (39.7 mg, 46.7%) was obtained. 
1H NMR (400 MHz, CD3CN): ?H 6.10 (m, 8H, HS5 and HS4), 6.35 (s, 4H, HT4), 6.77 (t, J
7.1 Hz, 2H, HN7), 6.86 (t, J 7.5 Hz, 2H, HN6), 7.16 (m, 6H, HN5 and HS3), 7.53 (d, J 7.9 
Hz, 2H, HN4), 7.66 (d, J 7.9 Hz, 2H, HN8), 8.38 (d, J 7.9 Hz, 2H, HN3), 8.58 (s, 2H, HN1),
9.44 (s, 4H, H
S2
), 14.90 (s, 4H, H
S1
), 34.5 (s, 4H, H
T5
), 70.1 (s, 4H, H
T3
), 74.5 (s, 4H, 
HT3?), 111.2 (br, 4H, HT6).
MS (ES): m/z = 1158.3 [M-PF6]
+, 784.2 [M-2PF6-(CH2CH2O)2CH2Nap]
+, 506.6 [M-
2PF6]
2+, 500.2 [L6+Na]+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 222 (233 x 103), 241 (60.4 x 103), 270 (57.3 x 
103), 303 (27.2 x 103).
Found: C, 54.28; H, 4.25; N, 6.50. Calc. for C60H54N6O6P2F12Co?H2O: C, 54.51; H, 4.27; 
N, 6.36%. 
? [Co(L7)2][PF6]2
Molecular formula: 
C64H62N6O8CoP2F12 
Molecular weight: 1392.07 
L
7 (50 mg, 0.096 mmol) and Co(OAc)2·4H2O (12 mg, 0.048 mmol) were used. A brown 
powder (54.4 mg, 81.5%) was obtained. 
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1H NMR (500 MHz, CD3CN): 
For Co(III) species: ?H 3.73 (m, 2.1H, HS4, HS5 and HS6), 3.83 (m, 0.7H, HS3), 4.14 (m, 
0.7H, HS2), 4.70 (s, 0.7H, HS7), 4.85 (m, 0.7H, HS1), 7.35 (dd, J 1.1, 6.1 Hz, 0.7H, HT6),
7.43 (m, 1.4H, HT5, HN6 and HN7), 7.48 (m, 0.35H, HN3), 7.83 (m, 1.4H, HN1, HN4, HN5 and 
HN8), 8.20 (td, J 1.4, 8.8 Hz, 0.7H, HT4), 8.51 (m, 1.4H, HT3 and HT3?).
For Co(II) species: ?H 4.59 (t, J 4.5 Hz, 4H, HS6), 5.12 (s, 4H, HS7), 5.21 (t, J 4.5 Hz, 4H, 
HS5), 6.11 (t, J 4.4 Hz, 4H, HS4), 6.42 (s, 4H, HT4), 6.60 (t, J 7.4 Hz, 2H, HN6), 6.77 (t, J
7.3 Hz, 2H, HN7), 6.99 (d, J 8.1 Hz, 2H, HN5), 7.15 (t, J 4.6 Hz, 4H, HS3), 7.48 (d, J 8.2 
Hz, 2H, HN4), 7.55 (d, J 8.0 Hz, 2H, HN8), 7.67 (d, J 7.7 Hz, 2H, HN3), 7.93 (s, 2H, HN1),
9.46 (s, 4H, HS2), 15.01 (s, 4H, HS1), 34.7 (s, 4H, HT5), 70.4 (s, 4H, HT3), 74.6 (s, 4H, 
H
T3?
), 111.8 (br, 4H, H
T6
). 
13C NMR (125 MHz, CD3CN): 
For Co(III) species: ?C 69.6 (CS2), 70.6 (CS6), 71.2 (CS4 and CS5), 71.6 (CS3), 72.5 (CS1), 
73.6 (CS7), 115.7 (CT3?), 126.9 (CN), 127.2 (CN), 127.7 (CT3), 128.6 (CN), 128.7 (CN),
128.9 (CN), 131.7 (CT5), 133.8 (CN9/ N10), 134.2 (CN10/ N9), 137.4 (CN2), 144.0 (CT4), 153.2 
(C
T6
), 157.1 (C
T2
), 157.8 (C
T2?
), 173.7 (C
T4?
).
For Co(II) species: ?C -127.7 (CT2/ T2?), -74.6 (CT6), -49.1 (CT2/ T2?), 71.7 (CS6), 72.9 (CS5),
74.0 (CS4), 74.1 (CS7), 75.3 (CS3), 78.9 (CS2), 80.4 (CS1), 126.2 (CN6), 126.6(CN7), 127.0 
(CN3), 127.1(CN1), 127.9 (CN5), 128.3 (CN8), 128.7 (CN4), 133.4 (CN10), 134.0 (CN9), 137.6 
(CN2), 161.7 (CT4), 304.8 (CT4?), 353.6 (CT3), 383.2 (CT3?), 499.4 (CT5).
MS (ES): m/z = 1246.2 [M-PF6]
+, 828.5 [M-2PF6-(CH2CH2O)2OCH2Nap]
+, 599.4 
[L7+Co+F]+, 551.7 [M-2PF6]
2+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 224 (260 x 103), 241 (63.1 x 103), 272 (63.7 x 
103), 305 (29.4 x 103).
Found: C, 51.27; H, 4.17; N, 5.58. Calc. for ?C64H62N6O8P2F12Co and 
?C64H62N6O8P3F18Co: C, 51.64; H, 4.20; N, 5.65%. 
? [Co(L8)2][PF6]2
Molecular formula: 
C60H42N6O2CoP2F12 
Molecular weight: 1227.88 
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L
8 (50 mg, 0.11 mmol) and Co(OAc)2·4H2O (14 mg, 0.055 mmol) were used. A brown 
powder (44.5 mg, 65.8%) was obtained. 
1H NMR (500 MHz, CD3CN): ?H 6.56 (s, 4H, HT4), 9.13 (m, 4H, HA3, A6), 9.84 (d, J 8.8 
Hz, 4H, HA4, A5), 10.13 (m, 4H, HA2, A7), 10.63 (s, 2H, HA10), 14.63 (d, J 8.9 Hz, 4H, HA1, 
A8), 16.77 (s, 4H, HS1), 34.7 (s, 4H, HT5), 69.7 (s, 4H, HT3), 73.8 (s, 4H, HT3?), 110.9 (br, 
4H, HT6).
MS (ES): m/z = 1083.2 [M-PF6]
+, 956.2 [M-PF6-PF5]
+, 876.1 [M-PF6-OCH2Ant]
+, 746.3 
[M-2PF6-CH2Ant]
+, 555.5 [M-2PF6-2CH2Ant]
+, 540.6 [M-2PF6-OCH2Ant-CH2Ant]
+,
517.1 [L8+Co+F]+, 191.4 [CH2Ant]
+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 254 (298 x 103), 281 (45.1 x 103), 315 (21.5 x 
103), 348 (16.0 x 103), 366 (21.1 x 103), 386 (19.3 x 103).
Found: C, 57.90; H, 3.53; N, 6.54. Calc. for C60H42N6O2P2F12Co·H2O: C, 57.84; H, 3.56; 
N, 6.75%. 
? [Co(L9)2][PF6]2
Molecular formula: C50H34N6S2CoP2F12 
Molecular weight: 1131.84 
L
9 (54 mg, 0.14 mmol) and Co(OAc)2·4H2O (17 mg, 0.070 mmol) were used. A brown 
powder (44.5 mg, 56.1%) was obtained. 
1H NMR (500 MHz, CD3CN): ?H 8.08 (s, 4H, HT4), 8.36 (t, J 7.8 Hz, 2H, HN6), 8.47 (t, J
7.7 Hz, 2H, HN7), 9.13 (d, J 8.4 Hz, 2H, HN5), 9.63 (d, J 8.4 Hz, 2H, HN8), 10.15 (d, J 8.3 
Hz, 2H, HN4), 12.37 (s, 2H, HN1), 12.67 (d, J 8.3 Hz, 2H, HN3), 34.1 (s, 4H, HT5), 55.9 (s, 
4H, HT3?), 61.6 (s, 4H, HT3), 102.8 (br, 4H, HT6).
13C NMR (125 MHz, CD3CN): ?C -85.8 (CT2/T2?), -55.5 (CT6), -11.7 (CT2/ T2?), 126.4 (CN2),
129.4(CN7), 130.2 (CN5), 130.4 (CN6), 131.0 (CN8), 134.0 (CN4), 136.9 (CN3), 137.3 (CN9),
137.3 (CN10), 141.7 (CN1), 158.2 (CT4), 247.0 (CT4?), 336.5 (CT3?), 339.0 (CT3), 464.5 (CT5).
MS (ES): m/z = 985.9 [M-PF6]
+, 421.2 [M-2PF6]
2+.
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UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 221 (146 x 103), 283 (74.0 x 103), 310 (49.7 x 
103).
Found: C, 52.38; H, 3.24; N, 7.32. Calc. for C50H34N6S2P2F12Co·CH3OH: C, 52.63; H, 
3.29; N, 7.22%. 
? [Co(terpy)2][PF6]2
Molecular formula: C30H22N6CoP2F12 
Molecular weight: 815.40 
Terpy (20 mg, 0.086 mmol) and Co(OAc)2·4H2O (11 mg, 0.043 mmol) were used. A 
brown powder (30.1 mg, 85.8%) was obtained. 
1H NMR (250 MHz, CD3CN): ?H 8.94 (s, 4H, HT4), 21.9 (s, 2H, HT4?), 34.5 (s, 4H, HT5),
48.1 (s, 4H, HT3?), 57.1 (s, 4H, HT3), 99.2 (br, 4H, HT6). 
MS (ES): m/z = 669.9 [M-PF6]
+, 544.0 [M-PF6-PF5]
+, 262.9 [M-2PF6]
2+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 280 (44.1 x 103), 314 (36.7 x 103).
Found: C, 43.65; H, 2.64; N, 10.11. Calc. for C30H22N6P2F12Co·H2O: C, 43.23; H, 2.91; N, 
10.09%. 
Partially oxidise the [Co(terpy)2][PF6]2 to a mixture of Co(II) and Co(III) species by 
adding one drop of Br2 to the [Co(terpy)2][PF6]2 in CH3CN. Then, aqueous NH4PF6 was 
added to the solution. The resultant brown precipitate was collected by filtration, washed 
and dried. 
1H NMR (500 MHz, CD3CN): 
For Co(III) species: ?H 7.24 (d, J 5.6 Hz, 4H, HT6), 7.41 (t, J 6.4 Hz, 4H, HT5), 8.21 (t, J
7.7 Hz, 4H, HT4), 8.60 (d, J 7.8 Hz, 4H, HT3), 9.03 (m, 6H, HT4? and HT3?).
For Co(II) species: ?H 9.12 (s, 4H, HT4), 22.0 (s, 4H, HT4?), 34.1 (s, 4H, HT5), 45.9 (s, 4H, 
HT3?), 56.0 (s, 4H, HT3), 97.5 (br, 4H, HT6).
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General method for the exchange experiments of the cobalt(II) complexes 
The solutions of the cobalt(II) complexes were prepared fresh, mixed and transferred 
immediately in an NMR tube. After an initial delay for shimming (about 5 mins), the spectra 
were recorded. 
(a) [Co(L
1
)2][PF6]2 and [Co(L
2
)2][PF6]2
Each [Co(L1)2][PF6]2  (4.7 mg, 5x10
-3 mmol) and [Co(L2)2][PF6]2 (5.1 mg, 5x10
-3 mmol) were 
dissolved in 0.5 mL CD3CN. 0.3 mL of each [Co(L
1)2][PF6]2 and [Co(L
2)2][PF6]2 were mixed 
together. The reaction mixture was monitored immediately by 
1
H NMR spectroscopy until 
equilibrium was established. 
(b) [Co(L
4
)2][PF6]2 and [Co(L
9
)2][PF6]2
Each [Co(L4)2][PF6]2  (5.6 mg, 5.0x10
-3 mmol) and [Co(L9)2][PF6]2 (5.7 mg, 5.0x10
-3 mmol) 
were dissolved in 0.5 mL CD3CN. 0.3 mL of each [Co(L
4)2][PF6]2 and [Co(L
9)2][PF6]2 were 
mixed together. The reaction mixture was monitored immediately by 1H NMR spectroscopy 
until equilibrium was established. 
(c) [Co(L8)2][PF6]2 and [Co(L
9)2][PF6]2
Each [Co(L8)2][PF6]2  (6.1 mg, 5.0x10
-3 mmol) and [Co(L9)2][PF6]2 (5.7 mg, 5.0x10
-3 mmol) 
were dissolved in 0.5 mL CD3CN. 0.3 mL of each [Co(L
8)2][PF6]2 and [Co(L
9)2][PF6]2 were 
mixed together. The reaction mixture was monitored immediately by 1H NMR spectroscopy 
until equilibrium was established. 
(d) [Co(L4)2][PF6]2 and [Co(L
8)2][PF6]2
Each [Co(L4)2][PF6]2  (5.6 mg, 5.0x10
-3 mmol) and [Co(L8)2][PF6]2 (6.1 mg, 5.0x10
-3 mmol) 
were dissolved in 0.5 mL CD3CN. 0.3 mL of each [Co(L
4)2][PF6]2 and [Co(L
8)2][PF6]2 were 
mixed together. The reaction mixture was monitored immediately by 1H NMR spectroscopy 
until equilibrium was established. 
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(e) [Co(terpy)2][PF6]2 and [Co(L
8)2][PF6]2
Each [Co(terpy)2][PF6]2  (4.1 mg, 5.0x10
-3 mmol) and [Co(L8)2][PF6]2 (6.1 mg, 5.0x10
-3
mmol) were dissolved in 0.5 mL CD3CN. 0.3 mL of each [Co(terpy)2][PF6]2 and 
[Co(L8)2][PF6]2 were mixed together. The reaction mixture was monitored immediately by 
1H
NMR spectroscopy until equilibrium was established. 
(f) [Co(Fc-terpy)2][PF6]2 and [Co(L
8)2][PF6]2
Each [Co(Fc-terpy)2][PF6]2 (4.1 mg, 5.0x10
-3 mmol) and [Co(L8)2][PF6]2 (6.1 mg, 5.0x10
-3
mmol) were dissolved in 0.5 mL CD3CN. 0.3 mL of each [Co(Fc-terpy)2][PF6]2 and 
[Co(L8)2][PF6]2 were mixed together. The reaction mixture was monitored immediately by 
1H
NMR spectroscopy until equilibrium was established. 
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Chapter 5 
Synthesis of Homoditopic 4?-Substituted-2,2?:6?,2?-Terpyridine 
Ligands
In Chapter 2, we discussed a few methodologies for synthesising 4?-substituted-
2,2?:6?,2?-terpyridine ligands. Homoditopic 4?-substituted-2,2?:6?,2?-terpyridine
ligands can also be synthesised by using the same method. Most of the known rigid 
bis(terpyridine) ligands were synthesised by the Kröhnke method or a coupling 
method.1,2 For example, 1,4-bis[4?-(2,2?:6?,2?-terpyridinyl)]benzene1 and 2,5-bis[4?-
(2,2?:6?,2?-terpyridinyl)]thiophene3 were synthesised in two steps by the Kröhnke 
strategy (Scheme 1). 1,1?-Bis[4?-(2,2?:6?,2?-terpyridinyl)]ferrocene can also be 
prepared from ferrocene-1,1?-dicarboxaldehyde by the Kröhnke methodology.4
Scheme 1. The Kröhnke strategy for synthesising 1,4-bis[4?-(2,2?:6?,2?-
terpyridinyl)]benzene and 2,5-bis[4?-(2,2?:6?,2?-
terpyridinyl)]thiophene. 
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The coupling reaction can also be used to prepare "back-to-back" terpyridine ligands, 
for example, 4,4?-bis[4?-(2,2?:6?,2?-terpyridinyl)]biphenyl5 and 6?,6?-bis(2-pyridyl)-
2,2?:4?,4?:2?,2??-quaterpyridine6-8. 4,4?-Bis[4?-(2,2?:6?,2?-terpyridinyl)]biphenyl can be 
prepared by coupling two equivalents of 4?-(4-chlorophenyl)-2,2?:6?,2?-terpyridine or 
4?-(4-bromophenyl)-2,2?:6?,2?-terpyridine with nickel(0)5, while 6?,6?-bis(2-pyridyl)-
2,2?:4?,4?:2?,2??-quaterpyridine can be synthesised by coupling two equivalents of 4?-
chloro-2,2?:6?,2?-terpyridine with nickel(0)6-8. Ziessel and co-workers have prepared a 
range of 2,5-diethynyl-3,4-dibutylthiophene-bridged "back-to-back" terpyridine 
ligands.9
4?-Hydroxy-2,2?:6?,2?-terpyridine (HO-terpy) can be coupled with 4?-chloro-
2,2?:6?,2?-terpyridine (Cl-terpy) using potassium hydroxide in N,N-
dimethylformamide at reflux to give the oxygen-bridged "back-to-back" ligand bis[4?-
(2,2?:6?,2?-terpyridinyl)]ether.10 Reaction of 1,10-diaza-18-crown-6(1,4,10,13-
tetraoxa-7,16-diazacyclooctadecane) with two equivalents of 4?-bromo-2,2?:6?,2?-
terpyridine or two equivalents of 4?-[(4-bromomethyl)phenyl]-2,2?:6?,2?-terpyridine 
afforded 1,10-bis[4?-(2,2?:6?,2?-terpyridinyl)]diaza-18-crown-6(1,4,10,13-tetraoxa-
6',6''-Bis(2-pyridyl)-2,2':4',4'':2'',2'''-quaterpyridine
NN
N
NN
N
N
N
N
N
N
N
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7,16-diazacyclooctadecane) or 1,10-bis[4?-(4-methylphenyl-2,2?:6?,2?-
terpyridinyl)]diaza-18-crown-6(1,4,10,13-tetraoxa-7,16-diazacyclooctadecane).11
In this chapter, the syntheses of several new homoditopic ligands based upon a 
naphthalene unit bearing two 4?-substituted-2,2?:6?,2?-terpyridine-terminated 
bis(ethyleneoxy) ligands (L10-L17) are discussed (Scheme 2). All of these homoditopic 
4?-substituted-2,2?:6?,2?-terpyridine ligands contain polyethyleneoxy chains which 
link to two different positions of the naphthalene unit and differ from one another in 
the length of the chains. 
Scheme 2. Diagram showing the homoditopic ligands L10-L17.
5.1 Synthesis 
As discussed in Chapter 2, different substituents can be introduced at the 4?-position 
of 2,2?:6?,2?-terpyridine ligands by electrophiles reacting with 4?-hydroxy-2,2?:6?,2?-
terpyridine (HO-terpy) or nucleophiles reacting with 4?-chloro-2,2?:6?,2?-terpyridine
(Cl-terpy).12-30 
The syntheses of different homoditopic 4?-substituted-2,2?:6?,2?-terpyridine ligands 
are described below. The ligands L10-L17 were designed with two tridentate binding 
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sites for complexation with metal ions and with bridging naphthalene domain. The 
2,2?:6?,2?-terpyridine and naphthyl domains in ligands L11-L17 were connected by 
ethyleneoxy linkage groups of different lengths. This is also important for controlling 
the size of metallomacrocycles when they react with metal ions. 
The reaction of 2,6-bis(hydroxymethyl)naphthalene, KOH and Cl-terpy in dry DMSO 
at 70ºC for 3 days, followed by column chromatography (alumina, CH2Cl2: hexane 
2:1, then CH2Cl2/ 1% CH3OH) gave L
10 as a yellow powder in 30% yield (Scheme 
3).29,30 The product tends to readily decompose. 
Scheme 3. Synthesis of L10.
2,6-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4-dioxapentyl]naphthalene (L11) and 2,6-
[bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7-trioxaoctyl]naphthalene (L12) were prepared 
from L1 and L2 respectively in 57% and 15% yields. The reaction of L1 or L2 with 
NaH and 2,6-bis(bromomethyl)naphthalene in THF at 80ºC for 2-4 days, followed by 
work up using column chromatography (alumina, CH2Cl2/ 1% CH3OH) resulted in 
L
11 as a white powder and L12 as yellow oily liquid (Scheme 4).31
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Scheme 4. Syntheses of L11 and L12.
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Heating HO-terpy, K2CO3 and 2,7-bis(2-methanesulfonatoethoxy)naphthalene in dry 
acetone at 70ºC for 4 days, followed by column chromatography (alumina, CH2Cl2/
0.5% CH3OH) resulted in the formation of L
13 as a white powder in 58% yield 
(Scheme 5).
Scheme 5. Synthesis of L13.
The synthesis of L14 is depicted in Scheme 6. L14 was prepared in 28% overall yield 
from 2,7-dihydroxynaphthalene in two steps; reaction of ClCH2CH2OCH2CH2OH 
with 2,7-dihydroxynaphthalene and K2CO3 in DMF gave the diol-functionalised 
compound 2,7-di[2-(2-hydroxyethoxy)ethoxy]naphthalene which was converted to 
L
14 by reaction with Cl-terpy and KOH in DMSO.29,30
Scheme 6. Synthesis of L14.
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The synthesis of L15 is depicted in Scheme 7. L15 was prepared in 12% overall yield 
from 2,7-dihydroxynaphthalene in two steps; reaction of ClCH2(CH2OCH2)2CH2OH 
with 2,7-dihydroxynaphthalene in dry acetone gave the diol-functionalised compound 
2,7-di{2-[2-(2-hydroxyethoxy)ethoxy]ethoxy}naphthalene which was converted to 
L
15 by reaction with Cl-terpy and KOH in DMSO.29,30
Scheme 7. Synthesis of L15.
Scheme 8. Synthesis of L16.
The synthesis of L16 is depicted in Scheme 8. L16 was prepared in 16% overall yield 
from 2,3-dihydroxynaphthalene in three steps; reaction of ethyl bromoacetate with 
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2,3-dihydroxynaphthalene and K2CO3 in acetone gave 2,3-
di(ethoxycarbonylmethoxy)naphthalene. The diester was then reduced to the diol-
functionalised compound 2,3-di(2-hydroxyethoxy)naphthalene which was converted 
to L16 by reaction with Cl-terpy and KOH in DMSO.29,30
Scheme 9. Synthesis of L17.
L
17 was prepared by using the similar reaction scheme for synthesis of L14 (Scheme 
9). L17 was prepared in 32% overall yield from 2,3-dihydroxynaphthalene in two 
steps; reaction of ClCH2CH2OCH2CH2OH with 2,3-dihydroxynaphthalene and K2CO3
in acetone gave the diol-functionalised compound 2,3-di[2-(2-
hydroxyethoxy)ethoxy]naphthalene which was converted to L17 by reaction with Cl-
terpy and KOH in DMSO.29,30
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5.2
1
H NMR spectroscopic characterisation 
All the ligands were characterised by 1H NMR spectroscopy in CDCl3 solution. The 
spectroscopic signatures of the ligands compare well with those of other terpy 
systems29, and the terpyridine proton signals are very similar from one ligand to 
another (Table 1). Table 2 shows the chemical shifts for the ethyleneoxy spacer and 
naphthalene ring proton signals. 
Proton resonance (?)
L
HT5 HT4 HT3? HT3 HT6
L10
7.35 (ddd) 
J 1.0, 4.8, 7.3 Hz 
7.87 (td) 
J 1.7, 7.7 Hz 
8.19 (s) 
8.64 (d) 
J 8.1 Hz 
8.72 (dd) 
J 1.0, 4.0 Hz 
L
11 7.32 (ddd) 
J 1.1, 4.8, 7.4 Hz 
7.84 (td) 
J 1.8, 7.7 Hz 
8.07 (s) 
8.61 (d) 
J 7.9 Hz 
8.68 (m) 
L
12 7.32 (dd) 
J 4.9, 6.5 Hz 
7.84 (td) 
J 1.6, 7.7 Hz 
8.05 (s) 
8.60 (d) 
J 7.9 Hz 
8.67 (d) 
J 4.1 Hz 
L
13 7.33 (ddd) 
J 1.2, 4.8, 7.5 Hz 
7.85 (td)  
J 1.8, 7.7 Hz 
8.14 (s) 
8.63 (dt) 
J 1.0, 8.0 Hz 
8.69 (ddd) 
J 0.9, 1.8, 4.8 Hz 
L
14 7.31 (ddd) 
J 1.2, 4.8, 7.5 Hz 
7.84 (td)  
J 1.8, 7.7 Hz 
8.05 (s) 
8.60 (dt) 
J 1.0, 8.0 Hz 
8.67 (ddd) 
J 0.9, 1.8, 4.8 Hz 
L
15 7.31 (ddd) 
J 1.2, 4.8, 7.5 Hz 
7.83 (td)  
J 1.8, 7.7 Hz 
8.04 (s) 
8.59 (dt) 
J 1.0, 7.9 Hz 
8.66 (ddd) 
J 0.9, 1.8, 4.8 Hz 
L
16 7.30 (dd) 
J 5.1, 7.0 Hz 
7.83 (t)  
J 7.5 Hz 
8.06 (s) 
8.57 (d) 
J 8.0 Hz 
8.64 (d) 
J 4.0 Hz 
L17 7.28 (m) 
7.80 (td)  
J 1.8, 7.7 Hz 
8.02 (s) 
8.56 (dt) 
J 1.0, 8.0 Hz 
8.64 (ddd) 
J 0.9, 1.8, 4.8 Hz 
Table 1.
1H NMR spectroscopic data for the terpyridine proton signals of L10-L17 in 
CDCl3 solution at room temperature. The 
1H NMR spectrum for L10 was 
measured at 400 MHz and all the others were measured at 500 MHz. 
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Proton resonance (?)
L
HS1 HS2 HS3 HS4 HS5 HS6
L
10 5.51 (s)      
L11
4.45 (t) 
J 4.7 Hz 
3.95 (t) 
J 4.7 Hz 
4.82 (s)    
L12
4.41 (t) 
J 4.7 Hz 
3.95 (t) 
J 4.7 Hz 
3.80 (m) 3.70 (m) 4.72 (s)  
L
13 4.67 (m) 4.52 (m)     
L14
4.44 (t) 
J 4.7 Hz  
4.02 (m) 
4.25 (t) 
J 4.8 Hz 
L15
4.39 (t) 
J 4.7 Hz 
3.93 (t) 
J 4.7 Hz 
3.78 (m) 
3.91 (t) 
J 4.8 Hz 
4.19(t) 
J 4.9 Hz 
L
16 4.70 (t) 
J 4.6 Hz 
4.56 (t)  
J 4.8 Hz 
    
L
17 4.39 (t) 
J 4.7 Hz 
4.04 (m) 
4.29 (t) 
J 4.9 Hz 
Proton resonance (?)
L
HN3, N7 HN4, N8 HN1, N5
L10
7.62 (dd)  
J 1.3, 8.3 Hz 
7.92 (d) 
J 8.1 Hz 
7.99 (s) 
L11
7.49 (dd) 
J 1.3, 8.3 Hz 
7.81 (m) 
L
12 7.44 (d)  
J 8.2 Hz 
7.77 (d) 
J 8.4 Hz 
7.74 (s) 
HN3, N6 HN1, N8 HN4, N5
L13
7.07 (dd) 
J 2.5, 8.9 Hz 
7.15 (d)  
J 2.5 Hz 
7.67 (d)  
J 9.0 Hz 
L14 7.02 (m) 
7.60 (d)  
J 8.7 Hz 
L15 6.98 (m) 
7.58 (d)  
J 9.6 Hz 
HN1, N4 HN6, N7 HN5, N8
L
16 7.28 (s) 7.35 (m) 7.70 (m) 
L17 7.14 (s) 7.28 (m) 7.63 (m) 
Table 2.
1H NMR spectroscopic data for the ethyleneoxy spacer proton and naphthyl 
proton signals of L10-L17 in CDCl3 solution at room temperature. The 
1H
NMR spectrum for L10 was measured at 400 MHz and all the others were 
measured at 500 MHz. 
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Figure 1.
1H NMR spectra of (a) L10 (400 MHz), (b) L11 (500 MHz) and (c) L12 (500 
MHz) in CDCl3 solution at room temperature. The signal marked * is the 
signal for CHCl3.
The 1H NMR spectra of L10, L11 and L12 in CDCl3 solution have very similar features 
from one to the other (Figure 1). L12 has the longest ethyleneoxy spacer groups 
among L10, L11, L12. There are eight signals for L12 in the aromatic region excluding 
the signal for CHCl3 (Figure 1c). The five terpyridine proton signals were assigned 
according to the ligands L1-L8 in Chapter 2. The assignment of the CH2 protons was 
made by COSY and NOESY and confirmed by HMQC and HMBC. The triplet at ?
4.41, which exhibits an NOE signal to HT3? at ? 8.05, is assigned to HS1 (Figure 2).
HS1 gives a COSY cross peak to HS2 at ? 3.95 (Figure 3). HS2 exhibits an NOE signal 
to the signal at ? 3.80 and this signal is assigned to HS3 (Figure 2). And then, HS3
gives a COSY cross peak to the signal for HS4 at ? 3.70 (Figure 3). H S4 exhibits an 
NOE signal to a singlet at ? 4.72, which is assigned to HS5 (Figure 2). Finally, HS5
exhibits NOE signals to a doublet and a singlet at ? 7.44 and 7.74, which are assigned 
to HN3, N7 and HN1, N5 respectively (Figure 2). HN3, N7 at ? 7.44 gives a COSY cross 
peak to a doublet at ? 7.77, and this signal is assigned to HN4, N8 (Figure 3).
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Figure 2. NOESY spectrum (500 MHz) of L12 in CDCl3 solution at room 
temperature. The signal marked * is the signal for CHCl3.
Figure 3. COSY spectrum (500 MHz) of L12 in CDCl3 solution at room temperature. 
The signal marked * is the signal for CHCl3.
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Figure 4.
1H NMR spectrum (500 MHz) of L13 in CDCl3 solution at room 
temperature. The signal marked * is the signal for CHCl3.
There are ten signals in the 1H NMR spectrum of a CDCl3 solution of the ligand L
13
excluding the signal for CHCl3 (Figure 4). Five terpyridine signals were found as 
expected by comparison with L10-L12; the rest of the signals belong to the naphthyl 
ring and ethyleneoxy protons and were further identified by NOESY and COSY 
techniques. The triplet at ? 4.67, which exhibits an NOE signal to HT3? at ? 8.14, is 
assigned to HS1 (Figure 5). The signal for HS1 gives a COSY cross peak to a signal for 
HS2 at ? 4.52 (Figure 6). The signal for HS2 exhibits an NOE signal to a doublet with 
a coupling constant of 2.5 Hz at ? 7.15, which is assigned to HN1, N8 (Figure 5). The 
doublet of doublets at ? 7.07, with coupling constants of 2.5 Hz and 8.9 Hz, is 
assigned to HN3, N6. From the COSY spectrum (Figure 6), the signal for HN3, N6 gives a 
cross peak to a signal at ? 7.67, and is assigned to HN4, N5. The assignment was also 
confirmed by HMQC and HMBC. 
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Figure 5. NOESY spectrum (500 MHz) of L13 in CDCl3 solution at room 
temperature. The signal marked * is the signal for CHCl3.
Figure 6. COSY spectrum (500 MHz) of L13 in CDCl3 solution at room temperature. 
The signal marked * is the signal for CHCl3.
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Figure 7.
1H NMR spectra (500 MHz) of (a) L13, (b) L14 and (c) L15 in CDCl3 solution 
at room temperature. The signal marked * is the signal for CHCl3.
The 1H NMR spectra of CDCl3 solutions of the ligand L
14 and L15 are similar to the 
spectrum of L13 (Figure 7). The assignment was made by using NOESY and COSY 
and confirmed by HMQC and HMBC techniques. There are no significant differences 
of the terpyridine signals, except HT3?. However, the naphthalene protons are shifted to 
slightly higher field as the ethyleneoxy spacer gets longer (Table 2).
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Figure 8.
1H NMR spectra (500 MHz) of (a) L16 and (b) L17 in CDCl3 solution at 
room temperature. The signal marked * is the signal for CHCl3.
The 1H NMR spectrum of L17 in CDCl3 solution exhibits 12 signals excluding the 
signal for CHCl3 (Figure 8b). The five terpyridine signals are assigned as before. The 
singlet for HT3? at ? 8.02 exhibits an NOE signal to a triplet at ? 4.39, which is 
assigned to HS1 (Figure 9). The signal for HS1 gives a cross peak to a signal at ? 4.04 
and this is assigned to HS2 (Figure 10). The singlet at ? 7.14, which has half the 
relative integral of the signal for HS1, is assigned to HN1, N4. The signal for HN1, N4
gives NOE signals to a triplet at ? 4.29 and a multiplet at ? 7.63, and so the signals are 
assigned to HS4 and HN8, N5 respectively (Figure 9). The signal for HS4 gives a cross 
peak to a signal at ? 4.04 which is assigned to HS3 (Figure 10). Also, the signal for 
HN8, N5 gives a cross peak to a multiplet at ? 7.28 which is assigned to HN7, N6 (Figure 
10). There are no significant differences between the 1H NMR spectra of L17 and L16,
except the naphthalene and ethyleneoxy protons are shifted to higher field as the 
ethyleneoxy spacer gets longer (Figure 8 and Table 2).
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Figure 9. NOESY spectrum (500 MHz) of L17 in CDCl3 solution at room 
temperature. The signal marked * is the signal for CHCl3.
Figure 10. COSY spectrum (500 MHz) of L17 in CDCl3 solution at room temperature. 
The signal marked * is the signal for CHCl3.
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5.3
13
C NMR spectroscopic characterisation 
Table 3 shows the terpyridine, ethyleneoxy spacer and naphthalene ring 13C signals of 
L
10-L17 in CDCl3 solution (see p.186 for the atom labelling scheme). The assignments 
were done by using HMQC and HMBC techniques. There are no significant changes 
in these signals as the length of the spacer between the terpyridine and the substituents 
is lengthened. All the terpyridine carbon signals of these ligands are comparable to 
each other. 
Carbon resonance (?)
L
CT3? CT3 CT5 CT4 CT6 CT2 CT2? CT4?
L
10 107.8 121.5 124.0 137.0 149.2 156.2 157.4 167.1 
L
11 107.5 121.3 123.8 136.8 149.1 156.1 157.1 167.0 
L
12 107.5 121.3 123.8 136.8 149.1 156.1 157.1 167.0 
L
13 107.7 121.4 123.8 136.8 148.9 156.0 157.2 167.0 
L14 107.6 121.5 124.0 136.9 149.2 156.2 157.3 167.1 
L15 107.6 121.5 124.0 137.0 149.0 156.0 157.1 167.1 
L16 108.1 121.8 124.2 137.5 148.7 155.3 156.5 167.2 
L17 107.6 121.4 123.9 136.8 149.13 156.1 157.2 167.1 
Carbon resonance (?)L
CS1 CS2 CS3 CS4 CS5 CN3, N7 CN1, N5 CN4, N8 CN9, N10 CN2, N6
L
10 70.1     125.8 126.4 128.7 133.1 134.1 
L
11 67.8 68.3 73.5   126.0 126.3 128.3 132.9 135.5 
L
12 67.8 69.5 71.1 69.5 73.4 126.0 126.3 128.2 132.8 135.7 
CS1 CS2 CS3 CS4 CS5 CS6 CN1, N8 CN3, N6 CN10 CN4, N5 CN9 CN2, N7
L
13 66.7 66.4     106.8 116.5 124.9 129.3 135.8 157.2 
L14 68.0 69.8 70.2 67.6   106.4 116.6 124.6 129.2 135.9 157.4 
L15 67.9 69.6 71.2 71.0 69.9 67.4 106.3 116.5 124.5 129.1 135.8 157.4 
CS1 CS2 CS3 CS4 CN1, N4 CN6, N7 CN5, N8 CN9, N10 CN2, N3
L
16 67.0 67.6   110.1 124.7 126.6 129.7 149.1 
L
17 68.0 69.9 70.0 68.7 108.7 124.3 126.5 129.5 149.10 
Table 3.
13C NMR spectroscopic data (125 MHz) for the terpyridine, ethyleneoxy 
spacer and naphthyl ring carbon signals of L10-L17 in CDCl3 solution at 
room temperature.  
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5.4 Mass spectrometric characterisation 
Fast-atom bombardment mass spectrometry (FAB-MS) was used to characterise the 
ligands. FAB-MS is relatively harsh methods and fragmentation is observed when 
these techniques are used. Therefore, not only is the parent peak [M+H]+ typically 
observed, but also other fragmentation peaks are detected (see Section 5.8).
5.5 Crystal structures of L
14
 and 2,7-di(2-
hydroxyethoxy)naphthalene 
(a) Crystal structure of L
14
A single crystal of L14, which was obtained by the slow diffusion of diethyl ether into 
a chloroform solution of L14, was suitable for X-ray crystallographic analysis (Figure 
11). Crystallographic data are given in Appendix IV and selected bond lengths and 
angles are given in Table 4. The crystal structure of L14, like other free 2,2?:6?,2?-
terpyridine ligands14,32,33, exists in a trans-trans conformation which minimises the 
repulsive N-N lone pair interactions that are present in the cis-cis conformation. The 
interannular C-C bonds, C5-C6, 1.491(6) Å, C7-C8, 1.472(6) Å, C37-C36, 1.468(7) 
Å, and C43-C44, 1.487(7) Å, and the other N-C, C-C bond lengths are within the 
reported range of 4?-[3-(1,2-dicarbadecaboranyl)propoxy]-2,2?:6?,2?-terpyridine.14 The 
three pyridine rings of each domain are not exactly coplanar and the torsion angles 
between C4-C5-C6-N2, C9-C8-C7-N2, C41-C37-C36-N5 and C45-C44-C43-N5 are -
1.53˚, -16.11˚, -2.68˚ and 1.19˚ respectively. These small deviations from planarity 
are typical for the free ligands.32
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Figure 11. An ORTEP representation (50% probability ellipsoids) of L14. Hydrogen 
atoms are omitted for clarity. Carbon atoms of the naphthyl group are 
numbered sequentially around the rings. 
For the ethyleneoxy chain, the angles C15-O1-C16 and C34-O6-C33 are 117.8(3)˚ and 
118.4(3)˚ respectively, which are comparable to the corresponding angle in 4?-ethoxy-
5,5?-dimethyl-2,2?:6?,2?-terpyridine34 and 4?-[3-(1,2-dicarbadecaboranyl)propoxy]-
2,2?:6?,2?-terpyridine14. The bond lengths O1-C15 and O6-C34 are 1.363(5) Å and 
1.355(5) Å respectively which, within experimental error, are the same as those in 4?-
ethoxy-5,5?-dimethyl-2,2?:6?,2?-terpyridine (1.357(3) Å)34 and 4?-[3-(1,2-
dicarbadecaboranyl)propoxy]-2,2?:6?,2?-terpyridine (1.361(1) Å)14. Also, the bond 
lengths O1-C16, 1.425(5) Å and O6-C33, 1.436(5) Å are within the range reported in 
4?-ethoxy-5,5?-dimethyl-2,2?:6?,2?-terpyridine (1.425(3) Å)34 and 4?-[3-(1,2-
dicarbadecaboranyl)propoxy]-2,2?:6?,2?-terpyridine (1.428(1) Å)14. The bond lengths 
of O1-C15 and O6-C34 are shorter than O1-C16 and O6-C33 and this suggests a 
degree of ?-conjugation between the oxygen O1 and O6 atoms with the adjacent 
aromatic rings.  
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C5-C6 1.491(6) C37-C36 1.468(7) C15-O1 1.363(5) 
C7-C8 1.472(6) C43-C44 1.487(7) O1-C16 1.425(5) 
N1-C5 1.319(6) N4-C37 1.325(7) C19-O3 1.424(6) 
C4-C5 1.389(7) C37-C41 1.381(7) O3-C20 1.359(6) 
N1-C1 1.333(6) N4-C38 1.339(7) C26-O4 1.353(6) 
N2-C6 1.335(6) N5-C36 1.342(6) O4-C30 1.425(6) 
C6-C13 1.391(6) C36-C35 1.389(6) C33-O6 1.436(5) 
N2-C7 1.351(6) N5-C43 1.337(6) O6-C34 1.355(5) 
C7-C14 1.378(6) C43-C42 1.376(7)   
N3-C8 1.330(6) N6-C44 1.321(7)   
C8-C9 1.366(7) C44-C45 1.370(8)   
N3-C12 1.337(7) N6-C48 1.327(8)   
      
C5-N1-C1 117.6(4) C37-N4-C38 117.3(5) O1-C15-C13 124.1(4)   
N1-C5-C4 122.3(5) N4-C37-C41 121.9(5) O1-C15-C14 115.9(4) 
N1-C5-C6 116.6(4) N4-C37-C36 116.5(4) C16-O1-C15 117.8(3) 
C4-C5-C6 121.1(4) C41-C37-C36 121.7(5) C19-O3-C20 118.4(4) 
C13-C6-C5 119.4(4) C35-C36-C37 120.2(4) O3-C20-C21 114.9(5) 
N2-C6-C5 116.7(4) N5-C36-C37 117.1(4) O3-C20-C29 124.7(5) 
N2-C6-C13 123.6(4) N5-C36-C35 122.6(4) O6-C34-C35 125.1(4) 
C6-N2-C7 117.1(4) C36-N5-C43 118.0(4) O6-C34-C42 115.3(4) 
N2-C7-C14 122.5(4) N5-C43-C42 122.7(4) C33-O6-C34 118.4(3) 
N2-C7-C8 116.7(4) N5-C43-C44 117.2(4) C30-O4-C26 117.8(4) 
C8-C7-C14 120.7(4) C44-C43-C42 120.1(5) O4-C26-C25 113.9(4) 
N3-C8-C7 116.0(4) N6-C44-C43 115.3(5) O4-C26-C27 125.2(5) 
C7-C8-C9 121.4(5) C43-C44-C45 121.5(5)   
N3-C8-C9 122.6(5) N6-C44-C45 123.2(5)   
C8-N3-C12 117.1(5) C44-N6-C48 117.1(6)   
C13-C15-C14 120.0(4) C35-C34-C42 119.5(4)   
C4-C5-C6-N2 -1.53 C13-C15-O1-C16 14.62 
C9-C8-C7-N2 -16.11 C19-O3-C20-C29 2.79 
C41-C37-C36-N5 -2.68 C35-C34-O6-C33 4.59 
C45-C44-C43-N5 1.19 C30-O4-C26-C27 4.03 
Table 4. Selected bond lengths (Å) and angles (˚) of L14.
There are face-to-face ? stacking interactions between the terpyridine domains. The 
plane-to-plane distance between the two terpyridine domains is around 3.6 Å. The 
closest distance between atom C4 of one pyridine ring and atom C37 of the other 
pyridine ring, and atom N2 of one pyridine ring and atom C42 of the other pyridine 
ring are 3.496 Å and 3.541 Å respectively (Figure 12).
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Figure 12. Packing diagram showing the ?-? stacking interactions between the 
terpyridine domains in the unit cell (the dotted lines are the closest 
distance between two atoms involved in the ?-? stacking interactions). 
(b) Crystal structure of 2,7-di(2-hydroxyethoxy)naphthalene 
Figure 13. An ORTEP representation (50% probability ellipsoids) of 2,7-di(2-
hydroxyethoxy)naphthalene. Hydrogen atoms (except H1 and H2) are 
omitted for clarity. The structure is disordered; with the H atom 
occupying two sites (H1 and H2) with 50% occupancy in each. 
A single crystal of 2,7-di(2-hydroxyethoxy)naphthalene which was obtained by 
recrystallisation from methanol was suitable for X-ray crystallographic analysis 
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(Figure 13). Crystallographic data are given in Appendix IV and selected bond 
lengths and angles are given in Table 5.
O2-C3 1.362(1) C3-C4 1.409(2) C9-C10 1.374(2) 
O2-C2 1.423(2) C4-C5 1.362(2) C10-C11 1.418(2) 
O1-C1 1.422(2) C5-C6 1.416(2) C11-C12 1.419(2) 
O3-C9 1.363(1) C6-C7 1.411(2) C12-C3 1.374(2) 
O3-C13 1.423(2) C7-C8 1.364(2) C6-C11 1.416(2) 
O4-C14 1.418(2) C8-C9 1.408(2)   
O1-C1-C2 111.0(1) C3-C4-C5 119.8(1) C9-C10-C11 119.7(1) 
C2-O2-C3 118.27(9) C4-C5-C6 120.8(1) C10-C11-C6 119.4(1) 
O2-C3-C4 113.6(1) C5-C6-C11 119.2(1) C10-C11-C12 121.3(1) 
O2-C3-C12 125.0(1) C5-C6-C7 121.7(1) C11-C12-C3 119.4(1) 
O4-C14-C13 113.3(1) C6-C7-C8 120.8(1) C12-C3-C4 121.4(1) 
C13-O3-C9 117.7(1) C7-C8-C9 120.1(1) C7-C6-C11 119.1(1) 
O3-C9-C8 113.7(1) C8-C9-C10 120.9(1) C6-C11-C12 119.3(1) 
O3-C9-C10 125.4(1)     
O1···O4 2.886 O4···O4 2.811 O1···O1 2.819 
O1-H1-O4 172.26 O4-H4-O4 138.68 O1-H2-O1 167.03 
C2-O2-C3-C12 -12.61 C13-O3-C9-C10 -5.49 
Table 5. Selected bond lengths (Å) and angles (˚) of 2,7-di(2-
hydroxyethoxy)naphthalene. 
This is the precursor for the synthesis of L13. One of the two OH groups in every 
molecule is disordered, with the H atom occupying two sites (H1 and H2) with 50% 
occupancy in each (Figure 13). Figures 14a, 14b and 14c show the intermolecular 
hydrogen bonding involving OH1 and OH2 respectively. There are hydrogen bonding 
intermolecular interactions between the O1-H1 and the O4 atoms, between the O4-H4 
and O4 atoms, and between the O1-H2 and O1 atoms. Since the hydrogen positions in 
the crystal structure were calculated instead of measured, the hydrogen-bonded 
interactions were investigated by measuring the distance between the atom connected 
to the hydrogen, which is the oxygen atom, and the other oxygen atom. The O1-O4, 
O4-O4 and O1-O1 distance are 2.886 Å, 2.811 Å and 2.819 Å, which are within the 
usual range for a hydrogen bond.35
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Figure 14. A view of the packing diagram of 2,7-di(2-hydroxyethoxy)naphthalene. 
The purple, blue and green lines indicate the hydrogen bonding 
intermolecular interactions between atom O1-H1 and atom O4, atom O4-
H4 and atom O4, and atom O1-H1 and atom O1 respectively. Hydrogen 
atoms are omitted for clarity except atoms H1, H2 and H4. 
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5.6 The side product of the synthesis of L
13
From the 1H NMR spectrum of the side product of the synthesis of L13 (Figure 15b), 
the ethyleneoxy proton signals at ? 4.2-4.7 and some of the naphthyl signals in the 
range ? 7.0-7.2 are no longer symmetrical compared to those of L13 (Figure 15a).
Therefore, it seems that only one side of the ester-functional group of the 2,7-bis(2-
methanesulfonatoethoxy)naphthalene was attached to the HO-terpy. The terpyridine 
proton signals were compatible to L13 and were assigned as those of L13.
Figure 15.
1H NMR spectra (500 MHz) of (a) L13 and (b) the side product of the 
synthesis of L13 in CDCl3 solution at room temperature. The signal 
marked * is the signal for CHCl3.
The 13C NMR spectrum of this side product shows that the molecule is asymmetrical 
with respect to the central naphthalene unit. From the HMBC spectrum, there is an 
extra quaternary signal at ? 171, which coupled to the proton signals at ? 4.66 and ?
2.12 (Figure 16).The spectroscopic and FAB-MS data are consistent with the side 
product being 2-(2-acetoxyethoxy)-7-{2-(2,2?:6?,2?-terpyridin-4?-
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yloxy)ethoxy}naphthalene. This implies that the side product arises from reaction of 
HO-terpy with the mono(methansulfonate)ester: 2-(2-acetoxyethoxy)-7-(2-
methanesulfonyloxyethoxy)naphthalene (Scheme 10). This was probably formed by 
excess NH4OAc remaining from the reaction of HO-terpy with the 2,7-bis(2-
methanesulfonatoethoxy)naphthalene.
Figure 16. HMBC spectrum of the side product of the synthesis of L13 in CDCl3
solution at room temperature. The signal marked * is the signal of CHCl3.
Scheme 10. Possible reaction for the formation of the side product. 
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5.7 Conclusion 
In this chapter, homoditopic ligands L10-L17, which based upon a naphthalene unit 
bearing two 4?-substituted-2,2?:6?,2?-terpyridine-terminated bis(ethyleneoxy), were 
synthesised. All of these homoditopic 4?-substituted-2,2?:6?,2?-terpyridine ligands 
contain polyethyleneoxy chains which link to two different positions of the 
naphthalene unit and differ from one another in the length of the chains. 
These ligands L10-L17 have been synthesised and characterised with 1H and 13C NMR 
spectroscopy, mass spectrometry (FAB), IR spectroscopy and elemental analysis. The 
solid-state structure of ligand L12 and 2,7-di(2-hydroxyethoxy)naphthalene, which is a 
precursor for the synthesis of L13, were determined by X-ray crystallography. 
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5.8 Experimental
? 2,6-Bis(2,2?:6?,2?-terpyridin-4?-yloxymethyl)naphthalene (L10)
? 2,6-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4-dioxapentyl]naphthalene (L11)
? 2,6-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7-trioxaoctyl]naphthalene (L12)
? 2,7-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4-dioxabutyl]naphthalene (L13)
? 2,7-Di[2-(2-hydroxyethoxy)ethoxy]naphthalene36
? 2,7-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7-trioxaheptyl]naphthalene (L14)
? 2,7-Di{2-[2-(2-hydroxyethoxy)ethoxy]ethoxy}naphthalene 
? 2,7-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7,10-tetraoxadecayl]naphthalene (L15)
? 2,3-Di(ethoxycarbonylmethoxy)naphthalene
? 2,3-Di(2-hydroxyethoxy)naphthalene
? 2,3-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4-dioxabutyl]naphthalene (L16)
? 2,3-Di[2-(2-hydroexyethoxy)ethoxy]naphthalene37
? 2,3-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7-trioxaheptyl]naphthalene (L17)
4?-Hydroxy-2,2?:6?,2?-terpyridine (HO-terpy)6, 4?-chloro-2,2?:6?,2?-terpyridine (Cl-terpy)6,
2,6-bis(bromomethyl)naphthalene38 and 2,7-bis(2-methanesulfonatoethoxy)naphthalene39
were prepared as previously reported in the literature. L1 and L2 were prepared as in Chapter 
2.
? 2,6-Bis(2,2?:6?,2?-terpyridin-4?-yloxymethyl)naphthalene (L10)
Molecular formula: C42H30N6O2
Molecular weight: 650.73 
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2,6-Bis(hydroxymethyl)naphthalene (0.50 g, 2.7 mmol) and finely powdered potassium 
hydroxide (1.8 g, 32 mmol) were stirred in 10 mL DMSO at 70ºC under nitrogen for 1 
hour. The reaction mixture was kept stirring at 70ºC and under nitrogen throughout the 
reaction. 4?-Chloro-2,2?:6?,2?-terpyridine (Cl-terpy) (2.8 g, 10 mmol) in 5 mL DMSO was 
added to the suspension and the mixture was stirred for 3 days at 70ºC. The reaction 
mixture was cooled to room temperature and treated with water (300 mL). A yellow 
precipitate was obtained and was washed with plenty of water and dried. After column 
chromatography (Al2O3, CH2Cl2: hexane 2:1, then CH2Cl2/ 1% CH3OH) and work up, a 
yellow powder of 2,6-bis(2,2?:6?,2?-terpyridin-4?-yloxymethyl)naphthalene (L10) (0.5 g, 
0.8 mmol, 30%) was obtained. 
1H NMR (400 MHz, CDCl3): ?H 5.51 (s, 4H, HS1), 7.35 (ddd, J 1.0, 4.8, 7.3 Hz, 4H, HT5),
7.62 (dd, J 1.3, 8.3 Hz, 2H, HN3, N7), 7.87 (td, J 1.7, 7.7 Hz, 4H, HT4), 7.92 (d, J 8.1 Hz, 
2H, HN4, N8), 7.99 (s, 2H, HN1, N5), 8.19 (s, 4H, HT3?), 8.64 (d, J 8.1 Hz, 4H, HT3), 8.72 (dd, 
J 1.0, 4.0 Hz, 4H, HT6).
13C NMR (125 MHz, CDCl3): ?C 70.1 (CS1), 107.8 (CT3?), 121.5 (CT3), 124.0 (CT5), 125.8 
(CN3, N7), 126.4 (CN1, N5), 128.7 (CN4, N8), 133.1 (CN9, N10), 134.1 (CN2, N6), 137.0 (CT4), 149.2 
(CT6), 156.2 (CT2), 157.4 (CT2?), 167.1 (CT4?).
MS (FAB): m/z = 651 [M]+ (29.5%), 402 [M-O-terpy]+ (20.1%), 250 [HO-terpy]+
(45.7%), 89 (46.7%), 77 (83.0%), 63 (55.4%), 51 (85.9%), 39 (100%). 
IR(solid, cm-1): 3055w, 3001w, 2924w, 2854w, 1734w, 1690w, 1605w, 1558s, 1512w, 
1466m, 1443w, 1404s, 1350s, 1250w, 1196s, 1119w, 1095w, 1041m, 987w, 941m, 864s, 
818w, 787s, 741m, 725m.  
Elemental Analysis: Found: C, 76.31; H, 4.68; N, 12.22. Calc. for C42H30N6O2·¾CH3OH: 
C, 76.09; H, 4.94; N, 12.46%. 
Melting point: decomposes at around 230ºC. 
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? 2,6-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4-dioxapentyl]naphthalene (L11)
Molecular formula: C46H38N6O4
Molecular weight: 738.83 
4?-(2-Hydroxyethoxy)-2,2?:6?,2?-terpyridine (L1) (0.50 g, 1.7 mmol) and NaH (60% 
suspended in oil) (0.10 g, 2.5 mmol) were added to anhydrous THF (60 mL). The reaction 
mixture was stirred at 80ºC under nitrogen for 1 hour. Then, 2,6-
bis(bromomethyl)naphthalene (0.22 g, 0.70 mmol) in 10 mL anhydrous THF was added 
dropwise to the suspension and the mixture was stirred for 2 days at 80ºC under nitrogen. 
The reaction was quenched with CH3OH and water. The solvent was removed under 
reduced pressure. The solution was washed with CH2Cl2 (75 mL) twice. The organic layer 
was dried (MgSO4), filtered and evaporated to dryness. The product L
11 was obtained as a 
white powder (0.3 g, 0.4 mmol, 57%) after column chromatography (Al2O3, CH2Cl2/ 1% 
CH3OH) and work up. 
1H NMR (500 MHz, CDCl3): ?H 3.95 (t, J 4.7 Hz, 4H, HS2), 4.45 (t, J 4.7 Hz, 4H, HS1), 
4.82 (s, 4H, HS3), 7.32 (ddd, J 1.1, 4.8, 7.4 Hz, 4H, HT5), 7.49 (dd, J 1.3, 8.3 Hz, 2H, HN3, 
N7), 7.81 (m, 4H, HN1, N5 and HN4, N8), 7.84 (td, J 1.8, 7.7 Hz, 4H, HT4), 8.07 (s, 4H, HT3?),
8.61 (d, J 7.9 Hz, 4H, HT3), 8.68 (m, 4H, HT6). 
13C NMR (125 MHz, CDCl3): ?C 67.8 (CS1), 68.3 (CS2), 73.5 (CS3), 107.5 (CT3?), 121.3 
(CT3), 123.8 (CT5), 126.0 (CN3, N7), 126.3 (CN1, N5), 128.3 (CN4, N8), 132.9 (CN9, N10), 135.5 
(CN2, N6), 136.8 (CT4), 149.1 (CT6), 156.1 (CT2), 157.1 (CT2?), 167.0 (CT4?).
ES (FAB): m/z = 739 [M]+ (50.4%), 462 [M-TerpyOCH2CH2]
+ (23.7%), 277 [Terpy-
OCH2CH2]
+ (24.6%), 250 [HO-Terpy]+ (100%), 221 (56.6%). 
IR (solid, cm-1): 3097w, 3063w, 3045w, 3016w, 2962w, 29392, 2914w, 2870w, 2243w, 
2189w, 1796w, 1793w, 1602w, 1583m, 1560s, 1468m, 1441m, 1404m, 1371m, 1346s, 
1286w, 1275w, 1254m, 1238w, 1202s, 1169w, 1122m, 1095s, 1061m, 1043w, 1011m, 
989m, 960m, 889m, 879m, 866m, 825s, 791m, 738s, 729m. 
T3'
T2'
T4'
N2
N3N
O
N N
OH
4'-(2-Hydroxyethoxy)-
2,2':6',2''-terpyridine 
(L1)
1. NaH, THF, 80oC, 1 hr
Br
Br
2.
2,6-[Bis(2,2':6',2''-terpyridin-4'-yl)-1,4-
dioxapentyl]naphthalene (L11)
O
O
N
N
N
O
O
N
N
N
in THF, 80oC, 2 days
T3
T4
T5
T6
S1
T2 N4 N5
N6
N7
N8
N9
N10
N1S2 S3
Chapter 5 
208 
Elemental Analysis: Found: C, 73.35; H, 5.26; N, 11.00. Calc. for C46H38N6O4·CH3OH: C, 
73.23; H, 5.50; N, 10.90%. 
Melting point: 181.3ºC-183.9ºC. 
? 2,6-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7-trioxaoctyl]naphthalene (L12)
Molecular formula: C50H46N6O6
Molecular weight: 826.9 
4?-[2-(2-Hydroxyethoxy)ethoxy]-2,2?:6?,2?-terpyridine (L2) (0.7 g, 2 mmol) and NaH 
(60% suspended in oil) (0.12 g, 3.0 mmol) were added to anhydrous THF (50 mL). The 
reaction mixture was stirred at 80ºC under nitrogen for 1 hour. 2,6-
Bisbromomethylnaphthalene (0.25 g, 0.80 mmol) in 30 mL dry THF was added dropwise 
to the suspension and the mixture was stirred for 4 days at 80ºC under nitrogen. The 
reaction was quenched with CH3OH and water. The solvent was removed under reduced 
pressure. The yellow crude product was extracted with CH2Cl2 (50 mL) twice. The 
organic layer was dried (MgSO4), filtered and evaporated to dryness. The product L
12 was 
obtained as yellow oil (0.10 g, 0.12 mmol, 15%) after column chromatography (Al2O3,
CH2Cl2/ 1% CH3OH) and work up. 
1H NMR (500 MHz, CDCl3): ?H 3.70 (m, 4H, HS4), 3.80 (m, 4H, HS3), 3.95 (t, J 4.7 Hz, 
4H, HS2), 4.41 (t, J 4.7 Hz, 4H, HS1), 4.72 (s, 4H, HS5), 7.32 (dd, J 4.9, 6.5 Hz, 4H, HT5), 
7.44 (d, J 8.2 Hz, 2H, HN3, N7), 7.74 (s, 2H, HN1, N5), 7.77 (d, J 8.4 Hz, 2H, HN4, N8), 7.84 
(td, J 1.6, 7.7 Hz, 4H, HT4), 8.05 (s, 4H, HT3?), 8.60 (d, J 7.9 Hz, 4H, HT3), 8.67 (d, J 4.1 
Hz, 4H, HT6).
13C NMR (125 MHz, CDCl3): ?C 67.8 (CS1), 69.5 (CS2 and CS4), 71.1 (CS3), 73.4 (CS5), 
107.5 (CT3?), 121.3 (CT3), 123.8 (CT5), 126.0 (CN3, N7), 126.3 (CN1, N5), 128.2 (CN4, N8), 132.8 
(CN9, N10), 135.7 (CN2, N6), 136.8 (CT4), 149.1 (CT6), 156.1 (CT2), 157.1 (CT2?), 167.0 (CT4?). 
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MS (FAB): m/z = 827 [M]+ (23.6%), 262 [Terpy-OCH2]
+ (31.2%), 250 [HO-Terpy]+
(100%), 221 (27.8%), 136 (40.2%), 89 (42.1%), 77 (58.4%), 65 (25.5%), 57 (21.1%), 51 
(34.4%), 41 (29.5%), 39 (45.4%). 
IR (solid, cm-1): 3057w, 2866w, 2860w, 1717w, 1600w, 1581m, 1558s, 1469m, 1441m, 
1405m, 1347m, 1278w, 1252w, 1202m, 1125w, 1090m, 1055m, 1038m, 990m, 966m, 
867m, 819w, 791s, 743m, 733m. 
Elemental Analysis: Found: C, 72.22; H, 5.89; N, 10.20. Calc. for C50H46N6O6: C, 72.62; 
H, 5.62; N, 10.17%. 
? 2,7-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4-dioxabutyl]naphthalene (L13)
Molecular formula: C44H34N6O4
Molecular weight: 710.78 
4?-Hydroxy-2,2?:6?,2?-terpyridine (HO-Terpy) (3.0 g, 12 mmol) was stirred with dry 
K2CO3 (16.7 g, 121 mmol) in 120 mL dry acetone for 2 hours at 70ºC under nitrogen. The 
reaction mixture was kept at 70ºC under nitrogen throughout the reaction. 2,7-Bis(2-
methanesulfonatoethoxy)naphthalene (0.69 g, 1.7 mmol) was added to the reaction 
mixture. The reaction was completed after 4 days. The reaction mixture was then filtered 
and the solvent was removed. The crude product was extracted with CH2Cl2 (200 mL) and 
water (200 mL). The product was purified by column chromatography (Al2O3, CH2Cl2/
0.5% CH3OH). The second fraction was the product 2,7-[bis(2,2?:6?,2?-terpyridin-4?-yl)-
1,4-dioxabutyl]naphthalene (L13) as a white powder (0.7 g, 0.98 mmol, 58%). 
1H NMR (500 MHz, CDCl3) ?H 4.52 (m, 4H, HS2), 4.67 (m, 4H, HS1), 7.07 (dd, J 2.5, 8.9 
Hz, 2H, HN3, N6), 7.15 (d, J 2.5 Hz, 2H HN1, N8), 7.33 (ddd, J 1.2, 4.8, 7.5 Hz, 4H, HT5), 
7.67 (d, J 9.0 Hz, 2H, HN4, N5), 7.85 (td, J 1.8, 7.7 Hz, 4H, HT4), 8.14 (s, 4H, HT3?), 8.63 
(dt, J 1.0, 8.0 Hz, 4H, HT3), 8.69 (ddd, J 0.9, 1.8, 4.8 Hz, 4H, HT6).
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13C NMR (125 MHz, CDCl3): ?C 66.4 (CS2), 66.7 (CS1), 106.8 (CN1, N8), 107.7 (CT3?), 116.5 
(CN3, N6), 121.4 (CT3), 123.8 (CT5), 124.9 (CN10), 129.3 (CN4, N5), 135.8 (CN9), 136.8 (CT4),
148.9 (CT6), 156.0 (CT2), 157.2 (CT2? and CN2, N7), 167.0 (CT4?). 
MS (FAB): m/z = 711 [M]+ (51.7%), 250 [HO-Terpy]+ (100%), 221 (46.9%), 57 (56.7%), 
43 (59.5%).
IR (solid, cm-1): 3680w, 3252w, 3061w, 2881w, 2311w, 1630w, 1597w, 1580m, 1560s, 
1514m, 1468m, 1447w, 1439w, 1406s, 1387m, 1354m, 1329w, 1259m, 1229m, 1202s, 
1155w, 1136w, 1068m, 1035m, 991m, 974w, 926w, 885w, 868m, 831s, 791s, 741s, 731s. 
Elemental Analysis: Found: C, 73.42; H, 4.96; N, 11.43. Calc. for C44H34N6O4·½CH3OH: 
C, 73.53; H, 5.00; N, 11.57%. 
Melting point: 179.7ºC-181.4ºC. 
Side product (fraction 1):
Molecular formula: C31H27N3O5
Molecular weight: 521.56 
1H NMR (500 MHz, CDCl3) ?H 2.12 (s, 3H, HCH3), 4.28 (m, 2H, HS2), 4.49 (m, 4H, HS1
and HS4), 4.66 (m, 2H, HS3), 7.03 (dd, J 2.5, 8.8 Hz, 1H, HN3), 7.07 (m, 2H, HN1 and HN6), 
7.11 (d, J 2.5 Hz, 1H HN8), 7.34 (ddd, J 1.2, 4.8, 7.3 Hz, 2H, HT5), 7.67 (d, J 8.8 Hz, 2H, 
HN4 and HN5), 7.86 (td, J 1.8, 7.7 Hz, 2H, HT4), 8.12 (s, 2H, HT3?), 8.63 (dt, J 1.0, 8.0 Hz, 
2H, HT3), 8.69 (ddd, J 0.9, 1.8, 4.8 Hz, 2H, HT6).
13C NMR (125 MHz, CDCl3): ?C 21.0 (CCH3), 62.9 (CS1), 65.9 (CS2), 66.2 (CS4), 66.7 
(CS3), 106.3 (CN1), 106.4 (CN8), 107.6 (CT3?), 116.4 (CN3), 116.6 (CN6), 121.4 (CT3), 123.9 
(CT5), 124.7 (CN10), 129.3 (CN5 and CN4), 135.7 (CN9), 136.9 (CT4), 149.0 (CT6), 155.9 
(CT2), 157.1 (CN2 and CT2?), 157.2 (CN7), 166.9 (CT4?), 171.1 (CCO).
ES (FAB): m/z = 522 [M]+ (39.6%), 250 [HO-Terpy]+ (20.6%), 87 [CH3CO2CH2CH2]
+
(100.0%), 57 (22.3%), 43 [CH3CO]
+ (55.3%).
IR (solid, cm-1): 3607w, 3371br, 3059w, 2935w, 2881w, 1736s, 11628m, 1582m, 1562m, 
1516m, 1470m, 1439m, 1389m, 1354m, 1300w, 1250m, 1204s, 1173m, 1142w, 1119w, 
1092w, 1065m, 1041s, 995m, 964m, 941w, 918w, 872w, 841s, 791s, 729m. 
Elemental Analysis: Found: C, 69.90; H, 5.48; N, 6.98. Calc. for C31H27N3O5·CH3OH: C, 
69.43; H, 5.64; N, 7.59%. 
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Melting point: 122.7ºC-124.6ºC. 
? 2,7-Di[2-(2-hydroexyethoxy)ethoxy]naphthalene36
Molecular formula: C18H24O6
Molecular weight: 336.38 
2,7-Dihydroxynaphthalene (1.0 g, 6.2 mmol), K2CO3 (5.18 g, 37.5 mmol) were stirred in 
60 mL dry DMF for 1 hour at 70ºC under nitrogen. The reaction mixture was kept at 70ºC 
under nitrogen throughout the reaction. Then, 2-(2-chloroethoxy)ethanol (2.3 g, 18 mmol) 
was added dropwise to the reaction mixture. After 1 day, 1 mL of 2-(2-
chloroethoxy)ethanol was added and the reaction mixture was kept at 70ºC for 2 days. 
The reaction mixture was cooled to room temperature. The solvent was removed in vacuo 
and the residue partitioned between CH2Cl2 and water (200 mL). The organic layer was 
separated and dried (MgSO4). The crude product was filtered and evaporated. The pure 
product was obtained after column chromatography (Al2O3, CH2Cl2/ 5% CH3OH) and 
was isolated as a pale green powder (0.8 g, 2.4 mmol, 39%). 
1H NMR (500 MHz, CDCl3) ?H 2.36 (br, 2H, HOH), 3.69 (m, 4H, HS2), 3.78 (m, 4H, H S1), 
3.91 (m, 4H, HS3), 4.23 (m, 4H, HS4), 7.02 (m, 4H, HN3, N6 and HN1, N8), 7.65 (m, 2H, HN4, 
N5).
13C NMR (125 MHz, CDCl3): ?C 61.8 (CS1), 67.4 (CS4), 69.7 (CS3), 72.6 (CS2), 106.3 (CN1, 
N8), 116.4 (CN3, N6), 124.6 (CN10), 129.2 (CN4, N5), 135.7 (CN9), 157.2 (CN2, N7). 
MS (EI): m/z = 336 [M]+ (64.2%), 248 [M-(CH2CH2O)2]
+ (27.6%), 160 [HO-Nap-OH]+
(89.7%), 45 (100%). 
IR (solid, cm-1): 3398br, 3312br, 2935w, 2980m, 1896w, 1798w, 1745m, 1742m, 1717w, 
1693w, 1630m, 1697w, 1560w, 1516m, 1487w, 1460w, 1437w, 1387m, 1339w, 1312w, 
1252s, 1213s, 1177m, 1122s, 1090m, 1057m, 1030m, 1003m, 978w, 953w, 899w, 852m, 
833m, 820m, 783w, 710w. 
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Elemental Analysis: Found: C, 63.73; H, 7.12; O, 29.19. Calc. for C18H24O6·¼H2O: C, 
63.42; H, 7.26; N, 29.34%. 
Melting point: 66.5ºC-67.3ºC. 
? 2,7-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7-trioxaheptyl]naphthalene (L14)
Molecular formula: C48H42N6O6
Molecular weight: 798.88 
2,7-Di[2-(2-hydroxyethoxy)ethoxy]naphthalene (400 mg, 1.19 mmol) was added to a 
suspension of finely powdered potassium hydroxide (800 mg, 14.3 mmol) in 10 mL dry 
DMSO and the mixture was stirred for 1 hour at 70ºC under nitrogen. The reaction 
mixture was kept at 70ºC under nitrogen throughout the reaction. After this period, 4?-
chloro-2,2?:6?,2?-terpyridine (Cl-terpy) (1.3 g, 4.9 mmol) was added and the reaction 
mixture was heated to 70ºC for 3 days. The reaction mixture was cooled to room 
temperature and treated with water (500 mL) to give a white precipitate, which was 
washed with plenty of water and dried to give white powder of 2,7-[bis(2,2?:6?,2?-
terpyridin-4?-yl)-1,4,7-trioxaheptyl]naphthalene (L14) (0.7 g, 0.88 mmol, 74%). 
1H NMR (500 MHz, CDCl3) ?H 4.02 (m, 8H, HS3 and HS2), 4.25 (t, J 4.8 Hz, 4H, HS4), 
4.44 (t, J 4.7 Hz, 4H, HS1), 7.02 (m, 4H, HN3, N6 and HN1, N8), 7.31 (ddd, J 1.2, 4.8, 7.5 Hz, 
4H, HT5), 7.60 (d, J 8.7 Hz, 2H, HN4, N5), 7.84 (td, J 1.8, 7.7 Hz, 4H, HT4), 8.05 (s, 4H, 
HT3?), 8.60 (dt, J 1.0, 8.0 Hz, 4H, HT3), 8.67 (ddd, J 0.9, 1.8, 4.8 Hz, 4H, HT6).
13C NMR (125 MHz, CDCl3): ?C 67.6 (CS4), 68.0 (CS1), 69.8 (CS2), 70.2 (CS3), 106.4 (CN1, 
N8), 107.6 (CT3?), 116.6 (CN3, N6), 121.5 (CT3), 124.0 (CT5), 124.6 (CN10), 129.2 (CN4, N5), 
135.9 (CN9), 136.9 (CT4), 149.2 (CT6), 156.2 (CT2), 157.3 (CT2?), 157.4 (CN2, N7), 167.1 
(CT4?).
Cl-terpy
Cl
N
N N
1. KOH,  DMSO, 70oC, 1 hr
2.
O
O
HO
O
O
OH
O
O
O
O
O
O
N N
N N N N
T3'
T2'
T4'
N2
N3
2,7-[Bis(2,2':6',2''-terpyridin-4'-yl)-1,4,7-
trioxaheptyl]naphthalene (L14)
2,7-Di[2-(2-
hydroxyethoxy)ethoxy]
naphthalene 70oC, 3 days
T3
T4
T6
T2
T5
S1
N4 N5
N6
N7
N8
N9
N10
N1
S2
S3 S4
Chapter 5 
213
MS (FAB): m/z = 799 [M]+ (30.5%), 262 [M-TerpyOCH2]
+ (20.9%), 250 [HO-Terpy]+
(100.0%), 89 [OCH2CH2OCH2CH2]
+ (21.4%), 78 (26.4%), 77 (25.9%), 51 (28.9%). 
IR (solid, cm-1): 3055w, 2920w, 2874w, 1628m, 1582s, 1560s, 1516m, 1468m, 1441m, 
1404s, 1350s, 1254m, 1202s, 1128s, 1090m, 1057s, 991s, 962m, 868m, 835m, 793s, 
743s, 733s. 
Elemental Analysis: Found: C, 70.06; H, 5.24; N, 10.00. Calc. for C48H42N6O6·H2O: C, 
70.57; H, 5.44; N, 10.29%. 
Melting point: 116.4ºC-117.8ºC. 
? 2,7-Di{2-[2-(2-hydroxyethoxy)ethoxy]ethoxy}naphthalene 
Molecular formula: C22H32O8
Molecular weight: 424.48 
2,7-Dihydroxynaphthalene (1.6 g, 0.010 mol), K2CO3 (12 g, 0.090 mol) were stirred in 
150 mL dry acetone for 2 hour at 70ºC under nitrogen. The reaction mixture was kept at 
70ºC under nitrogen throughout the reaction. Then, 2-[2-(2-chloroethoxy)ethoxy]ethanol 
(5.06 g, 0.0300 mol) was added dropwise to the reaction mixture. After 3 day, 1.45 mL of 
2-[2-(2-chloroethoxy)ethoxy]ethanol was added and the reaction mixture was kept at 
70ºC for 2 days. The reaction mixture was cooled to room temperature. The solvent was 
removed in vacuo and the residue partitioned between CH2Cl2 and water (250 mL). The 
organic layer was separated and dried (MgSO4). The product was obtained after filtration 
and drying to give a black oily solution (3.5 g, 8.2 mmol, 82%). 
1H NMR (500 MHz, CDCl3) ?H 2.76 (br, 2H, HOH), 3.60 (m, 4H, HS2), 3.71 (m, 12H, HS3,
HS1 and HS4), 3.89 (m, 4H, HS5), 4.22 (m, 4H, HS6), 7.01 (m, 4H, HN3, N6 and HN1, N8), 7.62 
(d, J 8.8 Hz, 2H, HN4, N5).
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13C NMR (125 MHz, CDCl3): ?C 61.8 (CS1), 67.4 (CS6), 69.8 (CS5), 70.4 (CS3), 70.9 (CS4), 
72.6 (CS2), 106.3 (CN1, N8), 116.5 (CN3, N6), 124.6 (CN10), 129.2 (CN4, N5), 135.8 (CN9), 157.3 
(CN2, N7).
MS (FAB): m/z = 425 [M]+ (22.7%), 45 (100%). 
IR (solid, cm-1): 3418br, 2916m, 2870m, 1628s, 1512m, 1458m, 1358w, 1258m, 1211s, 
1119s, 1065s, 957w, 887w, 833w. 
Elemental Analysis: Found: C, 61.46; H, 7.57. Calc. for C22H32O8·?H2O: C, 61.37; H, 
7.66%. 
? 2,7-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7,10-tetraoxadecayl]naphthalene (L15)
Molecular formula: C52H50N6O8
Molecular weight: 886.99 
2,7-Di{2-[2-(2-hydroxyethoxy)ethoxy]ethoxy}naphthalene (0.70 g, 1.6 mmol) was added 
to a suspension of finely powdered potassium hydroxide (1.1 g, 20 mmol) in 15 mL dry 
DMSO and the mixture was stirred for 1 hour at 70ºC under nitrogen. The reaction 
mixture was kept at 70ºC under nitrogen throughout the reaction. After this period, 4?-
chloro-2,2?:6?,2?-terpyridine (Cl-terpy) (1.3 g, 4.9 mmol) was added and the reaction 
mixture was heated to 70ºC for 5 days. The reaction mixture was cooled to room 
temperature and treated with water (500 mL) to give a white precipitate, which was 
washed with plenty of water and dried. The crude product was purified from column 
chromatography (Al2O3, CH2Cl2/ 0.5% CH3OH) to give 2,7-[bis(2,2?:6?,2?-terpyridin-4?-
yl)-1,4,7,10-tetraoxadecayl]naphthalene (L15) (0.20 g, 0.23 mmol, 14%) as an oily liquid. 
1H NMR (500 MHz, CDCl3) ?H 3.78 (m, 8H, HS4 and HS3), 3.91 (t, J 4.8 Hz, 4H, HS5), 
3.93 (t, J 4.7 Hz, 4H, HS2), 4.19 (t, J 4.9 Hz, 4H, HS6), 4.39 (t, J 4.7 Hz, 4H, HS1), 6.98 (m, 
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4H, HN3, N6 and HN1, N8), 7.31 (ddd, J 1.2, 4.8, 7.5 Hz, 4H, HT5), 7.58 (d, J 9.6 Hz, 2H, HN4, 
N5), 7.83 (td, J 1.8, 7.7 Hz, 4H, HT4), 8.04 (s, 4H, HT3?), 8.59 (dt, J 1.0, 7.9 Hz, 4H, HT3), 
8.66 (ddd, J 0.9, 1.8, 4.8 Hz, 4H, HT6).
13C NMR (125 MHz, CDCl3): ?C 67.4 (CS6), 67.9 (CS1), 69.6 (CS2), 69.9 (CS5), 71.0 (CS4), 
71.2 (CS3), 106.3 (CN1, N8), 107.6 (CT3?), 116.5 (CN3, N6), 121.5 (CT3), 124.0 (CT5), 124.5 
(CN10), 129.1 (CN4, N5), 135.8 (CN9), 137.0 (CT4), 149.0 (CT6), 156.0 (CT2), 157.1 (CT2?),
157.4 (CN2, N7), 167.1 (CT4?). 
MS (FAB): m/z = 887 [M]+ (18.2%), 262 [CH2O-terpy]
+ (11.4%), 250 [HO-terpy]+, 221 
[terpy]+ (21.4%), 97 (11.4%), 83 (17.0%), 71 (21.6%), 57 (47.7%), 43 (19.0%). 
IR (solid, cm-1): 3055w, 2870w, 1628m, 1582s, 1558s, 1512m, 1466m, 1443s, 1404s, 
1350m, 1257m, 1204s, 1126s, 1056s, 995w, 964w, 872w, 833w, 795m, 733m, 702w. 
Elemental Analysis: Found: C, 69.15; H, 5.61; N, 9.28. Calc. for C52H50N6O8·?H2O: C, 
69.47; H, 5.77; N, 9.35%. 
? 2,3-Di(ethoxycarbonylmethoxy)naphthalene
Molecular formula: C18H20O6
Molecular weight: 332.35 
2,3-Dihydroxynaphthalene (5 g, 0.03 mol) was stirred with dry K2CO3 (43.1 g, 0.312 mol) 
in 125 mL dry acetone for 1 hour at 70ºC and ethyl bromoacetate (11.5 g, 68.9 mmol) was 
added to the reaction mixture. The reaction mixture was refluxed for 1 day. The mixture 
was allowed to cool, filtered and then concentrated to give the crude product. A white fine 
powder (5.7 g, 0.017 mol, 57%) was obtained after recrystallisation with hexane. 
1H NMR (400 MHz, CDCl3) ?H 1.30 (t, J 7.1 Hz, 6H, HCH3), 4.29 (q, J 7.1 Hz, 4H, 
HOCH2CH3), 4.81 (s, 4H, HOCH2C=O), 7.11 (s, 2H, HN1, N4), 7.35 (m, 2H, HN6, N7), 7.66 (m, 2H, 
HN5, N8).
13C NMR (100 MHz, CDCl3): ?C 14.6 (CCH3), 61.8 (COCH2CH3), 66.7 (COCH2C=O), 110.1 
(CN1, N4), 125.2 (CN6, N7), 126.9 (CN5, N8), 129.9 (CN9, N10), 148.3 (CN2, N3), 169.1 (CC=O).
MS (EI): m/z = 332 [M]+ (100%), 171 (31.7%), 59 (46.0%). 
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IR (solid, cm-1): 2986w, 2908w, 1751m, 1720m, 1628w, 1597w, 1512m, 1481m, 1427m, 
1404m, 1373m, 1288m, 1258m, 1211m, 1165s, 1111m, 1080m, 1018s, 949w, 918w, 
856s, 748s. 
Elemental Analysis: Found: C, 64.56; H, 5.95; O, 29.53. Calc. for C18H20O6·
1/5H2O: C, 
64.35; H, 6.13; O, 10.53%. 
Melting point: 62.8ºC-63.7ºC. 
? 2,3-Di(2-hydroxyethoxy)naphthalene
Molecular formula: C14H16O4
Molecular weight: 248.27 
A solution of lithium aluminum hydride (0.4 g, 0.01 mol) in THF (40 mL) was cooled to 
0ºC and a solution of 2,3-di(ethoxycarbonylmethoxy)naphthalene (2.3 g, 6.9 mmol) in 
THF (20 mL) was added. The resulting mixture was stirred for 1 hr and then allowed to 
warm to room temperature and stirred overnight. The reaction was quenched with 
aqueous NaOH solution. The white foam was filtered. The organic solvent was removed. 
A white solid (1.4 g, 5.6 mmol, 81%) was filtered from the aqueous phase NaOH. 
1H NMR (500 MHz, CDCl3) ?H 3.29 (br, 2H, OH), 4.03 (t, J 4.2 Hz, 4H, HS1), 4.23 (t, J
4.4 Hz, 4H, HS2), 7.22 (s, 2H, HN1, N4), 7.36 (m, 2H, HN6, N7), 7.68 (m, 2H, HN5, N8).
13C NMR (125 MHz, CDCl3): ?C 61.3 (CS1), 71.6 (CS2), 110.3 (CN1, N4), 124.8 (CN6, N7),
126.6 (CN5, N8), 129.8 (CN9, N10), 149.0 (CN2, N3).
MS (EI): m/z = 248.1 [M]+ (41.8%), 160.1 [HO-Nap-OH]+ (100.0%). 
IR (solid, cm-1): 3221br, 2947w, 2862w, 2772w, 2667w, 1624w, 1601w, 1510w, 1481w, 
1450w, 1404w, 1375w, 1340w, 1256s, 1171s, 1117m, 1084w, 1034m, 928m,905m, 
851m, 789s. 
Elemental Analysis: Found: C, 63.10; H, 6.80; O, 30.26. Calc. for C14H16O4·H2O: C, 
63.14; H, 6.83; N, 30.04%. 
Melting point: 141.3ºC-142.8ºC. 
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? 2,3-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4-dioxabutyl]naphthalene (L16)
Molecular formula: C44H34N6O4
Molecular weight: 710.78 
2,3-Di(2-hydroxyethoxy)naphthalene (0.5 g, 2 mmol) was added to a suspension of finely 
powdered potassium hydroxide (1.4 g, 25 mmol) in 20 mL dry DMSO and the mixture 
was stirred for 1 hour at 70ºC under nitrogen. The reaction mixture was kept at 70ºC 
under nitrogen throughout the reaction. After this period, 4?-chloro-2,2?:6?,2?-terpyridine 
(Cl-terpy) (2.2 g, 8.1 mmol) was added and the reaction mixture was heated to 70ºC for 3 
days. The reaction mixture was cooled to room temperature and treated with water (500 
mL) to give a white precipitate, which was washed with plenty of water and dried to give 
2,3-[bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4-dioxabutyl]naphthalene (L16) (0.52 g, 0.73 mmol, 
37%). 
1H NMR (500 MHz, CDCl3) ?H 4.56 (t, J 4.8 Hz, 4H, HS2), 4.70 (t, J 4.6 Hz, 4H, HS1), 
7.28 (s, 2H, HN1, N4), 7.30 (dd, J 5.1, 7.0 Hz, 4H, HT5), 7.35 (m, 2H, HN6, N7), 7.70 (m, 2H, 
HN5, N8), 7.83 (t, J 7.5 Hz, 4H, HT4), 8.06 (s, 4H, HT3?), 8.57 (d, J 8.0 Hz, 4H, HT3), 8.64 (d, 
J 4.0 Hz, 4H, HT6).
13C NMR (125 MHz, CDCl3): ?C 67.0 (CS1), 67.6 (CS2), 108.1 (C T3?), 110.1 (CN1, N4),
121.8 (CT3), 124.2 (CT5), 124.7 (CN6, N7), 126.6 (CN5, N8), 129.7 (CN9, N10), 137.5 (CT4),
148.7 (CT6), 149.1 (CN2, N3), 155.3 (CT2), 156.5 (CT2?), 167.2 (CT4?).
MS (FAB): m/z = 711 [M]+ (10.3%), 250 [HO-Terpy]+ (14.1%), 107 (16.6%), 89 (81.8%), 
77 (100%), 63 (62.9%), 51 (87.8%), 39 (90.2%). 
IR (solid, cm-1): 1582s, 1558s, 1512w, 1474w, 1443m, 1404m, 1350m, 1250s, 1196m, 
1165w, 1119w, 1065m, 995w, 972w, 933w, 879w, 849w, 795s, 733m. 
Elemental Analysis: Found: C, 72.02; H, 5.00; N, 11.34. Calc. for 
C44H34N6O4·½(CH3)2SO: C, 72.08; H, 4.98; N, 11.21%. 
Melting point: 216.3ºC-217.6ºC. 
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? 2,3-Di[2-(2-hydroexyethoxy)ethoxy]naphthalene37
Molecular formula: C18H24O6
Molecular weight: 336.38 
2,3-Dihydroxynaphthalene (2.00 g, 12.5 mmol) and K2CO3 (12 g, 87 mmol) were stirred 
in 120 mL dry acetone for 1 hour at 70ºC under nitrogen. The reaction mixture was kept 
at 70ºC under nitrogen throughout the reaction. Then, 2-(2-chloroethoxy)ethanol (2.33 g, 
18.7 mmol) was added dropwise to the reaction mixture. After 1 day, 1 mL of 2-(2-
chloroethoxy)ethanol was added and the reaction mixture was kept at 70ºC for 2 days. 
The reaction mixture was cooled to room temperature. The solution was filtered to 
remove K2CO3 and the residue was washed with CH2Cl2. The solvent was removed in 
vacuo and the residue partitioned between CH2Cl2 and water (200 mL). The organic layer 
was separated and dried (MgSO4). The product was filtered and evaporated to give a 
green powder (1.6 g, 4.8 mmol, 38%). 
1H NMR (400 MHz, CDCl3) ?H 3.26 (br, 2H, HOH), 3.71 (m, 4H, HS2), 3.78 (m, 4H, HS1), 
3.99 (t, J 4.4 Hz, 4H, HS3), 4.27 (t, J 4.4 Hz, 4H, HS4), 7.12 (s, 2H, HN1, N4), 7.34 (m, 2H, 
HN6, N7,), 7.66 (m, 2H, HN8, N5).
13C NMR (100 MHz, CDCl3): ?C 62.1 (CS1), 68.6 (CS4), 69.5 (CS3), 73.3 (CS2), 108.2 (CN1, 
N4), 124.8 (CN6, N7), 126.8 (CN5, N8), 129.6 (CN9, N10), 148.9 (CN2, N3). 
MS (FAB): m/z = 337 [M]+ (30.3%), 89 [OCH2CH2OCH2CH2]
+ (19.1%), 45 (100%). 
IR (solid, cm-1): 3281br, 3055w, 2939w, 2897w, 2870w, 2162w, 1965w, 1701w, 1626w, 
1597m, 1581w, 1508m, 1483m, 1460m, 1450m, 1418w, 1400w, 1391w, 1350m, 1337w, 
1313w, 1250s, 1194w, 1171m, 1161m, 1132s, 1105s, 1086w, 1072m, 1055w, 1047m, 
1020w, 989w, 953m, 941m, 930m, 901s, 883w, 874w, 851s, 750s. 
Elemental Analysis: Found: C, 64.16; H, 7.21; O, 28.51. Calc. for C18H24O6: C, 64.27; H, 
7.21; N, 28.54%. 
Melting point: 55.4ºC-57.3ºC. 
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? 2,3-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7-trioxaheptyl]naphthalene (L17)
Molecular formula: C48H42N6O6
Molecular weight: 798.88 
2,3-Di[2-(2-hydroxyethoxy)ethoxy]naphthalene (0.81 g, 2.4 mmol) was added to a 
suspension of finely powdered potassium hydroxide (1.6 g, 29 mmol) in 20 mL dry 
DMSO and the mixture was stirred for 1 hour at 70ºC under nitrogen. The reaction 
mixture was kept at 70ºC under nitrogen throughout the reaction. After this period, 4?-
chloro-2,2?:6?,2?-terpyridine (Cl-terpy) (2.5 g, 9.3 mmol) was added and the reaction 
mixture was heated to 70ºC for 3 days. The reaction mixture was cooled to room 
temperature and treated with water (500 mL) to give a white precipitate, which was 
washed with plenty of water and dried to give 2,3-[bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7-
trioxaheptyl]naphthalene (L17) (1.6 g, 2.0 mmol, 83%). 
1H NMR (500 MHz, CDCl3) ?H 4.04 (m, 8H, HS3 and HS2), 4.29 (t, J 4.9 Hz, 4H, HS4), 
4.39 (t, J 4.7 Hz, 4H, HS1), 7.14 (s, 2H, HN1, N4), 7.28 (m, 6H, HT5 and HN6, N7), 7.63 (m, 
2H, HN5, N8), 7.80 (td, J 1.8, 7.7 Hz, 4H, HT4), 8.02 (s, 4H, HT3?), 8.56 (dt, J 1.0, 8.0 Hz, 
4H, HT3), 8.64 (ddd, J 0.9, 1.8, 4.8 Hz, 4H, HT6).
13C NMR (125 MHz, CDCl3): ?C 68.0 (CS1), 68.7 (CS4), 69.9 (CS2), 70.0 (CS3), 107.6 (C
T3?), 108.7 (CN1, N4), 121.4 (CT3), 123.9 (CT5), 124.3 (CN6, N7), 126.5 (CN5, N8), 129.5 (CN9, 
N10), 136.8 (CT4), 149.10 (CN2, N3), 149.13 (CT6), 156.1 (CT2), 157.2 (CT2?), 167.1 (CT4?).
MS (FAB): m/z = 799 [M]+ (43.3%), 262 [TerpyOCH2]
+ (30.3%), 250 [HO-Terpy]+
(100.0%), 221 (20.5%). 
IR (solid, cm-1): 3055w, 3016w, 2939w, 2878w, 1582s, 1558s, 1466w, 1443m, 1404m, 
1366w, 1335w, 1257s, 1180m, 1134m, 1088w, 1041m, 987w, 933w, 872m, 849m, 787s, 
741s. 
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Elemental Analysis: Found: C, 71.64; H, 5.35; N, 10.49. Calc. for C48H42N6O6·¼H2O: C, 
71.76; H, 5.34; N, 10.46%. 
Melting point: 130.4ºC-131.5ºC. 
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Chapter 6 
Synthesis of Linear Homodinuclear Ruthenium(II) Complexes from 
Homoditopic 4?-Substituted-2,2?:6?,2?-Terpyridine Ligands 
In Chapter 3, we mentioned the interesting properties of the complexes of 2,2?-
bipyridine and 2,2?:6?,2?-terpyridine derivatives. Not only the photochemical and 
photophysical properties of the mononuclear complexes, but also those of the 
dinuclear complexes formed from rigid bridging bis(terpyridine) ligands (Figure 1a)
have been investigated.
1-9
. The spacers have two main roles: (1) to control the 
supramolecular structure, especially the intercomponent distances and angles, and (2) 
to control the electronic communication between components through through-bond 
energy or electron transfer.  
Figure 1. Diagram showing dinuclear complexes with different spacers (a) complexes 
from the literature, and (b) complexes described in this chapter. 
In this chapter, some linear homodinuclear Ru(II) complexes, which incorporate 
ligands in which a naphthalene bis(ethyleneoxy) unit bridges the 4?-position of two 
2,2?:6?,2?-terpyridine domains, are discussed (Figure 1b). Only the structural 
characterisations are discussed in this chapter. There are two reasons for this. (1) In 
most of the cases found in the literature, rigid spacers containing ethynyl groups and 
N
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O
O
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aromatic rings are more common than flexible spacers. The naphthalene 
bis(ethyleneoxy) spacer of ligands L
11
-L
14
, L
16
-L
17
 does not have the appropriate 
characteristics to allow good electronic communication between two metal centres. 
(2) According to the literature, heterodinuclear complexes, such as Ru-Os or Ru-Rh 
systems, are more favoured for the energy-transfer than homodinuclear Ru-Ru 
complexes. No investigations of the electrochemical properties of the homodinuclear 
Ru(II) complexes described in this chapter were attempted. 
6.1 Synthesis 
The adduct [Ru(L
a
)Cl3] (where L
a
 = terpy or L
4
) were readily prepared as brown 
solids by directly heating RuCl3·3H2O with L
a
 in CH3OH for 3 hours. The reaction of 
1 equivalent of L
b
 (L
11
-L
14
, L
16
-L
17
) and 2 equivalents of [Ru(L
a
)Cl3] (where L
a
 = 
terpy or L
4
) with a few drops of N-ethylmorpholine (NEM) in boiling CH3OH for 3 
hours gave red solutions, which after chromatographic workup, gave the linear 
homodinuclear complexes [(L
a
)Ru(L
b
)Ru(L
a
)][PF6]4.
10-14
 The yield of the 
[(L
a
)Ru(L
b
)Ru(L
a
)][PF6]4 complexes (where L
b
 = L
11
-L
14
, L
16
-L
17
 and L
a
 = terpy or 
L
4
) ranged from 10-66% (Scheme 1).
Scheme 1. The general syntheses of linear homodinuclear complexes 
[(L
a
)Ru(L
b
)Ru(L
a
)][PF6]4 (where L
b
 = L
11
-L
14
, L
16
-L
17
 and L
a
 = terpy
or L
4
).
Ru Ru [PF6]4YY
 [(La)RuCl3], MeOH, 
NEM,  reflux 3 hr
L
a = L4 (Y = OCH2-2-naphthyl) 
or terpy (Y = H)
L
b
 (L
b
 = L
11
-L
14
, L
16
-L
17
)
= naphthyl domain
= ethylene chain
= terpyridine domain
[(L
a
)Ru(L
b
)Ru(L
a
)][PF6]4
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6.2
1
H NMR spectroscopic characterisation 
All the complexes were characterised by 
1
H NMR spectroscopy in CD3CN solution. 
The
1
H NMR spectra of the homodinuclear complexes [(L
a
)Ru(L
b
)Ru(L
a
)][PF6]4
exhibit resonances which are assigned to two different terpyridine groups. One set 
results from the terpyridine system of ligand L
a
 (L
a
 = terpy or L
4
) and the other one is 
due to the terpyridine system of ligand L
b
 (L
b
 = L
11
-L
14
, L
16
-L
17
). Assignments have 
been made using COSY and NOESY or ROESY experiments and by comparison with 
the spectra of symmetrical [Ru(L
a
)2][PF6]2 complexes. The terpyridine proton signals 
are similar in all the complexes, except in the case of [(L
4
)Ru(L
13
)Ru(L
4
)][PF6]4,
where L
a
 is L
4
 instead of terpy, and [(terpy)Ru(L
16
)Ru(terpy)][PF6]4, where the two 
metal centres are very close (Table 1).
Scheme 2. The structures and the atom labelling scheme of the six homodinuclear 
linear complexes [(L
a
)Ru(L
b
)Ru(L
a
)][PF6]4 (where L
b
 = L
11
-L
14
, L
16
-L
17
and L
a
 = terpy or L
4
).
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2
6 Proton resonance (?)
Lb = L11-L14, L16-L17 La = terpy or L4
HC5 HC6 HC4 HC3 HD3 HA5 HA6 HA4 HA3 HB3 HB4
[Ru(terpy)2][PF6]2
15      7.15 7.33 7.91 8.48 8.74 8.40 
[Ru(L4)2][PF6]2      
7.16
(ddd)
J 1.4, 5.7, 
7.5 Hz 
7.39
(ddd)
J 0.6, 1.4, 
5.6 Hz 
7.90 (td) 
J 1.5, 7.9 
Hz
8.47 (dt)
J 0.9, 8.1 
Hz
8.45 (s)  
[(terpy)Ru(L11)Ru(terpy)][PF6]4
7.11
(ddd)
J 1.3, 5.6, 
7.6 Hz 
7.29 
(ddd)  
J 0.7, 1.4, 
5.6 Hz 
7.86 (m) 
8.42
(ddd)
J 0.8, 1.2, 
8.1 Hz 
8.36 (s) 
7.14
(ddd)
J 1.4, 5.6, 
7.6 Hz 
7.40
(ddd)
J 0.7, 1.4, 
5.6 Hz 
7.90 (m) 
8.47
(ddd)
J 0.8, 1.2, 
8.1 Hz 
8.72 (d) 
J 8.2 Hz 
8.36 (t) 
J 8.1 Hz 
[(terpy)Ru(L12)Ru(terpy)][PF6]4 7.10 (m) 
7.28 (d) 
J 5.4 Hz 
7.85 (td) 
J 1.6, 7.8 
Hz
8.43 (d) 
J 8.4 Hz 
8.33 (s) 7.15 (m) 
7.40 (d) 
J 6.0 Hz 
7.90 (td) 
J 1.2, 7.8 
Hz
8.47 (d) 
J 8.4 Hz 
8.72 (d) 
J 8.4 Hz 
8.37 (t) 
J 8.1 Hz 
[(L4)Ru(L13)Ru(L4)][PF6]4 7.16 (m) 7.42 (m) 7.90 (m) 
8.49 (d) 
J 7.7Hz 
8.40 (s) 7.16(m) 7.42 (m) 7.90 (m) 
8.49 (d) 
J 7.7Hz 
8.47 (s)  
[(terpy)Ru(L14)Ru(terpy)][PF6]4
7.08
(ddd)
J 1.3, 5.6, 
7.6 Hz 
7.27 
(ddd)  
J 0.6, 1.4, 
5.6 Hz 
7.83 (td) 
J 1.4, 7.9 
Hz
8.40
(ddd)
J 0.7, 1.1, 
8.1 Hz 
8.33 (s) 
7.16
(ddd)
J 1.3, 5.7, 
7.6 Hz 
7.41
(ddd)
J 0.7, 1.4, 
5.6 Hz 
7.90 (td) 
J 1.4, 7.9 
Hz
8.47
(ddd)
J 0.8, 1.1, 
8.1 Hz 
8.72 (d) 
J 8.2 Hz 
8.36 (t) 
J 8.2 Hz
[(terpy)Ru(L16)Ru(terpy)][PF6]4
6.94 or 
7.08
(ddd)
J 1.3, 5.7, 
7.5 Hz 
7.28 or 
7.39 
(ddd)  
J 0.6 
(0.7), 1.4, 
5.6 Hz 
7.75 (m) 8.43 (m) 8.41 (s) 
7.08 or 
6.94
(ddd)
J 1.3, 5.7, 
7.5 Hz 
7.39 or 
7.28
(ddd)
J 0.7 
(0.6), 1.4, 
5.6 Hz 
7.75 (m) 8.43 (m) 
8.71 (d) 
J 8.2 Hz 
8.36 (t) 
J 8.1 Hz 
[(terpy)Ru(L17)Ru(terpy)][PF6]4
7.08
(ddd)
J 1.3, 5.6, 
7.6 Hz 
7.27 
(ddd)  
J 0.6, 1.4, 
5.6 Hz 
7.82 (td) 
J 1.5, 7.5 
Hz
8.39
(ddd)
J 0.7, 1.1, 
8.1 Hz 
8.32 (s) 
7.15
(ddd)
J 1.3, 5.6, 
7.6 Hz 
7.41
(ddd)
J 0.7, 1.4, 
5.6 Hz 
7.89 (td) 
J 1.5, 7.9 
Hz
8.47
(ddd)
J 0.7, 1.2, 
8.2 Hz 
8.72 (d) 
J 8.2 Hz 
8.36 (t) 
J 8.2 Hz 
J
JC34 8.1 Hz; JC45 7.6 Hz; JC46 1.4 Hz; JC53 1.2 Hz; JC56 5.6 
Hz; JC63 0.7 Hz 
JA34 8.1 Hz; JA45 7.6 Hz; JA46 1.4 Hz; JA53 1.3 Hz; JA56 5.6 Hz; JA63 0.7 
Hz; JB34 8.2 Hz 
(to be continued) 
2
2
7
Proton resonance (?)
HS1 HS2 HS3 HS4 HS5 HN3, N7 HN4, N8 HN1, N5    
[(terpy)Ru(L11)Ru(terpy)][PF6]4 4.75 (m) 4.13 (m) 4.86 (s)   
7.56 (dd) 
J 1.4, 8.5 
Hz
7.86 (m) 7.92 (s)    
[(terpy)Ru(L12)Ru(terpy)][PF6]4 4.69 (m) 
4.07 (t) 
J 4.2 Hz 
3.84 (m) 3.75 (m) 4.69 (m) 
7.47 (dd) 
J 1.2, 7.2 
Hz
7.81 (d) 
J 7.8 Hz 
7.79 (s)    
 HS1 HS2 HS3 HE3, E6 HE1, E8 HE4, E5 HF6, F7 HF3 HF5, F8 HF4 HF1
[Ru(L4)2][PF6]2 5.79 (s)      7.62 (m) 
7.79 (dd)
J 1.8, 8.4 
Hz
8.00 (m) 
and 8.03 
(m)
8.08 (d) 
J 8.5 Hz 
8.20 (s) 
[(L4)Ru(L13)Ru(L4)][PF6]4 4.97 (m) 4.71 (m) 5.79 (s) 7.16 (m) 7.42 (m) 
7.83 (d) 
J 9.0 Hz 
7.61 (m) 
7.79 (dd)
J 1.7, 8.4 
Hz
7.98 (m) 
8.07 (d) 
J 8.5 Hz 
8.20 (s) 
 HS1 HS2 HS3 HS4  HN3, N6 HN1, N8 HN4, N5    
[(terpy)Ru(L14)Ru(terpy)][PF6]4 4.71 (m) 4.15 (m) 4.04 (m)  4.28 (m)  
6.97 (dd) 
J 2.5, 8.9 
Hz
7.14 (d) 
J 2.7 Hz 
7.58 (d) 
J 9.0 Hz 
 HS1 HS2 HS3 HS4  HN7, N6 HN1, N4 HN8, N5    
[(terpy)Ru(L16)Ru(terpy)][PF6]4 5.01 (m) 4.83 (m)    7.43 (m) 7.58 (s) 7.86 (m)    
[(terpy)Ru(L17)Ru(terpy)][PF6]4 4.74 (m) 4.21 (m) 4.12 (m) 4.40 (m)  7.24 (m) 7.33 (s) 7.63 (m)    
Table 1.
1
H NMR spectroscopic data for the proton signals of the six [(L
a
)Ru(L
b
)Ru(L
a
)][PF6]4 (where L
b
 = L
11
-L
14
, L
16
-L
17
 and L
a
 = terpy or 
L
4
) complexes in CD3CN solution at room temperature (except [(terpy)Ru(L
12
)Ru(terpy)][PF6]4 was measured at 600 MHz; all the rest 
were measured at 500 MHz). The structures and the labeling scheme are shown in Scheme 2 on p.225. 
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Figure 2. The 
1
H NMR spectrum (600 MHz) of [(terpy)Ru(L
12
)Ru(terpy)][PF6]4 in 
CD3CN solution at room temperature. 
The
1
H NMR spectrum of [(terpy)Ru(L
12
)Ru(terpy)][PF6]4 in CD3CN solution has 
only nineteen proton resonances due to the symmetry of this complex (Figure 2). The 
absolute assignment of the two terpyridine systems (A, B and C, D rings) was made 
by using COSY and ROESY techniques. The doublet at ? 8.43, which exhibits a 
ROESY cross peak to the singlet signal for H
D3
 at ? 8.33, is assigned to HC3 (Figure
3). Once the H
C3
 signal was assigned, the rest of the signals belonging to the C ring 
were assigned from a COSY spectrum (Figure 4). The triplet for H
B4
 at ? 8.37 gives a 
COSY cross peak to the signal at ? 8.72, and this is then assigned to HB3 (Figure 4). 
The signal for H
B3
 exhibits a ROESY cross peak to the doublet signal at ? 8.47, and 
this is assigned to H
A3
 (Figure 3). Similarly, the rest of the A ring signals were 
assigned from a COSY spectrum (Figure 4). The assignment for the ethyleneoxy 
proton signals in the 
1
H NMR spectrum was made using the ROESY method. The 
signals for H
D3
 and H
N1, N5
 showed strong ROESY cross peaks to H
S1
 and H
S5
respectively. The signal for H
S5
 exhibits a ROESY cross peak to ? 3.75, and this 
signal is assigned to H
S4
. Therefore, H
S2
 and H
S3
 were assigned by a COSY spectrum 
since there were COSY cross peaks to H
S1
 and H
S4
 respectively. 
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Figure 3. ROESY spectrum (600 MHz) of [(terpy)Ru(L
12
)Ru(terpy)][PF6]4 in CD3CN
solution at room temperature. 
Figure 4. COSY spectrum (600 MHz) of [(terpy)Ru(L
12
)Ru(terpy)][PF6]4 in CD3CN 
solution at room temperature. 
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Figure 5. The 
1
H NMR spectrum (500 MHz) of (a) [Ru(L
4
)2][PF6]2 and (b) 
[(L
4
)Ru(L
13
)Ru(L
4
)][PF6]4 in CD3CN solution at room temperature. 
The
1
H NMR spectrum of [(L
4
)Ru(L
13
)Ru(L
4
)][PF6]4 was assigned by using COSY 
and NOESY techniques and also by making a comparison with the spectrum of the 
corresponding mononuclear [Ru(L
4
)2][PF6]2 complex. The substituents on the two 4?-
positions of the 2,2?:6?,2?-terpyridine rings are similar; therefore, all the terpyridine 
proton signals of the two systems overlap (Figure 5).
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Figure 6. The 
1
H NMR spectrum (500 MHz) of (a) [(terpy)Ru(L
16
)Ru(terpy)][PF6]4
and (b) [(terpy)Ru(L
17
)Ru(terpy)][PF6]4 in CD3CN solution at room 
temperature. 
The
1
H NMR spectrum of [(terpy)Ru(L
17
)Ru(terpy)][PF6]4 in CD3CN solution 
exhibits eighteen proton signals (Figure 6b). The proton signals of the two terpyridine 
systems were assigned as previously described from the NOESY and COSY spectra. 
The triplet for H
B4
 at ? 8.36 gives a COSY cross peak to the signal at ? 8.72, and this 
is then assigned to H
B3
 (Figure 7). The signal for H
B3
 exhibits an NOE signal to H
A3
at ? 8.47 (Figure 8). Therefore, the rest of the A ring signals were assigned from the 
COSY spectrum (Figure 7). The singlet signal for H
D3
 at ? 8.32 exhibits NOE signals 
to ? 8.39 and ? 4.74 (Figure 8). The signal at ? 8.39 is assigned to HC3 and the signal 
at ? 4.74 is then assigned to HS1. Similarly, the rest of the C ring signals were assigned 
from the COSY spectrum (Figure 7). The rest of the signals for the ethyleneoxy chain 
are fully assigned by COSY and NOESY spectra. The signal for H
S4
 at ? 4.40 exhibits 
an NOE signal to a singlet for H
N1, N4
 at ? 7.33 (Figure 8). Then, the multiplet signal 
at ? 7.63, which exhibits an NOE signal to HN1, N4, is assigned to HN5, N8 (Figure 8). 
The signal for H
N5, N8
 gives a COSY cross peak to the multiplet signal at ? 7.24, and 
this is then assigned to H
N6, N7
 (Figure 7).
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Figure 7. COSY spectrum (500 MHz) of [(terpy)Ru(L
17
)Ru(terpy)][PF6]4 in CD3CN 
solution at room temperature. 
Figure 8. NOESY spectrum (500 MHz) of [(terpy)Ru(L
17
)Ru(terpy)][PF6]4 in CD3CN 
solution at room temperature. 
The
1
H NMR spectra of [(terpy)Ru(L
16
)Ru(terpy)][PF6]4 in CD3CN solution were 
assigned according to the spectrum for[(terpy)Ru(L
17
)Ru(terpy)][PF6]4. There are no 
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significant differences in the chemical shift of the terpyridine signals (Table 1 and
Figure 6). However, the proton signals for the naphthyl ring shifted 0.2 ppm (Figure
6). 
6.3 Mass spectrometric characterisation 
Electrospray ionisation mass spectrometry (ES-MS) was used to characterise the new 
complexes. The mass spectrum shows peaks for ions with particular mass to charge 
ratios (m/z). Each signal arises from a unique combination of the isotopes of the 
elements in the complexes. The difference between the m/z values for each of the 
signals within the peak envelope is the reciprocal of the charge on the fragment from 
which the signal originates; e.g. if z = 4, the separation between peaks in an envelope 
is 0.25 mass units. Normally, ES-MS is a relatively soft ionisation method and, [M-
PF6]
+
, [M-2PF6]
2+
 , [M-3PF6]
3+
 and [M-4PF6]
4+
 peaks are found as the major peaks 
for homodinuclear Ru(II) complexes. However, if the voltage used to ionise the 
samples is relatively high, some other fragments are observed in the spectra (Table 2). 
m/z
[M-PF6]
+ [M-2PF6]
2+ [M-3PF6]
3+ [M-4PF6]
4+ Others 
[(terpy)Ru(L11)Ru(terpy)][PF6]4    351.8  
[(terpy)Ru(L12)Ru(terpy)][PF6]4  891.8 546.4 374.1  
[(L4)Ru(L13)Ru(L4)][PF6]4     706.0, 598.6 
[(terpy)Ru(L14)Ru(terpy)][PF6]4  879.2 537.5 367.4  
[(terpy)Ru(L16)Ru(terpy)][PF6]4   508.4 344.8  
[(terpy)Ru(L17)Ru(terpy)][PF6]4    367.2  
Table 2. The ES-MS data of the six homodinuclear Ru(II) complexes. 
In the ES-MS spectrum of [(terpy)Ru(L
14
)Ru(terpy)][PF6]4, which is shown in Figure
9, a peak at m/z 367.4 assigned to [M-4PF6]
4+
 was the major signal. The other two 
minor signals at m/z 879.2 and 537.5 correspond to [M-2PF6]
2+
 and [M-3PF6]
3+
respectively. 
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Figure 9. The ES-MS spectrum of [(terpy)Ru(L
14
)Ru(terpy)][PF6]4.
6.4 Absorption spectroscopic characterisation 
The electronic spectra of the dinuclear Ru(II) complexes were recorded in HPLC 
grade acetonitrile solution. The absorption spectra of these complexes are similar to 
the sum of the spectra of [Ru(terpy)2]
2+
 and those of the substituents. The absorption 
data for these six homodinuclear complexes are summarised in Table 3. The very 
intense bands in the UV region are assigned to the ligand-centred ?*?? transitions. 
The Ru(II) complexes exhibit a low energy metal-to-ligand charge transfer (MLCT) 
transition with ?max between 475 to 483 nm. The absorption coefficients of these 
dinuclear complexes are nearly double those observed for the mononuclear 
complexes.
12-14 
[M-4PF6]
4+ [M-2PF6]
2+[M-3PF6]
3+
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?max, nm ( ? / 103 M-1cm-1)
LC LMCT 
[(terpy)Ru(L11)Ru(terpy)][PF6]4 226 (182), 238 (98.4), 267 (111), 303 (132) 475 (36.5) 
[(terpy)Ru(L12)Ru(terpy)][PF6]4 229 (141), 241 (76.6), 269 (84.7), 305 (107) 480 (28.5) 
[(L4)Ru(L13)Ru(L4)][PF6]4 221 (218), 233 (130), 267 (108), 301 (95.7) 483 (27.8) 
[(terpy)Ru(L14)Ru(terpy)][PF6]4 234 (158), 269 (103), 305 (128) 481 (34.5) 
[(terpy)Ru(L16)Ru(terpy)][PF6]4 229 (126), 267 (89.1), 303 (105) 477 (28.9) 
[(terpy)Ru(L17)Ru(terpy)][PF6]4 230 (135), 267 (92.9), 303 (115) 476 (31.5) 
Table 3. Electronic spectroscopic data for the complexes in acetonitrile solution. 
6.5 Conclusion 
All six new homodinuclear Ru(II) complexes [(L
a
)Ru(L
b
)Ru(L
a
)][PF6]4 (where L
b
 = 
L
11
-L
14
, L
16
-L
17
 and L
a
 = terpy or L
4
), which incorporate ligands in which a 
naphthalene unit bridges the 4?-positions of two 2,2?:6?,2?-terpyridine domains, have 
been synthesised and characterised with 
1
H NMR spectroscopy, ES-MS spectrometry, 
UV/VIS spectroscopy and elemental analysis.  
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6.6 Experimental 
? [(terpy)Ru(L11)Ru(terpy)][PF6]4
? [(terpy)Ru(L12)Ru(terpy)][PF6]4
? [(L4)Ru(L13)Ru(L4)][PF6]4
? [(terpy)Ru(L14)Ru(terpy)][PF6]4
? [(terpy)Ru(L16)Ru(terpy)][PF6]4
? [(terpy)Ru(L17)Ru(terpy)][PF6]4
where L11 2,6-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4-dioxapentyl]naphthalene 
L
12
2,6-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7-trioxaoctyl]naphthalene 
L
13
2,7-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4-dioxabutyl]naphthalene 
L
14
2,7-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7-trioxaheptyl]naphthalene 
L
16
2,3-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4-dioxabutyl]naphthalene 
L
17
2,3-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7-trioxaheptyl]naphthalene 
   
L
4
4?-(Naphthalen-2-ylmethoxy)-2,2?:6?,2?-terpyridine 
terpy 2,2?:6?,2?-terpyridine 
General synthesis of linear homodinuclear ruthenium(II) metal complexes10-14
1 equivalent of Lb (L11-L14, L16-L17), 2 equivalents of [Ru(La)Cl3] (where L
a = terpy or L4) and 
a few drops of N-ethylmorpholine (NEM) were heated to reflux for 3 hours in CH3OH. The 
deep red reaction mixture was cooled, and excess aqueous NH4PF6 were added to precipitate 
the crude product. The crude product was collected by filtration. The red product was 
obtained after column chromatography or preparative TLC (SiO2, CH3CN: saturated aqueous 
KNO3: water 14:2:1). 
Ru Ru [PF6]4YY
 [(La)RuCl3], MeOH, NEM,  
reflux 3 hr
La = L4 (Y = OCH2-2-naphthyl) 
or terpy (Y = H)
L
b
 (L
b
 = L
11
-L
14
, L
16
-L
17
)
= naphthyl domain
= ethylene chain
= terpyridine domain
[(L
a
)Ru(L
b
)Ru(L
a
)][PF6]4
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? [(terpy)Ru(L11)Ru(terpy)][PF6]4
O
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Molecular formula: C76H60N12O4Ru2P4F24 
Molecular weigtht: 1987.36 
L
11 (0.05 g, 0.07 mmol) and [Ru(terpy)Cl3] (60 mg, 0.14 mmol) were used. After column 
chromatography (SiO2, CH3CN: saturated aqueous KNO3: water 14:2:1), a red powder of 
[(terpy)Ru(L11)Ru(terpy)][PF6]4 (14.1 mg, 10.1%) was obtained. 
1H NMR (500 MHz, CD3CN): ?H 4.13 (m, 4H, HS2), 4.75 (m, 4H, HS1), 4.86 (s, 4H, HS3), 
7.11 (ddd, J 1.3, 5.6, 7.6 Hz, 4H, HC5), 7.14 (ddd, J 1.4, 5.6, 7.6 Hz, 4H, HA5), 7.29 (ddd, 
J 0.7, 1.4, 5.6 Hz, 4H, HC6), 7.40 (ddd, J 0.7, 1.4, 5.6 Hz, 4H, HA6), 7.56 (dd, J 1.4, 8.5 
Hz, 2H, H
N3, N7
), 7.86 (m, 6H, H
N4, N8
 and H
C4
), 7.90 (m, 4H, H
A4
), 7.92 (s, 2H, H
N1, N5
),
8.36 (s, 4H, HD3), 8.36 (t, J 8.1 Hz, 2H, HB4), 8.42 (ddd, J 0.8, 1.2, 8.1 Hz, 4H, HC3), 8.47 
(ddd, J 0.8, 1.2, 8.1 Hz, 4H, HA3), 8.72 (d, J 8.2 Hz, 4H, HB3). 
MS (ES): m/z = 351.8 [M-4PF6]
4+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 226 (182 x 103), 238 (98.4 x 103), 267 (111 x 
103), 303 (132 x 103), 475 (36.5 x 103).
Elemental Analysis: Found: C, 44.69; H, 3.07; N, 8.42. Calc. for 
C76H60N12O4P4F24Ru2·3H2O: C, 44.71; H, 3.27; N, 8.24%. 
? [(terpy)Ru(L12)Ru(terpy)][PF6]4
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Molecular formula: C80H68N12O6Ru2P4F24 
Molecular weight: 2075.47 
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L
12 (0.13 g, 0.16 mmol) and [Ru(terpy)Cl3] (0.14 g, 0.32 mmol) were used. After 
preparative TLC (SiO2, CH3CN: saturate aqueous KNO3: water 14:2:1), a red powder of 
[(terpy)Ru(L
12
)Ru(terpy)][PF6]4 (89.8 mg, 27.0%) was obtained. 
1H NMR (600 MHz, CD3CN): ?H 3.75 (m, 4H, HS4), 3.84 (m, 4H, HS3), 4.07 (t, J 4.2 Hz, 
4H, HS2), 4.69 (m, 8H, HS1 and HS5), 7.10 (m, 4H, HC5), 7.15 (m, 4H, HA5), 7.28 (d, J 5.4 
Hz, 4H, HC6), 7.40 (d, J 6.0 Hz, 4H, HA6), 7.47 (dd, J 1.2, 7.2 Hz, 2H, HN3, N7), 7.79 (s, 
2H, H
N1, N5
), 7.81 (d, J 7.8 Hz, 2H, H
N4, N8
), 7.85 (td, J 1.6, 7.8 Hz, 4H, H
C4
), 7.90 (td, J
1.2, 7.8 Hz, 4H, HA4), 8.33 (s, 4H, HD3), 8.37 (t, J 8.1 Hz, 2H, HB4), 8.43 (d, J 8.4 Hz, 4H, 
HC3), 8.47 (d, J 8.4 Hz, 4H, HA3), 8.72 (d, J 8.4 Hz, 4H, HB3).
MS (ES): m/z = 891.8 [M-2PF6]
2+, 546.4 [M-3PF6]
3+, 374.1 [M-4PF6]
4+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 229 (141 x 103), 241 (76.6 x 103), 269 (84.7 x 
103), 305 (107 x 103), 480 (28.5 x 103).
Elemental Analysis: Found: C, 45.05; H, 3.38; N, 7.89. Calc. for 
C80H68N12O6P4F24Ru2·2H2O: C, 45.50; H, 3.44; N, 7.96%.
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Molecular formula: C96H72N12O6Ru2P4F24 
Molecular weight: 2271.67
L
13 (0.071 g, 0.10 mmol) and [Ru(L4)Cl3] (0.12 g, 0.20 mmol) were used. After column 
chromatography (SiO2, CH3CN: saturate aqueous KNO3: water 14:2:1), a red powder of 
[(L4)Ru(L13)Ru(L4)][PF6]4 (75.3 mg, 33.1%) was obtained. 
1H NMR (500 MHz, CD3CN): ?H 4.71 (m, 4H, HS2), 4.97 (m, 4H, HS1), 5.79 (s, 4H, HS3), 
7.16 (m, 10H, HA5, HC5 and HE3, E6), 7.42 (m, 10H, HA6, HC6 and HE1, E8), 7.61 (m, 4H, HF6
and HF7), 7.79 (dd, J 1.7, 8.4 Hz, 2H, HF3), 7.83 (d, J 9.0 Hz, 2H, HE4, E5), 7.90 (m, 8H, 
HA4 and HC4), 7.98 (m, 4H, HF5 and HF8), 8.07 (d, J 8.5 Hz, 2H, HF4), 8.20 (s, 2H, HF1), 
8.40 (s, 4H, HD3), 8.47 (s, 4H, HB3), 8.49 (d, J 7.7 Hz, 8H, HA3 and HC3).
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MS (ES): m/z = 706.0 [(O-Terpy)Ru(L13)Ru(Terpy-O)]2+, 598.6 [Ru(O-terpy)(HO-
terpy)]+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 221 (218 x 103), 233 (130 x 103), 267 (108 x 
103), 301 (95.7 x 103), 483 (27.8 x 103). 
Elemental Analysis: Found: C, 50.33; H, 3.60; N, 7.17. Calc. for C96H72N12O6P4F24Ru2: C, 
50.76; H, 3.19; N, 7.40%.
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3
46
3
4
5
N2
N33
4
3
4
5
A
B
S1
N4 N5
N6
N7
N8
N9
N10
N1S2 S3
S4
6 O
O
OO
O
O
N
N
N
N
N
N
N
N
N
N
N
N
Ru Ru
C
D
[PF6]4
Molecular formula: C78H64N12O6Ru2P4F24 
Molecular weight: 2047.42 
L
14 (0.08 g, 0.1 mmol) and [Ru(terpy)Cl3] (0.09 g, 0.2 mmol) were used. After column 
chromatography (SiO2, CH3CN: saturate aqueous KNO3: water 14:2:1), a red powder of 
[(terpy)Ru(L
14
)Ru(terpy)][PF6]4 (69.0 mg, 33.7%) was obtained. 
1H NMR (500 MHz, CD3CN): ?H 4.04 (m, 4H, HS3), 4.15 (m, 4H, HS2), 4.28 (m, 4H, HS4), 
4.71 (m, 4H, HS1), 6.97 (dd, J 2.5, 8.9 Hz, 2H, HN3, N6), 7.08 (ddd, J 1.3, 5.6, 7.6 Hz, 4H, 
HC5), 7.14 (d, J 2.7 Hz, 2H, HN1, N8), 7.16 (ddd, J 1.3, 5.7, 7.6 Hz, 4H, HA5), 7.27 (ddd, J
0.6, 1.4, 5.6 Hz, 4H, H
C6
), 7.41 (ddd, J 0.7, 1.4, 5.6 Hz, 4H, H
A6
), 7.58 (d, J 9.0 Hz, 2H, 
HN4, N5), 7.83 (td, J 1.4, 7.9 Hz, 4H, HC4), 7.90 (td, J 1.4, 7.9 Hz, 4H, HA4), 8.33 (s, 4H, 
HD3), 8.36 (t, J 8.2 Hz, 2H, HB4), 8.40 (ddd, J 0.7, 1.1, 8.1 Hz, 4H, HC3), 8.47 (ddd, J 0.8, 
1.1, 8.1 Hz, 4H, HA3), 8.72 (d, J 8.2 Hz, 4H, HB3). 
MS (ES): m/z = 879.2 [M-2PF6]
2+, 537.5 [M-3PF6]
3+, 367.4 [M-4PF6]
4+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 234 (158 x 103), 269 (103 x 103), 305 (128 x 
103), 481 (34.5 x 103).
Elemental Analysis: Found: C, 44.99; H, 3.25; N, 8.03. Calc. for 
C78H64N12O6P4F24Ru2·H2O: C, 45.35; H, 3.23; N, 8.14%. 
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? [(terpy)Ru(L16)Ru(terpy)][PF6]4
Molecular formula: C74H56N12O4Ru2P4F24 
Molecular weight: 1959.31 
L
16
 (0.04 g, 0.06 mmol) and [Ru(terpy)Cl3] (50 mg, 0.12 mmol) were used. A red powder 
of [(terpy)Ru(L16)Ru(terpy)][PF6]4 (25.2 mg, 21.4%) was obtained. 
1H NMR (500 MHz, CD3CN): ?H 4.83 (m, 4H, HS2), 5.01 (m, 4H, HS1), 6.94 (ddd, J 1.3, 
5.7, 7.5 Hz, 4H, HC5/A5), 7.08 (ddd, J 1.3, 5.7, 7.5 Hz, 4H, HA5/C5), 7.28 (ddd, J 0.6, 1.4, 
5.6 Hz, 4H, H
A6/C6
), 7.39 (ddd, J 0.7, 1.4, 5.6 Hz, 4H, H
A6/C6
), 7.43 (m, 2H, H
N7, N6
), 7.58 
(s, 2H, HN1, N4), 7.75 (m, 8H, HA4 and HC4), 7.86 (m, 2H, HN8, N5), 8.36 (t, J 8.1 Hz, 2H, 
HB4), 8.41 (s, 4H, HD3), 8.43 (m, 8H, HA3 and HC3), 8.71 (d, J 8.2 Hz, 4H, HB3).
MS (ES): m/z = 508.4 [M-3PF6]
3+, 344.8 [M-4PF6]
4+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 229 (126 x 103), 267 (89.1 x 103), 303 (105 x 
103), 477 (28.9 x 103).
Elemental Analysis: Found: C, 43.58; H, 3.06; N, 8.06. Calc. for 
C74H56N12O4P4F24Ru2·4H2O: C, 43.75; H, 3.18; N, 8.28%. 
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? [(terpy)Ru(L17)Ru(terpy)][PF6]4
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Molecular formula: C78H64N12O6Ru2P4F24 
Molecular weight: 2047.42 
L
17 (0.05 g, 0.06 mmol) and [Ru(terpy)Cl3] (50 mg, 0.12 mmol) were used. After column 
chromatography (SiO2, CH3CN: saturate aqueous KNO3: water 14:2:1), a red powder of 
[(terpy)Ru(L
17
)Ru(terpy)][PF6]4 (81.2 mg, 66.1%) was obtained. 
1H NMR (500 MHz, CD3CN): ?H 4.12 (m, 4H, HS3), 4.21 (m, 4H, HS2), 4.40 (m, 4H, HS4), 
4.74 (m, 4H, HS1), 7.08 (ddd, J 1.3, 5.6, 7.6 Hz, 4H, HC5), 7.15 (ddd, J 1.3, 5.6, 7.6 Hz, 
4H, HA5), 7.24 (m, 2H, HN6, N7), 7.27 (ddd, J 0.6, 1.4, 5.6 Hz, 4H, HC6), 7.33 (s, 2H, HN1, 
N4
), 7.41 (ddd, J 0.7, 1.4, 5.6 Hz, 4H, H
A6
), 7.63 (m, 2H, H
N5, N8
), 7.82 (td, J 1.5, 7.5 Hz, 
4H, HC4), 7.89 (td, J 1.5, 7.9 Hz, 4H, HA4), 8.32 (s, 4H, HD3), 8.36 (t, J 8.2 Hz, 2H, HB4), 
8.39 (ddd, J 0.7, 1.1, 8.1 Hz, 4H, HC3), 8.47 (ddd, J 0.7, 1.2, 8.2 Hz, 4H, HA3), 8.72 (d, J
8.2 Hz, 4H, HB3). 
MS (ES): m/z = 367.2 [M-4PF6]
4+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-1) 230 (135 x 103), 267 (92.9 x 103), 303 (115 x 
103), 476 (31.5 x 103).
Elemental Analysis: Found: C, 44.60; H, 3.45; N, 8.11. Calc. for 
C78H64N12O6P4F24Ru2·2H2O: C, 44.96; H, 3.30; N, 8.07%. 
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Chapter 7 
Synthesis of Metallomacrocyclic Ruthenium(II) and Iron(II) 
Complexes from Homoditopic 4?-Substituted-2,2?:6?,2?-Terpyridine
Ligands
Multitopic bipyridine, terpyridine or derivative ligands are used for metal-directed 
self-assembly of supramolecular systems1,2, such as rods3-7, helices8-20, knots21,
catenates21-24, rotaxanes25, boxes26-36, grids37-42, racks43, ladders44, cylinders45, cages46-
48, and dendrimers49-50. Most of these metallosupramolecules are formed 
spontaneously by the reaction of labile metal ions with multidentate ligands. The 
principle of their formation depends mainly on (1) the number and orientation of the 
coordination sites of the ligand and (2) the coordination number and geometry of the 
metal ion.1,51 For example, 2,2?:6?,2?:6?,2??-quaterpyridine (qterpy), which contains 
two bidentate 2,2?-bipyridine metal binding domains, react with metal ions that favour 
a tetrahedral coordination geometry [like copper(I) or silver(I)] and result in a 
dinuclear double helicate (Scheme 1).8,52
Scheme 1. The double helicate formed by two tetrahedral metal ions and two 
2,2?:6?,2?:6?,2??-quaterpyridine (qterpy) ligands (Chem3D Pro7.0). 
M+
2,2?:6?,2?:6?,2??-quaterpyridine 
(qterpy)
[M(qterpy)]2
2+
M = Cu(I) or Ag(I) 
?2+
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In this chapter, we show that the ligands L11-L17, which have two tridentate binding 
sites, react with octahedral coordinated metal ions and give a range of [n+n]
metallomacrocycles. The size of the metallomacrocycles depends on the rigidity and 
length of the spacer group between the metal binding sites (Scheme 2).
Scheme 2. The homoditopic ligands (L11-L17) used for the synthesis of the [n+n]
metallomacrocycles. 
7.1 Synthesis 
(a) General synthesis of macrocyclic ruthenium(II) metal complexes  
The self-assembled macrocyclic homoleptic Ru(II) complexes were prepared by 
reaction of the free bis(terpyridine) ligands L (L11, L13-L14, L16-L17) with one 
equivalent of the adduct [Cl3RuLRuCl3] and a few drops of N-ethylmorpholine 
(NEM) in CH3OH heated for a few hours at reflux.
36 The same ligand L is used in 
both components to yield homoleptic complexes. The TLC analysis (on silica) of the 
red solutions with A sol indicated that more than one ruthenium complexes were 
present and precipitation with NH4PF6 gave [{Ru(L)}n][PF6]2n as red powders. The 
yields of the major [{Ru(L)}n][PF6]2n (L = L
11, L13-L14, L16-L17, n = 2 or 3) complexes 
are low (ranging from 1-26% yield) after chromatographic workup (Scheme 3). There 
was no attempt to analyse the material (assumed to be polymeric) that remained on 
the baseline of the TLC plate. 
N
N
N
N
N
N
O
O
O
O
n
n
O O
OO
n n
n
L11   n = 1
L12   n = 2
L13   n = 1
L14   n = 2
L15   n = 3
L16   n = 1
L17   n = 2L
11- L17
OO
OO
n
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Scheme 3. The general synthesis of the metallomacrocyclic [{Ru(L)}n][PF6]2n
complexes (where L = L11, L13-L14, L16-L17). Only homoleptic 
complexes were made. 
(b) General synthesis of macrocyclic iron(II) metal complexes  
Reaction of L (L11-L17) with FeCl2·4H2O (1:1) in CH3OH at room temperature gave 
purple solutions.33-35 The TLC analysis (on silica) of the purple solutions with A sol 
indicated that more than one iron complexes were present and precipitation with 
NH4PF6 gave [{Fe(L)}n][PF6]2n as purple powders. After chromatographic workup, 
[{Fe(L)}n][PF6]2n (n = 1, 2 or 3) complexes were separated (Scheme 4). The yield of 
the major [{Fe(L)}n][PF6]2n (where L = L
11-L17, n = 1, 2 or 3) complexes ranged from 
1-47%. There was no attempt to analyse the material (assumed to be polymeric) that 
remained on the baseline of the TLC plate. 
Scheme 4. The general synthesis of the metallomacrocyclic [{Fe(L)}n][PF6]2n
complexes (where L = L11-L17). 
L (L = L11, L13-L14, L16-L17)
= naphthyl domain
= ethyleneoxy chain
= terpyridine domain
1. 2 equiv. RuCl3·3H2O,  
    MeOH, reflux 3 hr
Cl3Ru RuCl3
2. Excess aqueous NH4PF6
1. L , MeOH, reflux 3 hr, NEM
Step 2
Step 1
Ru
Ru
n-1
[PF6]2n
[{Ru(L)}n][PF6]2n
Fe
Fe
L (L = L11-L17)
= naphthyl domain
= ethyleneoxy chain
= terpyridine domain
n-1
[PF6]2n
[{Fe(L)}n][PF6]2n
2. Excess aqueous NH4PF6
1. 1 equiv. FeCl2·4H2O,  
    MeOH, room temp. for
    a few days
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7.2
1
H NMR spectroscopic and electrospray ionisation mass 
spectrometric characterisation  
Tables of the 1H NMR spectroscopic data of the metallomacrocyclic 
[{Ru(L)}n][PF6]2n (L = L
11, L13-L14, L16-L17) complexes and [{Fe(L)}n][PF6]2n (L = 
L
11-L17) complexes are shown in Appendix VI. All the 1H NMR spectra of the 
metallomacrocycles are consistent with symmetrical complexes and, as usual, they 
exhibit five terpyridine signals, with the exception of the 1H NMR spectrum of 
[{Fe(L14)}][PF6]2. Assignments have been made from COSY and NOESY 
experiments. However, the nuclearity of the metallomacrocycles cannot be elucidated 
by 1H NMR technique. It can be determined by ES-MS. The isotopic patterns of the 
metallomacrocycles with different nuclearities are diagnostic (i.e. the isotopic pattern 
of a parent ion of a [2+2] metallomacrocycle is different from that of a [3+3] 
metallomacrocycle). The ES-MS spectra of all the metallomacrocycles are shown in 
Appendix VI.
(a) Macrocyclic ruthenium(II) metal complexes  
? [{Ru(L11)}2][PF6]4
When L11 was treated with [Cl3RuL
11RuCl3], a range of [{Ru(L
11)}n][PF6]2n
complexes was formed. The ES-MS spectrum of the major metallomacrocycle 
[{Ru(L11)}n]
2n+, which was obtained after chromatography, in CH3CN solution 
showed a major peak at m/z 420.1, with 0.25 mass units for the separation between 
peaks in an envelope, corresponding to [{Ru(L11)}2]
4+. This was assigned to a [2+2] 
[{Ru(L11)}2][PF6]4 species. The 
1H NMR spectrum of the metallomacrocyclic 
[{Ru(L11)}2][PF6]4 complex shows that this coordinated complex is symmetrical with 
three aliphatic and eight aromatic proton resonances present (Figure 1b). The five 
terpyridine proton signals were assigned by comparison with signals in the spectrum 
of the mononuclear [Ru(L5)2]
2+ complex (Figure 1a) discussed in Chapter 3. There 
are around 0.1 ppm differences for the terpyridine proton signals between the 
mononuclear [Ru(L5)2]
2+ complex and the metallomacrocyclic [{Ru(L11)}2]
4+
complex (Figure 1).
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Figure 1. 1H NMR spectra of (a) mononuclear [Ru(L5)2][PF6]2 (250 MHz) and (b) 
metallomacrocyclic [{Ru(L11)}2][PF6]4 (400 MHz) in CD3CN solution at 
room temperature.  
? [{Ru(L13)}2][PF6]4 and [{Ru(L13)}3][PF6]6
When L13 was treated with [Cl3RuL
13RuCl3], a range of [{Ru(L
13)}n][PF6]2n
complexes was formed. From the TLC analysis of the crude product 
[{Ru(L13)}n][PF6]2n, there were two very close red bands (Rf values are 0.50 and 0.48 
in A sol) plus a large amount of presumably polymeric material which remained on 
the baseline of the TLC plate. Preparative TLC was used to separate the two bands. 
ES-MS analysis of each band in CH3CN solution provides strong evidence for the 
metallomacrocycles formation. The spectrum of the product with the Rf value 0.50 
contained a doubly charged ion at m/z 957.1 {[{Ru(L13)}2][PF6]2}
2+, a triply charged 
ion at m/z 589.7 {[{Ru(L13)2][PF6]}
3+, and a quadruply charged ion at m/z 406.4 
{[{Ru(L13)}2]}
4+. The other spectrum of the product with the Rf value 0.48 contained 
a triply charged ion at m/z 957.0 {[{Ru(L13)}3][PF6]3}
3+, a quadruply charged ion at 
T4 
N3, 
N7
N1, 
N5 
4.04.24.44.64.85.05.25.45.65.86.06.26.46.66.87.07.27.47.67.88.08.28.4
4.04.24.44.64.85.05.25.45.65.86.06.26.46.66.87.07.27.47.67.88.08.28.4
NO
O
N
N
T3'
T2'
T4'
N2N3
N O
O
N
N
Ru
T3
T4 T5
T6
S1
T2
N4
N5
N6 N7
N8
N9N10
N1
S2
S3
2+
T3 
T3?
T6 
T5 
N4, 
N8 
S3 
S2S1
S3
S2 S1
T3 
T3?
T6 
T5
N5, N8, 
N4, T4 N6, 
N7 
N3 
N1 
O
O
N
N N
O
O
N
N N
N1
N3
N4
S3S2
S1
T3
T4
T5
T6
N2
N5
N6
N7
N8
N9
N10
T3'
OO
N
NN
O O
N
NN
Ru
Ru
4+
(a)
(b) 
Chapter 7 
248 
m/z 681.2 {[{Ru(L13)}3][PF6]2}
4+, and a quintuply charged ion at m/z
515.8{[{Ru(L13)}3][PF6]}
5+. As mentioned before, the isotopic pattern of a peak 
depends on the number of metal atoms and ligand molecules present. Therefore, the 
[{Ru(L13)}2][PF6]4 and [{Ru(L
13)}3][PF6]6 can be distinguished by ES-MS. Peaks in 
the ES-MS of the metallomacrocyclic [{Ru(L13)}2][PF6]4 complex (higher Rf value) 
show an isotopic pattern which matches that of the calculated one (Figure 2).
Figure 2. The ES-MS of the metallomacrocyclic [{Ru(L13)}2][PF6]4 complex. 
The 1H NMR spectra of [{Ru(L13)}2][PF6]4 (Rf value 0.50) and [{Ru(L
13)}3][PF6]6 (Rf
value 0.48) in CD3CN solution were assigned as before. The data show each fraction 
contains one major component mixed with a minor amount of the second component. 
The spectra of the two species are highly symmetrical and the chemical shift 
[{Ru(L13)}2][PF6]4 [{Ru(L
13)}3][PF6]6
{[{Ru(L13)}2][PF6]2}
2+
{[{Ru(L13)}2][PF6]}
3+{[{Ru(L13)}2]}
4+
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differences are evident in the aromatic and also aliphatic regions of both species 
(Figure 3). There are significant differences in the chemical shifts for HS2, HN1, N8,
HT3 and HT3? between the two species. 
Figure 3. 1H NMR spectra (400 MHz) of (a) the fraction at Rf value 0.50, which 
contains mainly dinuclear [{Ru(L13)}2][PF6]4 and (b) the fraction at Rf
value 0.48, which contains mainly trinuclear [{Ru(L13)}3][PF6]6 in CD3CN
solution at room temperature. 
? [{Ru(L14)}2][PF6]4
When L14 was treated with [Cl3RuL
14RuCl3], a range of [{Ru(L
14)}n][PF6]2n
complexes was formed. The ES-MS spectrum of the metallomacrocycles 
[{Ru(L14)}n][PF6]2n in CH3CN solution, which were obtained after chromatographic 
workup, showed a major peak at m/z 648.8 with 0.33 mass units for the separation 
between peaks in an envelope (corresponding to {[{Ru(L14)}2][PF6]}
3+), and also 
peaks at m/z 1045.2 for a doubly charged ion {[{Ru(L14)}2][PF6]2}
2+ and at m/z 450.7 
for a quadruply charged ion {[{Ru(L14)}2]}
4+. This was assigned to a [2+2] 
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[{Ru(L14)}2][PF6]4 species. The 
1H NMR spectrum of this metallomacrocyclic 
[{Ru(L14)}2][PF6]4 complex showed that this coordinated complex was symmetrical 
with four aliphatic and eight aromatic proton resonances present. The five terpyridine 
proton signals were assigned as before. The signal for HT3? showed a cross peak to the 
signal for HS1. Therefore, the assignments of the ethyleneoxy spacer resonances in the 
1H NMR spectrum were made by using COSY and NOESY. Also, the signal for HS4
showed a cross peak to the signal for HN1, N8.
? [{Ru(L16)}2][PF6]4
When L16 was treated with [Cl3RuL
16RuCl3], a range of [{Ru(L
16)}n][PF6]2n
complexes was formed. The ES-MS of a CH3CN solution of [{Ru(L
16)}n][PF6]2n,
which was obtained after chromatographic work up, exhibited peaks that could be 
assigned to a [2+2] [{Ru(L16)}2][PF6]4 species (m/z 957.0 for a doubly charged ion 
{[{Ru(L16)}2][PF6]2}
2+, m/z 589.3 for a triply charged ion {[{Ru(L16)}2][PF6]}
3+ and 
m/z 406.2 for a quadruply charged ion {[{Ru(L16)}2]}
4+). The 1H NMR spectrum of 
the metallomacrocyclic [{Ru(L16)}2][PF6]4 complex is shown in Figure 4a. The 
assignments of the 1H NMR spectrum were made by COSY and NOESY techniques. 
The five terpyridine proton signals were assigned as before. The signals for HT3? and 
HN1, N4 showed cross peaks to HS1 and HS2 respectively. This allowed the assignment 
of the ethyleneoxy spacer resonances. 
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Figure 4. 1H NMR spectra (500 MHz) of (a) dinuclear [{Ru(L16)}2][PF6]4 and (b) 
dinuclear [{Ru(L17)}2][PF6]4 in CD3CN solution at room temperature. 
? [{Ru(L17)}2][PF6]4
When L17 was treated with [Cl3RuL
17RuCl3], a range of [{Ru(L
17)}n][PF6]2n
complexes was formed. The ES-MS of a CH3CN solution of [{Ru(L
17)}n][PF6]2n,
which was obtained after chromatography, exhibited a peak that could be assigned to 
a [2+2] [{Ru(L17)}2][PF6]4 species (m/z 449.9 for a quadruply charged ion 
{[{Ru(L17)}2]}
4+). The 1H NMR spectrum of the metallomacrocyclic 
[{Ru(L17)}2][PF6]4 complex is shown in Figure 4b. The assignments of the 
1H NMR 
spectrum were made by COSY and NOESY techniques. The five terpyridine proton 
signals were assigned as before. The signal for HT3? at ? 8.28 shows an NOE signal to 
the signal at ? 4.71, and this is assigned to HS1 (Figure 5). The signal for HS1 gives a 
COSY cross peak to the signal for HS2 at ? 4.16 (Figure 6). And, the signal for HS2
exhibits an NOE cross peak to the signal for HS3 at ? 4.11 (Figure 5). The signal for 
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HS3 gives a COSY cross peak to the signal at ? 4.39, and this is assigned to HS4
(Figure 6). The signal for HS4 exhibits a strong NOE cross peak to HN1, N4 at ? 7.34 
(Figure 5). The signal for HN1, N4 exhibits an NOE signal to HN5, N8 at ? 7.67. The 
signal for HN5, N8 gives a COSY cross peak to the signal at ? 7.29, and this is assigned 
to HN6, N7.
Figure 5. NOESY spectrum (500 MHz) of dinuclear [{Ru(L17)}2][PF6]4 in CD3CN
solution at room temperature. 
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Figure 6. COSY spectrum (500 MHz) of dinuclear [{Ru(L17)}2][PF6]4 in CD3CN 
solution at room temperature. 
(b) Macrocyclic iron(II) metal complexes  
? [{Fe(L11)}2][PF6]4
When ligand L11 was treated with FeCl2·4H2O, a range of [{Fe(L
11)}n][PF6]2n
complexes was formed. The ES-MS of a CH3CN solution of the major product 
[{Fe(L11)}n][PF6]2n obtained after chromatography exhibits peaks that could be 
assigned to a [2+2] [{Fe(L11)}2][PF6]4 species (m/z 578.2 for a triply charged ion 
{[{Fe(L11)}2][PF6]}
3+ and m/z 397.5 for a quadruply charged ion {[{Fe(L11)}2]}
4+)
(Figure 7). The isotope patterns match those of the simulated spectra. The 1H NMR 
spectrum of the metallomacrocyclic [{Fe(L11)}2][PF6]4 complex is shown in Figure 8.
The assignments of the 1H NMR spectrum were made by COSY and NOESY 
techniques. The five terpyridine proton signals were assigned as before. The signals 
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for HT3? and HN1, N5 showed cross peaks to the signals for HS1 and HS3 respectively. 
This allowed the assignment of the ethyleneoxy resonances. 
Figure 7. The ES-MS spectrum of [{Fe(L11)}2][PF6]4.
Figure 8. 1H NMR spectrum (500 MHz) of the metallomacrocyclic [{Fe(L11)}2][PF6]4
complex in CD3CN solution at room temperature.  
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? [{Fe(L12)}n][PF6]2n
Figure 9. The 1H NMR spectrum (500 MHz) of the major band of 
metallomacrocycles [{Fe(L12)}n][PF6]2n, which contained two 
compounds (A and B), in CD3CN solution at room temperature. 
When ligand L12 was treated with FeCl2·4H2O, a range of [{Fe(L
12)}n][PF6]2n species 
was formed. The major band of metallomacrocycles [{Fe(L12)}n][PF6]2n was obtained 
after preparative TLC chromatography. ES-MS analysis of this fraction in CH3CN 
solution provided evidence for the metallomacrocycle formation. The spectrum 
contained a singly charged ion at m/z 1027.2 {[{Fe(L12)}][PF6]}
+, a singly charged 
ion at m/z 901.6 {[{Fe(L12)}]F}+, and a doubly charged ion at m/z 441.7 
{[{Fe(L12)}]}2+. This indicated a [1+1] metallomacrocycle was formed. However, the 
1H NMR spectrum of this major fraction in CD3CN solution shows that there are two 
sets of proton signals. The ratio of the two sets of signals varied from ? 1:1 to ? 1.5:1 
when the reaction was repeated. Each sub-spectrum is consistent with a symmetrical 
product (Figure 9). This was proved by a range of NMR techniques, such as COSY, 
NOESY, HMQC, HMBC and NOE difference experiment at high temperature, that 
this fraction of the product contained two major compounds (A and B). This major 
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fraction remained as one band on the TLC plate in a variety of solvent systems, and 
the two compounds could not be separated. It was not possible to unambiguously 
assign compositions to the products A and B. Possibly, they are two different [n+n]
metallomacrocycles although the ES-MS showed it is a [1+1] metallomacrocycle. In 
the case below, although the ES-MS of the fraction showed only peaks belonged to a 
[2+2] [Fe{(L13)}2][PF6]4 metallomacrocycle, the fraction actually contained both 
[Fe{(L13)}2][PF6]4 and [{Fe(L
13)}3][PF6]6.
? [Fe{(L13)}2][PF6]4 and [{Fe(L13)}3][PF6]6
Figure 10. 1H NMR spectra (400 MHz) of (a) the fraction obtained after column 
chromatography [{Fe(L13)}n][PF6]2n (n = 2 and 3) [
# and § indicated two 
sets of signals] and (b) the fraction with Rf value 0.45, which contains 
mainly trinuclear [{Fe(L13)}3][PF6]6 obtained after preparative TLC in 
CD3CN solution at room temperature. 
When ligand L13 was treated with FeCl2·4H2O, a range of [{Fe(L
13)}n][PF6]2n
complexes was formed. There were two very close bands of metallomacrocycles 
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[{Fe(L13)}n][PF6]2n (Rf value are 0.47 and 0.45 in A sol) and also a large amount of 
presumably polymeric material which remained on the baseline of the TLC plate. 
Firstly, an attempt to separate the two close bands of the metallomacrocycles by 
column chromatography failed. The 1H NMR spectrum shows two sets of proton 
resonances (Figure 10a). However, the ES-MS analysis indicated it is only a [2+2] 
metallomacrocycle.  
Secondly, the two close bands were separated by preparative TLC. The two fractions 
were assigned to [2+2] and [3+3] metallomacrocycles from ES-MS analysis. The 
spectrum of higher Rf product contained a doubly charged ion at m/z 911.6 
{[{Fe(L13)}2][PF6]2}
2+, a triply charged ion at m/z 559.6 {[{Fe(L13)}2][PF6]}
3+, and a 
quadruply charged ion at m/z 383.5 {[{Fe(L13)}2]}
4+. This fraction can be assigned to 
a [2+2] metallomacrocycle. The mass spectrum of the other product with the Rf value 
0.45 contained a doubly charged ion at m/z 1440.3 {[{Fe(L13)}3][PF6]4}
2+, a triply 
charged ion at m/z 911.4 {[{Fe(L13)}3][PF6]3}
3+, a quadruply charged ion at m/z 647.5 
{[{Fe(L13)}3][PF6]2}
4+, a quintuply charged ion at m/z 489.1 {[{Fe(L13)}3][PF6]}
5+
and a sextuply charged ion at m/z 383.6 {[{Fe(L13)}3]}
6+. This indicated that this 
fraction is a [3+3] metallomacrocycle. The 1H NMR spectrum of the higher Rf value 
fraction could not be measured due to an insufficient amount of product. The 1H NMR 
spectrum of the fraction with Rf value 0.45 (i.e. the [3+3] metallomacrocycle) in 
CD3CN solution is highly symmetrical but the spectrum showed the presence of a 
small amount of [2+2] metallomacrocycle (Figure 10b). There is significant shifting 
for the proton signals, especially the signals at ? 6.80 and ? 4.23 of the [2+2] 
metallomacrocycle in the spectrum of the fraction after column (Figure 10a) compare 
with those signals in the spectrum of the fraction after preparative TLC (Figure 10b). 
It seems these two proton signals of the [2+2] metallomacrocycle are concentration 
dependent. 
? [{Fe(L14)}][PF6]2
The ES-MS of a CH3CN solution of the major product obtained from the reaction of 
L
14 with FeCl2·4H2O only exhibited peaks that could be assigned to a [1+1] 
[{Fe(L14)}][PF6]2 species. The spectrum contained singly charged ions at m/z 999.0 
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and 873.5, which were {[{Fe(L14)}][PF6]}
+ and {[{Fe(L14)}]F}+ respectively, and a 
doubly charged ion at m/z 427.1 assigned to {Fe(L14)}2+. The 1H NMR spectrum of a 
CD3CN solution of [{Fe(L
14)}][PF6]2 shows unusual features (Figure 11). The 
absolute assignments of the signals were made by using COSY, NOESY, HMQC and 
HMBC techniques. The spectrum shows two sets of signals assigned to coordinated 
terminal rings of the terpyridine ring, two HT3? signals from the terpyridine central 
ring (which are doublets with 2.2 Hz coupling constant) and two sets of signals for the 
ethyleneoxy group of the spacer, in each case in a 1:1 ratio. However, the naphthalene 
unit only gave rise to three signals with the resonances assigned to HN1, N8 being 
unusually highly shielded.
Figure 11. The 1H NMR spectrum (500 MHz) of [{Fe(L14)}][PF6]2 in CD3CN
solution at room temperature. (# is the signal of impurity CH2Cl2, the 
number next to the signal is the relative integral, and the ? and ?
indicated two sets of terpyridine proton signals). 
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Figure 12. COSY spectra (500 MHz) of [{Fe(L14)}][PF6]2 in CD3CN solution at room 
temperature. 
Figure 13. NOESY spectrum (500 MHz) of [{Fe(L14)}][PF6]2 in CD3CN solution at 
room temperature. 
S1b
S1a
S2a,
S2b S3a
S3b, S4a,
S4b
N1, N8
N4, N5
N3, N6
A5
A6A4A3
C6 
C5C4 
C3 B5 B3 
S1b
S1a 
S2a,
S2b
S3a 
S3b, S4a,
S4b
N1, N8 N4, N5 
N3, N6 
A5A6A4 A3 C6 C5
C4 C3 
B5 B3
A ring
C ring
Chapter 7 
260 
There are two sets of terpyridine proton signals (A and C ring) (Figure 11). The HB3
signal and HB5 signal exhibit NOE signals to HA3 and HC3 respectively (Figure 13).
Therefore, the proton signals for A and C ring are assigned (Figure 12). There is a 
pair of cross peaks between a doublet of doublets (J 2.5, 8.9 Hz) at ? 6.85 and a 
doublet (J 9.0 Hz) at ? 7.53 (Figure 12). Therefore, the doublet of doublets at ? 6.85 
and the doublet at ? 7.53 are assigned to HN3, N6 and HN4, N5 respectively. Also, the 
signal for HN3, N6 at ? 6.85 exhibits an NOE signal to a doublet (J 2.4 Hz) for HN1, N8 at 
? 4.86 (Figure 13). The signal for HN1, N8 exhibits an NOE signal to the signal at ?
3.79 (with 3 times the relative integral of the signal for HN1, N8), and this signal is 
assigned to HS4. The signal for HS4 gives a COSY cross peak to the signal at ? 4.07 
and this is assigned to HS3 (with a relative integral equal to that of the signal for HN1, 
N8). The signal for HS3 exhibits an NOE signal to the signal for HS2 at ? 4.13. The 
signal for HS2 at ? 4.13 also exhibits an NOE signal to the signal at ? 3.79 (which 2/3 
relative integral belongs to HS4), and therefore this is assigned to another 
diastereotopic pair of the HS3. The signal for HS2 gives COSY cross peaks to the 
signals for HS1 at ? 4.66 and ? 5.38. The CH2 protons appear as eight, partially 
overlapping resonances in the 1H NMR spectrum but there are only four 13C NMR 
signals. The pairwise relationship of the eight CH2 protons resonances to four carbon 
resonances was made from a 1H-13C correlation spectrum (Figure 14).
Figure 14. HMQC spectrum (500 MHz) of [{Fe(L14)}][PF6]2 in CD3CN solution at 
room temperature. 
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The 1H NMR spectroscopic data suggested that the naphthalene and the ethyleneoxy 
spacer are trapped between two terminal pyridine rings (A ring) of the terpyridine 
domains. That is due to the fact that the spacer is not long enough to allow it to rotate 
around the complex. Therefore, one terminal pyridine ring (A ring) of the terpyridine 
is different from the other terminal pyridine ring (C ring). This explained why there 
are two sets of terpyridine protons signals and two sets of diastereotopic CH2 protons. 
From a modelled structure and the single crystal structure of [{Fe(L14)}][PF6]2 (see 
Section 7.4), HN1, N8 points towards the [Fe(terpy)2]
2+ unit and lies in the shielding, 
anisotropic region above a pyridine ring. This explains the high field shift of the 
proton signal for HN1, N8 at ? 4.86 (Figure 11).
? [{Fe(L15)}][PF6]2
Reaction of a longer chain ligand L15 with FeCl2·4H2O resulted in the formation of a 
[1+1] metallomacrocycle as the major product. The ES-MS of this product in CH3CN
solution exhibited peaks that could be assigned to a [1+1] [{Fe(L15)}][PF6]2 species. 
The spectrum contained singly charged ions at m/z 1086.9, 961.3 and 553.3, which 
were assigned to {[{Fe(L15)}][PF6]}
+, {[{Fe(L15)}]F}+ and {[Fe(HO-Terpy)(O-
Terpy)]}+ respectively, and doubly charged ions at m/z 471.3 and 277.4, which was 
{[{Fe(L15)}]}2+ and {[Fe(O-Terpy)2]}
2+ respectively. The 1H NMR spectrum of 
[{Fe(L15)}][PF6]2 in CD3CN solution has a symmetrical appearance (Figure 15). The 
absolute assignments of the signals were made by using COSY and NOESY 
techniques. There are only six proton signals in the aromatic region but seven proton 
signals in the aliphatic region. As was seen for the [{Fe(L14)}][PF6]2 complex, the 
HN1, N8 signal (? 5.44) of [{Fe(L15)}][PF6]2 is shifted to the high field. 
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Figure 15. The 1H NMR spectrum (500 MHz) of [{Fe(L15)}][PF6]2 in CD3CN
solution at room temperature.  
A low temperature proton NMR experiment on the [{Fe(L15)}][PF6]2 in CD2Cl2
solution was made to investigate possible locking of the naphthalene ring as in the 
[{Fe(L14)}][PF6]2. However, there is no evidence for splitting into two sets of signals 
as in [{Fe(L14)}][PF6]2, even when the temperature was lowered to 180K. However, 
the signals for HN1, N8, HT3 and HT4 started to coalesce at around 190K but those for 
HN4, N6 and HT6 remained relatively sharp (Figure 16). This gives some information 
about the movement for the naphthalene ring. It seems that when the naphthalene ring 
is rotating around the [Fe(terpy)2]
2+ unit, the HN1, N8 protons remain close to the HT3
and HT4 protons.
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Figure 16. The 1H NMR spectrum (500 MHz) of [{Fe(L15)}][PF6]2 in CD2Cl2
solution at different temperatures (TE = temperature in K).  
? [{Fe(L16)}3][PF6]6
When L16 was treated with FeCl2·4H2O, a range of [{Fe(L
16)}n][PF6]2n complexes was 
formed. The TLC analysis of the reaction mixture indicated there was one major 
component, and small amounts of other component close to the major component plus 
some polymeric material on the TLC plate. The ES-MS spectrum of the major 
component was consistent with the formation of a [3+3] metallomacrocycle. The 
spectrum contained a triply charged ion at m/z 911.4 {[{Fe(L16)}3][PF6]3}
3+, a 
quadruply charged ion at m/z 647.5 {[{Fe(L16)}3][PF6]2}
4+, a quintuply charged ion at 
m/z 489.0 {[{Fe(L16)}3][PF6]}
5+ and a sextuply charged ion at m/z 383.4 
{[{Fe(L16)}3]}
6+. The 1H NMR spectrum showed eight aromatic and two aliphatic 
proton resonances. 
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? [{Fe(L17)}2][PF6]4
When L17 was treated with FeCl·4H2O, a range of [{Fe(L
17)}n][PF6]2n complexes was 
formed. The ES-MS analysis suggested that the major product separated from the 
reaction mixture was [{Fe(L17)}2][PF6]4. The ES-MS spectrum exhibited peaks at m/z
617.9 {[{Fe(L17)}2][PF6]}
3+ and at m/z 427.1 {[{Fe(L17)}2]}
4+. The compound had the 
expected spectroscopic properties with eight aromatic and four aliphatic proton 
resonances (Figure 17). The assignments were made by COSY and NOESY 
techniques. The signal for HT3? and HN1, N4 showed strong cross peak to HS1 and, HS4
and also HN5, N8, respectively.  
Figure 17. The 1H NMR spectrum (500 MHz) of [{Fe(L17)}2][PF6]4 in CD3CN 
solution at room temperature. 
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7.3 Absorption spectroscopic characterisation 
The electronic spectra of the macrocyclic Ru(II) and Fe(II) complexes were recorded 
in HPLC grade acetonitrile solution. The absorption spectra of these complexes are 
similar to the sum of the spectra of [M(terpy)2]
2+, where M is Fe (II) or Ru(II), and 
those of the substituents. The absorption data for these macrocyclic homonuclear 
complexes are summarised in Table 1. The very intense bands in the UV region are 
assigned to the ligand-centred ?*?? transitions. The Ru(II) complexes exhibit a low 
energy metal-to-ligand charge transfer (MLCT) transition with ?max between 484 to 
486 nm while the Fe(II) complexes exhibit a low energy metal-to-ligand charge 
transfer (MLCT) transition with ?max between 552 to 560 nm.  
?max, nm ( ? / 103, M-1cm-1)
LC LMCT 
[{Ru(L11)}2][PF6]4 226 (266), 239 (120), 265 (123), 302 (132) 484 (39.0) 
[{Ru(L13)}2][PF6]4  - - 
[{Ru(L13)}3][PF6]6 - - 
[{Ru(L14)}2][PF6]4  235 (272), 267 (138), 304 (155) 486 (41.4) 
[{Ru(L16)}2][PF6]4  230 (179), 264 (113), 303 (112) 485 (35.0) 
[{Ru(L17)}2][PF6]4 231 (224), 264 (120), 302 (126) 484 (35.7) 
[{Fe(L11)}2][PF6]4 226 (145), 241 (64.8), 270 (64.3), 314 (38.2) 552 (12.2) 
[{Fe(L12)}n][PF6]2n - - 
[{Fe(L13)}2][PF6]4 - - 
[{Fe(L13)}3][PF6]6 - - 
[{Fe(L14)}][PF6]2 233 (80.0), 269 (40.7), 314 (31.3), 555 (9.30) 
[{Fe(L15)}][PF6]2 232 (170), 269 (87.4), 313 (68.9) 554 (20.3) 
[{Fe(L16)}3][PF6]6 230 (143), 270 (103), 315 (84.2) 560 (40.4) 
[{Fe(L17)}2][PF6]4 231 (111), 269 (57.9), 314 (40.7) 553 (12.0) 
Table 1. Electronic spectroscopic data for the complexes in acetonitrile solution. 
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7.4 Crystal structures of [{Ru(L
11
)}2][PF6]4·
4
⁄5(C2H5)2O·2CH3CN,
[{Fe(L
14
)}][PF6]2·(C2H5)2O·½CH3CN and 
[{Fe(L
15
)}][PF6]2·CH3CN
(a) Crystal structure of [{Ru(L
11
)}2][PF6]4·
4
⁄5(C2H5)2O·2CH3CN 
Crystals of [{Ru(L11)}2][PF6]4·
4
⁄5(C2H5)2O·2CH3CN were obtained by slow diffusion 
of diethyl ether vapour into an acetonitrile solution of [{Ru(L11)}2][PF6]4. The crystals 
were of X-ray quality and the molecular structure of [{Ru(L11)}2][PF6]4·
4
⁄5
(C2H5)2O·2CH3CN was determined. The structure of the [{Ru(L
11)}2]
4+ cation is 
presented in Figure 18. Crystallographic data are given in Appendix V and selected 
bond lengths and angles are given in Table 2.
Figure 18. An ORTEP representation (50% probability ellipsoids) of the 
[{Ru(L11)}2]
4+ cation in [{Ru(L11)}2][PF6]4·
4
⁄5(C2H5)2O·2CH3CN. 
Hydrogen atoms are omitted for clarity. 
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As expected, the tridentate domains of the ligands exhibit the cisoid conformation 
about the interannular C-C bonds, which is necessary for the adoption of the chelating 
mode. The coordination sphere of the Ru(II) centre is similar to those in other 
complexes containing tridentate 2,2?:6?,2?-terpyridine ligands.53-55 The three pyridine 
rings in each domain are close to being coplanar and the torsion angles N1-C5-C6-N2, 
N2-C10-C11-N3, N4-C20-C21-N5 and N5-C25-C26-N6 are -5.20˚, -0.17˚, -6.71˚ and 
1.45˚ respectively. The angle between the planes containing atoms N1, N2, N3 and 
N4, N5, N6 is 83.3˚.54-55
Ru1-N1 2.072(4) N1-C1 1.353(6) C5-C6 1.460(6) 
Ru1-N2 1.986(4) N1-C5 1.370(7) C10-C11 1.474(7) 
Ru1-N3 2.085(4) N2-C6 1.349(6) C20-C21 1.484(8) 
Ru1-N4 2.080(4) N2-C10 1.345(6) C25-C26 1.497(7) 
Ru1-N5 1.983(4) N3-C11 1.372(6)   
Ru1-N6 2.069(4) N3-C15 1.340(6) C8-O1 1.350(6) 
  N4-C16 1.353(7) C31-O1 1.433(6) 
  N4-C20 1.349(7) C23-O4 1.352(6) 
  N5-C21 1.339(7) C46-O4 1.457(8) 
  N5-C25 1.337(7)   
  N6-C26 1.365(7)   
  N6-C30 1.353(7)   
      
N1-Ru1-N2 79.3(2) N4-Ru1-N5 78.9(2) C7-C8-O1 115.0(4) 
N1-Ru1-N3 158.0(2) N4-Ru1-N6 157.7(2) C9-C8-O1 124.8(4) 
N2-Ru1-N3 78.7(2) N5-Ru1-N6 78.9(2) C8-O1-C31 117.6(4) 
N1-Ru1-N4 84.4(2) N3-Ru1-N6 86.9(2) C24-C23-O4 126.0(6) 
N2-Ru1-N4 100.6(2) N1-Ru1-N5 101.0(2) C22-C23-O4 113.7(5) 
N3-Ru1-N4 99.4(2) N1-Ru1-N6 97.8(2) C23-O4-C46 120.4(5) 
N3-Ru1-N5 101.0(2) N2-Ru1-N6 101.6(2)   
  N2-Ru1-N5 179.3(2)   
Table 2. Selected bond lengths (Å) and angles (˚) of the [{Ru(L11)}2]
4+ cation in 
[{Ru(L11)}2][PF6]4·
4
⁄5(C2H5)2O·2CH3CN.
All the bond lengths of the interannular C-C bonds and N-C bonds are comparable to 
the corresponding bond lengths of other Ru(II) complexes containing tridentate 
2,2?:6?,2?-terpyridine ligands.54-55 The Ru-N contacts to the central ring of the 4?-
substituted-2,2?:6?,2?-terpyridine ligand (Ru1-N2, Ru1-N5) are shorter than those to 
the terminal rings (Ru1-N1, Ru1-N3, Ru1-N4 and Ru1-N6), which are within the 
reported range of Ru(II) complexes with 2,2?:6?,2?-terpyridine ligands.54-55 The torsion 
angles C9-C8-O1-C31 and C24-C23-O4-C46 are 10.97˚ and 13.47˚ respectively. The 
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bond lengths O1-C8 and O4-C23 are 1.350(6) Å and 1.352(6) Å respectively which 
are similar to the corresponding distances in the [Ru(poterpy)2]
2+ cation in the solid-
state structure of [Ru(poterpy)2][PF6]2·(CH3)2CO (poterpy = 4?-(2-propynyl-1-oxy)-
2,2?:6?,2?-terpyridine)55. The bond angles C7-C8-O1, C9-C8-O1, C22-C23-O4 and 
C24-C23-O4 are within the range reported in the [Ru(poterpy)2]
2+ cation55. Also the 
bond angles C8-O1-C31 and C23-O4-C46 are 117.6(4)˚ and 120.4(5)˚ respectively 
which are within the experimental error for the corresponding angles in 
([Ru(poterpy)2]
2+ cation (117.5(3)˚ and 118.1(3)˚)55.
There are no ?-? interactions between the molecules. Also, there are no solvent 
molecules or anions in the cavity of this [2+2] metallomacrocycle. The Ru-Ru 
distance is 13.1 Å. 
(b) Crystal structure of [{Fe(L
14
)}][PF6]2·(C2H5)2O·½CH3CN 
Crystals of [{Fe(L14)}][PF6]2·(C2H5)2O·½CH3CN were obtained by slow diffusion of 
diethyl ether vapour into an acetonitrile solution of [{Fe(L14)}][PF6]2. The crystals 
were of X-ray quality and the molecular structure of 
[{Fe(L14)}][PF6]2·(C2H5)2O·½CH3CN was determined. The structure of the 
[{Fe(L14)}]2+ cation is presented in Figure 19. Crystallographic data are given in 
Appendix V and selected bond lengths and angles are given in Table 3.
As expected, the tridentate domains of the ligand exhibit the cisoid conformation 
about the interannular C-C bonds, which is necessary for the adoption of the chelating 
mode. The coordination sphere of the Fe(II) centre is similar to those in other 
complexes containing tridentate 2,2?:6?,2?-terpyridine ligands. The three pyridine 
rings in each domain are close to being coplanar and the torsion angles N1-C5-C6-N2, 
N2-C10-C11-N3, N4-C38-C39-N5 and N5-C43-C44-N6 are 2.32˚, -0.24˚, 1.45˚ and -
0.51˚ respectively. The angle between the planes containing atoms N1, N2, N3 and 
N4, N5, N6 is 88.7˚.56-60
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Figure 19. An ORTEP representation (50% probability ellipsoids) of the 
[{Fe(L14)}]2+ cation in [{Fe(L14)}][PF6]2·(C2H5)2O·½CH3CN.
Hydrogen atoms are omitted for clarity except atoms H271 and H291. 
All the bond lengths of the interannular C-C bonds and N-C bonds are comparable to 
the corresponding bond lengths of other Fe(II) complexes containing tridentate 
2,2?:6?,2?-terpyridine ligands.56-57,59-60 The Fe-N contacts to the central ring of the 4?-
substituted-2,2?:6?,2?-terpyridine ligand (Fe1-N2 and Fe1-N5) are shorter than those 
to the terminal rings (Fe1-N1, Fe1-N3, Fe1-N4 and Fe1-N6), which are within the 
reported range of Fe(II) complexes with 2,2?:6?,2?-terpyridine ligands.56-60 The torsion 
angles C7-C8-O1-C16, C40-C41-O6-C33, C19-O3-C20-C29 and C30-O4-C26-C27 
are 4.50˚, 10.61˚, 10.80˚ and -7.01˚ respectively. The bond lengths O1-C8 and O6-
C41 are 1.346(4) Å and 1.344(4) Å respectively which are similar to the 
corresponding distances in (5,5?-bis(3-(10-(2,6-bis(pyrid-2-yl)pyrid-4-yl)-1,4,7,10-
tetraoxadecyl)phenyl)-2,2?-bipyridyl)-iron(II) bis(hexafluorophosphate) acetone 
solvate60. The bond angles C7-C8-O1, C9-C8-O1, C40-C41-O6 and C42-C41-O6 are 
within the range reported in the [Ru(poterpy)2]
2+ cation in the solid-state structure of 
[Ru(poterpy)2][PF6]2·(CH3)2CO
55. The bond angles C8-O1-C16 and C41-O6-C33 are 
121.8(3)˚ and 120.5(3)˚ respectively which, are bigger than the corresponding angles 
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in ([Ru(poterpy)2]
2+ cation (117.5(3)˚ and 118.1(3)˚)55 and in (5,5?-bis(3-(10-(2,6-
bis(pyrid-2-yl)pyrid-4-yl)-1,4,7,10-tetraoxadecyl)phenyl)-2,2?-bipyridyl)-iron(II) 
bis(hexafluorophosphate) acetone solvate (115.55˚ and 113.22˚)60.
Table 3. Selected bond lengths (Å) and angles (˚) of the [{Fe(L14)}]2+ cation in 
[{Fe(L14)}][PF6]2·(C2H5)2O·½CH3CN. 
The ehtyleneoxy chains and naphthalene unit lie snuggly in the cleft between two 
terminal pyridine rings (A ring) of the terpyridine as predicted from the 1H NMR 
spectroscopic data. There are ?-? interactions between the naphthalene and the 
terminal pyridine rings with an interplanar separation of 3.6 Å and a least squares 
interplane angle of 5.9˚. The atoms H271 and H291 lie directly above the other non-
stacked pyridine terminal ring. The distance between the plane of N4 ring to C27 
atom of the napthyl ring is 4.603 Å. 
Fe1-N1 1.962(3) N1-C1 1.343(5) C5-C6 1.471(5) 
Fe1-N2 1.876(3) N1-C5 1.371(4) C10-C11 1.463(5) 
Fe1-N3 1.970(3) N2-C6 1.334(4) C38-C39 1.471(5) 
Fe1-N4 1.970(3) N2-C10 1.346(4) C43-C44 1.465(5) 
Fe1-N5 1.874(3) N3-C11 1.365(5)   
Fe1-N6 1.961(3) N3-C15 1.330(5) C8-O1 1.346(4) 
  N4-C34 1.344(5) C16-O1 1.428(5) 
  N4-C38 1.370(4) C19-O3 1.422(6) 
  N5-C39 1.345(5) C20-O3 1.366(5) 
  N5-C43 1.350(4) C30-O4 1.420(6) 
  N6-C44 1.370(4) C26-O4 1.361(5) 
  N6-C48 1.337(5) C41-O6 1.344(4) 
    C33-O6 1.447(5) 
      
N1-Fe1-N2 80.9(1) N4-Fe1-N5 80.9(1) C7-C8-O1 125.4(3) 
N1-Fe1-N3 161.9(1) N4-Fe1-N6 161.9(1) C9-C8-O1 114.7(3) 
N2-Fe1-N3 81.0(1) N5-Fe1-N6 81.0(1) C8-O1-C16 121.8(3) 
N1-Fe1-N4 92.8(1) N3-Fe1-N6 92.7(1) C21-C20-O3 114.1(4) 
N2-Fe1-N4 96.7(1) N1-Fe1-N5 97.5(1) C29-C20-O3 125.0(4) 
N3-Fe1-N4 90.2(1) N1-Fe1-N6 89.9(1) C25-C26-O4 114.4(4) 
N3-Fe1-N5 100.6(1) N2-Fe1-N6 101.4(1) C27-C26-O4 125.0(4) 
  N2-Fe1-N5 177.1(1) C40-C41-O6 124.3(3) 
    C42-C41-O6 115.6(3) 
    C41-O6-C33 120.5(3) 
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(c) Crystal structure of [{Fe(L
15
)}][PF6]2·CH3CN 
Crystals of [{Fe(L15)}][PF6]2·CH3CN were obtained by slow diffusion of diethyl ether 
vapour into an acetonitrile solution of [{Fe(L15)}][PF6]2. The crystals were of X-ray 
quality and the molecular structure of [{Fe(L15)}][PF6]2·CH3CN was determined. The 
structure of the [{Fe(L15)}]2+ cation is presented in Figure 20. Crystallographic data 
are given in Appendix V and selected bond lengths and angles are given in Table 4.
The crystal structure of this [{Fe(L15)}]2+ cation is very similar to that of the 
[{Fe(L14)}]2+ cation previously described. 
Figure 20. An ORTEP representation (50% probability ellipsoids) of the 
[{Fe(L15)}]2+ cation in [{Fe(L15)}][PF6]2·CH3CN. Hydrogen atoms are 
omitted for clarity except atoms H441 and H461. 
As expected, the tridentate domains of the ligand exhibit the cisoid conformation 
about the interannular C-C bonds, which is necessary for the adoption of the chelating 
mode. The coordination sphere of the Fe(II) centre is similar to those in other 
complexes containing tridentate 2,2?:6?,2?-terpyridine ligands. The three pyridine 
rings in each domain are close to being coplanar and the torsion angles N1-C5-C6-N2, 
N2-C10-C11-N3, N4-C20-C21-N5 and N5-C25-C26-N6 are 3.09˚, -0.88˚, 2.73˚ and -
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0.44˚ respectively. The angle between the planes containing atoms N1, N2, N3 and 
N4, N5, N6 is 88.7˚.56-60 
Table 4. Selected bond lengths (Å) and angles (˚) of the [{Fe(L15)}]2+ cation in 
[{Fe(L15)}][PF6]2·CH3CN.
All the bond lengths of the interannular C-C bonds and N-C bonds are comparable to 
the corresponding bond lengths of other Fe(II) complexes containing tridentate 
2,2?:6?,2?-terpyridine ligands.56-57,59-60 The Fe-N contacts to the central ring of the 4?-
substituted-2,2?:6?,2?-terpyridine ligand (Fe1-N2 and Fe1-N5) are shorter than those 
to the terminal rings (Fe1-N1, Fe1-N3, Fe1-N4 and Fe1-N6), which are within the 
reported range of Fe(II) complexes with 2,2?:6?,2?-terpyridine ligands.56-60 The torsion 
angles C7-C8-O1-C31, C24-C23-O8-C52, C36-O4-C37-C46 and C47-O5-C43-C44 
are -0.54˚, 2.40˚, -4.01˚ and -6.69˚ respectively. The bond lengths O1-C8 and O8-C23 
are 1.343(3) Å and 1.352(4) Å respectively which are similar to the corresponding 
distances in (5,5?-bis(3-(10-(2,6-bis(pyrid-2-yl)pyrid-4-yl)-1,4,7,10-
Fe1-N1 1.979(2) N1-C1 1.349(3) C5-C6 1.472(4) 
Fe1-N2 1.881(2) N1-C5 1.364(3) C10-C11 1.466(4) 
Fe1-N3 1.971(2) N2-C6 1.352(3) C20-C21 1.466(4) 
Fe1-N4 1.980(2) N2-C10 1.358(3) C25-C26 1.461(4) 
Fe1-N5 1.898(2) N3-C11 1.366(3)   
Fe1-N6 1.968(2) N3-C15 1.346(3) C8-O1 1.343(3) 
  N4-C16 1.349(4) C31-O1 1.447(3) 
  N4-C20 1.358(4) C36-O4 1.429(4) 
  N5-C21 1.346(4) C37-O4 1.368(4) 
  N5-C25 1.343(4) C47-O5 1.430(4) 
  N6-C26 1.377(4) C43-O5 1.367(4) 
  N6-C30 1.337(4) C23-O8 1.352(4) 
    C52-O8 1.437(4) 
      
N1-Fe1-N2 80.70(9) N4-Fe1-N5 80.7(1) C7-C8-O1 125.0(2) 
N1-Fe1-N3 161.85(9) N4-Fe1-N6 161.2(1) C9-C8-O1 115.1(2) 
N2-Fe1-N3 81.15(9) N5-Fe1-N6 80.5(1) C8-O1-C31 118.5(2) 
N1-Fe1-N4 92.55(9) N3-Fe1-N6 92.94(9) C38-C37-O4 114.3(3) 
N2-Fe1-N4 95.45(9) N1-Fe1-N5 99.98(9) C46-C37-O4 125.3(3) 
N3-Fe1-N4 88.97(9) N1-Fe1-N6 91.41(9) C42-C43-O5 114.5(3) 
N3-Fe1-N5 98.12(9) N2-Fe1-N6 103.3(1) C44-C43-O5 124.8(3) 
  N2-Fe1-N5 176.1(1) C24-C23-O8 126.8(3) 
    C22-C23-O8 112.8(3) 
    C23-O8-C52 122.2(3) 
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tetraoxadecyl)phenyl)-2,2?-bipyridyl)-iron(II) bis(hexafluorophosphate) acetone 
solvate60. The bond angles C7-C8-O1, C9-C8-O1, C24-C23-O8 and C22-C23-O8 are 
within the range reported in the [Ru(poterpy)2]
2+ cation in the solid-state structure of 
[Ru(poterpy)2][PF6]2·(CH3)2CO
55. The bond angles C8-O1-C31 and C23-O8-C52 are 
118.5(2)˚ and 122.2(3)˚ respectively which, are bigger than the corresponding angles 
in ([Ru(poterpy)2]
2+ cation (117.5(3)˚ and 118.1(3)˚)55 and in (5,5?-bis(3-(10-(2,6-
bis(pyrid-2-yl)pyrid-4-yl)-1,4,7,10-tetraoxadecyl)phenyl)-2,2?-bipyridyl)-iron(II) 
bis(hexafluorophosphate) acetone solvate (115.55˚ and 113.22˚)60.
The ethyleneoxy chains and naphthalene unit lie snuggly in the cleft between two 
terminal pyridine rings of the terpyridine. There are ?-? interactions between the 
naphthalene and the terminal pyridine rings with an interplanar separation of 3.6 Å. 
The closest distance between the C3 atom of N1 ring to C44 atom of the naphthyl ring 
is 3.526 Å. The atoms H441 and H461 lie directly above the other non-stacked 
pyridine terminal ring.  
7.5 Stereochemical properties of the chiral complex 
[{Fe(L
14
)}][PF6]2
Chiral products are not only involved in chemical reactions, but also produced in the 
supramolecular self-assembly systems. Reaction of the octahedral metal ions, Co(II), 
Fe(II) or Ru(II), and 2,2?-bipyridine (bipy) or 1,10-phenanthroline (phen) with a 
variety of substituents give ?- and ?-[M(X-bipy)3]2+ or [M(X-phen)3]2+ (M = Co, Fe 
or Ru) complexes (Figure 21).61 Reaction of achiral di-bidentate ligands (L) with 
octahedral metal ion resulted in plus (P) and minus (M) trihelical enantiomers (Figure
22).62-63 von Zelewsky has reported a reaction of achiral di-tridentate ligand 2,5-
bis([2,2?]bipyridin-6-yl)-pyrazine with octahedral metal ions which resulted in grid-
like complexes or chiral molecular squares (Figure 23).64
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Figure 21. The ? and ? enantiomers formed from the reaction of an octahedral cation 
with three bidentate ligands. 
Figure 22. The P and M trihelical enantiomers formed from the reaction of an 
octahedral cation with three bis-bidentate ligands. 
Figure 23. The grid and two enantiomers of the molecular square formed from the 
reaction of an octahedral cation with four di-trientate ligands. 
A few pairs of enantiomeric complexes have been successfully separated by ion-pair 
chromatography63,65-66 or selective crystallisation67-68 with an enantiopure anion. In 
the last decades, NMR spectroscopy has been used to measure the enantiomeric purity 
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of the chiral species.69 This method requires addition of a chiral auxiliary that 
converts the mixture of enantiomers into a mixture of diastereoisomeric ion pairs. As 
long as the analogous proton signals of the two diastereoisomeric complexes are well 
separated, the enantiomeric purity can be determined by direct measurement of the 
integral of the two analogous proton signals. 
Chiral lanthanide shift reagents have been used for analyses the enantiomeric purity of 
the chiral species by using NMR spectroscopy. However, the lack of interactions with 
chiral cations, line broadening and distorted baselines limit their efficiency.70
Recently, a series of hexacoordinated phosphate anions, such as TRISPHAT, 
BINPHAT, HYPHAT and TARPHAT have been reported by Lacour and applied as 
NMR chiral shift agents (Figure 24).71-73 These anions can also be used as resolving 
agents and asymmetry-inducers.  
Figure 24. A series of hexacoordinated phosphate anions. 
There is report on the resolution of the chiral cations, [Ru(bipy)3]
2+ and [Ru(Me2-
bipy)3]
2+, with enantiopure TRISPHAT by thin layer chromatography over silica gel 
(eluent CH2Cl2).
74 This method was also extended to the separation of ? and ?
enantiomers of a mononulear iron(II) tris(diimine) complex.75 There is also a report of 
the resolution of racemic ruthenium(II) tris(diimine) derivatives with enantiopure 
TRISPHAT by extraction since one of the diastereoisomeric pairs is more soluble in 
CHCl3 than in water (Figure 25).
76 The diastereoisomeric ratio (d.r.) can be up to 
49:1. By using the same protocol for a diiron(II) triple helicate, P and M enantiomers 
of this helicate can be separated.77
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Figure 25. Stereoselective extraction of racemic [Ru(Me2-phen)3][Cl]2 complexes by 
[R3NH][?-TRISPHAT]. 
It is possible to use these hexacoordinated phosphate anions to afford selectively 
intermolecular diastereoselective interactions and then control the stereoselectivity 
between the two pair of diastereoisomeric pairs (Pfeiffer effect).78 Iron(II) 
tris(diimine) complexes79-81 and dicobalt(II) helicates82 were studied with TRISPHAT 
anions in different solvent polarities. The NMR signals of the chiral cations were split 
by the presence of the anions and the diastereoisomeric ratio (d.r.) can be up to 50:1. 
The homoditopic achiral ligand L14 reacted with octahedral iron(II) metal ions and 
resulted in a [1+1] mononuclear iron(II) complex. Since the naphthalene ring and the 
ethyleneoxy spacer chains are locked in between two terminal rings of terpyridine and 
cannot rotate freely around the molecule, the complex becomes chiral. This was 
confirmed by the solid-state structure and the unusual proton NMR spectrum (see 
Section 7.4(b) and 7.2). As the complex is chiral, we did some preliminary studies of 
its stereochemical properties by using hexacoordinated phosphate NMR chiral shift 
agents. The following results were done by Dr. R. Frantz and Professor J. Lacour at 
the University of Geneva. 
Firstly, the hexacoordinated phosphate anions [Bu4N][?-TRISPHAT] or 
[Me2NH2][?-TMT] were added to the racemic [{Fe(L14)}][PF6]2 in CH2Cl2/acetone. 
The desired complexes [{Fe(L14)}][?-TRISPHAT]2 or [{Fe(L14)}][?-TMT]2 were 
isolated on a small preparative chromatography plate. There is an NMR 
enantiodifferentiation in both cases. Some of the proton signals indicated the splitting 
of the signals in roughly 1:1 ratio for the diastereoisomeric pairs (Figure 26).
[Ru(Me2-phen)3][Cl]2
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H2O
CHCl3
Stirring [?-Ru(Me2-phen)3][Cl]2
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Figure 26. The 1H NMR spectra (500 MHz, ? 6.3-9) of the chiral cation [{Fe(L14)}]2+
(a) in PF6 salt, (b) in [?-TRISPHAT] salt and (c) [?-TMT] salt in CD2Cl2
at room temperature. 
Figure 27. Diagram representing the Pfeiffer effect on [{Fe(L14)}][?,S-BINPHAT]. 
Secondly, increasing amounts of hexacoordinated phosphate anions [Bu4N][?,S-
BINPHAT] were added to racemic [{Fe(L14)}][PF6]2 in CD2Cl2. Not only 
enantiodifferentiation of the enantiomers of the cation was observed, but also an 
asymmetric induction (where the splitting of the signals was not 1:1 any more) 
resulted. This is because one of the diastereoisomeric pair becomes predominant (i.e. 
Pfeiffer effect) (Figure 27). The diastereoselectivity (de) is up to 45% (±2%) when 10 
equivalents of [Bu4N][?,S-BINPHAT] were added. The Pfeiffer effect was 
N4, N5 N3, N6 A5 A6 A4A3 C6 C5C4 C3 
B5 
B3 
(a)
(b)
(c) 
Pfeiffer effect 
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maximised upon the decreasing the solvent polarity (decease the % of DMSO in 
CDCl3).
When the solvent polarity decreased, one of the diastereoisomeric pairs has better 
interactions between the cation and [?,S-BINPHAT] anion than the other pair. The 
diastereoselectivity (de) is up to 60% (±2%) when the sample was measured with 2% 
DMSO in CDCl3 (Figure 28). In 1% DMSO/CHCl3, the complex exhibits a Cotton 
effect in the circular dichroism (CD) spectrum with the value ??618 = 1.1 dm3mol-1cm-
1 and ??559 = -1.2 dm3mol-1cm-1 for the MLCT band. Since there are no CD spectra of 
other similar compounds to which we can compare our results, a time-dependent 
density functional theory (TDDFT) calculation for the CD spectrum of 
[{Fe(L14)}][PF6]2 is currently being undertaken. 
Figure 28. The 1H NMR spectra (500 MHz, ? 7.3-8.7) of [{Fe(L14)}][?,S-BINPHAT] 
in decreasing amount of DMSO in CDCl3 at room temperature. The 
signals with black and red are the two diastereoisomeric pairs. 
A3C3 B5 B3 
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7.6 Conclusion 
Mono-, di- and tri-nuclear metallomacrocyclic Ru(II) and Fe(II) complexes 
[{M(L)}n][PF6]2n, where M = Ru(II) or Fe(II), L= L
11-L17 and n = 1, 2 or 3, have been 
synthesised and characterised with 1H NMR spectroscopy, ES-MS spectrometry, 
UV/VIS spectroscopy and elemental analysis. Three representative crystal structures 
have been determined. The formation of different nuclearity metallomacrocycles 
depends on the rigidity and length of the spacer group between the metal binding 
sites. 1H NMR spectroscopy can give the information about the purity of the 
metallomacrocycles while ES-MS spectrometry can confirm the size of the 
metallomacrocycles. The solid state structures of [{Ru(L11)}2][PF6]4,
[{Fe(L14)}][PF6]2 and [{Fe(L
15)}][PF6]2 proved that the size of the 
metallomacrocycles can be correctly assigned using these two techniques. 
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7.7 Experimental 
? [{Ru(L11)}2][PF6]4 ? [{Fe(L11)}2][PF6]4
? [{Fe(L12)}n][PF6]2n
? [{Ru(L13)}n][PF6]2n (n = 2 or 3) ? [{Fe(L13)}n][PF6]2n (n = 2 or 3) 
? [{Ru(L14)}2][PF6]4 ? [{Fe(L14)}][PF6]2
? [{Fe(L15)}][PF6]2
? [{Ru(L16)}2][PF6]4 ? [{Fe(L16)}3][PF6]6
? [{Ru(L17)}2][PF6]4 ? [{Fe(L17)}2][PF6]4
where L11 2,6-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4-dioxapentyl]naphthalene 
L
12
2,6-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7-trioxaoctyl]naphthalene 
L
13
2,7-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4-dioxabutyl]naphthalene 
L
14
2,7-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7-trioxaheptyl]naphthalene 
L
15
2,7-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7,10-tetraoxadecayl]naphthalene 
L
16 2,3-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4-dioxabutyl]naphthalene 
L
17 2,3-[Bis(2,2?:6?,2?-terpyridin-4?-yl)-1,4,7-trioxaheptyl]naphthalene 
(a) General synthesis of macrocyclic ruthenium(II) metal complexes36
L (L = L11, L13-L14, L16-L17)
= naphthyl domain
= ethylene chain
= terpyridine domain
1. 2 equiv. RuCl3·3H2O,  
    MeOH, reflux 3 hr
Cl3Ru RuCl3
2. Excess aqueous NH4PF6
1. L , MeOH, reflux 3 hr, NEM
Step 2
Step 1
Ru
Ru
n-1
[PF6]2n
[Ru(L)]n[PF6]2n
Step 1 
1 equivalent of L (L11, L13-L14, L16-L17) and 2 equivalents of RuCl3·3H2O were heated to 
reflux for 3 hours in CH3OH. The brownish red precipitate [Cl3RuLRuCl3] was filtered, 
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collected and washed well with water. The crude product was used for the second step 
without purification. 
Step 2 
1 equivalent of L (L11, L13-L14, L16-L17), 1 equivalent of [Cl3RuLRuCl3] (where L = L
11,
L
13-L14, L16-L17) and a few drops of N-ethylmorpholine (NEM) were heated to reflux for 3 
hours in CH3OH. The deep red reaction mixture was cooled, and excess aqueous NH4PF6
were added to precipitate the crude product. The crude product was collected by filtration 
and redissolved in CH3CN. The solvent was removed again and a red powder was 
obtained. The major red product was obtained after column chromatography or 
preparative TLC (SiO2, CH3CN: saturated aqueous KNO3: water 14:2:1). 
? [{Ru(L11)}2][PF6]4
L
11 (0.06 g, 0.08 mmol) and 2 equivalents of RuCl3·3H2O (43 mg, 0.16 mmol) were 
refluxed in 10 mL CH3OH. The crude product [Cl3RuL
11RuCl3] (0.08 g, 0.07 mmol) was 
used for the second step without purification.  
[Cl3RuL
11RuCl3] (0.08 g, 0.07 mmol) and L
11 (0.05 g, 0.07 mmol) were used for the 
second step. After preparative TLC (SiO2, CH3CN: saturated aqueous KNO3: water 
14:2:1), a red powder of [{Ru(L11)}2][PF6]4 (40 mg, 0.018 mmol, 26% yield in this step) 
were obtained as the major product. 
Molecular formula: C92H76N12O8Ru2P4F24 
Molecular weight: 2259.66 
1H NMR (400 MHz, CD3CN): ?H 4.00 (m, 8H, HS2), 4.72 (m, 8H, HS1), 4.75 (s, 8H, HS3), 
6.97 (m, 8H, HT5), 7.23 (d, J 5.6 Hz, 8H, HT6), 7.33 (dd, J 1.0, 8.6 Hz, 4H, HN3, N7), 7.51 
(d, J 8.1 Hz, 4H, HN4, N8), 7.74 (m, 12H, HT4 and HN1, N5), 8.32 (s, 8H, HT3?), 8.33 (m, 8H, 
HT3).
MS (ES): m/z = 420.1 [M-4PF6]
4+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-3) 226 (266 x 103), 239 (120 x 103), 265 (123 x 
103), 302 (132 x 103), 484 (39.0 x 103).
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Elemental analysis: Found: C, 45.59; H, 3.45; N, 7.34. Calc. for 
C92H76N12O8P4F24Ru2·9H2O: C, 45.62; H, 3.92; N, 6.94%. 
? [{Ru(L13)}n][PF6]2n
L
13 (71 mg, 0.10 mmol) and 2 equivalents of RuCl3·3H2O (53 mg, 0.20 mmol) were 
refluxed in 10 mL CH3OH. The crude product [Cl3RuL
13RuCl3] (112 mg, 0.100 mmol) 
was used for the second step without purification.  
[Cl3RuL
13RuCl3] (112 mg, 0.100 mmol) and L
13 (71 mg, 0.10 mmol) were used for the 
second step. After preparative TLC (SiO2, CH3CN: saturated aqueous KNO3: water 
14:2:1), there are two fractions, which are very close together on the TLC plate. A red 
powder of [{Ru(L13)}2][PF6]4 (8.8 mg, 0.0040 mmol, 4.0% yield in this step) and 
[{Ru(L13)}3][PF6]6 (6.1 mg, 0.0018 mmol, 1.8% yield in this step) were obtained. 
However, both fractions are not pure and they have small amount of the other fraction. 
Fraction 1 Rf = 0.5: (with around 10% Fraction 2)
Molecular formula: C88H68N12O8Ru2P4F24 
Molecular weight: 2203.55 
1H NMR (400 MHz, CD3CN): ?H 4.13 (s, 8H, HS2), 4.77 (s, 8H, HS1), 6.68 (d, J 2.0 Hz, 
4H, HN1, N8), 7.12 (m, 12H, HT5 and HN3, N6), 7.44 (d, J 5.2 Hz, 8H, HT6), 7.70 (td, J 1.2, 
7.8 Hz, 8H, HT4), 7.88 (d, J 9.2 Hz, 4H, HN4, N5), 8.06 (s, 8H, HT3?), 8.19 (d, J 8.0 Hz, 8H, 
HT3).
MS (ES): m/z = 957.1 [M-2PF6]
2+, 589.7 [M-3PF6]
3+, 406.4 [M-4PF6]
4+.
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Fraction 2 Rf = 0.48: (with around 20% Fraction 1)
Molecular formula: 
C132H102N18O12Ru3P6F36 
Molecular weight: 3305.33 
1H NMR (400 MHz, CD3CN): ?H 4.65 (m, 12H, HS2), 4.94 (m, 12H, HS1), 7.12 (m, 18H, 
HT5 and HN3, N6), 7.30 (d, J 2.4 Hz, 6H, HN1, N8), 7.36 (d, J 5.6 Hz, 12H, HT6), 7.81 (m, 
18H, HT4 and HN4, N5), 8.32 (s, 12H, HT3?), 8.39 (d, J 8.0 Hz, 12H, HT3). 
MS (ES): m/z = 957.0 [M-3PF6]
3+, 681.2 [M-4PF6]
4+, 515.8 [M-5PF6]
5+.
? [{Ru(L14)}2][PF6]4
L
14 (60 mg, 0.075 mmol) and 2 equivalents of RuCl3·3H2O (39 mg, 0.15 mmol) were 
refluxed in 10 mL CH3OH. The crude product [Cl3RuL
14RuCl3] (90 mg, 0.074 mmol) was 
used for the second step without purification.  
[Cl3RuL
14RuCl3] (90 mg, 0.074 mmol) and L
14 (59 mg, 0.074 mmol) were used for the 
second step. After column chromatography (SiO2, CH3CN: saturated aqueous KNO3:
water 14:2:1), a red powder of [{Ru(L14)}2][PF6]4 (21.3 mg, 0.00895 mmol, 12.1% yield 
in this step) was obtained as the major product. 
Molecular formula: 
C96H84N12O12Ru2P4F24 
Molecular weight: 2379.76
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1H NMR (500 MHz, CD3CN): ?H 3.98 (m, 8H, HS3), 4.06 (m, 8H, HS4), 4.12 (m, 8H, HS2), 
4.72 (m, 8H, HS1), 6.69 (d, J 2.4 Hz, 4H, HN1, N8), 6.85 (dd, J 2.5, 8.9 Hz, 4H, HN3, N6),
7.00 (ddd, J 1.3, 5.7, 7.5 Hz, 8H, HT5), 7.29 (ddd, J 0.7, 1.5, 5.6 Hz, 8H, HT6), 7.39 (d, J
9.0 Hz, 4H, HN4, N5), 7.69 (td, J 1.5, 7.9 Hz, 8H, HT4), 8.27 (m, 8H, HT3), 8.28 (s, 8H, 
HT3?).
MS (ES): m/z = 1045.2 [M-2PF6]
2+, 648.8 [M-3PF6]
3+, 450.7 [M-4PF6]
4+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-3) 235 (272 x 103), 267 (138 x 103), 304 (155 x 
103), 486 (41.4 x 103).
Elemental analysis: Found: C, 47.62; H, 3.73; N, 6.88. Calc. for 
C96H84N12O12P4F24Ru2·H2O: C, 48.08; H, 3.62; N, 7.01%. 
? [{Ru(L16)}2][PF6]4
L
16 (92 mg, 0.13 mmol) and 2 equivalents of RuCl3·3H2O (68 mg, 0.26 mmol) were 
refluxed in 25 mL CH3OH. The crude product [Cl3RuL
16RuCl3] (124 mg, 0.110 mmol) 
was used for the second step without purification.  
[Cl3RuL
16RuCl3] (124 mg, 0.110 mmol) and L
16 (75 mg, 0.11 mmol) were used for the 
second step. After preparative TLC (SiO2, CH3CN: saturated aqueous KNO3: water 
14:2:1), a red powder of [{Ru(L16)}2][PF6]4 (2.6 mg, 0.0012 mmol, 1.1% yield in this 
step) was obtained as the major product. The red product remained on the silica of the 
TLC plate even when washed with A sol. Therefore, the yield was low. 
Molecular formula: 
C88H68N12O8Ru2P4F24 
Molecular weight: 2203.55
1H NMR (500 MHz, CD3CN): ?H 4.79 (t, J 5.0 Hz, 8H, HS2), 5.02 (t, J 5.1 Hz, 8H, HS1), 
6.77 (m, 8H, HT5), 7.19 (dd, J 0.7, 5.6 Hz, 8H, HT6), 7.26 (m, 8H, HT4), 7.46 (m, 4H, HN6, 
N7), 7.57 (s, 4H, HN1, N4), 7.87 (m, 4H, HN5, N8), 8.26 (d, J 7.9 Hz, 8H, HT3), 8.36 (s, 8H, 
HT3?).
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MS (ES): m/z = 957.0 [M-2PF6]
2+, 589.3 [M-3PF6]
3+, 406.2 [M-4PF6]
4+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-3) 230 (179 x 103), 264 (113 x 103), 303 (112 x 
103), 485 (35.0 x 103).
? [{Ru(L17)}2][PF6]4
L
17 (60 mg, 0.075 mmol) and 2 equivalents of RuCl3·3H2O (39 mg, 0.15 mmol) were 
refluxed in 10 mL CH3OH. The crude product [Cl3RuL
17RuCl3] (79 mg, 0.065 mmol) was 
used for the second step without purification.  
[Cl3RuL
17RuCl3] (79 mg, 0.065 mmol) and L
17 (52 mg, 0.065 mmol) were used for the 
second step. After column chromatography (SiO2, CH3CN: saturated aqueous KNO3:
water 14:2:1), a red powder of [{Ru(L17)}2][PF6]4 (18.2 mg, 0.00765 mmol, 11.8%) was 
obtained as the major product. 
Molecular formula: 
C96H84N12O12Ru2P4F24 
Molecular weight: 2379.76
1H NMR (500 MHz, CD3CN): ?H 4.11 (m, 8H, HS3), 4.16 (m, 8H, HS2), 4.39 (m, 8H, HS4), 
4.71 (t, J 4.5 Hz, 8H, HS1), 6.73 (ddd, J 1.3, 5.6, 7.5 Hz, 8H, HT5), 7.22 (ddd, J 0.6, 1.4, 
5.6 Hz, 8H, HT6), 7.29 (m, 4H, HN6, N7), 7.34 (s, 4H, HN1, N4), 7.42 (td, J 1.4, 7.8 Hz, 8H, 
HT4), 7.67 (m, 4H, HN5, N8), 8.26 (d, J 7.8 Hz, 8H, HT3), 8.28 (s, 8H, HT3?).
MS (ES): m/z = 449.9 [M-4PF6]
4+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-3) 231 (224 x 103), 264 (120 x 103), 302 (126 x 
103), 484 (35.7 x 103).
Elemental analysis: Found: C, 46.97; H, 3.67; N, 7.18. Calc. for 
C96H84N12O12P4F24Ru2·3H2O: C, 47.37; H, 3.73; N, 6.90%. 
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(b) General synthesis of macrocyclic iron(II) metal complexes33-35
1 equivalent of FeCl2·4H2O in CH3OH was added to 1 equivalent of L (L
11-L17) in 
CH3OH dropwise and the mixture were stirred for a few days. The deep purple reaction 
mixture was filtered and concentrated. Excess aqueous NH4PF6 were added to precipitate 
the crude product. The crude product was collected by filtration and redissolved in 
CH3CN. The solvent was removed and a purple powder was obtained. The major product 
was obtained after column chromatography or preparative TLC (SiO2, CH3CN: saturated 
aqueous KNO3: water 14:2:1). 
? [{Fe(L11)}2][PF6]4
FeCl2·4H2O (40 mg, 0.20 mmol) in 20 mL CH3OH was added to L
11 (0.15 g, 0.20 mmol) 
in 750 mL CH3OH dropwise and the mixture were stirred for 4 days. After preparative 
TLC (SiO2, CH3CN: saturated aqueous KNO3: water 14:2:1), a purple powder of 
[{Fe(L11)}2][PF6]4 (62.4 mg, 0.0288 mmol, 28.8%) was obtained as the major product. 
Molecular formula: C92H76N12O8Fe2P4F24 
Molecular weight: 2169.21 
1H NMR (500 MHz, CD3CN): ?H 4.05 (m, 8H, HS2), 4.78 (s, 8H, HS3), 4.81 (m, 8H, HS1), 
6.87 (ddd, J 1.3, 5.7, 7.4 Hz, 8H, HT5), 6.99 (ddd, J 0.7, 1.4, 5.6 Hz, 8H, HT6), 7.34 (dd, J
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1.3, 8.4 Hz, 4H, HN3, N7), 7.47 (d, J 8.3 Hz, 4H, HN4, N8), 7.71 (m, 8H, HT4), 7.72 (s, 4H, 
HN1, N5), 8.29 (dt, J 0.9, 8.0 Hz, 8H, HT3), 8.47 (s, 8H, HT3?).
MS (ES): m/z = 578.2 [M-3PF6]
3+, 397.5 [M-4PF6]
4+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-3) 226 (145 x 103), 241 (64.8 x 103), 270 (64.3 x 
103), 314 (38.2 x 103), 552 (12.2 x 103). 
Elemental analysis: Found: C, 47.89; H, 3.63; N, 7.47. Calc. for 
C92H76N12O8P4F24Fe2·7H2O: C, 48.14; H, 3.96; N, 7.32%. 
? [{Fe(L12)}n][PF6]2n
FeCl2·4H2O (26 mg, 0.13 mmol) in 20 mL CH3OH was added to L
12 (0.11 g, 0.13 mmol) 
in 750 mL CH3OH dropwise and the mixture were stirred for 4 days. After preparative 
TLC (SiO2, CH3CN: saturated aqueous KNO3: water 14:2:1), a purple powder of 
[{Fe(L12)}n][PF6]2n were obtained. However, from the proved of the NMR experiment, 
this fraction contains two components (A and B) although the ES-MS suggests it is 
[{Fe(L12)}][PF6]2.
[{Fe(L12)}n][PF6]2n (A:B = 1.09: 1)
1H NMR (500 MHz, CD3CN): ?H 3.70 (m, 4H, H(A)S4), 3.73 (m, 4H, H(B)S4), 3.80 (m, 4H, 
H(A)S3), 3.84 (m, 4H, H(B)S3), 4.05 (m, 4H, H(A)S2), 4.11 (m, 4H, H(B)S2), 4.47 (s, 4H, 
H(A)S5), 4.51 (s, 4H, H(B)S5), 4.86 (m, 4H, H(A)S1), 4.94 (m, 4H, H(B)S1), 6.67 (d, J 8.3 Hz, 
2H, H(B)N4, N8), 6.76 (d, J 8.2 Hz, 2H, H(A)N4, N8), 6.81 (ddd, J 1.3, 5.7, 7.5 Hz, 4H, H(B)T5), 
6.83 (s, 4H, H(A,B)N1, N5), 6.90 (ddd, J 0.7, 1.4, 5.6 Hz, 4H, H(B)T6), 6.96 (dd, J 1.5, 8.4 Hz, 
2H, H(A)N3, N7), 7.04 (dd, J 1.3, 8.4 Hz, 2H, H(B)N3, N7), 7.14 (ddd, J 1.0, 5.1, 7.6 Hz, 4H, 
H(A)T5), 7.49 (ddd, J 0.9, 1.6, 5.1 Hz, 4H, H(A)T6), 7.63 (ddd, J 1.5, 7.6, 8.0 Hz, 4H, H(B)T4),
7.93 (ddd, J 1.7, 7.6, 8.0 Hz, 4H, H(A)T4), 8.25 (ddd, J 0.8, 1.3, 8.0 Hz, 4H, H(B)T3), 8.33 (s, 
4H, H(A)T3?), 8.37 (dt, J 1.0, 8.1 Hz, 4H, H(A)T3), 8.62 (s, 4H, H(B)T3?).
MS (ES): m/z = 1027.2 [M-PF6]
+, 901.6 [M-PF6-PF5]
+, 441.7 [M-2PF6]
2+
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? [{Fe(L13)}n][PF6]2n
FeCl2·4H2O (20 mg, 0.10 mmol) in 20 mL CH3OH was added to L
13 (71 mg, 0.10 mmol) 
in 750 mL CH3OH dropwise and the mixture were stirred for 5 days. After preparative 
TLC (SiO2, CH3CN: saturated aqueous KNO3: water 14:2:1), a purple powder of 
[{Fe(L13)}2][PF6]4 (1 mg, 0.0005 mmol, 1%) and [{Fe(L
13)}3][PF6]6 (5 mg, 0.002 mmol, 
6%) were obtained. However, both fractions were not pure and contained a small amount 
of the other fractions. 
Fraction 1: [{Fe(L13)}2][PF6]4 (Rf value = 0.47)
Molecular formula: C88H68N12O8Fe2P4F24
Molecular weight: 2113.10 
1H NMR: the amount of material was too small for NMR investigation. 
MS (ES): m/z = 911.6 [M-2PF6]
2+, 828.3 [Fe+L+NO3]
+, 785.5 [Fe+L+F]+, 559.6 [M-
3PF6]
3+, 383.5 [M-4PF6]
4+.
Fraction 2: [{Fe(L13)}3][PF6]6 (Rf value = 0.45)
Molecular formula: 
C132H102N18O12Fe3P6F36 
Molecular weight: 3169.66 
1H NMR (400 MHz, CD3CN): ?H 4.71 (m, 12H, HS2), 5.03 (m, 12H, HS1), 7.02 (m, 12H, 
HT5), 7.13 (d, J 4.8 Hz, 12H, HT6), 7.16 (dd, J 2.6, 9.0 Hz, 6H, HN3, N6), 7.34 (d, J 2.0 Hz, 
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6H, HN1, N8), 7.80 (m, 18H, HT4 and HN4, N5), 8.36 (d, J 8.4 Hz, 12H, HT3), 8.47 (s, 12H, 
HT3?).
MS (ES): m/z = 1440.3 [M-2PF6]
2+, 911.4 [M-3PF6]
3+, 647.5 [M-4PF6]
4+, 489.1 [M-
5PF6]
5+, 383.6 [M-6PF6]
6+.
? [{Fe(L14)}][PF6]2
FeCl2·4H2O (19 mg, 0.09 mmol) in 20 mL CH3OH was added to L
14 (75 mg, 0.09 mmol) 
in 750 mL CH3OH dropwise and the mixture were stirred for 2 days. After column 
chromatography (SiO2, CH3CN: saturated aqueous KNO3: water 14:2:1), a purple powder 
of [{Fe(L14)}][PF6]2 (40.4 mg, 0.0353 mmol, 39.2%) was obtained as the major product. 
Molecular formula: C48H42N6O6FeP2F12 
Molecular weight: 1144.65 
1H NMR (500 MHz, CD3CN): ?H 3.79 (m, 6H, HS4a, HS4b and HS3b), 4.07 (m, 2H, HS3a), 
4.13 (m, 4H, HS2a and HS2b), 4.66 (dt, J 2.0, 13.9 Hz, 2H, HS1b), 4.86 (d, J 2.4 Hz 2H, HN1, 
N8), 5.38 (m, 2H, HS1a), 6.52 (ddd, J 1.3, 5.7, 7.5 Hz, 2H, HA5), 6.65 (ddd, J 0.7, 1.4, 5.6 
Hz, 2H, HA6), 6.85 (dd, J 2.5, 8.9 Hz, 2H, HN3, N6), 7.02 (ddd, J 1.3, 5.6, 7.5 Hz, 2H, HC5),
7.31 (td, J 1.5, 7.8 Hz, 2H, HA4), 7.35 (ddd, J 0.7, 1.4, 5.6 Hz, 2H, HC6), 7.53 (d, J 9.0 Hz, 
2H, HN4, N5), 7.84 (td, J 1.5, 7.8 Hz, 2H, HC4), 8.18 (d, J 7.8 Hz, 2H, HA3), 8.37 (dt, J 1.0, 
8.0 Hz, 2H, HC3), 8.41 (d, J 2.2 Hz, 2H, HB5), 8.82 (d, J 2.2 Hz, 2H, HB3).
MS (ES): m/z = 999.0 [M-PF6]
+, 873.5 [M-PF6-PF5]
+
.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-3) 233 (80.0 x 103), 269 (40.7 x 103), 314 (31.3 
x 103), 555 (9.30 x 103).
Elemental analysis: Found: C, 50.10; H, 3.71; N, 7.51. Calc. for C48H42N6O6P2F12Fe: C, 
50.36; H, 3.71; N, 7.34%. 
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? [{Fe(L15)}][PF6]2
FeCl2·4H2O (32 mg, 0.16 mmol) in 20 mL CH3OH was added to L
15 (0.14 g, 0.16 mmol) 
in 750 mL CH3OH dropwise and the mixture were stirred for 3 days. After column 
chromatography (SiO2, CH3CN: saturated aqueous KNO3: water 14:2:1), a purple powder 
of [{Fe(L15)}][PF6]2 (93.6 mg, 0.0759 mmol, 47.4%) was obtained as the major product. 
Molecular formula: C52H50N6O8FeP2F12 
Molecular weight: 1232.76 
1H NMR (500 MHz, CD3CN): ?H 3.56 (t, J 4.7 Hz, 4H, HS6), 3.76 (m, 4H, HS4), 3.82 (m, 
4H, HS5), 3.86 (m, 4H, HS3), 4.12 (m, 4H, HS2), 4.84 (m, 4H, HS1), 5.44 (d, J 2.4 Hz, 2H, 
HN1, N8), 6.87 (m, 6H, HT5 and HN3, N6), 7.07 (ddd, J 0.7, 1.3, 5.6 Hz, 4H, HT6), 7.59 (d, J
9.0 Hz, 4H, HN4, N5), 7.60 (td, J 1.5, 7.8 Hz, 4H, HT4), 8.23 (dt, J 0.9, 7.8 Hz, 4H, HT3),
8.51 (s, 4H, HT3?). 
MS (ES): m/z = 1086.9 [M-PF6]
+, 961.3 [M-PF6-PF5]
+, 553.3 [Fe+HO-Terpy+O-Terpy]+,
471.3 [M-2PF6]
2+, 227.4 [Fe+O-Terpy+O-Terpy]2+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-3) 232 (170 x 103), 269 (87.4 x 103), 313 (68.9 x 
103), 554 (20.3 x 103).
Elemental analysis: Found: C, 51.47; H, 4.24; N, 6.47. Calc. for C52H50N6O8P2F12Fe: C, 
50.66; H, 4.09; N, 6.82%. 
? [{Fe(L16)}3][PF6]6
FeCl2·4H2O (40 mg, 0.20 mmol) in 20 mL CH3OH was added to L
16 (0.14 g, 0.20 mmol) 
in 750 mL CH3OH dropwise and the mixture was stirred for 4 days. After column 
chromatography (SiO2, CH3CN: saturated aqueous KNO3: water 14:2:1), a purple powder 
of [{Fe(L16)}3][PF6]6 (80.9 mg, 0.0255 mmol, 38.3%) was obtained as the major product.  
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Molecular formula: 
C132H102N18O12Fe3P6F36 
Molecular weight: 3169.66
1H NMR (250 MHz, CD3CN): ?H 4.84 (br, 12H, HS2), 5.06 (br, 12H, HS1), 6.87 (t, J 6.5 
Hz, 12H, HT5), 7.12 (d, J 5.8 Hz, 12H, HT6), 7.46 (m, 6H, HN6, N7), 7.59 (s, 6H, HN1, N4), 
7.60 (m, 12H, HT4), 7.88 (m, 6H, HN5, N8), 8.35 (d, J 8.0 Hz, 12H, HT3), 8.54 (s, 12H, HT3?). 
MS (ES): m/z = 911.4 [M-3PF6]
3+, 647.5 [M-4PF6]
4+, 489.0 [M-5PF6]
5+, 383.4 [M-
6PF6]
6+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-3) 230 (143 x 103), 270 (103 x 103), 315 (84.2 x 
103), 560 (40.4 x 103).
Elemental analysis: Found: C, 43.79; H, 3.41; N, 6.87. Calc. for 
C132H102N18O12P6F36Fe·23H2O: C, 44.23; H, 4.17; N, 7.04%. 
? [{Fe(L17)}2][PF6]4
FeCl2·4H2O (40 mg, 0.20 mmol) in 20 mL CH3OH was added to L
17 (0.16 g, 0.20 mmol) 
in 750 mL CH3OH dropwise and the mixture were stirred for 4 days. After column 
chromatography (SiO2, CH3CN: saturated aqueous KNO3: water 14:2:1), a purple powder 
of [{Fe(L17)}2][PF6]4 (75 mg, 0.033 mmol, 33%) was obtained as the major product. 
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Molecular formula: 
C96H84N12O12Fe2P4F24
Molecular weight: 2289.31
1H NMR (500 MHz, CD3CN): ?H 4.14 (m, 8H, HS3), 4.21 (m, 8H, HS2), 4.42 (m, 8H, HS4), 
4.79 (m, 8H, HS1), 6.65 (m, 8H, HT5), 6.98 (dd, J 0.6, 5.6 Hz, 8H, HT6), 7.29 (m, 4H, HN6, 
N7), 7.33 (m, 8H, HT4), 7.35 (s, 4H, HN1, N4), 7.67 (m, 4H, HN5, N8), 8.19 (d, J 8.0 Hz, 8H, 
HT3), 8.41 (s, 8H, HT3?).
MS (ES): m/z = 617.9 [M-3PF6]
3+, 427.1 [M-4PF6]
4+.
UV/VIS (CH3CN): ?max/ nm (?max, M-1cm-3) 231 (111 x 103), 269 (57.9 x 103), 314 (40.7 x 
103), 553 (12.0 x 103).
Elemental analysis: Found: C, 41.55; H, 3.42; N, 6.14. Calc. for 
C96H84N12O12P4F24Fe2·2KPF6·6H2O: C, 41.69; H, 3.51; N, 6.08%. 
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Appendix I 
(a) Single X-ray crystallographic data of L
2
The cif file is provided in the attached CD. 
Crystal data 
Formula C19H19N3O3
Formula weight 337.38 
Crystal system Monoclinic 
Space group Cc (No. 9) 
a, b, c [Å] 10.5509(3), 22.5202(7), 7.2890(2) 
?, ?, ? [°] 90, 109.0636(16), 90 
V [Å3] 1636.94(8) 
Z 4 
D(calc) [gcm-3] 1.369 
µ (MoK?) [mm-1] 0.094
F(000) 712 
Crystal size [mm] 0.04 x 0.21 x 0.32 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoK?, 0.71073 
? Min (Max) [°] 4.9 (31.9) 
Total number of reflections 5652 
Number of unique reflections 2835 
R(int) 0.020 
Observed data [I > 2.0 ??(I)] 1970
Refinement 
Number of reflections  1970 
Number of parameters 227 
R 0.0502 
wR2 0.0580 
Goodness of fit (GOF) 1.06 
Max. and av. Shift/Error 0.00, 0.00 
Min. and max. residual electron Density [eÅ-3] -0.32, 0.67 
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(b) Single X-ray crystallographic data of [HL
9
]
+
Cl
-
·H2O
The cif file is provided in the attached CD. 
Crystal data 
Formula (C25H18N3S1)
+Cl-·H2O
Formula weight 445.97 
Crystal system Orthorhombic 
Space group Pca21 (No. 29) 
a, b, c [Å] 41.930(7), 5.1238(11), 9.745(4) 
?, ?, ? [°] 90, 90, 90 
V [Å3] 2093.6(10) 
Z 4 
D(calc) [gcm-3] 1.415 
µ (MoK?) [mm-1] 0.306
F(000) 928 
Crystal size [mm] 0.10 x 0.10 x 0.40 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoK?, 0.71073 
? Min (Max) [°] 4.5 (32.0) 
Total number of reflections 42258 
Number of unique reflections 7178 
R(int) 0.110 
Observed data [I > 2.0 ??(I)] 3301
Refinement 
Number of reflections  3301 
Number of parameters 352 
R 0.0405 
wR2 0.0394 
Goodness of fit (GOF) 1.03 
Max. and av. Shift/Error 0.01, 0.00 
Min. and max. residual electron Density [eÅ-3] -0.56, 0.58 
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Appendix II 
(a) Crystal structure of [Fe(L
4
)2][PF6]2·CH3CN 
The cif file is provided in the attached CD. 
Crystal data 
Formula C54H41F12Fe1N7O2P2
Formula weight 1165.74 
Crystal system Triclinic 
Space group P-1 (No. 2) 
a, b, c [Å] 12.640(2), 13.617(3), 14.744(2) 
?, ?, ? [°] 85.194(13), 85.942(11), 76.607(13) 
V [Å3] 2456.6(8) 
Z 2 
D(calc) [gcm-3] 1.576 
µ (MoK?) [mm-1] 0.470
F(000) 1188 
Crystal size [mm] 0.20 x 0.21 x 0.41 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoK?, 0.71073 
? Min (Max) [°] 4.1 (32.5) 
Total number of reflections 126877 
Number of unique reflections 17732 
R(int) 0.080 
Observed data [I > 2.0 ??(I)] 11423
Refinement 
Number of reflections  11423 
Number of parameters 703 
R 0.0347 
wR2 0.0362 
Goodness of fit (GOF) 1.08 
Max. and av. Shift/Error 0.00, 0.00 
Min. and max. residual electron Density [eÅ-3] -0.46, 0.51 
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(b) Crystal structure of [Ru(L
4
)2][PF6]2·CH3CN
The cif file is provided in the attached CD. 
Crystal data 
Formula C54H41F12N7O2P2Ru1
Formula weight 1210.96 
Crystal system Triclinic 
Space group P-1 (No. 2) 
a, b, c [Å] 12.5716(7), 13.6977(16), 14.845(2) 
?, ?, ? [°] 85.459(11), 86.045(7), 76.722(7) 
V [Å3] 2476.8(5) 
Z 2 
D(calc) [gcm-3] 1.624 
µ (MoK?) [mm-1] 0.479
F(000) 1224 
Crystal size [mm] 0.20 x 0.27 x 0.35 
Data Collection 
Temperature (K) 193 
Radiation [Å] MoK?, 0.71073 
? Min (Max) [°] 5.0 (30.0) 
Total number of reflections 62842 
Number of unique reflections 14311 
R(int) 0.070 
Observed data [I > 2.0 ??(I)] 9830
Refinement 
Number of reflections  9830 
Number of parameters 703 
R 0.0335 
wR2 0.0301 
Goodness of fit (GOF) 1.10 
Max. and av. Shift/Error 0.00, 0.00 
Min. and max. residual electron Density [eÅ-3] -0.47, 0.48 
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(c) Crystal structure of [Fe(L
5
)2][PF6]2
The cif file is provided in the attached CD. 
Crystal data 
Formula Fe1C56H46N6O4P2F12
Formula weight 1212.79 
Crystal system Monoclinic 
Space group P21/n (No. 14) 
a, b, c [Å] 16.897(3), 32.914(11), 18.693(11) 
?, ?, ? [°] 90, 85.16(2), 90 
V [Å3] 10359(7) 
Z 8 
D(calc) [gcm-3] 1.555 
µ (MoK?) [mm-1] 0.452
F(000) 4960 
Crystal size [mm] 0.10 x 0.22 x 0.27 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoK?, 0.71073 
? Min (Max) [°] 1.2 (24.0) 
Total number of reflections 64205 
Number of unique reflections 16197 
R(int) 0.110 
Observed data [I > 2.0 ??(I)] 8382
Refinement 
Number of reflections  8382 
Number of parameters 1459 
R 0.0800 
wR2 0.1149 
Goodness of fit (GOF) 1.06 
Max. and av. Shift/Error 0.00, 0.00 
Min. and max. residual electron Density [eÅ-3] -0.73, 1.04 
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(d) Crystal structure of [Ru(L
5
)2][PF6]2
The cif file is provided in the attached CD. 
Crystal data 
Formula C56H46F12N6O4P2Ru1
Formula weight 1258.01 
Crystal system Monoclinic 
Space group P21/n (No. 14) 
a, b, c [Å] 16.8109(3), 33.2255(11), 18.7663(5) 
?, ?, ? [°] 90, 93.5640(15), 90 
V [Å3] 10461.7(5) 
Z 8 
D(calc) [gcm-3] 1.597 
µ (MoK?) [mm-1] 0.459
F(000) 5104 
Crystal size [mm] 0.17 x 0.30 x 0.33 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoK?, 0.71073 
? Min (Max) [°] 1.2 (27.5) 
Total number of reflections 187884 
Number of unique reflections 24040 
R(int) 0.080 
Observed data [I > 2.0 ??(I)] 14204
Refinement 
Number of reflections  14204 
Number of parameters 1495 
R 0.0657 
wR2 0.0272 
Goodness of fit (GOF) 1.14 
Max. and av. Shift/Error 0.00, 0.00 
Min. and max. residual electron Density [eÅ-3] -0.89, 1.31 
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Appendix III 
(a) Crystal structure of [Co(L
4
)2][PF6]2
The cif file is provided in the attached CD. 
Crystal data 
Formula C52H38Co1F12N6O2P2
Formula weight 1127.77 
Crystal system Triclinic 
Space group P-1 (No. 2) 
a, b, c [Å] 8.6442(11), 14.5481(11), 19.3199(11) 
?, ?, ? [°] 94.776(6), 100.481(7), 92.586(9) 
V [Å3] 2376.3(4) 
Z 2 
D(calc) [gcm-3] 1.576 
µ (MoK?) [mm-1] 0.526
F(000) 1146 
Crystal size [mm] 0.07 x 0.11 x 0.53 
Data Collection 
Temperature (K) 193 
Radiation [Å] MoK?, 0.71073 
? Min (Max) [°] 3.0 (28.5) 
Total number of reflections 90328 
Number of unique reflections 12042 
R(int) 0.070 
Observed data [I > 2.0 ??(I)] 6690
Refinement 
Number of reflections  6690 
Number of parameters 679 
R 0.0540 
wR2 0.0673 
Goodness of fit (GOF) 1.10 
Max. and av. Shift/Error 0.00, 0.00 
Min. and max. residual electron Density [eÅ-3] -0.64, 0.94 
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(b) Crystal structure of [Co(L
8
)2][PF6]2·1¾CH3CN
The cif file is provided in the attached CD. 
Crystal data 
Formula C63.50H47.25Co1F12N7.75O2P2
Formula weight 1299.73 
Crystal system Monoclinic 
Space group P21/c (No. 14) 
a, b, c [Å] 14.3860(16), 16.9112(16), 23.923(2) 
?, ?, ? [°] 90, 91.326(8), 90 
V [Å3] 5819.5(10) 
Z 4 
D(calc) [gcm-3] 1.484 
µ (MoK?) [mm-1] 0.442
F(000) 2654 
Crystal size [mm] 0.08 x 0.10 x 0.27 
Data Collection 
Temperature (K) 193 
Radiation [Å] MoK?, 0.71073 
? Min (Max) [°] 3.1 (27.5) 
Total number of reflections 56031 
Number of unique reflections 13258 
R(int) 0.080 
Observed data [I > 2.0 ??(I)] 7122
Refinement 
Number of reflections  7122 
Number of parameters 803 
R 0.0822 
wR2 0.0888 
Goodness of fit (GOF) 1.02 
Max. and av. Shift/Error 0.05, 0.00 
Min. and max. residual electron Density [eÅ-3] -0.63, 0.67 
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Appendix IV 
(a) Crystal structure of L
14
The cif file is provided in the attached CD. 
Crystal data 
Formula C48H42N6O6
Formula weight 798.90 
Crystal system Monoclinic 
Space group P21/c (No. 14) 
a, b, c [Å] 24.985(3), 10.5259(6), 15.4926(19) 
?, ?, ? [°] 90, 104.514(9), 90 
V [Å3] 3944.4(7) 
Z 4 
D(calc) [gcm-3] 1.345 
µ (MoK?) [mm-1] 0.090
F(000) 1680 
Crystal size [mm] 0.08 x 0.10 x 0.24 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoK?, 0.71073 
? Min (Max) [°] 5.0 (26.2) 
Total number of reflections 60269 
Number of unique reflections 7914 
R(int) 0.070 
Observed data [I > 2.0 ??(I)] 4337
Refinement 
Number of reflections  4337 
Number of parameters 541 
R 0.0931 
wR2 0.0891 
Goodness of fit (GOF) 0.85 
Max. and av. Shift/Error 0.00, 0.00 
Min. and max. residual electron Density [eÅ-3] -0.45, 0.49 
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(b) Crystal structure of 2,7-di(2-hydroxyethoxy)naphthalene 
Crystal data 
Formula C14H16O4
Formula weight 248.28 
Crystal system Monoclinic 
Space group C2/c (No. 15) 
a, b, c [Å] 23.639(2), 11.4451(9), 9.1870(5) 
?, ?, ? [°] 90, 105.391(6), 90 
V [Å3] 2396.4(3) 
Z 8 
D(calc) [gcm-3] 1.376 
µ (MoK?) [mm-1] 0.100
F(000) 1056 
Crystal size [mm] 0.20 x 0.30 x 0.32 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoK?, 0.71073 
? Min (Max) [°] 4.2 (35.0) 
Total number of reflections 86650 
Number of unique reflections 5278 
R(int) 0.090 
Observed data [I > 2.0 ?(I)] 2690
Refinement 
Number of reflections  2690 
Number of parameters 168 
R 0.0415  
wR2 0.0451 
Goodness of fit (GOF) 1.02 
Max. and av. Shift/Error 0.01, 0.00 
Min. and max. residual electron Density [eÅ-3] -0.37, 0.44 
The cif file is provided in the attached CD. 
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Appendix V 
(a) Crystal structure of [{Ru(L
11
)}2][PF6]4·
4
⁄5(C2H5)2O·2CH3CN 
Crystal data 
Formula C51.60H48F12N8O4.40P2Ru1
Formula weight 1241.59 
Crystal system Monoclinic 
Space group P21/c (No. 14) 
a, b, c [Å] 14.9497(5), 11.6405(5), 30.8449(9) 
?, ?, ? [°] 90, 101.256(2), 90 
V [Å3] 5264.4(3) 
Z 4 
D(calc) [gcm-3] 1.566 
µ (MoK?) [mm-1] 0.456
F(000) 2523 
Crystal size [mm] 0.16 x 0.17 x 0.20 
Data Collection 
Temperature (K) 123 
Radiation [Å] MoK?, 0.71073 
? Min (Max) [°] 3.2 (27.5) 
Total number of reflections 65618 
Number of unique reflections 12056 
R(int) 0.120 
Observed data [I > 2.0 ?(I)] 7487
Refinement 
Number of reflections  7487 
Number of parameters 739 
R 0.0784 
wR2 0.0823 
Goodness of fit (GOF) 0.90 
Max. and av. Shift/Error 0.03, 0.00 
Min. and max. residual electron Density [eÅ-3] -0.73, 1.20 
The cif file is provided in the attached CD. 
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(b) Crystal structure of [{Fe(L
14
)}][PF6]2·(C2H5)2O·½CH3CN 
Crystal data 
Formula [FeC48H42N6O6]·2PF6·0.5(C4H10O)·CH
3CN 
Formula weight 1222.78 
Crystal system Triclinic 
Space group P-1, (No. 2) 
a, b, c [Å] 11.4241(11), 13.635(2), 18.271(2) 
?, ?, ? [°] 75.402(9), 87.442(9), 78.327(11) 
V [Å3] 2697.1(6) 
Z 2 
D(calc) [gcm-3] 1.506 
µ (MoK?) [mm-1] 0.438
F(000) 1254 
Crystal size [mm] 0.02 x 0.15 x 0.31 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoK?, 0.71073 
? Min (Max) [°] 4.1 (27.5) 
Total number of reflections 67536 
Number of unique reflections 12329 
R(int) 0.120 
Observed data [I > 2.0 ?(I)] 7800
Refinement 
Number of reflections  7800 
Number of parameters 820 
R 0.0610 
wR2 0.0665 
Goodness of fit (GOF) 1.11 
Max. and av. Shift/Error 0.01, 0.00 
Min. and max. residual electron Density [eÅ-3] -0.81, 0.72 
The cif file is provided in the attached CD. 
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(c) Crystal structure of [{Fe(L
15
)}][PF6]2·CH3CN 
Crystal data 
Formula [C52H50FeN6O8]·2PF6·C2H3N
Formula weight 1273.83 
Crystal system Monoclinic 
Space group P21/c (No. 14) 
a, b, c [Å] 18.2659(1), 14.8059(1), 20.5792(2) 
?, ?, ? [°] 90, 92.9257(5), 90 
V [Å3] 5558.25(7) 
Z 4 
D(calc) [gcm-3] 1.522 
µ (MoK?) [mm-1] 0.430
F(000) 2616 
Crystal size [mm] 0.12 x 0.27 x 0.30 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoK?, 0.71073 
? Min (Max) [°] 1.7 (28.7) 
Total number of reflections 54042 
Number of unique reflections 14324 
R(int) 0.048 
Observed data [I > 2.0 ?(I)] 8366
Refinement 
Number of reflections  8366 
Number of parameters 811 
R 0.0425 
wR2 0.0660 
Goodness of fit (GOF) 1.12 
Max. and av. Shift/Error 0.03, 0.00 
Min. and max. residual electron Density [eÅ-3] -0.46, 0.59 
The cif file is provided in the attached CD. 
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Appendix VI 
(a) Table of the 1H NMR spectroscopic data for the terpyridine, ethyleneoxy 
spacer and the naphthyl signals of the metallomacrocyclic complexes 
[{Ru(L)}n][PF6]2n (L = L
11, L13-L14, L14-L17, n = 1, 2 or 3). 
(b) Table of the 1H NMR spectroscopic data for the terpyridine signals of the 
metallomacrocyclic complexes [{Fe(L)}n][PF6]2n (L = L
11-L17, n = 1, 2 or 3). 
(c) Table of the 1H NMR spectroscopic data for the ethyleneoxy spacer and the 
naphthyl signals of the metallomacrocyclic complexes [{Fe(L)}n][PF6]2n (L = 
L
11-L17, n = 1, 2 or 3). 
(d) The ES-MS spectra of the metallomacrocyclic complexes [{Ru(L)}n][PF6]2n (L
= L11, L13-L14, L14-L17, n = 1, 2 or 3) and [{Fe(L)}n][PF6]2n (L = L
11-L17, n = 1, 
2 or 3). 
312 Proton resonance (?)
HT5 HT6 HT4 HT3? HT3 HS1 HS2 HS3 HS4 HN3, N7 HN4, N8 HN1, N5
[{Ru(L11)}2][PF6]4
(400) 6.97 (m) 
7.23 (d)
J 5.6 Hz 
7.74 (m) 8.32 (s) 8.33 (m) 4.72 (m) 4.00 (m) 4.75 (s)  
7.33 (dd)
J 1.0, 8.6 
Hz
7.51 (d) 
J 8.1 Hz 
7.74 (m) 
          HN1, N8 HN3, N6 HN4, N5
[{Ru(L13)}2][PF6]4
(400) 7.12 (m) 
7.44 (d)
J 5.2 Hz 
7.70 (td)
J 1.2, 7.8 
Hz
8.06 (s) 
8.19 (d)
J 8.0 Hz 
4.77 (m) 4.13 (m)   
6.68 (d) 
J 2.0 Hz 
7.12 (m) 
7.88(d) 
J 9.2 Hz 
[{Ru(L13)}3][PF6]6
(400) 7.12 (m) 
7.36 (d)
J 5.6 Hz 
7.81 (m) 8.32 (s) 
8.39 (d)
J 8.0 Hz 
4.94 (m) 4.65 (m)   
7.30 (d) 
J 2.4 Hz
7.12 (m) 7.81 (m) 
[{Ru(L14)}2][PF6]4
(500)
7.00
(ddd)
J 1.3, 
5.7, 7.5 
Hz
7.29 
(ddd)  
J 0.7, 
1.5, 5.6 
Hz
7.69 (td) 
J 1.5, 7.9 
Hz
8.28 (s) 8.27 (m) 4.72 (m) 4.12 (m) 3.98 (m)  4.06 (m) 
6.69 (d) 
J 2.4 Hz 
6.85 (dd)
J 2.5, 8.9 
Hz
7.39 (d) 
J 9.0 Hz 
          HN7, N6 HN1, N4 HN8, N5
[{Ru(L16)}2][PF6]4
(500) 6.77 (m) 
7.19 (dd)
J 0.7, 5.6 
Hz
7.26 (m) 8.36 (s) 
8.26 (d)
J 7.9 Hz 
5.02 (t) 
J 5.1 Hz 
4.79 (t) 
J 5.0 Hz 
  7.46 (m) 7.57 (s) 7.87 (m) 
[{Ru(L17)}2][PF6]4
(500)
6.73
(ddd)
J 1.3, 
5.6, 7.5 
Hz
7.22 
(ddd)  
J 0.6, 
1.4, 5.6 
Hz
7.42 (td) 
J 1.4, 7.8 
Hz
8.28 (s) 
8.26 (d)
J 7.8 Hz 
4.71 (t) 
J 4.5 Hz 
4.16 (m) 4.11 (m) 4.39 (m) 7.29 (m) 7.34 (s) 7.67 (m) 
J
J34 7.9 Hz; J45 7.7 Hz; J46 1.4 Hz; J53 1.3 Hz; J56 5.6 Hz; J63
0.7 Hz 
       
Table (a). The 1H NMR spectroscopic data for the terpyridine, ethyleneoxy spacer and the naphthyl signals of the metallomacrocyclic 
complexes [{Ru(L)}n][PF6]2n (L = L
11, L13-L14, L14-L17, n = 1, 2 or 3). 
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Table (b). The 1H NMR spectroscopic data for the terpyridine signals of the metallomacrocyclic complexes [{Fe(L)}n][PF6]2n (L = L
11-L17, n = 
1, 2 or 3).
Proton resonance (?)
HT5 HT6 HT4 HT3 HT3?
[{Fe(L11)}2][PF6]4
(500) 6.87 (ddd) 
J 1.3, 5.7, 7.4 Hz 
6.99 (ddd) 
J 0.7, 1.4, 5.6 Hz 
7.71 (m) 
8.29 (dt)  
J 0.9, 8.0 Hz 
8.47 (s) 
[{Fe(L12)}n][PF6]2n (A)
(500) 7.14 (ddd) 
J 1.0, 5.1, 7.6 Hz 
7.49 (ddd) 
J 0.9, 1.6, 5.1 Hz 
7.93 (ddd) 
J 1.7, 7.6, 8.0 Hz 
8.37 (dt) 
J 1.0, 8.1 Hz 
8.33 (s) 
[{Fe(L12)}n][PF6]2n (B)
(500) 6.81 (ddd) 
J 1.3, 5.7, 7.5 Hz 
6.90 (ddd) 
J 0.7, 1.4, 5.6 Hz 
7.63 (ddd) 
J 1.5, 7.6 8.0 Hz 
8.25 (ddd) 
J 0.8, 1.3, 8.0 Hz 
8.62 (s) 
[{Fe(L13)}2][PF6]4
(400)      
[{Fe(L13)}3][PF6]6
(400) 7.02 (m) 
7.13 (d) 
J 4.8 Hz 
7.80 (m) 
8.36 (d) 
J 8.4 Hz 
8.47 (s) 
[{Fe(L14)}][PF6]2
 (500)
6.52 (ddd)  
J 1.3, 5.7, 7.5 Hz 
and
7.02 (ddd) 
J 1.3, 5.6, 7.5 Hz 
6.65 (ddd)  
J 0.7, 1.4, 5.6 Hz 
and
7.35 (ddd)  
J 0.7, 1.4, 5.6 Hz 
7.31 (td)  
J 1.5, 7.8 Hz 
and 
7.84 (td)  
J 1.5, 7.8 Hz 
8.18 (d) 
J 7.8 Hz 
and
8.37 (dt)  
J 1.0, 8.0 Hz 
8.41 (d)  
J 2.2 Hz 
and
8.82  
J 2.2 Hz (d) 
[{Fe(L15)}][PF6]2
 (500) 6.87 (m) 
7.07 (ddd)  
J 0.7, 1.3, 5.6 Hz 
7.60 (td)  
J 1.5, 7.8 Hz 
8.23 (dt)  
J 0.9, 7.8 Hz 
8.51 (s) 
[{Fe(L16)}2][PF6]4
(250) 6.87 (t)  
J 6.5 Hz 
7.12 (d) 
J 5.8 Hz 
7.60 (m) 
8.35 (d) 
J 8.0 Hz 
8.54 (s) 
[{Fe(L17)}2][PF6]4
(500) 6.65 (m) 
6.98 (dd)  
J 0.6, 5.6 Hz 
7.33 (m) 
8.19 (d) 
J 8.0 Hz 
8.41 (s) 
J J34 7.9 Hz; J45 7.7 Hz; J46 1.4 Hz; J53 1.3 Hz; J56 5.6 Hz; J63 0.7 Hz 
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Table (c). The 1H NMR spectroscopic data for the ethyleneoxy spacer and the naphthyl signals of the metallomacrocyclic complexes 
[{Fe(L)}n][PF6]2n (L = L
11-L17, n = 1, 2 or 3). 
Proton resonance (?)
HS1 HS2 HS3 HS4 HS5 HS6 HN3, N7 HN4, N8 HN1, N5
[{Fe(L11)}2][PF6]4
(500) 4.81 (m) 4.05 (m) 4.78 (s)    
7.34 (dd) 
J 1.3, 8.4 Hz 
7.47 (d) 
J 8.3 Hz 
7.72 (s) 
[{Fe(L12)}n][PF6]2n (A)
(500) 4.86 (m) 4.05 (m) 3.80 (m) 3.70 (m) 4.47 (s)  
6.96 (dd) 
J 1.5, 8.4 Hz 
6.76 (d) 
J 8.2 Hz 
6.83 (s) 
[{Fe(L12)}n][PF6]2n (B)
(500) 4.91 (m) 4.11 (m) 3.84 (m) 3.73 (m) 4.51 (s)  
7.04 (dd) 
J 1.3, 8.4 Hz 
6.67 (d) 
J 8.3 Hz 
6.83 (s) 
 HS1 HS2 HS3 HS4 HS5 HS6 HN1, N8 HN3, N6 HN4, N5
[{Fe(L13)}2][PF6]4
(400)          
[{Fe(L13)}3][PF6]6
(400) 5.03 (m) 4.71 (m)     
7.34 (d) 
J 2.0 Hz
7.16 (m) 7.80 (m) 
[{Fe(L14)}][PF6]2
 (500)
4.66 (dt)  
J 2.0, 13.9 
Hz and 5.38 
(m)
4.13 (m) 
3.79 and 4.07 
(m)
3.79 (m)   
4.86 (d) 
J 2.4 Hz 
6.85 (dd) 
J 2.5, 8.9 Hz 
7.53 (d) 
J 9.0 Hz 
[{Fe(L15)}][PF6]2
 (500) 4.84 (m) 4.12 (m) 3.86 (m) 3.76 (m) 3.82 (m) 
3.56 (t) 
J 4.7 Hz 
5.44 (d) 
J 2.4 Hz 
6.87 (m) 
7.59 (d)  
J 9.0 Hz 
 HS1 HS2 HS3 HS4   HN7, N6 HN1, N4 HN8, N5
[{Fe(L16)}2][PF6]4
(250) 5.06 (br) 4.84 (br)     7.46 (m) 7.59 (s) 7.88 (m) 
[{Fe(L17)}2][PF6]4
(500) 4.79 (m) 4.21 (m) 4.14 (m) 4.42 (m)   7.29 (m) 7.35 (s) 7.67 (m) 
Appendix VI 
315
(d) The ES-MS spectra of the metallomacrocyclic complexes [{Ru(L)}n][PF6]2n (L = 
L
11, L13-L14, L14-L17, n = 1, 2 or 3) and [{Fe(L)}n][PF6]2n (L = L
11-L17, n = 1, 2 or 
3).
? The ES-MS spectrum of [{Ru(L11)}2][PF6]4
? The ES-MS spectrum of [{Ru(L13)}2][PF6]4
{[{Ru(L13)}2][PF6]2}
2+
{[{Ru(L13)}2][PF6]}
3+{[{Ru(L13)}2]}
4+
{[{Ru(L11)}2]}
4+
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? The ES-MS spectrum of [{Ru(L13)}3][PF6]6
? The ES-MS spectrum of [{Ru(L14)}2][PF6]4
{[{Ru(L14)}2]}
4+ {[{Ru(L14)}2][PF6]}
3+
{[{Ru(L14)}2][PF6]2}
2+
{[{Ru(L13)}3][PF6]3}
3+
{[{Ru(L13)}3][PF6]}
5+ {[{Fe(L13)}3][PF6]}
4+
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? The ES-MS spectrum of [{Ru(L16)}2][PF6]4
? The ES-MS spectrum of [{Ru(L17)}2][PF6]4
{[{Ru(L16)}2]}
4+ {[{Ru(L16)}2][PF6]}
3+
{[{Ru(L16)}2][PF6]2}
2+
{[{Ru(L17)}2]}
4+
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? The ES-MS spectrum of [{Fe(L11)}2][PF6]4
? The ES-MS spectrum of [{Fe(L12)}n][PF6]2n
{[{Fe(L11)}2][PF6]}
3+ {[{Fe(L11)}2]}
4+
{[{Fe(L12)}]F}+{[{Fe(L12)}]}2+
{[{Fe(L12)}][PF6]}
+
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? The ES-MS spectrum of [{Fe(L13)}2][PF6]4
? The ES-MS spectrum of [{Fe(L13)}3][PF6]6
The insert spectra are shown in the next page. 
{[{Fe(L13)}2]}
4+
{[{Fe(L13)}2][PF6]}
3+ {[{Fe(L13)}2][PF6]2}
2+
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The insert spectra of [{Fe(L13)}3][PF6]6:
? The ES-MS spectrum of [{Fe(L14)}][PF6]2
{[{Fe(L14)}]F}2+ {[{Fe(L14)}][PF6]}
+
{[{Fe(L13)3}]}
6+ {[{Fe(L13)}3][PF6]}
5+ {[{Fe(L13)3}][PF6]2}
4+
{[{Fe(L13)}3][PF6]3}
3+ {[{Fe(L13)}3][PF6]4}
2+
{[{Fe(L14)}]F}+
{[{Fe(L14)}][PF6]}
+
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? The ES-MS spectrum of [{Fe(L15)}][PF6]2
The insert spectra are shown below. 
{[{Fe(L15)}]}2+
{[{Fe(L15)}]F}+ {[{Fe(L
15)}][PF6]}
 +
{[Fe(O-terpy)2]}
2+ {[Fe(O-terpy)(HO-terpy)]}+
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? The ES-MS spectrum of [{Fe(L16)}3][PF6]6
? The ES-MS spectrum of [{Fe(L17)}2][PF6]4
{[{Fe(L16)}3]}
6+
{[{Fe(L16)}3]
[PF6]}
5+
{[{Fe(L16)}3][PF6]2}
4+
{[{Fe(L16)}3]
[PF6]3}
3+
{[{Fe(L17)}2]}
4+
{[{Fe(L17)}2][PF6]}
3+
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